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Carbohydrates are a widely abundant class of biological compounds that play pivotal 
roles in medicine, cellular function and nutrition. Despite the ubiquity of carbohydrates in 
living systems, their efficient synthesis presents a significant challenge. Major reasons for this 
include the difficulties in controlling the stereochemistry of the glycosylation reaction and the 
laborious, time-consuming nature of oligosaccharide preparation. This thesis describes 
efforts to overcome these challenges through new technologies that expedite glycosylation 
reactions and subsequent product purification. 
 A library of glycosyl donors and acceptors was prepared. Using these substrates, a 
cooperative thiourea-Brønsted acid dual organocatalytic glycosylation strategy for the 
synthesis of 2-deoxyglycosides was probed. Experiments were performed to uncover 
mechanistic information about the organocatalytic reaction. Subsequently, a palladium 
catalysed glycosylation protocol for the preparation of 2-deoxyglycosides was developed. 
After optimisation of the model reaction, the tolerance of the method for various glycosyl 
acceptors was assessed through a substrate screen. Generally, high product yields were 
obtained with excellent α selectivity. A probable mechanism is discussed. 
 Continuous flow glycosylation reactions were then explored. Initially, a flow 
glycosylation protocol using a gold(I) catalyst was surveyed. Some promising results were 
discovered, however, the system proved inconsistent and ultimately unsuitable for the flow 
regime. Ionic liquid supported glycosylations in flow were then explored for the first time. 
After reaction optimisation, excellent yields of glycosylation product were obtained in just 15 
seconds residence time, with no requirement for column chromatography. Application of the 
optimal reaction conditions to several other glycosyl donors and acceptors proved challenging 
due to unexpected protecting group reactivity leading to side products and irreproducibility 
of results. Nonetheless, mixtures of β-1,2-glucans were successfully prepared using this 
method, whilst a novel glycosyl donor featuring an orthogonal carbonate protecting group 
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1.  Abbreviations 
Ac Acetyl M Molar 
AIBN Azobisisobutyronitrile MALDI Matrix Assisted Laser 
Desorption/Ionisation 
BINOL 1,1'-Bi-2-naphthol min Minutes 
Bn Benzyl MS Mass Spectrometry 
Boc tert-Butyloxycarbonyl ms Molecular sieves 
bpy 2,2’-Bipyridine nBu n-Butyl 
Bu Butyl NBS N-Bromosuccinimide 
Bz Benzoyl NCS N-Chlorosuccinimide 
13C Carbon-13 NIS N-Iodosuccinimide 
CAN Ceric ammonium nitrate NMR Nuclear Magnetic Resonance 
Cbz Benzyloxycarbonyl Nu Generic nucleophile 
DABCO 1,4-Diazabicyclo[2.2.2]octane P Promoter 
DBU 1,8-Diazabicyclo[5.4.0]undec-7-
ene 
PG Protecting group 








DMF Dimethylformamide R Generic residue 
DTBMP 2,6-Di-tert-butyl-4-
methylpyridine 
Rf Retention factor 
eq Equivalents RT Room temperature 
ESI Electrospray ionization s Seconds 
Fmoc 9-Fluorenylmethoxycarbonyl TBAF tert-Butylammonium fluoride 
1H Proton TBDMS tert-Butyldimethylsilyl 
h Hours TBDPS tert-Butyldiphenylsilyl 
HPLC High Performance Liquid 
Chromatography 
tBu tert-Butyl 
HRMS High Resolution Mass 
Spectrometry 
Tf Trifluoromethanesulfonyl 
ICROS Ionic Catch and Release 
Oligosaccharide Synthesis 
TFA Trifluoroacetic acid 
IDCP Iodonium dicollidine 
perchlorate 
THF Tetrahydrofuran 
IL Ionic Liquid TIPS Triisopropylsilyl 
iPr Isopropyl TLC Thin Layer Chromatography 
IR Infra-red TMS Trimethylsilyl 
L Ligand Tol para-Methylphenyl 
LA Lewis acid Troc 2,2,2-Trichlorethoxycarbonyl 
LED Light Emitting Diode Ts para-Toluenesulfonyl 
Lev Levulinyl X Generic group 
LG Leaving group   
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2.  Introduction 
 Section 2.1. of this introduction will outline the ubiquity and chemistry of 
carbohydrates and the individual monosaccharide subunits that comprise them, as well as 
contextualising carbohydrates and glycoscience through a brief examination of some of the 
biological and medicinal roles that carbohydrates play. Section 2.2. will then go on to examine 
the glycosylation reaction in which a glycosyl donor and acceptor are coupled, including the 
principles behind traditional routes to stereochemical control and some factors that affect 
reactivity of the coupling partners. In section 2.3. 2-deoxyglycosides will be introduced. 
Attention will be paid to glycals as glycosyl donors for 2-deoxyglycoside synthesis, then some 
existing routes to 2-deoxyglycosides will be outlined. In section 2.4. a modest examination of 
the applications of transition metal catalysis to the glycosylation reaction will be undertaken, 
including examples of 2-deoxyglycoside synthesis using transition metal catalysts. Conversely, 
section 2.5. will outline some organocatalytic glycosylation approaches. Section 2.6. will focus 
on shedding light upon the emerging scope for glycosylation through flow methodology by 
examining some recent literature reports, whilst section 2.7. will briefly study the use of ionic 
liquid tags as supports for the expedition of oligosaccharide synthesis. 
 Carbohydrates 
 Carbohydrates represent the most plentiful type of natural products on the planet, 
exhibiting immense structural diversity and myriad biological functionality.1-8 
Oligosaccharides have been established as being an essential component for various 
biological processes including inflammation, neural development, cell signalling, protein 
folding, fertilisation and embryogenesis.4 Moreover, complex naturally occurring glycans play 
a crucial role in the development and proliferation of various diseases, since carbohydrates 
are known to be involved in biological events such as immune response, bacterial adhesion, 
viral infection and cancer. These roles make carbohydrates valuable target compounds for 
the diagnosis, comprehension and treatment of disease.9-14  
 Carbohydrates are a group of natural products that are so named because the simplest 
carbohydrates have the empirical formula Cn(H2O)n, literally hydrates of carbon. However, 
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this empirical formula does not account for the wide variety of compounds encompassed 
within the broad terminology of “carbohydrate” that do not adhere to this formula. 
Monosaccharides are the simplest carbohydrate units from which all other carbohydrates are 
built. They may be joined into chains of two monosaccharides (disaccharides), roughly 3-10 
monosaccharides (oligosaccharides) or up to thousands of monosaccharides 
(polysaccharides) through glycosidic linkages. Monosaccharides take many forms but are 
generally variations on the theme of a 5 or 6-membered heterocyclic ring featuring an 
endocyclic oxygen atom (Figure 1). Each monosaccharide contains at least one carbonyl 
moiety and several hydroxyl groups, giving rich stereo- and regiochemical diversity to even 
simple carbohydrates. Furthermore, the word “carbohydrate” also describes chemicals 
derived from monosaccharides through transformations including reduction or oxidation of 
terminal carbonyl groups and molecules in which hydroxyl groups have been replaced with 
other functional groups including H atoms, amines, thiols and amides. 
 
Figure 1. The structures of two common monosaccharides: α-D-glucopyranose 1 and β-D-
ribofuranose 2, with carbon atoms numbered in the conventional manner. 
 In order to highlight the importance of carbohydrates and justify their study, one 
might look to some poignant examples that showcase their relevance. In the 14th century, the 
malady bubonic plague swept through Europe, killing an estimated 100 million people within 
just eight years, around half of the population of the continent at the time. The causative 
microbe responsible for this devastation is now known to be the bacteria Yersinia pestis.15, 16 
In the rare cases of plague that occur today, the first line of defence is generally the amino 
glycoside streptomycin 3 (Figure 2), a carbohydrate derived antibiotic that destroys bacteria 
through inhibition of protein synthesis.17 This is generally sufficient to prevent serious harm 
from the infection. One might consider the dire consequences of antibiotic resistance18 in 
bacterial strains in this light and reflect upon the implications of a lack of comprehension of 
the essential medicinal role of carbohydrates.  




Figure 2. Carbohydrate derived antibiotic streptomycin 3. 
 Another insidious ailment that is a major concern in the 21st century is cancer. In the 
U.K., 977 people are diagnosed with cancer every day, whilst 446 die from cancer each day.19 
Furthermore, half of the people born after 1960 are predicted to be diagnosed with some 
form of cancer in their lifetime.19 Thus, the requirement for effective therapeutics to treat 
cancer and prevent these fatalities is paramount. Here again, carbohydrates may offer 
opportunities to save lives through an appreciation of their biological significance and 
functional role. Several cancer treatment drugs feature a sugar moiety intrinsic to the 
function of the drug. Perhaps the most well-known example is doxorubicin 4 (Figure 3), an 
anthracycline that has been a staple chemotherapy agent for some 30 years.20 Moreover, 
carbohydrates may be used not only as drugs for cancer treatment, but also as cancer 
vaccines.21 For instance, the Globo-H cancer vaccine, originally developed for treatment of 
metastatic breast cancer but applicable to a number of different cancer types, contains an 
oligosaccharide moiety that encourages immunological response to cancerous cells.12 Whilst 
carbohydrate derivatives can be used as effective drugs,22 relatively few of the therapeutics 
currently available contain carbohydrate motifs, owing primarily to the pharmacokinetic 
disadvantages of these molecules.23 Orally administered carbohydrates suffer poor transit 
through the small intestine wall and are often rapidly excreted renally. Nonetheless, 
carbohydrates represent an under-explored source of new therapeutics. 




Figure 3. 2-Deoxyglycoside containing anticancer drug doxorubicin 4. 
 Carbohydrates are the products of photosynthesis and thus have a major role as a 
form of chemical energy storage, with billions of tons being produced by plants and 
cyanobacteria every year.8 The energy stored within carbohydrates forms perhaps the most 
important part of the biological food chain for many animals. Indeed, the role of carbohydrate 
foodstuffs with respect to nutrition, healthy diet and resultant disease prevention in humans 
is an area of ongoing research.24, 25 Carbohydrates serve further roles as both constituents of 
cell walls and as structural features in the supporting tissue of plants and animal shells.7 The 
carbohydrates expressed as part of the glycocalyx on the surface of human cells are used to 
regulate healthy cellular function.9 
 It should therefore be apparent that continued exploration of the function, prevalence 
and applications of carbohydrates is crucial. Whilst the research presented in this thesis 
comprises only a minute area of glycoscience, it is nonetheless important to recognise the 
purpose of these studies in a larger context and be mindful of the distant, lofty, but 
incrementally attainable goals and applications of this work. 
 Glycosylation 
 In order to study the role that carbohydrates play in biology, adequate quantities of 
pure, structurally defined carbohydrates must be prepared. For the synthetic glycoscientist, 
a key reaction is that of glycoside bond formation. Numerous glycosylation strategies exist 
that utilise a wide variety of glycosyl donors, acceptors, promoters and catalysts, both 
chemical26-36 and enzymatic.37-42 Despite each methodology having distinct advantages, at 
present there is no universal glycosylation strategy that can give access to all required 
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oligosaccharides with consistently high levels of stereoselectivity and efficiency. Hence, more 
advanced protocols for glycosylation are imperative in order to prepare the carbohydrates 
found in nature on a reasonable scale and with high purity and thus advance our 
comprehension of carbohydrate function. 
 Glycosylation is the name given to the process by which a carbohydrate (the glycosyl 
donor) is linked to a functional group, often a hydroxyl group, of another molecule (the 
glycosyl acceptor).4 Whilst nature has evolved enzymes that catalyse glycosylations with 
excellent stereo- and regiochemical control, the substrate scope of enzymatic glycosylations 
can be quite limited owing to the specific conformational requirements of the enzyme active 
site. An alternative is chemical glycosylation, in which the reaction conditions are much less 
specific to particular reactants, but control of the stereo- and regiochemistry during the 
reaction is often challenging. Consider the general glycosylation shown in Scheme 1.  
 
Scheme 1. Scheme showing the standard strategy for a chemical glycosylation and the problem of 
stereochemistry at the anomeric carbon (C-1). 
General electrophilic glycosyl donor 5 forms a donor-promoter complex 6 upon 
reaction with a promoter reagent, which then undergoes loss of the leaving group (LG), to 
irreversibly generate cationic oxocarbenium ion 7. Recent studies by Blériot43 and co-workers 
have proven  by NMR spectroscopy the existence of the highly reactive oxocarbenium ion in 
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a condensed phase by stabilising it under super-acidic conditions. This would imply that 
glycosylation reactions advance via a unimolecular SN1 mechanism. However, chemical 
glycosylations are usually performed under much milder conditions than those used by Blériot 
and co-workers and hence it is impossible to confidently discount an SN2 or SN2-like 
mechanism.44-46 Furthermore, the tendency for the reaction to progress through an SN1 or 
SN2 type mechanism will be influenced by the complex specific reaction conditions, with 
variables including glycosyl donor and acceptor, promoter/catalyst, additives, reaction 
temperature and solvent affecting the mechanism, making a clear distinction between SN1 
and SN2 type mechanisms difficult. Nonetheless, today it is generally assumed that 
glycosylation reactions prefer to progress via an SN1 type mechanism.45 
The nucleophilic glycosyl acceptor Nu may attack on either the “top” face (blue 
pathway) or “bottom” face (red pathway) of oxocarbenium ion 7 to generate a glycosidic 
bond. These two pathways lead to two diastereomers, the equatorial anomer 8 and axial 
anomer 9. For all sugars in the D-series the axial anomer is designated the α anomer, whilst 
the equatorial anomer is designated β by convention. These two diastereomeric species will 
tend to exhibit different behaviour in biological systems and can be very difficult to separate 
by conventional chemical purification methods such as chromatography, trituration or 
recrystallisation. Thus, successful glycosylation approaches will favour the formation of one 
anomer over the other, ideally forming a single anomer exclusively. Note that protecting 
groups must generally be installed on all free nucleophilic functional groups on the glycosyl 
donor (and acceptor if applicable), otherwise any free nucleophile may act as the glycosyl 
acceptor, leading to a complex mixture of products. Over the years, a great many 
glycosylation strategies have been developed to meet the challenge of stereoselectivity 
during glycosylation.30, 32, 34, 47, 48 
A key factor dictating the stereochemical outcome of the glycosylation reaction is the 
anomeric effect. This effect describes the higher than expected tendency for formation of the 
axial anomer in glycosylations. Generally, substituents on a cyclohexane derivative in a chair 
conformation prefer to adopt an equatorial position to minimise steric repulsion. The 
anomeric effect states that when the anomeric substituent is a polar group, for instance an 
alkoxy group or a halide, there is a thermodynamic preference for the axial rather than 
equatorial configuration, despite the unfavourable 1,3-diaxial steric repulsions this atomic 
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configuration experiences. Note that more specifically, this effect is known as the endo 
anomeric effect, not to be confused with the gauche effect (sometimes called the exo 
anomeric effect). 
Various explanations have been put forward to explain the anomeric effect (Figure 
4).8, 32 The first proposal (A) concerns the dipole moment of the endocyclic oxygen lone pairs 
and the dipole moment of the anomeric C-X bond, where X is an electronegative atom. In the 
equatorial β anomer the dipole moment that points along the C-X bond partially aligns with 
the O lone pair dipole moment, causing a repulsive destabilisation. Conversely, in the axial α 
anomer, the C-X bond dipole moment points away from the O lone pair dipole moment, 
partially neutralising the two dipoles and thus stabilising this configuration. Scenario B shows 
a very similar theory; however, this proposal suggests that it is the dipole moment caused by 
the lone pairs on atom X, rather than the C-X bond, that is responsible for the anomeric effect. 
The relative weighting of contribution to the dipole moment between the C-X bond and the 
X lone pairs likely depends upon the identity of atom X, amongst other factors. Perhaps the 
most convincing explanation is the stereoelectronic effect that molecular orbital theory 
describes (C). In the case of the axial anomer, the non-bonding lone pair n orbital on the 
endocyclic O atom can overlap with the C-X σ* antibonding orbital. This hyperconjugation 
allows delocalisation of the non-bonding electrons and hence lowers their energy. In the case 
of the equatorial anomer, such orbital overlap is not possible, since the n and σ* orbitals do 
not have the required antiperiplanar relationship. This explanation is further strengthened by 
the observation of a shorter endocyclic O-C1 bond and longer C1-X bond in the axial anomer, 
but not the equatorial anomer.8  




Figure 4. Different proposed explanations for the anomeric effect. A. Partial dipole moments of the 
endocyclic O atom lone pairs and C-X bond. B. Partial dipole moments of the endocyclic O atom lone 
pairs and X lone pairs. C. Hyperconjugation allows delocalisation of O non-bonding electrons into C-
X σ* orbital in the axial anomer but not the equatorial anomer. 
 Synthesis of 1,2-trans glycosides can be accomplished using neighbouring group 
participation, otherwise known as anchimeric assistance. This involves the use of a C-2 
protecting group that can react intramolecularly with an oxocarbenium ion. This protecting 
group will generally be an ester, or in the case of 2-amino saccharides, an amide or carbamate. 
A general synthesis of a 1,2-trans glycoside is shown in Scheme 2. O-2 ester protected 
oxocarbenium ion 10 is formed by loss of a leaving group as in Scheme 1. However, the ester 
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group can spontaneously form dioxolenium ion 11 by formation of a 5 membered ring, thus 
blocking the cis face of the sugar ring. The attacking glycosyl acceptor alcohol R’OH is then 
restricted to attack at the trans face, forming 1,2-trans glycoside 12 as product. 
 
Scheme 2. Neighbouring group participation as a strategy in 1,2-trans glycosylation. 
 The synthesis of 1,2-cis glycosides presents a greater challenge, although there are 
now a multitude of approaches available.36 One of the first successful approaches was the “in 
situ anomerisation” strategy developed by Lemieux,49 in which an α-halo glycosyl donor 13 is 
anomerised to the more reactive β-halo glycosyl donor 14 in situ using a tetraalkylammonium 
halide salt, NR4X. Fast reaction of the β-halo glycosyl donor with an acceptor in an SN2 type 
mechanism furnishes the 1,2-cis glycoside 15 (Scheme 3). 
 
Scheme 3. The principles underlying 1,2-cis glycosylation by in situ anomerisation. 
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 Other approaches include neighbouring group participation using a chiral auxiliary as 
the C-2 protecting group as demonstrated by Boons and co-workers (Scheme 4).31 Activation 
of trichloroacetimidate donor 16 creates short-lived trans-decalin type β-sulfonium structure 
17, blocking the trans face from attack. The incoming nucleophile is forced to approach from 
the α face, giving the α 1,2-cis glycoside 18 selectively.  
 
Scheme 4. Formation of β trans-decalin structure 17 blocks attack of a glycosyl acceptor on the β 
face, encouraging α selectivity to give a 1,2-cis glycoside. 
Additionally, temperature and solvent choice can affect selectivity, with ethereal 
solvents participating to favour 1,2-cis glycosides.47 One may also exploit hydrogen bond 
mediated aglycone delivery, metal coordination or indirect glycosylation as strategies to 
facilitate preparation of 1,2-cis glycosides.36 
 Protecting Group Influence on Glycosyl Donor Reactivity 
 Research has uncovered stark differences in glycosyl donor reactivity dependent upon 
the protecting groups chosen to protect the hydroxyl substituents around the 
monosaccharide ring.50-57 A key concept when considering donor reactivity is the “armed-
disarmed” model as coined by Fraser-Reid,51 which explains the reactivity differences 
between donors bearing electron withdrawing protecting groups such as esters, and those 
bearing more electron donating protecting groups like ethers. Several years later, Wong and 
co-workers experimentally determined relative reactivity values (RRVs) for a wide range of 
 2.  Introduction  
12 
 
differently protected thioglycoside donors that amply demonstrate the armed-disarmed 
concept in one-pot glycosylation strategies.57 A number of the glucose derived donors they 
studied are shown in Figure 5 along with the relative reactivity value for glycosylation with 
methanol shown in parentheses, where a higher value denotes greater reactivity. 
 
Figure 5. Relative reactivity values for the glycosylation of some glucose derived STol donors as 
determined by Wong and co-workers.57 
 Disarmed donors bearing acetyl or benzoyl protecting groups such as 19 and 20 have 
the lowest reactivity values. Removing an ester functionality and replacing it with a hydroxyl 
group as in 21 gives a modest increase in reactivity. The presence of a less electron 
withdrawing carbamate protecting group at C-2 as in donors 22 and 23 gives a much greater 
increase in reactivity value. Finally looking to armed donor 24 bearing benzyl ether protecting 
groups, we see a dramatically higher reactivity value.  
 This armed-disarmed concept can be explained by considering that electron 
withdrawing groups will destabilise the oxocarbenium ion formed during a glycosylation 
reaction by inductively withdrawing electron density from the anomeric carbon atom and 
increasing the magnitude of positive charge at the atom. This effect decreases the reactivity 
of disarmed donors during glycosylation reactions. Conversely, electron donating groups 
cause electron density to accumulate at the anomeric carbon atom of the oxocarbenium ion, 
thus stabilising it and increasing the reactivity of armed donors. As shown in Figure 5, varying 
the identity and position of the protecting groups can change the reactivity of the donor along 
the armed-disarmed spectrum. By carefully selecting orthogonally protected donors along 
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the armed-disarmed spectrum, it is possible to facilitate sequential glycosylations and thus 
construct oligosaccharides in one-pot by exploiting the differing reactivities of the donors. 
 Building further on this concept, Bols and co-workers were able to develop a “super-
armed” donor that surpasses the reactivity of other armed donors.55 With the observation 
that axial polar substituents are less electron withdrawing than the same substituents in an 
equatorial position,58 the researchers used bulky TBDMS protecting groups to sterically 
induce a conformational change in their glucose-derived donor 25. Whilst the usual 
energetically preferred conformation for glucose derivatives is a chair, the researchers show 
that donor 25 adopts a twist-boat conformation in which the TBDMS groups are axially 
positioned. A competition glycosylation experiment (Scheme 5) in which donor 25 and armed 
donor 26 were put into one pot along with glycosyl acceptor 27 was performed to assess the 
reactivity of donor 25. Disaccharide 28, obtained by reaction of donor 25 with the acceptor 
formed in 75 % yield, confirming the higher reactivity of super-armed donor 25 over armed 
donor 26. The authors attribute the reactivity to stabilisation of the intermediate 
oxocarbenium ion formed from donor 25 owing to the axially positioned TBDMS groups that 
are less electron withdrawing than equatorially orientated groups.  
 Demchenko and co-workers developed an alternative approach to super-armed 
donors.52, 53 By combining an ester protecting group at C-2 that is capable of neighbouring 
group participation with electron donating benzyl ether groups at C-3, C-4 and C-6, the donor 
can be electronically super-armed. This was exemplified in the synthesis of super-armed 
donor 29 (Figure 6). Competition glycosylation experiments similar to those performed by 
Bols and co-workers demonstrated the enhanced reactivity of donor 29 over armed donors. 
Further work by Demchenko and Bols50 combined both conformational and electronic super-
arming strategies and incorporated them into a single donor 30 (Figure 6). They determined 
that conformational super-arming was more powerful than electronic super-arming when 
attempting to increase donor reactivity, since donor 30 was more reactive than donor 29, but 
less so than donor 25. However, the benzoyl group at C-2 in donor 30 allowed for complete 
stereocontrol during glycosylation, whereas donor 25 did not allow this level of selectivity. 




Scheme 5. Sterically super-armed donor 25 undergoes glycosylation preferentially to armed donor 
26 in a competition experiment conducted by Bols and co-workers.55 
  
Figure 6. Electronically super-armed donor 29 and combined conformationally and electronically 
super-armed donor 30. 
Conformational restraints are also able to disarm donors. Commonly used acetal 
protecting groups, in particular 4,6-O-acetals, have been shown to decrease reactivity of the 
glycosyl donor through a combination of torsional and electronic destabilisation of the 
oxocarbenium ion.59-61 
 The content of this thesis concerns the investigation of novel, expedient and 
stereoselective glycosylation strategies that may be grouped into two categories – improved 
methods for stereoselective synthesis of 2-deoxyglycosides catalysed by transition metals and 
organocatalysts, and expediting glycosylation using chromatography-free ionic liquid 
supported synthesis under continuous flow conditions. Each of these research areas will be 
briefly evaluated through a concise survey of recent examples in the literature. 




 2-Deoxyglycosides constitute a particular class of carbohydrates that have been the 
challenging subject of recent synthetic attention. 2-Deoxyglycosides are monosaccharides in 
which no C-2 oxygen atom is present, instead two hydrogen atoms are bonded to C-2. They 
are frequently featured in biologically active natural products and drug compounds,62-64 
including the glycopeptide antibiotic vancomycin,64 the enediyne antibiotic calicheamicin γI165 
and the anticancer drug aclarubicin66 (Figure 7). Elucidation of the biological interactions of 
2-deoxyglycoside containing compounds such as mithramycin67 and apoptolidin68 reveal the 
2-deoxyglycoside functionality to be essential for the bioactivity of the compound. Thus, 
methods for the efficient construction of 2-deoxyglycosides are highly desirable.  
 
Figure 7. Structures of vancomycin, calicheamicin γI1 and aclarubicin.8 
 In the absence of a directing group at C-2, stereoselective chemical glycosylation of 2-
deoxyglycosides can be challenging. Generally, α substitution is observed predominantly due 
 2.  Introduction  
16 
 
to the anomeric effect but mixtures of anomers are common. Furthermore, 2-
deoxyglycosides have shown greater susceptibility to hydrolysis than their fully oxygenated 
counterparts, making their handling difficult.69 This results from the increased electron 
density at the anomeric carbon due to the lack of an inductively electron withdrawing oxygen 
atom at the C-2 position, which in turn stabilises the oxocarbenium ion formed upon 
departure of a leaving group relative to 2-oxyglycosides. In spite of these obstacles, significant 
progress has been made in the field of 2-deoxyglycoside synthesis.70-72 This section will give 
an introduction to glycals and their roles in 2-deoxyglycoside synthesis, followed by some of 
the key avenues to 2-deoxyglycosides that exist in the literature. 
 Glycals 
 Glycals are 1,2-unsaturated monosaccharide derivatives that serve as useful building 
blocks in carbohydrate chemistry.73 The traditional route to glycals such as D-glucal involves 
treatment of a peracetylated glycosyl bromide with zinc and acetic acid.5 In the example 
reaction shown in Scheme 6 acetobromo-α-D-glucose is transformed into 3,4,6-tri-O-acetyl-
D-glucal 31. The harsh reaction conditions shown in Scheme 6 are unsuitable for some 
substrates, however, many alternative reducing conditions are available, including Zn/Ag on 
graphite or lithium in liquid ammonia. In practice, preparation of glycals in a research 
laboratory is uncommon, since many are commercially available. 
 
Scheme 6. Treatment of peracetylated α-bromo-glucose with zinc/acetic acid furnishes 3,4,6-tri-O-
acetyl-D-glucal 31. 
 Glycals can undergo a number of reactions including electrophilic addition, 
rearrangement and cycloadditions, with their reactivity being dictated by the enol ether 
functionality common to all glycals. The highly polarised C=C double bond imparts significant 
regioselectivity in addition reactions (Figure 8).  




Figure 8. Delocalisation of charge in glycals allows highly selective addition reactions. 
 Due to the partial negative charge at C-2, electrophiles such as halogens or peroxides 
tend to add at this position, leaving the anomeric carbon susceptible to nucleophilic attack. 
In the context of glycosylation, this nucleophile may be a glycosyl acceptor. This reactivity 
makes glycals well-suited as glycosyl donors in the synthesis of 2-deoxyglycosides.  
Another well documented reaction of glycals is that of the Lewis acid catalysed allylic 
Ferrier rearrangement.74, 75 In this reaction, Lewis acid catalysis induces a shift in the position 
of the unsaturated C=C bond from 1,2-unsaturation to 2,3-unsaturation, with concomitant 
loss of a leaving group at C-3 as shown in Scheme 7 with peracetylated glucal 31. Nucleophilic 
attack at the anomeric carbon by a nucleophile creates a new glycosidic bond and furnishes 
a hex-2-enopyranoside as product. It should be noted that the leaving group at C-3 has the 
potential to act as a nucleophile itself. The Ferrier rearrangement can be a versatile 
transformation, but it may also be an inconvenient side reaction when the intention is to 
prepare a 2-deoxyglycoside from a glycal donor. 
 
Scheme 7. Lewis acid catalysed Ferrier rearrangement of glycals furnishes hex-2-enopyranosides.  
 2-Deoxyglycoside Syntheses 
 The lack of a directing group at C-2 is a major hurdle for the stereochemical control of 
2-deoxyglycoside glycosylations. An approach that circumvents this problem is to use a 
substrate featuring a C-2 group that can engage in neighbouring group participation to install 
a glycosyl acceptor stereoselectively, then cleave the C-2 group to afford the 2-
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deoxyglycoside once the glycosidic bond has been formed. This approach is known as an 
indirect synthesis. The alternative is to try to induce stereoselectivity from the stereochemical 
information inherent in the donor, acceptor or catalyst in a strategy known as direct synthesis. 
2.3.2.1.  Indirect Syntheses 
 One of the oldest syntheses treats a glycal with an electrophilic iodine source to give 
an intermediary iodonium ion that may be ring opened by a glycosyl acceptor.76-78 Scheme 8 
shows a general preparation using this protocol. General glycal 32 is treated with an 
electrophilic iodine source such as NIS or iodinium-(di-sym-collidine) perchlorate (IDCP) to 
give iodonium ion 33. The 3-membered ring will usually form on the β face of the sugar ring, 
with the C-1-I bond pseudoequatorial. This can be rationalised by the so-called reverse 
anomeric effect. This effect describes the tendency for positively charged heteroatoms 
bonded to the anomeric carbon to prefer an equatorial configuration for electrostatic 
reasons. However, the validity of the reverse anomeric effect is seriously doubted, since most 
substrates that show this behaviour are sterically large, and therefore the “effect” may be 
explained by considering steric repulsions alone.  
The incoming alcohol nucleophile must attack on the α face of iodonium ion 33 due 
to the steric bulk of the iodine atom making attack at the β face prohibitively high in energy. 
Ring opening of 33 by the alcohol gives 2-deoxy-2-iodoglycoside 34. Reductive cleavage of the 
iodine atom may be accomplished with either catalytic hydrogenation or radical reduction 
with reagents such as AIBN or tributyltin hydride to give 2-deoxy-α-glycoside 35. 
 
Scheme 8. General procedure for 2-deoxyglycoside synthesis via an iodonium intermediate. 
 Synthesis of 2-deoxy-β-glycosides tends to be more challenging than α anomers, since 
the anomeric effect must be overcome to bias formation of the β anomer. One strategy 
reported by Beau and co-workers79 uses a two-step approach with the directing effect of a 
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1,2-episelenonium ion dictating glycosidic bond stereochemistry. Scheme 9 shows an 
example of the approach. Tri-O-benzyl-D-glucal 36 is treated with phenylselenyl chloride and 
then silver acetate is added to the reaction mixture. An equilibrium is established between 
glucal 36 and glycosidically pseudoaxial 1,2-episelenonium ion 37 and pseudoequatorial 1,2-
episelenonium ion 38. These ions are then trapped by the acetate anion acting as a 
nucleophile, attacking on the opposite face of the sugar ring to the phenylselenyl group for 
the same steric reasons as described above with iodonium ions. This furnishes separable 1,2-
trans acetoxy-selenides 39 and 40, with high selectivity for glucose derived β compound 39. 
The authors note that biasing the selectivity of the reaction towards the glucose derived β 
compound is difficult, being sensitive to protecting groups, solvent and additives chosen. 
 Glycosylation of β 1,2-trans acetoxy-selenide 39 with glycosyl acceptor 41 using 
TMSOTf as promoter gives a mixture of disaccharides 42 and 43 in very high yield, with a 
strong preference for glucose type β anomer 42 over α anomer 43. Interestingly, a small 
amount of mannose type α anomer 43 is formed, despite the glycosyl donor being purely 
glucose type, thus the orientation of the C-2-Se bond changes during the reaction. The 
researchers suggest that such a configurational change occurs through re-establishment of 
the equilibrium from the first reaction, with formation of glucal 36 scrambling 
stereochemistry. However, since the product of the reaction is biased so heavily towards β 
anomer 42, it can be assumed that the amount of phenylselenyl isomerisation is small under 
these specific reaction conditions. Finally, treatment of 42 with triphenyltin hydride in 
refluxing toluene furnished 2-deoxy-β-glycoside 44β quantitatively. 




Scheme 9. Strategy reported by Beau and co-workers for accessing 2-deoxy-β-glycosides via a 1,2-
trans acetoxy-selenide intermediate. 
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 A more recent example of indirect 2-deoxyglycoside synthesis developed by Castillón 
and co-workers80 utilises furanose precursors with a free hemiacetal group as starting 
materials. Wittig-Horner olefination gives alkenyl sulfanyl derivatives, then electrophilic 
iodinium-mediated cyclisation forms phenyl 2-deoxy-2-iodo-1-thio-hexo-glycosides. 
Subsequent glycosylation of the thioglycoside donors gives 2-deoxy-2-iodo glycosides in good 
yields and selectivities. Scheme 10 shows an example of the multi-step strategy. 
 
Scheme 10. Transformation of 2,3,5-tri-O-benzyl-D-xylose 45 into 2-deoxy-2-iodo-O-glycoside 48 via 
alkenyl sulfanyl intermediate 46 and 2-deoxy-2-iodo-1-thio-D-gulose 47.71, 80 
 Xylose 45 undergoes a Wittig-Horner olefination using diphenyl phenylsulfanylmethyl 
phosphine oxide to give alkenyl sulfanyl intermediate 46 in 60 % yield as an inseparable Z:E 
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mixture. Treatment of 46 with IDCP forms an iodonium ion and induces ring closure to give 
gulose 47 in 77 % yield and good β selectivity. Several examples of different 2-deoxy-2-iodo-
1-thioglycosides were synthesised. In each case, a 6-endo cyclisation occurred with the C-2-I 
bond exhibiting a cis relationship with the C-3 substituent almost exclusively. Glycosylation of 
thioglycoside 47 with cholesterol as the glycosyl acceptor using NIS/TfOH as promoters 
furnished O-glycoside 48 in 66 % yield and 1:8 α:β selectivity. Glycosylation selectivities using 
cholesterol as the glycosyl acceptor ranged from 1:8 to 1:37 in favour of a 1,2-trans 
relationship between the C-1-O bond and the C-2-I bond.  
 The Castillón group went on to develop the system into a one-pot electrophile-
induced cyclisation-glycosylation, shown in Scheme 11.81 Alkenyl sulfanyl species 49 was 
treated with an excess of N-iodosuccinimide to firstly induce ring closure, then subsequent 
addition of triflic acid activated the thiophenyl leaving group. Departure of the leaving group 
and addition of glycosyl acceptor cholesterol gives 2-deoxy-2-iodoglycoside 50 in 54 % yield 
and very high α selectivity in accordance with the previously observed propensity for 1,2-
trans glycosylation in this system. Radical mediated dehalogenation furnished 2-
deoxyglycoside 51 in 75 % yield. 
 
Scheme 11. One-pot cyclisation-glycosylation procedure leading to 2-deoxyglycoside 51.81 
 Whilst indirect 2-deoxyglycoside preparations are able to impart very good selectivity 
in both 1,2-trans and 1,2-cis fashion through different strategies, they are inherently 
inefficient. The installation and removal of the directing group will require at least two 
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additional steps in any glycosylation strategy, which will almost certainly lead to a reduction 
in yield and a lengthier preparation. An alternative route that has received considerable 
attention in recent years is that of direct synthesis. 
2.3.2.2.  Direct Syntheses 
 A recent route to 2-deoxyglycosides reported by Kim and co-workers uses (2’-
carboxyl)benzyl glycosides as glycosyl donors in a direct synthesis approach.82 Intriguingly, 
small changes in the donor protecting groups lead to complete reversal of stereoselectivity. 
Scheme 12 shows examples of this stereocontrol.  
 
Scheme 12. Glycosylation of differently protected (2’-carboxyl)benzyl glycosides gave 2-
deoxydisaccharides with opposite stereochemical outcome.71, 82 
Glucose derived glycosyl donor 52 made from tri-O-benzyl-D-glucal 36, can be 
activated with triflic anhydride and the hindered base DTBMP to undergo glycosylation with 
secondary glycosyl acceptor 53, giving disaccharide 54 in excellent yield and total α selectivity. 
Other secondary glycosyl acceptors also showed preference for formation of the α anomer, 
with α:β ratios from 9.4:1 to complete α selectivity. In contrast, when the C-4 and C-6 benzyl 
protecting groups on the glycosyl donor were replaced with a benzylidene acetal group as in 
donor 55, the same reaction conditions gave disaccharide 56 in good yield and complete β 
selectivity. Other secondary acceptors showed α:β selectivity from 1:8 to complete β 
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selectivity when donor 55 was used. For both donors 52 and 55, little or no stereoselectivity 
was observed when primary glycosyl acceptors were used, with α:β ratios close to 1:1. 
 The Kim group rationalised the observed selectivities by suggesting that reactions 
between donor 55 and secondary glycosyl acceptors proceeded via intermediate 57 in an SN2 
type mechanism to give inversion of stereochemistry, whilst in the case of primary acceptors 
the reaction proceeded through oxocarbenium ion 58 in an SN1 type manner, thus imparting 
little selectivity (Figure 9). However, no mechanistic studies were performed and 
intermediate 57 was not detected. 
 
Figure 9. Proposed α-glycosyl triflate intermediate 57 and oxocarbenium ion 58.71, 82 
 Another example of a direct 2-deoxyglycoside synthesis that makes use of glycals as 
glycosyl donors was reported by Satyanarayana and co-workers.83 The lanthanide cerium salt 
CeCl3.7H2O may be used in combination with sodium iodide to effect glycosylation of 
peracetylated glycals with a range of aliphatic, aromatic, olefinic and alkynylic primary 
alcohols. Scheme 13 shows a general scheme of the reactions performed. Acetylated glucal 
31 was treated with CeCl3.7H2O and sodium iodide and an alcoholic glycosyl acceptor to give 
selectively α 2-deoxyglycosides in very good yields. The reaction worked well even when 
water was not strictly excluded from the reaction vessel as is normally necessary for 
glycosylation reactions. The authors note that treatment of glucals with the cerium(III) salt in 
the absence of sodium iodide gave the 2,3-unsaturated Ferrier rearrangement product in very 
good yield, but poor to moderate selectivity. The researchers suggest that glycal activation by 
hydroiodic acid formed in situ was responsible for the observed reactivity, giving 2-
deoxyglycoside products. Unfortunately, the authors did not make any suggestions as to the 
tolerance of the method for saccharide derived glycosyl acceptors, secondary alcohols or for 
protecting groups other than the acetyl group. 




Scheme 13. Transformation of peracetylated D-glucal 31 into 2-deoxyglycosides and Ferrier 
rearrangement products using CeIII chloride. 
 These examples of direct 2-deoxyglycoside synthesis and many more that are beyond 
the scope of this introduction demonstrate that efficient, high yielding and selective direct 
preparations of 2-deoxyglycosides are possible if the donor, acceptor and catalyst/promoter 
reagents are carefully selected. Ideally, a highly tolerant and efficacious methodology can be 
developed for 2-deoxyglycoside synthesis, using synthetically versatile glycals as glycosyl 
donors. 
 Glycosylation by Transition Metal Catalysis 
 Catalysis is the widespread chemical process by which reaction rate is increased using 
a catalyst, a substance that accelerates the reaction without being consumed itself. This 
occurs because the catalyst offers a reaction pathway that requires lower activation energy 
than the uncatalysed pathway. Generally, sub-stoichiometric quantities of catalyst are used, 
since the catalyst should be regenerated after each reaction cycle and thus acts repeatedly. 
Transition metals are used extensively as catalysts, with transition metal catalysis having 
become an incredibly varied and valuable field. Transition metals as both homogeneous and 
heterogeneous catalysts are essential for large scale industrial chemical production as well as 
almost all research lab scale branches of organic chemistry. Of particular note is the explosion 
 2.  Introduction  
26 
 
of research that has gone into palladium mediated C-C and C-heteroatom bond formation, 
for example the Heck reaction84 and the Buchwald-Hartwig amination/etherification.85, 86  
 Metal catalysts are able to exploit reactivity in organic chemicals that is inaccessible 
by traditional organic synthesis, offering the opportunity for rapid, highly selective 
transformations. This reactivity is primarily due to the partial occupation of d orbitals 
exhibited by transition metal catalysts. The d orbitals possess differing symmetry to that of 
the s and p orbitals occupied by carbon-based organics, allowing orbital interaction of 
organics and metal atoms that leads to synthetically useful bond breaking and forming 
reactions. Moreover, due to the developing fields of green chemistry and sustainability,87  
science and chemistry in particular must respond to the demand for more efficient, atom 
economic, environmentally innocuous and economically viable processes. Transition metal 
catalysts represent a path to this goal, by reducing wasteful volumes of reagent, solvent and 
catalyst, improving safety in the laboratory and in industrial plants whilst motivating 
innovation in chemistry. Transition metal catalysis has seen extensive exploitation for 
glycoside synthesis in recent years.28, 33 
 Glycosyl trichloroacetimidates are perhaps one of the most widely used glycosyl 
donors, owing to their ease of preparation and synthetic versatility.88 Hence, Nguyen and co-
workers opted to apply palladium(II) catalysis to the glycosylation of trichloroacetimidate 
donors.89 By employing 5 mol % of cationic Pd(MeCN)4(BF4)2 as the catalyst, various 
glycosylations were performed giving products in high yields and excellent stereoselectivities. 
For instance, glycosylation of mannose donor 59 with secondary acceptor 60 furnished 
disaccharide 61 in 94 % yield and complete α selectivity (Scheme 14).  




Scheme 14. Glycosylation of mannosyl trichloroacetimidate donor 59 with acceptor 60 using 
Pd(MeCN)4(BF4)2 as catalyst.89 
 The non-coordinating nature of the tetrafluoroborate counterions was shown to be 
integral to catalytic activity, since the use of complex Pd(PhCN)2Cl2 as an alternative catalyst 
gave only very low (<5 %) yields. Mechanistically, the palladium complex is proposed to act 
as a Lewis acid, encouraging departure of the trichloroacetimidate group to give an 
oxocarbenium ion that may be attacked by a nucleophile. The reaction worked well for 
glycosyl donors that possess an axial C-2 group, or with donors capable of anchimeric 
assistance, however, stereoselectivity deteriorated when using a donor with non-
participating functionality. 
 In pursuance of a solution to the loss of selectivity, a second-generation catalyst was 
developed by the Nguyen group that utilised very weakly coordinating triflate counterions, 
thereby enhancing the cationic character of the metal centre and increasing catalyst activity. 
Pd(PhCN)2(OTf)2, generated in situ from Pd(PhCN)2Cl2 and AgOTf, proved to be a highly active 
catalyst for the β selective glycosylation of glycosyl trichloroacetimidates bearing various 
different ether-type protecting groups.90 The protocol also tolerates a range of glycosyl 
acceptors. Scheme 15 shows how perbenzylated glucosyl donor 62 can be smoothly 
glycosylated with galactose derived acceptor 63 in high yield and β selectivity to give 
disaccharide 64. The authors also demonstrate that 2-deoxyglycosides can be prepared using 
this method, as shown in the synthesis of 66 directly from donor 65.  




Scheme 15. Glycosylation of glycosyl trichloroacetimidate donors using catalyst Pd(PhCN)2(OTf)2 
generated in situ furnished disaccharides in high yields and β selectivities. 
 Whilst the yield for the preparation of 66 is very high, the selectivity is much lower 
than for other fully oxygenated donors. The authors proposed that the high β selectivity seen 
when fully oxygenated donors are used stems from the palladium atom coordinating the 
imidate N atom and the C-2-O atom simultaneously to form a transient 7-membered ring, 
which directs nucleophilic attack to the β face (Scheme 16). Accordingly, in 2-deoxy donor 65, 
no C-2-O atom is present to coordinate the Pd and therefore β selectivity deteriorates 
dramatically. The synthesis of oligosaccharides is also amenable to this method, as 
exemplified in the synthesis of a trisaccharide. The work was subsequently extended to 
permit glycosylation using aryl alcohols as glycosyl acceptors to give β-O-aryl glycosides 
selectively.91 




Scheme 16. Mechanistic pathway proposed by Nguyen and co-workers for the β selective PdII 
catalysed glycosylation.90 
 The use of metal complexes that can participate in single electron transfer redox 
reactions under the influence of photochemical excitation is emerging as a powerful tool for 
catalysis.92 This reactivity was exploited by Ragains and co-workers for the α selective 
glycosylation of selenoglycosides.93 By using a catalytic quantity of Ru(bpy)3(PF6)2 in 
combination with tetrabromomethane as an electron acceptor, a base and irradiation by blue 
LED light, selenoglycosides were glycosylated in good yields and reasonable selectivity. Four 
examples of glycosylation using selenoglucoside 67 and several alcohol acceptors are 
reported, with α:β selectivities up to 8.5:1 and yields up to 81 % (Scheme 17). It should also 
be noted that the reaction also worked with organocatalytic diphenylselenide in place of the 
ruthenium complex.  
The proposed catalytic cycle for the reaction is outlined in Figure 10. The cycle begins 
with irradiation of the Ru(bpy)32+ complex with blue light, causing electron excitation. 
Tetrabromomethane is then able to abstract an electron from the excited complex to give 
Ru(bpy)33+, which may oxidise the selenoglycoside donor 67 to give radical cation 68 and 
regenerate Ru(bpy)32+. Radical cation 68 then rapidly fragments to produce an oxocarbenium 
ion that is susceptible to nucleophilic attack by the glycosyl acceptor, furnishing the product 
glycoside. 








Figure 10. Proposed catalytic cycle for the photoredox catalysed glycosylation of selenoglycosides. 
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 An ideal requirement for successful and versatile glycosylation strategies is that of 
chemical orthogonality. Ideally, one anomeric latent leaving group will be activated under 
specific conditions which ought not to interfere with other chemical functionalities present in 
the reaction vessel, whilst another leaving group can be activated under alternative 
conditions, enabling facile oligosaccharide synthesis. Hence, the search for anomeric leaving 
groups that remain stable under most conditions, only becoming reactive when convenient, 
is a tantalising prospect. Building upon the notable alkynophilicity exhibited by gold 
catalysts,94-96 Kashyap and co-workers sought to develop propargyl groups as anomeric 
leaving groups that could be activated through gold catalysis.97 Using AuCl3 as a catalyst, 
propargyl glucosyl donor 69 was shown to be smoothly glycosylated with six examples of 
alcohols, including aromatic, alkenyl and saccharide derived acceptors (Scheme 18). Yields 
were fair to excellent, however α:β stereoselectivities were generally poor. Two further 
glycosyl donors bearing benzyl protecting groups were amenable to the reaction conditions, 
however, electron withdrawing ester protecting groups were not tolerated, suggesting that 
the reaction works best with armed donors, whilst disarmed donors lack the reactivity to be 
activated by the gold catalyst. The authors went on to suggest a plausible mechanism in which 
gold activation of the alkyne moiety causes departure of the propargyl leaving group, but did 
not offer experimental information in support of it. 
 
Scheme 18. AuIII catalysed glycosylation of glycosyl donor 69 bearing a propargyl leaving group at 
the anomeric position. 
 Zhu and co-workers further extended the use of alkynyl glycosyl donor activation with 
gold catalysis by applying the strategy to the synthesis of 2-deoxy- and 2,6-
dideoxyglycosides.98 A series of 2-deoxy glycosyl donors bearing an S-but-3-ynyl group at the 
anomeric position were prepared. Treatment with catalytic gold(I) species 70, featuring an 
appropriate phosphine ligand, and silver triflate afforded products in short reaction times 
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under very mild conditions (Scheme 19). Glucosyl donor 71 gave product 75 in very high yield 
in the reaction with acceptor 74, however, the selectivity was reasonably low. In contrast 
galactose derived donors 72 and 73 afford products 76 and 77 in the reaction with acceptor 
74 with high preference for the α anomer. 
 
Scheme 19. Gold(I) catalysed glycosylation of 2-deoxy-S-but-3-ynyl thioglycoside donors using 
glycosyl acceptor 74 afforded 2-deoxy glycosides in high yields and α selectivities. 
 The authors detected 2,3-dihydrothiophene 82 as a side product of the reaction and 
proposed the mechanism shown in Figure 11. Gold catalyst 78 coordinates with the triple 
bond of donor 71 to form complex 79. 5-endo-dig cyclisation forms species 80, which then 
fragments to make gold complex 81 and an oxocarbenium ion. The glycosyl acceptor alcohol 
traps the oxocarbenium ion affording the product, whilst the liberated proton permits proto-
deauration of complex 81 to create 2,3-dihydrothiophene 82 and regenerate gold catalyst 78. 




Figure 11. Proposed catalytic cycle for the gold(I) catalysed synthesis of 2-deoxyglycosides reported 
by Zhu and co-workers.98 
 Building further upon gold catalysed glycosylations, Galan and co-workers also used 
gold catalyst 70, but instead of activating an alkyne moiety, the enol ether group of the glycal 
donor was activated (Scheme 20).99 This glycosylation protocol utilised galactal, glucal and 
rhamnal type donors in combination with a wide variety of glycosyl acceptors to synthesise 
2-deoxyglycosides with excellent α selectivities of generally >30:1 α:β. Reactions reached 
completion quickly, usually requiring just 35 minutes at room temperature for complete 
conversion. Moreover, the method can be used to prepare oligosaccharides, as evidenced by 
the synthesis of a tetrasaccharide in 18 % overall yield over five steps. 




Scheme 20. Gold(I) catalysed glycosylation of glycals to produce 2-deoxyglycosides with excellent α-
selectivity, as reported by Galan and co-workers.99 
 The field of transition metal catalysed glycosylations is already large and will 
undoubtedly continue to grow. For an exhaustive evaluation of transition metal catalysed 
glycosylations to date, two recent reviews cover the topic in depth.28, 33 The use of transition 
metals allows much better stereochemical control of glycosylation reactions than traditional 
methods through formation of transient metal complexes that may direct attack of the 
glycosyl acceptor. Furthermore, the small amount of metals required for efficient 
glycosylation minimises waste whilst allowing mild conditions. It should also be noted that 
transition metal catalysts facilitate the use of novel glycosyl donors that can be 
chemoselectively activated, amplifying the scope for orthogonal glycosylation strategies. 
However, a complementary approach to glycosylation chemistry with its own distinct 
advantages uses organocatalysts. 
 Glycosylation by Organocatalysis 
 A viable alternative to transition metals is organocatalysis, which relies on organic 
molecules as catalysts. Difficult synthetic transformations in many areas of chemistry have 
been accomplished using a rationally selected small organic molecule to catalyse the reaction. 
Investigation into this field has led to efficient routes to target molecules, with high chemo-, 
regio- and enantioselectivity.100-103 Furthermore, organocatalysis provides a green pathway 
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to desired compounds without requiring the use of transition metal catalysts, thus 
circumventing the potential expense, toxicity and environmental harmfulness associated with 
many transition metals.87  
 Organocatalysts, particularly in the case of Brønsted acid or hydrogen bonding 
catalysts, possess several distinct advantages over more traditional Lewis acidic metal 
catalysts. Organic transformations including glycosylations have been catalysed using Lewis 
acidic metals for decades. Commonly, promoters including salts of tin, silver and mercury are 
used for traditional glycosylation. However, due to the enthalpic tendency towards 
coordination of electron deficient metals by heteroatoms, metal catalysts are frequently 
sensitive to moisture and air. Furthermore, the metal catalyst may be poisoned through 
strong binding to the glycosylation product. Conversely, organocatalysts often bind more 
weakly to the reactants and products thereby avoiding these issues, although this may also 
result in reduced catalytic turnover frequency.104  
On the other hand, strong Brønsted acids such as mineral acids may be used to 
catalyse glycosylations. Yet they often suffer from poor chemoselectivity due to 
indiscriminate interaction with functional groups throughout the reactant molecule, leading 
to unwanted side products. Organic Brønsted acids are generally much weaker than standard 
strong Brønsted acids, permitting superior chemoselectivity, tolerance of diverse functional 
groups and often greater stereocontrol during glycosylations.  
 Another factor that contributes to the attractiveness of organocatalysts is their 
modifiability. Since they are often easily synthesised from simple starting materials, the steric 
and electronic nature of the catalyst can be tuned to the requirements of the reaction. 
Moreover, chiral motifs can be incorporated into the organocatalyst structure, thus imparting 
stereochemical information during the catalytic reaction and biasing the stereochemical 
outcome of the reaction. The application of organocatalysis to the glycosylation reaction has 
the potential to minimise waste, provide an orthogonal glycosylation strategy to most existing 
methods whilst remaining tolerant to protecting groups and allowing rapid access to densely 
functionalised oligosaccharides under mild conditions. This part of the introduction will 
outline some recent examples of organocatalytic glycosylation strategies.105 
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 In 2014, Bennett and co-workers reported an organocatalytic BINOL derived 
phosphoric acid that was able to selectively catalyse the formation of different 2-
deoxyglycoside anomers dependent upon the matched/mismatched chiral relationship 
between the organocatalyst and the glycosyl donor anomeric configuration.106 For their 
study, perbenzylated 2-deoxy trichloroacetimidate glycosyl donors 83α and 83β were chosen. 
It was discovered that by using sterically bulky chiral Brønsted acid catalysts 84-(S) and 84-(R) 
for the glycosylations with 1-octanol as glycosyl acceptor, both anomers of the product, 85α 
and 85β, could be preferentially synthesised.  Scheme 21 shows that treatment of α donor 
23α with the (S) enantiomer of the Brønsted acid catalyst 84-(S) affords synthetically 
challenging β 2-deoxyglycoside 85β in excellent yield and selectivity, whilst using the (R) 
enantiomer of the catalyst (84-(R)) with the same donor deteriorated selectivity and 
lengthened reaction time. Conversely, the glycosylation of 83β using 84-(R) gave the α 
anomer of the product 85α preferentially. However, the reactions had to be run at low 
temperature owing to the instability of the glycosyl donors, leading to exceptionally lengthy 
reaction times. When a saccharide derived glycosyl acceptor was used in place of 1-octanol 
in the glycosylation of 83α, the β selectivity was largely maintained (α:β 1:14), however, the 
yield dropped to 15 %. Nevertheless, the study amply demonstrated the importance of 
matching the chirality of the organocatalyst with the glycosyl donor in order to maximise 
stereocontrol during the glycosylation. 




Scheme 21. Glycosylation using the matched/mismatched catalyst/substrate methodology 
developed by Bennett and co-workers gives 2-deoxyglycosides stereoselectively.106 
 Inspired by reports that electron deficient thiourea 86 efficiently catalyses the 
tetrahydropyranylation of alcohols,107 the Galan group set out to apply this methodology to 
suitably protected glycals as a novel route to access 2-deoxyglycosides.108 Using thiourea 86 
at low catalyst loadings, a wide variety of galactals bearing diverse protecting groups were 
glycosylated over 24 hours at reflux in DCM (Scheme 22). The yields were excellent and 
complete α-selectivity was achieved. The method was amenable to both primary and 
secondary glycosyl acceptor alcohols. However, the reaction did not tolerate glucal donors 
well, since reactions using glucals were slower, less stereoselective and lead to more side 
products.109 




Scheme 22. Glycosylation of galactals catalysed by thiourea 86 furnishes 2-deoxyglycosides with 
complete α selectivity.108 
The authors undertook a mechanistic investigation of the reaction mechanism using 
deuterated galactal 87. When subjected to the reaction conditions using glycosyl acceptor 63, 
2-deoxyglycoside 88 was synthesised in 95 % yield, with a cis relationship between the newly 
formed C-2-H and C-1-O bonds, indicating a syn addition of the alcohol group to the α face of 
galactal 87 (Scheme 23). It was thus hypothesised that the reaction proceeds via addition of 
a proton from the alcohol-thiourea complex formed in situ to the less sterically hindered face 
of the galactal (A); to transiently produce tight ion pair (B), which will immediately go on to 
form deoxyglycoside 88 and liberate thiourea 86. It is thought that there is a propensity for 
formation of the α anomer over the β anomer during the glycosidic bond forming step as a 
result of the anomeric effect, a lower energy steric interaction and a lower energy chair-like 
transition state. Note that here, as in the tetrahydropyranylation reported by Schreiner and 
co-workers,107, 110 the thiourea was proposed to act as a dual hydrogen bond donor that binds 
to the oxygen atom on the alcohol. 




Scheme 23. Mechanistic pathway proposed by Galan and co-workers to explain the organocatalytic 
ability of thiourea 86 in the synthesis of 2-deoxyglycosides.108 
 In 2017 Jacobsen and co-workers described an organocatalytic glycosylation attained 
through the use of a macrocyclic bis-thiourea as an organocatalyst, further demonstrating the 
versatility of thiourea derived organocatalysts.111 The reaction uses a wide variety of α 
glycosyl chlorides as donors in combination with saccharide derived acceptors and novel 
macrocyclic (R,R) bis-thiourea 89 to prepare disaccharides with inversion of stereochemistry 
at the anomeric carbon, furnishing β glycosides with high selectivity (Scheme 24). Reactions 
usually took 48 h at RT or 40 ˚C and tended to produce the desired disaccharides in >60 % 
yield and with an α:β ratio of >1:9. The donor scope of the reaction in particular was excellent, 
as 12 different donors including fully oxygenated and deoxy or dideoxy glycosides were 
shown to work well under the reaction conditions. This generality was exploited to synthesise 
challenging 2-deoxy β glycosides and 1,2-cis β mannosides.  




Scheme 24. The macrocyclic bis-thiourea catalysed glycosylation strategy developed by Jacobsen 
and co-workers.111 
 Surprisingly, the stereocontrol of the glycosylation was demonstrated to depend 
almost completely on the glycosyl donor configuration. Experiments were performed to 
independently vary the chirality of both the alcohol acceptor and the bis-thiourea 
organocatalyst. The results showed only very small changes in β selectivity, indicative of an 
SN2 type mechanism. Experimental and computational studies into the mechanism 
established that bis-thiourea 89 is precisely suited to catalyse the reaction. Small 
modifications in, for instance, amide substituent or linker length caused a large decrease in 
yield and selectivity. The authors proposed a transition state structure as shown in Figure 12. 
The four NH protons of the bis-thiourea simultaneously form hydrogen bonds to the chlorine 
atom on the donor, whilst the amide carbonyl bond is able to form a hydrogen bond with the 
incoming alcohol. This allows a complex to form between the glycosyl chloride, alcohol and 
bis-thiourea that encourages an SN2 type substitution. 




Figure 12. Transition state complex proposed by Jacobsen and co-workers in the glycosylation of 
glycosyl chlorides mediated by bis-thiourea 89.111 
 Organoboron compounds possess the ability to reversibly make boron-carbon and 
boron-oxygen bonds, a useful feature for controlling stereochemistry, but also regiochemistry 
in glycosylation.112, 113 In 2011, Taylor and co-workers reported a Koenigs-Knorr glycosylation 
of carbohydrates catalysed by a diphenylborinic acid derivative in combination with silverI 
oxide.114 Intriguingly, the reaction used saccharide derived glycosyl acceptors that only 
required protection at C-1 and C-6. As long as a single 1,2-cis diol moiety was present in the 
saccharide acceptor, total regioselectivity for the equatorial alcohol group in the cis diol was 
observed. Accordingly, α-halo glycosyl donors furnished disaccharides in excellent yields and 
complete β selectivity (Scheme 25). The substrate scope of the reaction was very good, with 
a range of seven glycosyl donors bearing ester and ether type protecting groups proving 
amenable to glycosylation with a number of mannose, galactose, fucose, arabinose and 
rhamnose derived glycosyl acceptors. The reaction utilised diphenylborinic acid 90 as an 
organocatalyst in combination with stoichiometric silverI oxide to produce desired 
disaccharides in 16 hours. The excellent β selectivity achieved is perhaps not surprising in 
cases where the glycosyl donor had a participating protecting group at C-2 that may bias the 
formation of a 1,2-trans glycoside, however, the β selectivity is maintained even when non-
participating benzyl protecting groups were employed. Furthermore, rigorous exclusion of 
moisture during the reaction was not necessary to maintain high yields. Mechanistic 
experiments undertaken led the authors to believe that catalyst 90 is in fact a precatalyst that 
is activated through displacement of ethanolamine by 1,2-cis hydroxyl groups present on the 
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saccharide glycosyl acceptor. An SN2 type glycosylation was proposed in which a silver-halide 
interaction encourages attack by intermediate 91 (Figure 13). This glycosylation protocol was 
subsequently applied to the regioselective preparation of the cardiac glycoside natural 
product digitoxin.115 
 
Scheme 25. Regioselective glycosylation using diphenylborinic acid derivative 90 developed by 
Taylor and co-workers.114 
 
Figure 13. Mechanistic rationale for observed selectivity in glycosylation catalysed by 
organocatalyst 90.114 
 In a subsequent publication, the authors built upon their previously reported work 
with organoboron catalyst 90 to prepare 2-deoxy- and 2,6-dideoxyglycosides.116 Through the 
use of electron withdrawing acyl protecting groups installed on a 2-deoxy glycosyl donor with 
an anomeric α-chloro substituent, excellent regioselectivity was maintained whilst β 
selectivity remained highly favoured. Thus, the reaction conditions were successfully applied 
to three different galactosyl, glucosyl, and rhamnosyl derived donors using either 1,2- or 1,3-
cis diol-bearing saccharide acceptors (Scheme 26). 




Scheme 26. Extension of the work by the Taylor group to encompass 2-deoxy and 2,6-
dideoxyglycosyl donors in organoboron catalysed glycosylation.116 
 Glycosylation under Flow Conditions 
 A further area of interest for the work described in this thesis is that of flow chemistry. 
Pumping solutions of reagents along tubing or etched channels and allowing chemical 
reactions to take place in a continuously flowing stream can offer significant advantages over 
conventional batch reactions. Reaction times can be controlled with exquisite precision, 
excellent mixing and heat transfer are possible and extremes in temperature and pressure 
are safely attainable. Flow chemistry has seen recent advancement in many areas of 
chemistry, including glycosylation.117-122  
 Performing chemical reactions in a continuously flowing stream, as opposed to a static 
reaction vessel as is traditional, offers several important advantages for reaction control, 
efficiency and the exploration of new regions of chemical reactivity.117, 123 Rather than using 
the parameters of stoichiometry and reaction time to quantify a chemical reaction, one can 
instead use solution concentration and residence time. The residence time is the time that 
reactants spend in the reactor zone, given by the ratio of reactor volume to flow rate. Whilst 
not all chemical reactions are well suited to flow, especially those long reactions lasting 
several hours or days, reactions in flow possess several attributes that often make them 
superior to traditional batch reactions.  
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 Firstly, due to the small dimensions of flow reactor tubing/channels in which the 
reaction occurs, the rate of mixing in flow reactors is generally far greater than that observed 
in batch reactors. This is because mixing is controlled by diffusion in a flow reactor as opposed 
to the turbulence-driven mixing usually required for batch reactions. A high mixing rate allows 
homogeneity of the reaction mixture that aids reaction rate. Furthermore, the rate of heat 
transfer is very high for the flow reactor compared to a batch reaction vessel such as a round-
bottomed flask due to a high surface area to volume ratio, allowing more precise temperature 
control of the reaction. It is generally also possible, with the right setup, to heat the reaction 
solvent well above its boiling point safely. This allows reactions to take place within the 
superheated regime and often affords faster and cleaner reactions. Flow chemistry also lends 
itself to industrial scale chemical production, as scale-up and automation are reasonably 
straightforward in comparison with batch processes.123 Perhaps one of the most useful 
aspects of flow chemistry in the research lab setting is the ability to telescope flow reactions 
together, permitting a multi-step synthesis in a fraction of the time it would take to do the 
same multi-step synthesis in batch. Moreover, telescoping reactions together means that a 
species can be synthesised within the confines of the flow reactor and immediately undergo 
a second reaction without ever having to be isolated. In this case, there is only ever a small 
quantity of the species in question present at any one time, allowing exploration of chemical 
space that would simply not be feasible in batch due to the safety concerns or decomposition 
of highly reactive, dangerous or short-lived chemicals. Flow chemistry has seen use in many 
synthetic chemistry disciplines, notably in the syntheses of medicinal compounds and natural 
products, but also for chemical glycosylation strategies. This section will describe several 
important developments in the literature for flow glycosylations. 
 In 2014, Lay and co-workers described the experiments they carried out to optimise 
glycosylation of trichloroacetimidate and thioglycoside donors under flow conditions.121 The 
aim was to evaluate the potential advantages and disadvantages of flow microreactor 
glycosylations as opposed to batch reactions. Batch reactions were performed under 
standard conditions, then comparative reactions in flow were undertaken, with appropriate 
optimisation of variables such as residence time and temperature. Scheme 27 shows the 
results of the glycosylation of trichloroacetimidate donor 62 with several glycosyl acceptors 
41, 53 and 92, under flow conditions using TMSOTf as promoter. Disaccharide products were 
 2.  Introduction  
45 
 
obtained in 77-95 % yields within 1 minute residence time at room temperature, giving 
slightly higher yields than their batch reaction counterparts. Stereoselectivities were fair to 
good, but generally showed little change on moving from batch to flow. Similar results were 
obtained for several other glycosyl donors bearing trichloroacetimidate or thionyl leaving 
groups. The flow paradigm proved amenable to scale-up, as evidenced by production of 0.44 
g (90 % yield) of a disaccharide over 100 minutes. Furthermore, dry solvents and exclusion of 
moisture were not strictly required for the flow reaction, reagent grade solvents were 
sufficient to allow high yields to be attained. The study culminated in a multi-step flow 
synthesis of a trisaccharide from constituent monosaccharides in 51 % overall yield. 
 
Scheme 27. Glycosylation under flow conditions using glycosyl donor 62 as reported by Lay and co-
workers.121 
 A fascinating area in which glycosylation plays a pivotal part is in nucleoside synthesis. 
In 2011, Jamison et al. disclosed an organocatalytic Brønsted acid catalysed glycosylation of a 
ribofuranose donor with a number of different nucleobases to prepare ribonucleosides using 
continuous flow techniques.124, 125 Ribonucleosides are often synthesised using the 
Vorbrüggen variation of the silyl-Hilbert-Johnson reaction. This method uses a Lewis acid in 
stoichiometric quantities as a promoter, leading to difficulties with functional group tolerance 
and the generation of significant amounts of chemical waste. By employing 2,6-di-tert-butyl-
4-methylpyridinium triflate 93 as an organocatalyst, suitably protected ribofuranose 94 was 
N-glycosylated using various uracil derived nucleobases 95a-f (Scheme 28), in addition to 
several guanine, cytosine and adenine derived nucleobases. 




Scheme 28. Pyridinium derived Brønsted acid 93 catalyses the synthesis of ribonucleosides under 
flow conditions.124 
 The reaction furnished the desired products in excellent yields and with total β 
selectivity. This outcome may be ascribed to the anchimeric assistance of the neighbouring 
benzoyl group at C-2 of the glycosyl donor. The authors noted that the glycosylation worked 
well in flow if the temperature was regulated to maintain the solubility of reactants and 
products, but also worked in batch with microwave irradiation to stimulate the reaction. By 
scaling up the reaction to a commercial flow system, multi-gram quantities of ribonucleosides 
were produced in high purity with minimal optimisation. Screening experiments of the 
organocatalyst determined that the characteristics of both the cation and the anion were 
essential to ensure high yields of product. Further work by the authors exploited this 
glycosylation in a telescoped multi-step flow synthesis to prepare a number of 5’-
deoxyribonucleoside pharmaceuticals.126 
 In the final report that shall be considered in this section, Seeberger and co-workers 
brought the synthetic potential of gold catalysis to continuous flow methodology.127 The 
alkynophilicity of gold has been previously described in this report in the context of propargyl 
and S-but-3-ynyl donors for glycosylation. Subsequent to those reports, the advent of glycosyl 
ortho-alkynylbenzoates as a new class of glycosyl donors amenable to gold activation 
appeared in the literature. The Yu group developed this gold(I) catalysed glycosylation into a 
powerful strategy that allows the synthesis of glycosides in excellent yields.128-130 In 2015, the 
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Seeberger group successfully applied the glycosylation of glycosyl ortho-alkynylbenzoates 
through gold(I) catalysis to the flow regime. Several differentially protected donors were 
screened using the catalyst PPh3AuOTf at 13 mol % stoichiometry to furnish products in good 
to excellent yields over reasonably short residence times of 20-30 minutes. Using 
anchimerically participating donor 96, five product glycosides were prepared in 50-87 % yield 
and total β selectivity (Scheme 29). 
 
Scheme 29. Glycosylation of glycosyl ortho-alkynylbenzoates through gold(I) catalysis in flow.127 
 After establishing optimal reaction conditions using donor 96, a donor bearing non-
participating benzyl protecting groups in place of benzoyl groups was tested to ascertain the 
α:β selectivity of the reaction. Whilst yields remained very high in most cases, selectivities 
were generally poor to moderate. Furthermore, 2-amino and 2-deoxy glycosyl donors were 
successfully glycosylated, demonstrating the versatility of the method. The mechanism of the 
reaction has been investigated extensively by Yu and co-workers128 and features a gold-
catalysed activation of the anomeric leaving group, encouraging SN2 substitution at the 
anomeric centre. However, the mechanism is somewhat intricate and the SN1-SN2 character 
depends upon the specific reaction conditions. 
 The discipline of glycosylation using flow conditions is still in its infancy, however, the 
scope for rapid and clean reactions is unquestionable. Additionally, a major obstacle in 
glycosylation optimisation is the synthesis of precursor donor and acceptor glycosides, each 
of which frequently requires a substantial number of synthetic steps to prepare. Flow 
microreactors minimise this issue as only very small quantities of reagent are required in 
order to perform many reactions. The application of highly efficient catalytic processes to the 
flow regime is sure to be an area that sees literature attention over the coming years. 
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 Glycosylation Using Imidazolium Based IL Supports 
Ionic liquids (ILs) are a versatile and synthetically useful class of compounds that have 
found use in diverse fields, for instance as green solvents, catalysts or co-catalysts and 
ligands.131-136 ILs make excellent candidates for greener alternative solvents to volatile organic 
media, owing to their negligible vapour pressure and lack of flammability. They therefore 
pose a much lower risk to human health and the environment, particularly the atmosphere, 
where volatile organic solvents can cause significant damage through photochemistry. 
However, ionic liquids may also be used as soluble supports through covalent linkage to a 
desired substrate, facilitating easy analysis and purification of the substrate as chemical 
transformations are performed upon it. 
 In supported oligosaccharide synthesis, the oligosaccharide chain is firstly attached to 
a support, that can be either solid or soluble. Reactions are then performed upon the attached 
carbohydrate, for example glycosylations to lengthen the oligosaccharide chain or protecting 
group manipulations. After each reaction, purification can be achieved very easily by simply 
washing away all non-supported material including side products or excess reagents. When 
the desired oligosaccharide has been constructed, the product can be cleaved from the 
support chemoselectively to liberate the free desired compound (Scheme 30).137  
 
Scheme 30. General representation of a supported oligosaccharide synthesis strategy. 
Ionic tags (I-Tags) are ionic functional groups that can be used as a solution phase 
purification handle and a MS reaction progress reporter.136 These types of labels often bear 
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quaternary amine groups and are covalently linked to one of the monosaccharide units of a 
growing oligosaccharide target. I-Tags are well suited to serve as supports for oligosaccharide 
synthesis for several reasons. Firstly, mass spectrometry relies on molecular ions that bear a 
positive charge for detection. Since I-Tagged sugars already bear a full positive charge, they 
do not rely on the ionisation technique to cause ionisation like neutral molecules do, they 
need only be vaporised. Therefore, since 100 % of the sample can theoretically be detected 
by the mass spectrometer, minute quantities of material can be easily analysed by MS.138 
Thus, where for instance an NMR spectrum of a reaction mixture may be difficult to interpret 
due to many overlapping signals, the mass spectrum will generally show all neutral 
compounds as part of the baseline whilst I-Tagged compound detection limits are much 
lower. Secondly, in contrast to solid supports, I-Tag supports are soluble in more polar organic 
solvents such as DCM and acetonitrile and thus supported reactions can take place under 
homogeneous solution phase conditions. This means that smaller quantities of reagents can 
be used compared to solid supported strategies, whilst conventional analysis techniques such 
as NMR spectroscopy, MS and HPLC can be used to track reaction progress. 
Thirdly, the presence of a permanent positive charge dramatically increases the net 
polarity of the molecule. This property changes the propensity for dissolution of the I-Tagged 
sugar in different solvents according to the polarity of the solvent. Hence, owing to the 
polarity difference between protected neutral sugars and sugars bearing I-Tags, purification 
of the I-Tagged sugar may be achieved through trituration with various combinations of 
solvents or a biphasic workup. This becomes especially useful when purifying a protected I-
Tagged sugar after a glycosylation reaction. Apolar solvents such as hexane and diethyl ether 
(or a combination thereof) may be used to dissolve and wash away protected neutral sugar 
molecules, for example unreacted or hydrolysed glycosyl donor, whilst the product I-Tagged 
sugar is too polar to be dissolved in these solvents. Conversely, water, being an extremely 
polar solvent, may be used to wash away very polar impurities such as mineral acids or 
inorganic salts, whilst the I-Tagged sugar, if appropriately protected, is too apolar to be 
dissolved in water. This approach allows purification of glycosylation products with no 
requirement for time-consuming column chromatography as would be traditionally required 
(Figure 14).  




Figure 14. Strategy for trituration-based purification of oligosaccharides using an I-Tag support. 
Finally, an appropriately designed glycosyl donor bearing orthogonal or semi-
orthogonal protecting groups can be used to rapidly construct an oligosaccharide through a 
repeated glycosylation-deprotection-trituration sequence. Consider the example shown in 
Scheme 31. Attaching an I-Tag to an appropriate glycosyl donor gives a product amenable to 
purification by simple trituration. Deprotection of protecting group PG1 furnishes a free 
alcohol that can act as a glycosyl acceptor for a glycosyl donor in a glycosylation reaction. 
Continued iterations of the glycosylation-deprotection-trituration sequence permits the 
synthesis of complex oligosaccharides quickly and efficiently. Final universal deprotection 
yields a free oligosaccharide if required. This may include removal of the I-Tag if a cleavable 
linker is used. 




Scheme 31. Representation of the strategy used to construct complex oligosaccharides using an I-
Tag motif as a tool in the facile purification of synthetic intermediates. 
 Earlier reports of I-Tag supported oligosaccharide syntheses tended to attach the I-
Tag via an ester linkage to the glycosyl donor.139-143 However, this strategy, though 
synthetically useful, had several drawbacks. Ester protecting groups are used commonly in 
carbohydrate chemistry and thus attaching the I-Tag via an ester linkage prevents the use of 
common protecting groups such as acetates and benzoates, because the removal of such 
protecting groups, usually achieved through base catalysed esterification or hydrolysis, is also 
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likely to cleave the I-Tag at an inconvenient time. Secondly, installing the I-Tag on the donor 
is likely to increase the number of steps required in the overall synthesis, since the I-Tag must 
be removed after each glycosylation performed which may hamper the efficiency of 
oligosaccharide synthesis using this approach. Lastly, it is common to use an excess of donor 
in glycosylations to encourage a higher yield of product. Excess donor often becomes 
hydrolysed or undergoes side reactions due to the inherent anomeric reactivity of the donor. 
The products of such undesired reactions are usually removed during the purification stage, 
but if they bear I-Tag functionality, it is impossible to separate them from the I-Tagged desired 
product by trituration. 
 As a result of these concerns, it has become more common in the literature to install 
the I-Tag on the glycosyl acceptor, often at the anomeric carbon, via an ethereal linkage. Such 
an approach was taken by Galan and co-workers in 2011 when they disclosed the so-called 
ICROS (Ionic Catch and Release Oligosaccharide Synthesis).144 Two different I-Tags were 
reported, shown in Scheme 32. I-Tag1 featuring a propyl linker is a highly robust group, able 
to survive common reaction conditions used in carbohydrate manipulation. Cleavage may be 
achieved through acid catalysed Fischer glycosylation in water or methanol. However, such 
cleavage conditions may also break other glycosidic bonds in an oligosaccharide, resulting in 
truncated structures.145 To avoid this problem, I-Tag2 was developed using a benzylic linker 
that may be cleaved using palladium catalysed hydrogenolysis whilst leaving other glycosidic 
bonds in the saccharide intact. 




Scheme 32. The two I-Tags developed by Galan and co-workers and strategies for orthogonal I-Tag 
cleavage.144 
 Scheme 33 shows the strategy used for installation of I-Tag1 and subsequent I-Tag 
oligosaccharide synthesis to construct β 1,6-D-glucans found naturally in fungal cell walls. The 
multi-step synthetic strategy begins with glycosylation of orthogonally protected glycosyl 
trichloroacetimidate donor 97 with glycosyl acceptor 3-bromopropan-1-ol to furnish product 
98 in 83 % yield over 1 hour. Reacting 98 with 1-methylimidazole in the presence of potassium 
triflate gave I-Tagged sugar 99 in 83 % yield after 18 hours. Deprotection of the O-6 
triisopropylsilyl ether protecting group was completed using a solution of hydrochloric acid in 
methanol over 18 hours to produce I-Tagged glycosyl acceptor 100 bearing a free alcohol 
group in 94 % yield. Finally, glycosylation of 100 with donor 97 using TMSOTf as the promoter 
was completed over 18 hours to give I-Tagged disaccharide 101 in 94 % yield. The silyl ether 
deprotection and glycosylation sequence was repeated twice more to afford a 
tetrasaccharide in 69 % yield. Following each deprotection and glycosylation reaction after I-
Tag1 was installed, purification was achieved through trituration using Et2O/n-hexane. 




Scheme 33. ICROS strategy developed by Galan and co-workers to synthesise β 1,6-D-glucans.144 
 This work was later extended to encompass combinatorial oligosaccharide synthesis, 
in which several oligosaccharide targets were synthesised over a few days.146 Over three 
cycles of partial glycosylation and partial deprotection of I-Tagged glycosyl acceptor 102 a di-
, tri- and tetrasaccharide were synthesised as shown in Scheme 34. Purification of 
intermediates was performed by washing with Et2O:hexane 1:1, whilst reaction progress was 
monitored using HPLC, MALDI MS and 1H NMR spectroscopy to control the degree of 
glycosylation and silyl ether deprotection at each step of the cycle. Following completion of 
the third cycle, size-exclusion chromatography was used to separate the individual protected 
oligosaccharides in good yield when considered cumulatively as 54 % total yield over 6 steps. 
Base catalysed removal of benzoyl groups followed by catalytic hydrogenolysis afforded the 
globally deprotected glycosides in excellent yields. 




Scheme 34. Combinatorial ICROS protocol reported by Galan and co-workers. A mixture of di-, tri- 
and tetrasaccharides were synthesised, then separated using size-exclusion chromatography. Global 
deprotection yielded globally deprotected pure glycosides.146 
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 Beau and co-workers also recently reported the use of I-Tag supports for 
chitooligosaccharide synthesis.147 The same cationic I-Tag structure I-Tag2 was used for the 
ionic liquid support, but with a hexafluorophosphate counterion rather than triflate. Their 
synthetic approach towards orthogonally protected β-1,4-tetrasaccharide 108 is outlined in 
Scheme 35. Tetrasaccharide 108 is a key intermediate in the preparation of naturally 
occurring lipo-chitooligosaccharides and N,N,N-trimethylglucosamine-chitotriomycin, 
compounds that exhibit noteworthy biological activities. I-Tagged glycosyl acceptor 103 was 
smoothly glycosylated with thioglycoside donor 104 to afford disaccharide 105 in excellent 
yield and complete β stereoselectivity. Deprotection of the Fmoc group with triethylamine 
afforded 106 in 90 % yield, which was then used as a glycosyl acceptor in the reaction with 
donor 107 in a 2 + 2 glycosylation to furnish 108 in 83 % yield. In each case the I-Tagged 
product was purified by solvent washes. However, the authors noted that final deprotection 
of the tetrasaccharide was challenging, being impossible to purify through solvent washes. 
They attributed this unusual behaviour to the particular physicochemical properties of the 
oligo-chitin acetamido structure bearing an I-Tag. 
 The use of I-Tag2 was exploited further by Li and co-workers in the preparation of a 
synthetically challenging β-1,3-glucan hexasaccharide.148 β-1,3-glucans, known as laminarin 
polysaccharides, are found throughout many natural sources, for instance in yeast cell walls. 
They have garnered synthetic interest as a result of their antibacterial, antitumour and 
immunostimulating medicinal properties. In their strategy, the researchers described how 
orthogonally protected donor 110, bearing a levulinyl group that may be deprotected using 
hydrazine, could be used to efficiently construct the desired hexasaccharide in just 15 hours. 
Initial reactions by the authors using TMSOTf as the glycosylation promoter proved 
unsuccessful, due to unintended formation of the TMS ether at the glycosyl acceptor hydroxyl 
group during glycosylation. However, BF3.Et2O was found to facilitate smooth glycosylation 
with no significant side products. 




Scheme 35. I-Tag supported synthesis of β-1,4-chitotetrasaccharide 108 as reported by Beau and 
co-workers.147 
 Scheme 36 shows the iterative oligosaccharide preparation approach employed by 
the Li group. Monosaccharide glycosyl acceptor 109 bearing I-Tag2 was glycosylated using 
donor 110, with simple chromatography-free purification. Rapid levulinyl deprotection 
followed to regenerate a glycosyl acceptor bearing a free hydroxyl group. The cycle continued 
several times to form protected hexasaccharide 111 in 54 % overall yield, with an average 
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yield of greater than 90 % per step. Final global deprotection afforded unprotected 
hexasaccharide 112 in 48 % yield over 3 steps. 
 
Scheme 36. Repeated sequence of glycosylation, purification and deprotection afforded β-1,3-
glucan laminarihexaose using I-Tag support.148 
 Whilst I-Tag supported oligosaccharide synthesis only emerged fairly recently, it is 
rapidly becoming a useful tool in the carbohydrate chemist’s repertoire for tackling 
challenging target molecules. The simple purification opportunity permitted through the I-
Tag support saves a great deal of time, however, the synthesis of oligosaccharides is 
ultimately a highly laborious endeavour that would benefit from further innovations to 
expedite the process. 
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3.  Project Aims 
 The introduction section describes state-of-the-art work reported in the scientific 
literature for the preparation of diverse and often biologically relevant carbohydrates. 
However, it is clear that despite considerable effort, this is still a very difficult and protracted 
endeavour. Two of the key obstacles that hamper expediency in oligosaccharide synthesis are 
firstly, stereocontrol of the glycosylation reaction and secondly, tedious and time-consuming 
reactions and chromatographic purifications. The goal of this PhD project was to build upon 
previous work in overcoming these hurdles.  In the first part of the project, efficient, 
stereoselective, catalytic routes to challenging 2-deoxyglycosides that are simpler and more 
versatile than those that had been reported previously were explored. The second part of the 
project was to investigate whether, given conditions that allow for stereoselective glycosidic 
bond formation, the application of continuous flow techniques could permit faster and more 
expedient oligosaccharide synthesis. 
 As described previously, the Galan research group developed an organocatalytic α-
selective 2-deoxygalactoside synthesis that used thiourea 86 to effect glycosylation. Whilst a 
very powerful transformation, the reaction had some drawbacks, namely that only galactal 
type donors were suitable for the reaction and reactions generally took 24 – 48 hours in 
refluxing DCM to reach completion. To address these problems, it was hypothesised that the 
synergistic combination of thiourea 86 with a Brønsted acid as dual organocatalysts may 
permit a more efficient, fast and widely applicable glycosylation than either a thiourea or acid 
alone (Scheme 37).  




Scheme 37. Proposed glycosylation of glycals to form 2-deoxyglycosides through cooperative 
catalysis using a thiourea and a Brønsted acid. 
 Simultaneously, the possibility of using transition metal catalysis for glycosylation of 
glycals was evaluated. More specifically, palladium catalysis applied to 2-deoxyglycoside 
preparation from glycal donors had not been attempted in the literature prior to our work. It 
was thought that choosing an appropriate ligand in conjunction with the palladium metal may 
temper the Lewis acidity of the metal, thus biasing reactivity towards 2-deoxyglycoside 
synthesis as opposed to Ferrier rearrangement. Both the organocatalytic and palladium 
catalysed glycosylation projects were contributed to during the course of the PhD studies.  
 Firstly, a library of glycosyl acceptors and donors were prepared for use in the 
glycosylation reactions. With respect to the organocatalytic glycosylation project, a potential 
Brønsted acid was screened for its ability to synergistically catalyse the glycosylation. Also, a 
reaction using deuterated methanol as the glycosyl acceptor was explored in order to provide 
mechanistic information about the glycosylation. However, involvement with the palladium 
catalysed glycosylation project formed the bulk of early work during my PhD studies. By the 
time my work on the project began, a number of metal complexes and ligands had already 
been screened for their ability to catalyse coupling of glycals and alcohols and a “hit” had 
been discovered. The palladium(II) species bis(acetonitrile)dichloropalladium(II) 113 was 
found to have some activity with the sterically bulky phosphine ligand 2-(di-tert-
butylphosphanyl)-1-phenyl-1H-pyrrole 114. 




Figure 15. The active palladium species 113 and ligand 114 identified as being cooperative in the 
glycosylation reaction. 
 The objectives of my work throughout this stage of my PhD research were firstly to 
investigate the activity of the catalyst and optimise the reaction by altering experimental 
variables including solvent, concentration, reaction temperature and duration and 
stoichiometry of reactants. Secondly, the tolerance of the methodology for different glycosyl 
acceptor alcohols – both sugars and other simple alcohols was probed. Both the thiourea- 
Brønsted acid organocatalysis project and the palladium catalysis project were ultimately 
successful, culminating in publications published during the course of my PhD.149, 150 
 As time went on, continuous flow synthesis was surveyed as a strategy to increase 
efficiency and reproducibility of glycosylation reactions, whilst reducing the time required for 
complete reaction. Thus, attempts were made to take glycosylation protocols that had been 
developed within the Galan group as a batch reaction and translate the reaction into the 
continuous flow regime, hopefully improving the reaction by doing so.123, 151 At this point in 
time, the gold(I) catalysed glycosylation of glycal donors using gold catalyst 70 previously 
outlined in the introduction section 2.4.  (Scheme 20) had very recently been developed. The 
glycosylations had been performed in batch, however, it appeared that if suitable 
optimisation was performed, the reaction conditions could be amenable to flow.99 Therefore, 
investigations into glycosylation in the flow regime with this gold(I) catalysed protocol began. 
 Over time, another flow glycosylation opportunity presented itself that showed 
considerably more promise. The use of carbohydrates bearing I-Tags as glycosyl acceptors for 
glycosylation was probed in the manner depicted previously in Scheme 31. Whilst I-Tags have 
been pioneered in the Galan laboratory with batch reactions as described in the introduction, 
they have never been applied to the flow regime.144, 146 Thus, the aim was to translate known 
batch reactivity using I-Tags to flow glycosylation.  
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4.  Results and Discussion 
 Synthesis of Starting Materials 
 Glycosyl Acceptor Syntheses 
 At the beginning of the project, a range of glycosyl acceptors were synthesised in 
multi-gram quantities for use in catalytic glycosylation experiments. However, the majority of 
the chemistry used in these syntheses is well established, therefore only a few of the key 
preparations will be discussed in detail. For full experimental details of the library of acceptors 
that were prepared, please refer to the experimental section. 
 
Scheme 38. Synthetic route from methyl α-D-glucopyranoside 115 to methyl 2,3,4-tri-O-benzoyl-α-
D-glucopyranoside 74. 
 The preparation of C-6 primary glycosyl acceptor 74 begins with commercially 
available, cheap methyl α-D-glucopyranoside 115 (Scheme 38). Silylation of the primary 
alcohol using triisopropylsilyl chloride and imidazole in anhydrous pyridine proceeded 
smoothly over 16 h at room temperature. The large steric bulk of the three triisopropyl groups 
bonded to the silicon atom and the low reaction temperature help to ensure that only the 
most reactive primary C-6 alcohol undergoes silylation, leaving the more sterically hindered 
secondary C-2,3,4-OH groups unreacted. In the same reaction pot an excess of benzoyl 
chloride is added. The electrophilicity of the benzoyl chloride carbonyl group is sufficient to 
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permit nucleophilic attack by the pyridine solvent (or imidazole) as shown in Scheme 39. This 
is followed with nucleophilic substitution of the aromatic nitrogen species by secondary 
alcohol groups on the sugar ring. Subsequent deprotonation of the oxygen atom by the basic 
solvent completes the reaction scheme. 
 
Scheme 39. Reaction mechanism for esterification of saccharide alcohol groups. 
 Quenching excess benzoyl chloride using methanol followed by an aqueous workup 
affords fully protected glycoside 117. Deprotection of the silyl ether protecting group can be 
performed using Brønsted acid catalysed hydrolysis. In this case, stirring in a mixture of THF, 
water and trifluoroacetic acid was sufficient to fully deprotect the C-6 silyl ether group. 
Column chromatography gave primary glycosyl acceptor 74 in 67 % yield over three steps. 
 Benzylidene 120 is a useful intermediate as it is a common precursor to a number of 
different glycosyl acceptors dependent upon the deprotection strategy. Its synthesis begins 
with methyl β-D-galactopyranoside 118 (Scheme 40). Following the catalytic benzylidene 
acetal protection reported by Galan,152 the starting material was dissolved in anhydrous 
acetonitrile followed by addition of copperII triflate and benzaldehyde dimethyl acetal. 
Sonication for 70 min, deactivation of the copper catalyst with triethylamine and column 
 4.  Results and Discussion  
64 
 
chromatography gave intermediate benzylidene 119. In the benzylation step, saccharide 119 
is dissolved in anhydrous DMF, to which sodium hydride and benzyl bromide is added.  
 
Scheme 40. Synthetic route from methyl β-D-galactopyranoside 118 to methyl 2,3-di-O-benzyl-4,6-
O-benzylidene-β-D-galactopyranoside 120. 
 The strong base sodium hydride is needed to increase the nucleophilicity of the free 
alcohol groups to allow nucleophilic substitution of the bromine atom in benzyl bromide 
(Scheme 41). Sodium hydride abstracts the alcoholic proton leaving the sodium alkoxide and 
liberating gaseous hydrogen, the formation of which is both enthalpically and entropically 
favourable. This more reactive alkoxide species is then able to attack benzyl bromide, thus 
installing the benzyl protecting group on the alcohol and producing sodium bromide as a side 
product. After a methanol quench of excess sodium hydride, aqueous workup and column 
purification fully protected benzylidene 120 was obtained in 78 % yield over two steps. 




Scheme 41. Reaction pathway for alcohol deprotonation and attack of benzyl bromide. 
 Galactoside 121 can be prepared from benzylidene 120 through regioselective hydride 
delivery using triethylsilane and trifluoroacetic acid (Scheme 42). The underlying rationale for 
this regioselectivity is not well understood and is susceptible to changes in reagent and 
solvent. Nonetheless, when the reported conditions153 are replicated, excellent 
regiochemistry can be achieved in hydride delivery, allowing preparation of product 121 in 83 
% yield. 
 
Scheme 42. Regioselective reductive ring opening of the benzylidene acetal in 120 affords 
galactoside 121.  
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 Alternatively, Scheme 43 shows how acid catalysed cleavage of galactopyranoside 120 
with methanol and p-toluenesulfonic acid monohydrate affords diol 122. Treatment of 122 
with TIPSCl and imidazole in anhydrous DMF as described previously afforded galactoside 
123. 
 
Scheme 43. Synthetic route from benzylidene 120 to galactoside 123. 
 Glycal Donor Syntheses 
 In addition to the synthesis of a range of differentially protected primary and 
secondary glycosyl acceptors, some glycal donors were also synthesised. For example, 
beginning from D-galactal 124 persilylation or perbenzylation can be performed in a single 
step to afford fully protected donors (Scheme 44). In this manner tert-butyldimethylsilyl ether 
protected galactal 125 can be prepared in 87 % yield, whilst benzyl ether protected donor 126 
can be prepared in 67 % yield. 
 
Scheme 44. D-Galactal 124 may be protected in a single step to give silyl ether protected donor 125 
or benzyl ether protected donor 126 in good yield. 
 An important consideration when preparing glycosyl donors and acceptors is ensuring 
high purity of the final compound. Impurities, even in small quantities, are capable of 
poisoning catalysts and retarding glycosylation progress. In the case of donor 126, a study 
published during my PhD studies showed that when benzylation reactions using benzyl 
bromide and sodium hydride are performed using DMF as a solvent, the tertiary amine 127 is 
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formed.154 The amine 127 is formed from decomposition of DMF into carbon monoxide and 
dimethylamine and subsequent reaction of the dimethylamine, culminating in a Sommelet-
Hauser rearrangement to form 127 as shown in Scheme 45. This impurity elutes during flash 
chromatography at the same time as protected galactal 126 and is thus difficult to separate 
from the product by this method. The authors showed that amine 127 acts as a poison for 
thiourea organocatalysts such as 86 and prevents glycosylation from occurring. However, an 
aqueous acidic wash during workup protonates amine 127, extracting it into the aqueous 
phase whilst the glycosyl donor remains in the organic phase. Indeed, when perbenzylated 
donor 126 was synthesised, after initial column chromatography 1H NMR spectroscopy 
showed the presence of amine 127. To remove this, the impure compound was dissolved in 
hexane and washed with 1 M HCl (aq.), NaHCO3 (sat. aq.) and water. Following drying over 
magnesium sulfate and removal of solvent, 1H NMR spectroscopy revealed that amine 127 
had been completely removed, leaving the desired compound in high purity. 
 
Scheme 45. Dimethylamine, formed from decomposition of DMF, undergoes reaction with benzyl 
bromide and sodium hydride to form tertiary amine 127.154 
 Cooperative Organocatalytic Glycosylation 
 Experiments Using an Organocatalytic Triazolium Salt 
 Experiments using triazolium salt 128 were performed in an attempt to 
organocatalytically synthesise 2-deoxyglycosides from glycals. It is known that salt 128 can be 
deprotonated to form an N-heterocyclic carbene, and it was hypothesised that the salt, with 
its labile proton, may be able to act as a Brønsted acid. Therefore, a reaction was attempted 
using donor 126 and acceptor 41 in combination with 0.1 equivalents of salt 128 in order to 
prepare 2-deoxyglycoside 44α as shown in Scheme 46. 




Scheme 46. Attempted use of triazolium salt 128 as a Brønsted acid organocatalyst. 
Unfortunately, no product was observed even after 27 hours of reaction time. In order to 
probe the synergistic effects of salt 128 and thiourea 86 on the glycosylation, several 
experiments were performed as shown in Table 1. In entry 1 0.1 eq of thiourea 86 in 
combination with 0.1 eq of triazolium salt 128 furnished product 44 in 35 % conversion and 
α:β ratio of 4:1 as determined by 1H NMR spectroscopy. Increasing the temperature from RT 
to reflux as in entry 2 gives better selectivity but with slightly decreased yield. Finally, in entry 
3, thiourea 86 is used as the sole organocatalyst, giving product 44α in 59 % conversion. 




NMR Yield of 
Product 44 (%) 
α:β 
1 RT 35 4:1 
2 Reflux 28 α 
3a Reflux 59 α 
                                                        aReaction performed with no triazolium salt 128. 
 The results clearly demonstrate that salt 128 is not beneficial to the glycosylation 
reaction, giving worse results than when thiourea 86 is used alone. This may be rationalised 
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by considering the pKa values of the organocatalysts. Thiourea 86 has a pKa in DMSO of 8.5 ± 
0.1155 whereas triazolium salt 128 is many orders of magnitude less acidic, with a pKa of 16.5 
in aqueous solution.156 The relative lack of acidity of salt 128 is unlikely to be able to activate 
the glycal donor for glycosylation and the absence of product formation when 128 was used 
as an organocatalyst as in Scheme 46 supports this hypothesis. 
 Methanol-d4 Mechanistic Experiment 
 As the project continued, a colleague in the lab, Dr. Carlos Palo-Nieto, identified a 
cooperative Brønsted acid-thiourea organocatalysed glycosylation protocol as shown in 
Scheme 47.  
 
Scheme 47. α-selective glycosylation of glycals using a cooperative thiourea-Brønsted acid 
organocatalytic approach. 
 By utilising thiourea 86 in addition to chiral BINOL derived phosphoric acid 129, the 
glycosylation of several different glycosyl donors, including galactals, glucals and rhamnals, 
was accomplished with excellent yields and generally >30:1 α stereoselectivities in 2-6 hours 
at RT or 45 ℃. It is noteworthy that the chirality of the acid is able to influence 
stereoselectivity in the glycosyl product. Acid 129, the R enantiomer, was used to glycosylate 
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donor 126 with acceptor 41, giving the product 44 in >30:1 α:β ratio. However, when the S 
enantiomer of 129 is used, the stereoselectivity drops to 7:1 α:β. Furthermore, the 
acceleration of reaction rate by using acid 129 in conjunction with thiourea 86 relative to 
using thiourea 86 alone is supported by considering the pKa of the acid, which was calculated 
as 2.63 ± 0.08 in DMSO.157 The greater acidity of acid 129 relative to thiourea 86 will activate 
the glycal donor more rapidly than using 86 as the sole organocatalyst. 
 I performed a reaction using donor 126 with methanol-d4 as the glycosyl acceptor in 
order to help elucidate the mechanism of the reaction. The reaction is shown in Scheme 48. 
The reaction used fully anhydrous conditions; the donor and organocatalysts were dried 
under vacuum for 16 h in flame-dried glassware prior to the reaction, whilst the methanol-d4 
was dried using activated 3Å molecular sieves prior to use. The reaction gave two products 
which differ only in the isotope present in the equatorial position at C-2. In compound 130, 
the equatorial C-2 substituent is a deuterium atom, whilst in 131 this atom is protium. In both 
compounds the OCD3 group has complete α configuration, with no β anomer present. 1H NMR 
spectroscopy shows that approximately 54 % of the product is fully deuterated 130, whilst 46 
% is protium substituted 131. 
 
Scheme 48. Experiment performed using deuterated methanol-d4 as glycosyl acceptor gave a 
mixture of two isotopically labelled products 130 and 131. 
 Several important insights can be gleaned from the reaction results. Firstly, no product 
is present with an axially substituted C-2 deuterium atom. This would suggest that deuteron 
or proton addition to the glycal occurs on the bottom α face selectively (red path in Figure 
16), since only this attack orientation would lead to the equatorial deuterium seen in 130. 
Conversely, the blue path in Figure 16 does not appear to occur. This implies a syn addition 
of CD3OD across the glycal double bond. 




Figure 16. The two potential orientations for deuteron addition to galactal donor 126. The red path 
with addition to the “bottom” α face leads to observed product 130, whilst the blue path with 
addition to the “top” β face leads to an unobserved product with an axially configured C-2 deuterium 
atom. 
 Furthermore, the mixture of 130 and 131 in the observed ratios requires some 
thought. The equatorial deuterium atom in 130 must come from the alcoholic deuteron in 
CD3OD, however, close to half of the total product (product 131) has two protium atoms 
bonded to C-2. This must be as a result of either, or both, of the following: i) proton donation 
to the glycal from molecules other than CD3OD, or ii) H/D exchange between CD3OD and the 
labile protons of other molecules in the reaction mixture prior to glycal activation. In either 
case, the obviously labile protons present in the reaction mixture are the acidic proton from 
acid 129 and the two NH protons in thiourea 86 (Figure 17). If all these protons were 
incorporated into the product(s) of the reaction in place of methanol-d4 deuterons, we would 
expect to see a product ratio of approximately 130:131 = 64:36 based on the stoichiometry 
of the reaction. However, 46 % of the product mixture is 131, significantly more than 36 %. 
The only conclusion to account for this result is that other protons in the reaction mixture are 
labile enough to depart from their parent molecule and be incorporated in product 131, at 
least to some extent. No other hydrogen atoms present in the molecules of the solvent or the 
reactants ought to be labile enough to be abstracted as protons by any base within the 
reaction mixture. Therefore, the additional protons incorporated into 131 must have come 
from some adventitious compound that was unintentionally added to the reaction vessel. The 
most likely identity of this compound is water, as complete removal of water from the 
reactants may be very difficult to achieve, even with extensive vacuum drying. This 
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adventitious water as a proton source may help to explain the observed product distribution 
ratio. 
 
Figure 17. Probable sources of labile protons within the reaction mixture for the reaction shown in 
Scheme 48. 
 This reaction gives mechanistic data consistent with the mechanism proposed in the 
publication for this work,149 shown in Scheme 49, in which deuterated donor 87 was reacted 
with model acceptor 41 to give product 132 with an axial deuterium atom at C-2.  The 
formation of 132 selectively further supports the hypothesis of a syn addition of the glycosyl 
acceptor alcohol across the “bottom” α face of the glycal donor. Hence, the proposed 
mechanism involves increasing the acidity of acid 129 through hydrogen bonding with 
thiourea 86 to give a thiourea-acid complex that delivers a proton to the less hindered face 
of the glycal donor. The short-lived oxocarbenium ion formed is then trapped by the 
nucleophilic alcohol acceptor, concomitantly regenerating the acid organocatalyst. However, 
the results from the reaction using methanol-d4 as acceptor, as well as further work by 
Pápai158 and McGarrigle159 suggest that the propensity for thiourea 86 to act as a Brønsted 
acid itself, as opposed to a dual hydrogen bond donor, has been underestimated. As such, the 
limited role of thiourea 86 solely as a hydrogen bond donor in the proposed mechanism 
seems unlikely, a more plausible mechanism may involve a complex interplay between 
thiourea Brønsted acidity and hydrogen bonding. 




Scheme 49. Mechanism proposed for the synergistic organocatalytic synthesis of 2-deoxyglycosides 
using thiourea 86 and chiral phosphoric acid 129. 
 Palladium Catalysed Glycosylation 
 Optimisation of Palladium Catalysed Glycosylation 
 Prior work in the research group had identified the active Pd(MeCN)2Cl2  113 catalyst 
and ligand 114 described in the project aims. The project was then continued by myself in 
collaboration with colleagues working in the lab, primarily Dr. Abhijit Sau. The model reaction 
used to investigate this catalytic reaction is shown in Scheme 50. The chosen donor tri-O-
benzyl-D-galactal 126 and acceptor methyl 2,3,4-tri-O-benzyl-α-D-glucopyranoside 41 were 
selected for a number of reasons. Firstly, the benzyl protecting group is generally cleaved to 
liberate the free alcohol by heterogeneous catalytic hydrogenation using hydrogen gas with 
solid palladium dispersed on a charcoal support. The benzyl group is, however, stable to most 
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conditions likely to be experienced during the reaction, including acidic and basic media. 
Furthermore, the benzyloxide group is a poor leaving group. This helps to discourage the 
undesired Ferrier rearrangement which requires departure of a C-3 leaving group. Secondly, 
the acceptor is a primary alcohol. Primary glycosyl acceptors tend to exhibit greater reactivity 
than secondary acceptors on the basis of less steric hindrance in the transition states of steps 
in the reaction pathway. Moreover, galactal donors are known to generally display greater 
reactivity than their glucal counterparts. This heightened reactivity enables identification of 
conditions most conducive to rapid, selective reaction. Finally, the methoxy group present in 
the acceptor and disaccharide product(s) offers a useful handle for analysis of the crude 
reaction mixture by 1H NMR spectroscopy, since the CH3 peaks for the acceptor and both 
anomers do not overlap in the 1H NMR spectrum and hence acceptor conversion to product 
can be calculated based on integration of the peaks. 
 
Scheme 50. Model reaction for optimisation of palladium catalysed synthesis of 2-deoxyglycosides. 
 In order to assess the success of a given set of reaction conditions for the catalytic 
system in question, two basic metrics should be considered. Firstly, conversion of limiting 
reagent glycosyl acceptor 41 to the desired 2-deoxy-disaccharide product, with minimisation 
of side product formation. Secondly, the anomeric α:β ratio of disaccharide product. Ideally 
only one anomer would be formed. Table 2 summarises the reactions performed as part of 
the optimisation of reaction conditions, following the general reaction profile described in 
Scheme 50. 
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Table 2. Optimisation experiments performed and conditions used in each. All reactions were 








of 41 to 44 
(%) 
α:β 
1 0.5 1.0 MeCN 2 mL 27 2.9:1 
2 0.5 0.5 MeCN 2 mL 79 6.2:1 
3 0.75 0.4 DCM 2 mL 28 2.5:1 
4 0.75 0.3 DCM 2 mL 93 
α 
only 
5a 0.75 0.3 DCM 2 mL 53 7.8:1 
6 0.75 0.3 DCM 1 mL 99 
α 
only 
                       aReaction performed at RT. 
 In entry 1, when a stoichiometric amount of palladium complex is used, conversion to 
the product and stereoselectivity are both very poor, whilst entry 2 shows that decreasing 
the amount of palladium complex 113 to 0.5 eq gives a dramatic boost to conversion from 27 
% to 79 %. At this point in the project, a colleague’s experiments showed that DCM was a 
superior solvent for the glycosylation than MeCN, and thus further experiments used DCM as 
the solvent (refer to the publication accompanying this work for further information).150 This 
is likely due to the ability of the nitrogen atom in MeCN being able to complex the palladium 
atom, tempering its Lewis acidity, whereas DCM has no moiety that can effectively chelate 
palladium. Comparing entries 3 and 4 shows that in DCM, even a slight excess of palladium 
complex 113 relative to the 0.3 eq of ligand 114 used is extremely detrimental to product 
formation. However, in entry 4 where equivalent amounts of complex 113 and ligand 114 are 
used, excellent conversion to product as well as complete α stereoselectivity are seen. 
Reaction temperature is important for the reaction, as shown in entry 5, which shows that 
the reaction performed at RT as opposed to 50 ˚C causes a large drop in conversion and 
selectivity. Finally, in entry 6, the volume of solvent is decreased such that the concentration 
of the reaction goes from 0.06 M in donor in entry 4 to 0.12 M in donor in entry 6. In this case, 
99 % conversion to product is seen, with complete α selectivity. 
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 The conditions found in entry 6 represent the optimised conditions for the reaction, 
shown in Scheme 51, allowing the preparation of disaccharide 44 as the α anomer in 86 % 
isolated yield. These conditions were carried forward to assess the substrate tolerance of the 
reaction. My role in the project was to probe the tolerance of the method for a library of 
glycosyl acceptors. 
 
Scheme 51. Optimised conditions for palladium catalysed 2-deoxyglycoside synthesis from glycals. 
Disaccharide 44 was isolated in 86 % yield as the α anomer. 
 Acceptor Scope 
4.3.2.1.  Primary Saccharide Glycosyl Acceptors 
 Acceptor alcohols were screened according to the optimised conditions discussed 
above, with the model galactal donor 126 used in each case. The glycosyl acceptors tested in 
the catalytic system are shown in Table 3. The reaction of glucoside 74 (entry 1) proceeded 
smoothly to give very high yields of desired product, with excellent α selectivity. In entry 2, 
the thioglycoside acceptor 133 was used. The thiophenyl moiety at the anomeric position 
present in this acceptor offers the potential for further glycosylation reactions on the 
disaccharide product to give oligosaccharides. However, the concern for this acceptor was 
that the sulfur atom may irreversibly bind to the palladium atom, thus reducing catalytic 
activity and resulting in a decrease in yield. As expected, the obtained yield of 56 % was 
somewhat lower than the structurally similar acceptor 74, whilst the α selectivity observed is 
also lower.  As the project progressed, deuterated reactant studies helped to elucidate the 
probable mechanism of the reaction. Knowledge of the reaction mechanism allowed 
repetition of the experiment in entry 2 by a colleague, but by altering the order of addition of 
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reagents a yield of 84 % was obtained, as described below during discussion of the reaction 
mechanism in section 4.3.3.  













18 90 >30:1 82 
2 
 
21 - 6:1 56 (α only) 
3 
 
42 64 1.3:1 36 (α only) 
 
 Finally, in entry 3 the isopropylidene protected galactose acceptor 63 was screened. 
In this reaction, very poor α selectivity was observed, as well as low conversion to the desired 
product. This may be due to the steric hindrance caused by the 3,4 isopropylidene group. For 
benzyl and benzoyl protecting groups the large phenyl ring can be positioned far from the 
sugar ring in space by using the OCH2 or OCO groups as a “hinge”, whereas the rigid and bulky 
CMe2 group of isopropylidene is held much closer in space to the sugar ring, possibly affording 
greater steric hindrance during steps along the reaction pathway. Moreover, acceptor 63 is 
the only primary galactose derived acceptor screened. It is likely that the axial (C-4)-O 
configuration also contributes to steric clash not experienced by the equatorial (C-4)-O 
configuration seen in glucose derived acceptors.  
 A much longer reaction time of 42 h was required to achieve a reasonable conversion 
of acceptor 63, determined to be approximately 64 % from 1H NMR spectroscopy. Generally, 
separation of α and β anomers by column chromatography is difficult or impossible, but in 
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this case the anomers were successfully separated to give a pure sample of the α anomer in 
36 % yield. 
4.3.2.2.  General Primary Alcohol Acceptors 
 To evaluate the applicability of the protocol for general couplings of alcohols to glycal 
donors, a number of general primary alcohols were screened. The results of these 
experiments are shown in Table 4. 


















18 95 α only 88 
3 
 
18.5 - 9:1 63 
4 
 
17 - >30:1 96 
5 
 
23 - α only 66 
 
 In general, very pleasing α selectivity was seen, with two examples showing only α 
product formed. Furthermore, the 2-deoxy-saccharide products were obtained in good to 
excellent yields, with all reaction times under 24 h. It is worth noting that for many of these 
alcohols, it is difficult to determine a quantitative conversion from the crude 1H NMR 
spectrum, as there is no NMR “handle” signal to monitor that doesn’t overlap between 
reactant and product(s). In many cases however, it is possible to qualitatively determine 
whether significant reaction has occurred, using for example the diagnostic peaks 
corresponding to the axial and equatorial C-2 protons on the 2-deoxysaccharide ring.  
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 A complication during some of the syntheses was the purification. The presence of 
phosphine ligand 114 was detected through two principal methods: TLC and 1H NMR 
spectroscopy. TLC plates were usually stained by treatment with a solution of sulfuric acid in 
ethanol, then charred using a heat gun to enable visualisation of compounds. This staining 
method works well for carbohydrates, whether protected or unprotected, and sometimes 
shows other types of compound on the TLC plate depending upon the functional groups 
featured on the compound in question.  
 
Figure 18. A. TLC plate from the reaction to form 2-deoxyglycoside 139 as shown in Entry 1 of Table 
4. B. Section of the 1H NMR spectrum for 2-deoxyglycoside 139 showing H-2 peaks and tBu peaks 
from ligand 114. 
 Figure 18 A shows a typical TLC plate (Hexane:EtOAc 7:3) for the reaction between 
model glycal donor 126 and phenethyl alcohol 134 after an initial column purification (α and 
β anomers were successfully separated for this compound). The product glycoside 139 is seen 
as the darker upper spot at Rf ≈ 0.6, whilst ligand 114 can be seen as the streak covering Rf ≈ 
0-0.16. Figure 18 B shows a section from the 1H NMR spectrum of 139. The doublet of triplets 
and doublet of doublets on the left correspond to protons H-2a and H-2b on the sugar ring. 
The ligand impurity can be seen as the two large peaks ringed in red, corresponding to the 
C(CH3)3 signals from the two tert-butyl groups, whilst the remaining peaks seen in this section 
of the spectrum arise from impurities in the solvent.  
A B 
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 Despite the apparent high polarity of the ligand suggested by the silica TLC plate, when 
performing column chromatography the ligand tends to elute from the column at around the 
same time as other products with an Rf of ≈ 0.6 (Hexane:EtOAc 7:3); including the reaction 
products from entries 1, 4 and 5 from Table 4. Even HPLC was found to be insufficient to 
separate the mixture. After experimenting with trituration purification unsuccessfully, it was 
found that running a very long silica column at a shallow solvent gradient can at least partially 
separate the mixture to give a product of acceptable purity. Figure 19 displays a section of 
another 1H NMR spectrum of 2-deoxyglycoside 139 that has undergone a lengthy column 
purification. Integration of saccharide and ligand peaks reveals a ratio of 
1H(saccharide):9H(ligand) = 3.37:1, corresponding to ≈ 97 % purity of the product. 
 
Figure 19. Section of the 1H NMR spectrum for 2-deoxy-saccharide 139 with greater purity than that 
shown in Figure 18 B. 
 Of course, this purification difficulty only arises for products that have Rf of ≈ 0.6 
(Hexane:EtOAc 7:3). For compounds such as the heptyl 2-deoxyglycoside product from entry 
3 in Table 4 (Rf > 0.6) and the protected serine glycoside product from entry 2 (Rf < 0.6), 
purification proceeds smoothly. A further noteworthy point is that the reaction using 
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cinnamyl alcohol 138 as a substrate proceeded satisfactorily, indicating that the palladium 
complex can tolerate the presence of an alkene group in the reaction mixture without its 
catalytic activity being compromised. 
4.3.2.3.  Secondary Saccharide Glycosyl Acceptors 
 With the greater steric hindrance found for a secondary alcohol, reactivity is generally 
lower than that of primary alcohols. Table 5 documents the secondary saccharide derived 
glycosyl acceptors screened for activity in the catalytic glycosylation system. 













46 82 >30:1 64 
2 
 
45 - 4:1 72 
3 
 
45 - 3.5:1 70 
4 
 
45 - - 
Complex 
Mixture 
                          aWith a subsequent silyl ether removal step using TBAF for purification purposes. 
 As expected, yields were found to be lower than some of the primary glycosyl 
acceptors, but certainly not prohibitively low. However, in order to achieve complete 
reaction, reaction times of around 45 h were required, in contrast to the 18 h generally 
needed for primary acceptors. Entry 1 reveals that interestingly, despite the bulky C-6 TIPS 
protecting group present in glycosyl acceptor 140, good selectivity and a moderate yield were 
obtained. In entries 2 and 3, although yields are good for the reactions, the major problem is 
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poor stereoselectivity for the 6-O-benzyl acceptors 53 and 121. Finally, in entry 4, the use of 
galactose derived donor 123 bearing a C-6 TIPS protecting group gave a complex mixture of 
products from which no desired product could be isolated. 
4.3.2.4.  General Secondary Alcohol Acceptors 
 Next, the applicability of the method for a range of aliphatic and aromatic secondary 
and tertiary alcohols was examined (Table 6). Unfortunately, the results obtained were rather 
unsatisfactory, with difficulties being encountered in both selectivity and yield. Entry 1 shows 
that the electron rich aromatic glycosyl acceptor p-methoxyphenol 141 successfully gave the 
desired product in moderate yield, albeit with poor selectivity. In entries 2 and 3, acceptors 
cholesterol 142 and menthol 143 also gave the desired products, but in poor yield. Other 
glycosyl acceptors tested, including (S)-1-indanol 144, the tertiary alcohol 1-adamantol 145 
and 1-naphthol 146 did not form any of the desired product. Instead, the formation of 
deoxyglycoside 147 is confirmed by examining the 1H NMR spectra of the crude product 
mixtures from entries 4, 5 and 6.  
 2-Deoxyglycoside 147 was intentionally formed as the product of entry 4, Table 4, in 
which benzyl alcohol 137 was used as the glycosyl acceptor. However, in the entries shown in 
Table 6, no benzyl alcohol is added to the reaction mixture. The likely mechanism for the 
formation of 2-deoxyglycoside 147 is shown in Scheme 52. Under the reaction conditions with 
Pd(MeCN)2Cl2 113, Lewis acid catalysed Ferrier rearrangement of galactal donor 126 may 
occur to give cation 148 and liberate a benzyloxide anion. This anion may go on to act as a 
nucleophilic glycosyl acceptor with another molecule of donor 126, forming the observed 
product 147. This reaction pathway only appears to predominate when the reactivity of the 
desired glycosyl acceptor is low, as is the case in entries 4, 5 and 6 of Table 6. 
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Scheme 52. Ferrier rearrangement of donor 126 liberates a benzyloxide anion, which may go on to 
glycosylate another molecule of the donor to give 2-deoxyglycoside 147. 
 Mechanism of Palladium Catalysed Glycosylation 
 As the project continued, colleagues in the lab conducted mechanistic experiments, 
including deuterated reactant NMR spectroscopy studies similar to those described in section 
4.2.2. and a mechanism consistent with the experimental data was proposed (Figure 20). For 
full details of these mechanistic elucidation experiments, please refer to the publication in 
which this work was reported.150 It should be noted that no palladium oxidation states are 
given in the catalytic cycle, as no evidence for metal oxidation state was acquired; therefore 
any oxidation state assertions would be entirely speculative. However, one might consider 
that whilst complex 113 featuring palladium(II) is added to the reaction mixture, it is possible 
that the active catalyst contains palladium(0), with the metal having being reduced from 
palladium(II) in situ. 




Figure 20. Proposed catalytic cycle for the palladium catalysed glycosylation of glycals to form 2-
deoxyglycosides. 
 The cycle begins with addition of the phosphine ligand 114 to the palladium centre to 
give the active catalyst 149, the exact nature of which is unknown. This complexation of the 
palladium metal by ligand 114 serves to attenuate the catalytic activity of the catalyst by 
decreasing Lewis acidity, thereby minimising side product formation. It also helps to prevent 
direct coordination of other potential ligands through electronic and steric saturation at the 
metal centre. The reaction is then thought to proceed, not through palladium coordination 
to the glycal π bond as one might expect, but rather through addition of the alcohol acceptor 
to the palladium centre to give an alkoxy-palladium intermediate 150 with concomitant 
release of a proton. Proton catalysed glycal activation gives a short-lived oxocarbenium ion 
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that is trapped by intermediate 150 through delivery of the alkoxide to the α face of the sugar 
ring, regenerating the catalytic palladium species and furnishing the product deoxyglycoside 
with the newly formed C-2-H and C-1-O bonds cis to one another. Note that a 
hydroalkoxypalladation mechanism, in which formal alcoholic oxidative addition to palladium 
occurs to form a Pd-H bond, cannot be completely discounted. However, experiments in 
which bases 1-phenylpyrrole or potassium carbonate were added to the reaction mixture 
return only starting materials, suggesting that Brønsted acid catalysis features in the 
mechanism. 
With reference to the reaction of thioglycoside acceptor 133 as described in section 
4.6.1., mechanistic information allows far more complete reaction than the standard 
procedure followed allows. Active catalyst 149 is preformed by dissolving metal catalyst 113 
and phosphine ligand 114 in DCM, preferably with a slight excess of phosphine ligand to 
ensure the greatest conversion to the active catalyst. A separate solution of donor and 
thioglycoside acceptor can then be made up and added to the active catalyst solution, 
beginning the catalytic cycle. This order of addition of reagents means that the palladium is 
not poisoned by irreversible chelation by the sulfur atom from the acceptor, as the phosphine 
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 Glycosylation Using Continuous Flow Techniques 
 The other major facet of my research throughout my PhD aside from identifying and 
exploring novel catalytic glycosylation systems was the development of continuous flow 
techniques applied to glycosylations. Firstly, the continuous flow apparatus used will be 
described, followed by the results of gold(I) catalysed glycosylations in flow. Finally, results 
from I-Tag supported glycosylation experiments in flow will be reported. 
 Flow Reactors Used 
 Two different types of flow reactor were used for experiments for this project. The 
first approach taken was a reasonably simplistic, yet pragmatic and cheap, coil reactor (Figure 
21). The reactor was made using PTFE and/or stainless-steel tubing of the type used for HPLC 
instruments (inner diameter 0.102 cm). Two introductory tubing pieces, each connected to a 
syringe, met at a T-junction. This T-junction led to a length of reactor tubing, in which the 
reaction takes place. Solution leaving the reactor tubing may be chemically quenched in a 
receiving flask. Syringe pumps were used to flow the solution through the reactor at a well-
defined flow rate. The coil reactor was primarily used for the gold catalysed glycosylations 
discussed in section 4.5. 




Figure 21. Coil reactor constructed for flow glycosylation experiments. Here, the introductory tubing 
pieces are stainless steel, as is the T-junction. These lead to a 5 m length of PTFE reactor tubing, 
collected into a bundle, which deposits the reaction solution into the beaker. 
 
  
 4.  Results and Discussion  
89 
 
 The second flow reactor was purchased later into the project from Micronit 
Microfludics. This was a microreactor setup consisting of a microfluidic borosilicate glass slide 
with a channel etched into it, for a total internal volume of 18.7 μL (Figure 22). The 
microreactor chip features two inlet ports and a single outlet port, where PTFE tubing can be 
affixed using ferrules. The PTFE tubing used in this system has a much a smaller internal 
diameter (0.03 cm) than the coil reactor tubing, in keeping with the smaller dimensions of the 
channels in the reactor chip. The inlet tubing pieces are connected to syringes containing 
reactant solutions, whilst the outlet tubing piece leads to a receiving flask. The small 
dimensions of this microreactor chip maximise the rapid mixing and heat transfer that make 
flow chemistry advantageous, whilst proving well suited to very short residence times, or to 
small quantities of material. This reactor chip was used for the glycosylation of I-Tagged 
sugars as discussed in section 4.6.  
  
 




Figure 22. Microreactor chip used for flow reactions. The top image shows the chip in detail, with 
the inlet and outlet ports highlighted. The bottom image shows the chip fixed in its cradle, with 
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Several other factors are worth thinking through to clearly design a flow reaction. 
Firstly, the flow rate for each of the two syringes must be set at half of the desired flow rate 
for the reaction, since two solution streams are coming together, and the volume of the 
reactor remains constant. Secondly, the reagent solutions that are made up for injection into 
the flow reactor must be made up at double the desired concentration for the flow reaction. 
This is again because two solution streams are joining together and there will be twice as 
much solvent for the solutes to dissolve in when the reaction occurs. One must also consider 
some sort of quench to stop the reaction, or the reaction may continue after leaving the flow 
reactor, invalidating the residence time. In some instances, such as air or moisture sensitive 
reactions, exposure to air or a reagent grade “wet” solvent may be sufficient to quench the 
reaction. In other instances, a specific chemical must be added to the receiving flask to halt 
the reaction.  
 Fourthly, solid particles that precipitate during the chemical reaction are anathema to 
continuous flow methods, as solids can block the reaction tubing, preventing solution from 
flowing. Hence, ensuring all solutes remain dissolved is imperative for successful flow 
reactions. A final concern is the concentration of solutions that are to be injected into the 
reactor. This becomes especially relevant when small volumes of solvent are used, and the 
solution is concentrated. As the solutes dissolve in the solvent, the final volume of the solution 
may be significantly higher than the volume of solvent added. This means that the final 
concentration of the solution must be calculated using the observed final volume of the 
solution. For instance, if 0.4 mL of solvent is added to the desired solutes of known molar 
amounts, the volume of the resulting solution might be 0.5 mL. Hence, the concentration of 
solution must be calculated using a volume of 0.5 mL, not the 0.4 mL of solvent added. In 
practice, this minor difference in solution concentration ought to make little difference to the 
chemical reaction. However, it does make a difference when percentage yields are calculated, 
since the theoretical maximum yield is derived from the volume of solution that passes 
through the flow reactor, which is generally calculated by timing the flow reaction. 
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 Flow Glycosylations Catalysed by a Gold(I) Catalyst 
 Investigations into the glycosylation of glycals began following reported batch 
conditions. Gold catalyst 70, featuring an appropriate phosphine ligand, is used in 
combination with silver triflate to catalyse this glycosylation, in which reactions are generally 
complete in 30-45 min. The model reaction chosen for preliminary screening used benzyl 
protected galactal donor 126 and primary alcoholic acceptor 74 to give 2-deoxyglycoside 151. 
Disaccharide 151 was prepared in batch according to the procedure reported by Palo-Nieto 
et al.99 as shown in Scheme 53.  
 
Scheme 53. Model batch reaction for glycosylation of glycal 126 and glycosyl acceptor 74 catalysed 
by gold(I) catalyst 70. 
 For the flow reactions, the conditions shown in Scheme 53 were followed precisely, 
except for the solvent. DCM is a poor solvent for silver triflate; however, toluene allows 
dissolution of silver triflate to give a slightly cloudy mixture and does not compromise yield in 
this reaction. Since ensuring the tubing does not become blocked is very important in flow, 
toluene was chosen as the reaction solvent. One solution containing the donor and acceptor 
and another containing gold catalyst 70 and silver triflate were made up and these solutions 
were flowed directly through the nitrogen-flushed flow reactor. Reactions were quenched 
using a solution of triethylamine in DCM in the receiving flask. The first flow reaction 
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performed using this reaction protocol used the coil reactor with a residence time of 45 min 
and furnished the product disaccharide 151 in 75 % yield and >20:1 α selectivity, coming very 
close to that achieved in batch. Encouraged by this exciting result, experiments were then 
undertaken to explore the necessary residence time to allow high yields in this reaction. The 
results are shown in Table 7. All results showed very high (>20:1) selectivity for the α anomer. 
NMR yield was calculated from the 1H NMR spectrum by comparison of the OCH3 singlet peaks 
for acceptor 74 and product 151. 
Table 7. Results from early flow reactions using the coil reactor and following reaction conditions in 
Scheme 53. Residence time for the reaction was varied and yield of product according to 1H NMR 






of 74 to 
151 (%) 
1 1 33 
2 3 55 
3 5 66 
4 7.5 80 
5 10 89 
6 20 85 
7 30 80 
8 40 82 
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 The results show that under flow conditions, glycosylation can be achieved in high 
yields in a residence time of just 10 minutes (entry 5). As the time is decreased from 10 
minutes, the NMR yield steadily decreases to just 33 % conversion for a 1 minute residence 
time (entry 1-4), whilst the yield also decreases slowly if the residence time is longer than 10 
minutes, as shown in entries 6-8, suggesting a residence time of 10 minutes is the optimum 
for this reaction. This appeared to be an excellent starting point for further research, 
however, a repeat reaction of the 10 minute conditions in entry 5 of Table 7 gave a lower 
NMR yield of 63 % with no clear explanation as to why. In an effort to use less precious reagent 
and to increase reproducibility, an alternative method was devised, closely following a 
literature procedure described by Seeberger and co-workers on a similar gold catalysed 
glycosylation in flow.127 In this method, rather than making up large quantities of reaction 
solutions and flowing them directly through the reactor, the reactor can instead be flushed 
with anhydrous solvent (toluene), then a small amount of each of the two reaction solutions 
can be injected into the two introductory tubing pieces. Reconnecting solvent syringes to the 
reactor and setting the desired flow rate allows the solvent to push the reaction solutions 
through the reactor. This approach is illustrated more clearly in Figure 23.  




Figure 23. Representation of the new method for flow reactions. Two introductory tubing pieces 
deliver solvent to a T-mixer (large circle), leading to reactor tubing. In this representation, the dark 
blue lines indicate anhydrous solvent, the red and light blue lines indicate the two reactant solutions 
and the pink lines represent reacting solution resulting from the mixture of the red and light blue 
reactant solutions. 
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 Using this method (Figure 23), disaccharide 151 was synthesised in 89 % yield in a 
15 min residence time. At this point, it was decided to explore the scope of suitable glycosyl 
acceptors for the flow reaction, using the acceptors that had been reported in the batch 
publication. Primary alcohol acceptors 41 and 63 had been reacted with model glycosyl donor 
126 to give 2-deoxy disaccharide products 44 and 152 in good yield as shown in Scheme 54. 
 
Scheme 54. Previously reported batch reaction conditions for the gold catalysed glycosylation 
reaction between donor 126 and acceptors 41 and 63. 
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 Following on from the excellent yield of disaccharide 151 of 89 % in a flow reaction 
and given the batch success of acceptors 41 and 63, good results were expected when these 
acceptors were tested in flow with donor 126. Unfortunately, this did not occur. A summary 
of results can be found in Table 8.  






NMR Yield of 
Product (%) 
1 41 15 0 
2 41 15 11 
3 41 30 20 
4 41 45 30 
5 63 15 18 
 
 Generally, very poor results were obtained, even when the residence time was 
increased to match that of the batch reaction as in entry 4. Repeat reactions (entry 2 
compared to entry 1) did not give the same result. To determine the cause of the reaction 
failure, known batch reactions were repeated for acceptors 41, 63 and for benzyl alcohol 137 
with conditions matching those in Scheme 54. The results of these batch reaction are 
summarised in Table 9. 
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NMR Yield of 
Product (%) 
1 41 45 5 
2 63 45 85 
3 63 50 10 
4 137 45 0 
 
 
 Repetition of batch reactions reported to work well gave troubling and inconsistent 
results. Acceptor 41 bearing benzyl protecting groups and benzyl alcohol 137 both gave very 
low yields of desired product, whilst acceptor 63 bearing isopropylidene protecting groups 
did give the expected high yield of product (entry 2), but when the reaction was repeated 
(entry 3), a very low NMR yield of 10 % was obtained, without any clear explanation. The most 
obvious conclusion that adequately accounts for these results is that in most cases, some very 
small amount of impurity was poisoning the catalyst and preventing glycosylation from taking 
place. However, determining what this impurity might be proved exceptionally difficult, since 
the donor and acceptors all appeared to be of very high purity by 1H NMR spectroscopy. The 
fact that benzoyl protected acceptor 74 works notably well, whilst no other acceptor does, 
was also very difficult to explain. Perhaps the donor 126 contained an impurity that was 
poisoning gold catalyst 70 in most cases, but benzoyl protected acceptor 74 (or another 
impurity contained within the sample) prevented this from happening somehow. 
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Alternatively, an impurity was contained in most acceptors, but not benzoyl protected 
acceptor 74. 
 To investigate further, the role of tri-O-benzyl-D-galactal donor 126 was probed. Thus 
far, a quantity of 126 I had previously synthesised had been used.154 This had been used 
successfully in the thiourea mediated organocatalytic glycosylation protocol described in 
section 4.2.  without any issue.149 This ruled out that any significant amount of amine impurity 
was present, since it is known that amines will poison this thiourea organocatalyst and 
prevent glycosylation from occurring.154 A new quantity of donor 126 was purchased from 
Santa Cruz Biotechnology and used in a batch reaction with acceptor 41. 1H NMR 
spectroscopy revealed that after 45 min, 10 % conversion to product had occurred, whilst 
after 2 h 20 min, 70 % conversion had occurred. This would seem to indicate that the impurity 
preventing glycosylation is present in acceptor 41 rather than the donor, since even with the 
commercial quantity of donor 126, the reaction is much slower than had been previously 
reported. A reaction with a different donor, 153, was also performed, as shown in Scheme 
55. Previously in batch, disaccharide 154 had been obtained in 94 % yield over 42 min.99 
However, when the reaction was repeated, only 10 % conversion to product was seen by 
analysis of the crude 1H NMR spectrum after 45 min. This further suggests that the impurity 
poisoning the catalyst came with the acceptor. 
 
Scheme 55. Batch reaction conditions for the gold catalysed glycosylation of donor 153. 
 At this point, the colleague who had originally performed the reactions attempted to 
replicate results that he had previously obtained but came up with the same lack of success. 
To overcome this obstacle, new bottles of gold catalyst 70, silver triflate and donor 126 were 
purchased from Sigma-Aldrich. With these new reagents to hand, the batch reaction between 
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donor 126 and acceptor 41 was repeated. This time, 63 % of acceptor had converted to 
product disaccharide 44 after 45 min. Repeating the reaction with 5 mol % of catalyst 70 and 
10 mol % of silver triflate, as opposed to 3 mol % and 6 mol % as previously, gave 81 % 
conversion to product over 45 min, coming very close to the published results (89 % over 
42 min). The yields obtained showed a marked improvement over those using the old 
reagents but were still marginally lower than those previously reported. These results seemed 
to suggest that the reason for lack of reactivity may lie with purity of gold catalyst 70, and/or 
silver triflate used. The question then became, how is it that benzoyl protected acceptor 74 
underwent glycosylation so smoothly with the old catalyst bottles? The answer is far from 
clear. 
 Nonetheless, with a conversion to disaccharide product 44 of 81 % seen, the 
conditions used in the most successful batch reaction were taken forward for use in the flow 
regime. In order not to change any variables that might influence the course of the reaction, 
DCM was used as the solvent for flow as in batch, but sonication was used to help dissolve 
the silver triflate. For these reactions, both the coil reactor and the newly purchased 
microchip reactor were used. The results of these experiments are shown in Table 10. 
 Entries 1 and 2 show that on moving from batch to flow conditions, a significant drop 
in conversion to product of around 20 % is seen when acceptor 41 is used. This decrease in 
conversion is maintained irrespective of whether the reaction is in the coil or microchip 
reactor (entries 3 and 4). Somewhat more positively, when acceptor 63 is used as in entry 5, 
79 % conversion to product is seen with 45 min residence time. However, following these 
results, the decision was taken that this system is too sensitive and unreliable to be easily 
translated from batch to flow conditions and thus work on this project was halted. 
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Table 10. Results from flow reactions after having found optimised batch reaction conditions for 








NMR Yield of 
Product (%) 
1 41 Coil 45 61 
2 41 Coil 60 58 
3 41 Microchip 30 33 
4 41 Microchip 45 57 
5 63 Microchip 45 79 
 
 
 I-Tag Supported Glycosylation in Continuous Flow  
 In this project, the aim was to construct oligosaccharides in flow using the iterative 
glycosylation-deprotection-trituration sequence with sugars bearing I-Tags. In pursuing this 
goal, previous publications by Galan and co-workers described in the introduction section 2.7.  
served as a guide for the translation of batch glycosylation reactions to the flow regime.144, 
146 Consider once more the I-Tag supported batch experiments originally conducted by Galan 
and co-workers, first shown in the introduction section but reproduced here in Scheme 56.  




Scheme 56. Batch ICROS reactions previously reported by Galan and co-workers. The limitations of 
this synthesis that might be overcome through continuous flow methods are highlighted in blue. 
 This synthesis is rather elegant, but not without limitations. Transformation of glycosyl 
donor 97 to I-Tagged sugar 99 is completed over two steps in 69 % overall yield. Whilst this 
yield is reasonably high, it was hoped that this part of the synthesis could be streamlined by 
glycosylating donor 97 with an alcohol acceptor already bearing I-Tag functionality, so that I-
Tagged sugar 99 may be accessed from donor 97 in a single step and ideally in a yield higher 
than 69 %. Another problem for this synthesis is that the TIPS deprotection of 99 to form 
glycosyl acceptor 100 and the subsequent glycosylation of 100 are both overnight reactions. 
Whilst the yields are very high (>90 %) for these reactions, the long reaction times limit the 
expediency of oligosaccharide assembly using an I-Tag strategy. Furthermore, long reaction 
times of 18 hours are totally unfeasible for the microflow regime, which is much better suited 
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to fast reactions. Therefore, if these reactions were to be successfully translated from batch 
conditions to flow, reaction time would have to be dramatically reduced. The properties of 
flow reactors may permit faster reaction rates than those achievable in batch and so, with 
suitable reaction optimisation, rapid reaction times might be attainable. In this respect, the 
continuous flow glycosylation study reported by Lay and co-workers that was described in 
introduction section 2.6. proved that very fast 1 minute glycosylations could be performed in 
the flow regime in a straightforward manner. This study was an encouraging indication that 
translation of I-Tagged batch reactions to flow, with a large decrease in required reaction 
time, was possible. 
 Initial Results and Optimisation of Model Reaction 
 The model reaction for screening flow glycosylation reactions and optimising variables 
is shown in Scheme 57. Trichloroacetimidate donor 62 can be synthesised as an anomerically 
pure α glycoside in one step from the commercially available free hemiacetal 2,3,4,6-tetra-O-
benzyl-D-glucopyranose as shown. Furthermore, being an armed donor, high reactivity would 
be expected and thus 62 was chosen as the model donor. Glycosyl acceptor 155 was 
synthesised on a multi-gram scale from 3-bromopropan-1-ol and 1-methylimidazole and used 
as the glycosyl acceptor. Reactions were performed in anhydrous acetonitrile since the polar 
I-Tagged alcohol 155 was insoluble in DCM. The glycosylation reaction shown in Scheme 57 
was firstly tested under batch conditions by adding TMSOTf to a solution of donor 62 and 
acceptor 155 as shown in Scheme 58. The NCHN and NCH3 peaks present in both the acceptor 
and product provide a useful “handle” by which to determine reaction progress by 1H NMR 
spectroscopy. Encouragingly, glycoside 156 was produced in 65 % conversion from acceptor 
155, with an α:β ratio of 1:1.35.  
 




Scheme 57. Model reaction chosen to explore the glycosylation of glycosyl donor 62 with alcoholic 
I-Tag 155 to produce I-Tagged glycoside product 156. 
 
 
Scheme 58. Initial batch reaction performed using donor 62 and acceptor 155. 
With this positive batch result to hand, flow reactions and optimisation could begin 
following the conditions in Scheme 57.  
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4.6.1.1.  Optimisation of Model Reaction in a Flow Microreactor 
 A beauty of flow reactions is that many different residence times can be tested rapidly 
by simply altering the rate at which the syringe pumps depress the plungers of the syringes 
containing the reaction solution. Thus, several residence times were tested for each set of 
reaction parameters. One solution containing the donor and acceptor and another containing 
TMSOTf were prepared and these solutions were flowed directly through the flow 
microreactor chip, as shown in Figure 24.   
 
Figure 24. The experimental setup for I-Tag supported flow glycosylations in a microreactor.  
 At this stage of the project, the reaction solution leaving the outlet tubing of the flow 
reactor was fed directly into a solution of triethylamine in DCM to quench the TMSOTf, 
stopping the reaction and thus providing a precise residence time. It should be noted that the 
reaction will continue to occur in the outlet tubing after leaving the microreactor chip. The 
total volume of the reactor zone will therefore be the 18.7 μL internal volume of the chip, in 
addition to the 14.1 μL internal volume of a 20 cm length of PTFE outlet tubing, for a total 
reactor volume of 32.8 μL. This is important as the internal volume of the reactor must be 
known to calculate the necessary flow rate to achieve a particular residence time. In every 
reaction the α:β ratio of product 156 was in the range of 1:1.1 to 1:1.7. Table 11 shows the 
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results of initial optimisation experiments for the model reaction, in which the influence of 
residence time in particular was explored. 









of 155 to 156 (%) 
1a 0.05 0.2 5 61 
1b 0.05 0.2 3 62 
1c 0.05 0.2 1 62 
1d 0.05 0.2 0.5 63 
2a 0.05 0.1 5 36 
2b 0.05 0.1 3 34 
2c 0.05 0.1 1 48 
2d 0.05 0.1 0.5 50 
3a 0.10 0.2 5 32 
3b 0.10 0.2 3 44 
3c 0.10 0.2 1 66 
3d 0.10 0.2 0.5 68 
3e 0.10 0.2 0.25 66 
4a 0.10 0.15 3 66 
4b 0.10 0.15 1 69 
4c 0.10 0.15 0.5 65 
4d 0.10 0.15 0.25 64 
4e 0.10 0.15 0.10 63 
 
 In entry 1, four different residence times were tested, ranging from 5 minutes down 
to 30 seconds. Intriguingly, the variation in residence time made virtually no difference to the 
conversion of acceptor to product. α:β ratios remain essentially constant across residence 
times. In entry 2 flow reactions use just 0.1 eq of TMSOTf rather than 0.2 eq. A reduction in 
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conversion to product is seen, though interestingly this decrease in yield is more severe at 
longer residence times, though the reason for this is not entirely clear. Because of the reduced 
yield in entry 2, the amount of TMSOTf was increased to 0.2 eq once again. Furthermore, the 
concentration of all reagents was doubled, making the acceptor 0.10 M during the reaction. 
Moreover, since the faster residence times seemed to give very similar or better conversions 
to product than the longer residence times, an additional short residence time of 15 seconds 
was also performed. Entry 3 shows that as in entry 2, the highest conversions are seen in 
residence times of 1 minute or less, whilst longer residence times showed poor conversions. 
Finally, in entry 4, the concentration was maintained at 0.10 M in acceptor 155, whilst the 
stoichiometry of TMSOTf was adjusted to 0.15 eq. In these reactions, conversion to product 
was in the 60-70 % range across all residence times tested, even at a residence time of just 6 
seconds. Although, at this residence time, manually operating the flow reactor and changing 
collection flasks becomes difficult to do quickly given the very high flow rate. The results from 
entry 4 in comparison with entry 2 suggests that the concentration of reacting solution has a 
significant influence on product formation. Overall, these data clearly show that performing 
reactions at longer residence times has no benefit for the reaction, so a rapid residence time 
of 15 seconds was tested exclusively in future reactions. Further optimisation experiments 
are summarised in Table 12.  
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of 155 to 156 (%) 
1 0.10 1.5 0.15 67 
2 0.10 2.0 0.15 79 
3 0.10 2.0 0.3 85 (84)a 
4 0.05 2.0 0.3 72 
5 0.10 2.0 0.5 80 
6 0.10 3.0 0.6 81 
                                     aIsolated yield. 
 In entry 1, the amount of donor used is increased to 1.5 eq from 1.2 eq, whilst 0.15 eq 
of TMSOTf is used as previously. At a residence time of 15 seconds, 67 % conversion to 
product is seen. This is essentially the same as the 64 % conversion seen in entry 4d from 
Table 11. By further increasing the amount of donor used to 2.0 eq as in entry 2, an increase 
in conversion to product from 67 % to 79 % is observed. Entry 3 shows that using 0.3 eq 
TMSOTf, an excellent conversion to product of 85 % is observed, especially given the 
extremely short reaction time. This is even more remarkable considering that for the batch 
reactions performed earlier in the group, the glycosylation of an I-Tagged glycosyl acceptor 
was an overnight reaction. Entry 4 confirms that reducing concentration is detrimental to 
yield, with 72 % conversion compared to 85 % in entry 3. In entry 5, a higher loading of 
TMSOTf of 0.5 eq was used. This gave a slightly reduced conversion to product of 80 % 
compared to entry 3. Finally, entry 6 shows that further increasing the amount of donor to 
3 eq as well as TMSOTf to 0.6 eq does not give higher conversion to product than the 
conditions from entry 3. The conditions leading to highest conversion to product were those 
found in entry 3, in which the acceptor was 0.10 M in the reactor zone, 2 eq of donor and 
0.3 eq TMSOTf were used and the residence time was set to 15 seconds. The product 156 was 
obtained in high purity from the reaction shown in entry 3 with purification achieved through 
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simple washes using firstly water, then hexane:Et2O 1:1 to give the product in 84 % isolated 
yield and α:β ratio of 1:1.6. The optimised reaction conditions were used as the basis for 
subsequent exploration of substrate scope for this flow reaction protocol. 
 Exploration of Substrate Scope 
 Several glycosyl donors and acceptors were now subjected to the optimised reaction 
conditions discovered during the optimisation of the model reaction, as shown in Scheme 59. 
The results of these experiments are summarised in Table 13. Isolated yields reported are 
following purification by solvent washing, with no requirement for column chromatography.  
 Peracetylated donor 158 was obtained from a colleague and used in these 
experiments directly, whilst donor 159 was synthesised from tri-O-benzyl-D-glucal 36 in 26 % 
yield over four steps, featuring a selective dihydroxylation reaction across the enol ether 
double bond. In entry 1, model donor 62 is reacted with benzyl linked I-Tagged alcohol 157 
to furnish the product saccharide as an anomeric mixture in 90 % isolated yield. Entry 2 shows 
that the reaction between donor 62 and saccharide derived I-Tagged alcohol 100 also 
proceeds smoothly, giving the desired disaccharide product in 86 % isolated yield. However, 
no product could be isolated when peracetylated glycosyl donor 158 was used as in entries 3 
and 4. 1H NMR spectroscopy revealed a complex mixture, whilst TLC showed no spots 
corresponding to product. Finally in entry 5, the reaction between donor 159 and acceptor 
155 was performed, with the resulting product being isolated in 73 % yield as the pure β 
anomer, owing to the neighbouring group participation of the C-2 acetate group in donor 159 
during the glycosylation reaction.  
 The concept of armed and disarmed glycosyl donors may help to explain the results 
shown in Table 13. Armed donor 62 consistently undergoes reaction smoothly, whilst 
disarmed donor 158 does not give appreciable product formation under these conditions. 
Donor 159 is electronically super-armed in the manner reported previously by Demchenko 
and co-workers by using a participating ester protecting group at C-2, and arming benzyl ether 
groups at C-3,4 and 5. As may be expected, this reactive donor gave the desired product in 
good yield. 




Scheme 59. Optimised conditions used for exploration of the substrate scope of I-Tag glycosylation 
in flow. 
Table 13. Results of flow glycosylation experiments using different glycosyl donors and acceptors. 
Entry Donor Acceptor Result 
1a 
  




















73 %, β 
only 
 
aReaction performed with 3 eq donor and 0.6 eq TMSOTf. 
 At this point in the project, the use of mass spectrometry as a tool for the analysis of 
crude reaction mixtures became important, especially since the reactions that did not 
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proceed smoothly produced a complex mixture that was difficult to analyse accurately by 
NMR spectroscopy. However, it is not possible to accurately determine a percentage yield 
value from mass spectrometry, since the signal intensity observed is affected by several 
factors, not just quantity of compound. Furthermore, at this point, it became apparent that 
triethylamine was a potentially poor choice as a quenching agent for this reaction. This is 
because the triethylammonium salts that can form upon quenching may be difficult to 
separate from the I-Tag, which is itself an ammonium salt. Instead, it was reasoned that 
contact with water in the atmosphere and in the reagent grade solvent in the collection flask 
would be sufficient to stop further reaction from occurring. Evidence acquired by monitoring 
the reaction mixture exiting the flow reactor by 1H NMR spectroscopy confirmed this 
hypothesis, since no change in ratio of starting material and product was seen over time, even 
with no triethylamine or other chemical quenching compound added to the receiving flask. 
This indicated that no further reaction was occurring after the solution exited the outlet 
tubing of the flow reactor, and hence the calculated residence time was accurate. 
 Reactions Using Triisopropylsilyl Ether Protected Donors 
Next, the reaction between orthogonally protected donor 97 and I-Tagged alcohol 155 
was tested. The use of donor 97 is important, as complete or at least very high anomeric 
selectivity, achieved in this case through neighbouring group participation, is imperative for 
oligosaccharide assembly. Moreover, the presence of an orthogonal protecting group at C-6 
is essential for the glycosylation-deprotection-trituration sequence to prepare β-1,6-glucans. 
The results of the experiment are shown in Scheme 60.  




Scheme 60. Outcome of the reaction between donor 97 and acceptor 155 using the optimised 
reaction conditions. 
Since donor 97 was used extensively in previous publications, the expectation was that 
this reaction would work. However, the results from the reaction were disappointing. TLC 
indicated that two species were present that had a polarity in the range that would be 
expected for I-Tag product 99, though both appeared to be formed in very low yield, with the 
majority of carbohydrate material visible by TLC being of a polarity that would be expected 
for a neutral protected carbohydrate molecule. NMR analysis of the crude reaction product 
mixture revealed predominantly unreacted acceptor 155 was present. Trituration of the 
crude material using water, then hexane/diethyl ether was performed. NMR analysis of the 
residue revealed two species that appeared largely similar by NMR, that were not anomers. 
A LC-MS experiment elucidated the identity of the two species. One species was the desired 
product 99, the other was TIPS-deprotected product 100. It appeared that under the reaction 
conditions, the TIPS group could be deprotected during the reaction. However, there was no 
evidence by mass spectrometry that 6-hydroxyl product 100 had reacted with another 
molecule of 97 to form a disaccharide. Since the deprotection of the TIPS group was the next 
step in the synthetic pathway, if the TIPS deprotection was not competitive with the desired 
glycosylation reaction, it was reasoned that this deprotection may not be an issue. However, 
at this stage, the products 99 and 100 could not be fully purified. In order to ameliorate the 
reaction using orthogonally protected donor 97, further reaction conditions were screened 
moving forward. 
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 The use of TfOH as the activator in the next reaction in place of TMSOTf gave virtually 
identical results to using TMSOTf. The crude product was analysed by LC-MS, which indicated 
that of the glycosylation product that formed, approximately 58 % still bore the TIPS group, 
whilst 42 % had lost the TIPS to furnish the free alcohol. Following trituration with 
hexane/diethyl ether, the residue was dissolved in a solution of HCl in methanol to fully 
deprotect the product. Purifying the resultant alcohol 100 by trituration yielded pure product 
as the β anomer, but in very low yield (<10%). Experiments continued to try and improve the 
yield of the reaction.  
In future experiments between donor 97 and acceptor 155, the outlet tubing from the 
flow reactor was fed directly into a methanolic HCl solution to immediately complete TIPS 
deprotection whilst simultaneously halting glycosylation. Further experiments indicated that 
the product can degrade if exposed to aqueous sodium hydroxide, hence the acidic methanol 
should not be neutralised, but simply transferred to an aqueous phase through dilution with 
water and DCM, retaining the product in the DCM phase. In the next experiment, after 
purification by trituration, I-Tagged alcohol 100 was obtained in less than 15 % yield and could 
not be entirely purified, with small amounts of impurity remaining in the sample. It appeared 
that there was no way to increase the yield to useful levels. Another issue was that during 
some of the reactions between donor 97 and acceptor 155, solid particles began to form in 
the microreactor chip and/or the outlet tubing, preventing solution flow. This led to 
irreversible blockage of the reactor. Considering the persistently poor yields amongst other 
problems, the reaction conditions were re-evaluated to ensure they were optimal. 
Thus far, the only variable that had not been changed that was likely to cause a 
meaningful increase in product yield was temperature. It was reasoned that in the reaction 
between the disarmed, less reactive donor 97 and acceptor 155, an increased reaction 
temperature might help the reaction to progress further, whilst stopping the insoluble 
particles from precipitating out of solution. To elevate the reaction temperature, the reactor 
was submerged in an oil bath at 75 ˚C. Since only the reactor, not the outlet tubing, was at 
75 ˚C, the residence time was adjusted to use the 18.7 μL reactor chip as the internal volume, 
whilst the outlet tubing reaction at room temperature was considered as “background 
reaction”. It is also probable that the glycosylation would be complete by the time the 
reacting solution entered the outlet tubing at RT after spending 15 seconds in the reactor chip 
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at 75 ˚C. In some cases, the residence time was reduced from 15 seconds to 10 or 6 seconds. 
This was done to keep flow rate high and prevent the solid particles from precipitating in the 
reactor, though previous evidence acquired during the optimisation of the model reaction 
suggests that a small change in residence time would have a very minor effect on the reaction. 
The 75 ˚C experiments performed are summarised in Table 14. In each of the five entries, the 
same reaction was performed, except with small alterations in residence time as described. 
Table 14. Flow glycosylation experiments performed at 75 ˚C using donor 97 and acceptor 155 with 













 Perhaps the most striking feature of the results contained in Table 14 is the huge 
discrepancies in yield encountered for the same reaction. Additionally, whilst the high 
temperature prevented solid particles from forming in the reactor, they did sometimes form 
in the much cooler outlet tubing, blocking it. Overall, very poor conversions were achieved in 
this reaction, despite this donor working well in batch reactions in previous work. 
 Alongside experiments using donor 97, experiments were also performed using super-
armed donor 160 (Scheme 61). The reasoning behind this was that some success had been 
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achieved using super-armed donor 159 and therefore another super-armed donor might 
work well. When this donor was tested using the optimised reaction conditions at room 
temperature, the yield of product 161 was only 14 % (Table 15). Further reactions altered the 
reaction temperature to both higher and lower reaction temperatures. The logic behind these 
changes was that a higher temperature might encourage reaction if the reactivity of the 
substrates was low. Conversely, if the donor was highly reactive, it could be reacting 
intramolecularly or rearranging before glycosylation could happen, in which case lowering the 
temperature might stabilise the donor in order that glycosylation is able to take place. Indeed, 
this appeared to be the case, since the NMR yield of product 161 at 75 ̊ C was 11 %, increasing 
to 18 % when the reaction temperature was lowered to -10 ̊ C. Ideally, the temperature would 
have been lowered further still, but -10 ˚C was found to be the minimum accessible 
temperature. This was because lowering the temperature any more caused the solutes to 
precipitate out of solution in the flow reactor. 
 
Scheme 61. Reaction conditions used when investigating donor 160 as a suitable donor for flow 
glycosylations of I-Tags. 
Table 15. Flow glycosylation experiments performed at different temperatures using super-armed 




NMR Yield of 
Product 161 (%) 
1 RT 14 
2 75 11 
3 -10 18 
 
 One observation from experiments using donor 160 was seen that led to an improved 
silyl ether deprotection step. As in the case of donor 97, after the flow glycosylation reaction 
was performed, a mixture of I-Tagged product still bearing the TIPS group and product 161 
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that had lost the TIPS group were present in the crude residue from each reaction. This 
mixture was subjected to a methanolic solution of HCl to effect complete TIPS deprotection, 
a reaction generally taking at least 3 hours to complete. However, this led to an undesired 
side product observed by LC-MS. The mass of the product and its polarity relative to 161 
suggested the loss of an acetyl group, and thus the side reaction that leads to this product is 
postulated in Scheme 62. Acid catalysed transesterification of the O-2 acetyl protecting group 
with methanol was observed, leading to an inseparable mixture of acetyl protected 161 and 
deprotected diol 162. To overcome this obstacle, a solution of HCl in diethyl ether was used 
instead. Since ethers are much less nucleophilic than alcohols, it was hypothesised that this 
solvent would keep the acetate protecting group intact. This turned out to be correct and no 
acetate group removal was seen by mass spectrometry. Furthermore, the TIPS deprotection 
proceeded much faster in ether than in methanol, with reaction times reduced to only 10-30 
min. It should be noted that addition of water to the HCl/ether solution degraded the 
saccharide product 161, therefore, the workup first requires evaporation of the HCl/ether 
solution under reduced pressure prior to aqueous washes. 
 
Scheme 62. A solution of HCl in methanol can cause undesired deprotection of the C-2 acetate 
protecting group. 
 Although several important discoveries had been made, the general story was a 
disappointing lack of high yields with any donors apart from the model donor 62 and super-
armed donor 159 (Figure 25). It became apparent that a constant factor in the donors that 
hadn’t worked (apart from peracetylated donor 158) was the TIPS protecting group at C-6. An 
especially stark difference in reactivity was observed between super-armed donors 159 and 
160, which are differentiated solely by the C-6 protecting group. It was reasoned that the TIPS 
group is rather sterically bulky, obstructing the β face of the sugar ring. It also tends to be 
deprotected during the flow reaction, potentially inhibiting the glycosyl donor from being 
glycosylated.  




Figure 25. Donors used in flow glycosylations. 
To investigate this idea further, the identity of the unknown solid compound that had 
tended to block the reaction tubing during flow glycosylations with benzoyl protected donor 
97 was elucidated. To do this, donor 97 was dissolved in dry acetonitrile in a vial to make a 
solution of the same concentration as was used for the flow reactions, to which TMSOTf was 
added directly. The mixture was swirled for 3 minutes, then reagent grade “wet” acetonitrile 
was added along with air exposure to quench the reaction. The solid compound did not 
precipitate from solution directly but appeared when the solvent was evaporated. The crude 
product was purified by washing with a small amount of acetonitrile three times. The 
unknown compound was insoluble in water, but soluble in DCM and chloroform. NMR 
spectroscopy and MS analysis elucidated the identity of this compound as 1,6-anhydro sugar 
163 (Scheme 63). A particularly diagnostic characteristic for this compound was the change 
in J coupling values in the 1H NMR spectrum for H-2,3 and 4 according to the Karplus equation, 
as the six membered chair conformation switches from the 4C1 conformer to the 1C4 
conformer. Under the reaction conditions, it appears that the Lewis acid TMSOTf activates 
the trichloroacetimidate group as expected. However, if the TIPS group has been lost to give 
a free alcohol at O-6, it appears that this alcohol group can act as a nucleophile competitively 
with acceptor 155. Intramolecular formation of a glycosidic bond furnishes 1,6-anhydro sugar 
163. In this case, the lack of reactivity in the intermolecular glycosylation for donors 97 and 
160, both of which have an O-6 TIPS group, is well explained, since they are reacting 
intramolecularly before intermolecular glycosylation can occur, limiting yields of desired 
product to usually 10-20 %. 




Scheme 63. Suggested mechanism for the intramolecular transformation of glycosyl donor 97 to 
1,6-anhydro-β-D-glucose-2,3,4-tri-O-benzoate 163 with Lewis acid TMSOTf. 
 At this point, the conspicuous question that arose was: why is it that the TIPS group is 
totally stable to TMSOTf during batch reactions at room temperature overnight, but is not 
stable with the same reagents in flow? The reaction being performed in flow was clearly not 
essential, since 1,6-anhydro sugar 163 was synthesised in a “batch” vial. Most other reaction 
parameters, including temperature and solution concentration were the same or similar in 
the flow reactions compared to the batch reactions. Therefore, the only difference envisaged 
to be influential was solvent. Presumably DCM, used during previously performed batch 
reactions, must protect against TIPS cleavage, where acetonitrile does not. A publication by 
Li and co-workers describes similar reactivity in the formation of 1,6-anhydro sugars from 6-
O-TBDPS protected substrates using perchloric acid supported on silica.160 The authors 
suggest a mechanism (Scheme 64) by which an oxocarbenium ion is generated through acid 
catalysed departure of the anomeric leaving group to produce an oxocarbenium ion. The 
intermediate ion is stabilised by interaction with the acetonitrile solvent, allowing 
conformational switching from the 4C1 conformer to the 1C4 conformer, which can then 
undergo intramolecular nucleophilic substitution to give 1,6-anhydro sugar 164. It is likely 
that a similar mechanism is responsible for the formation of 1,6-anhydro sugars in the I-Tag 
supported flow glycosylation system, suggesting that the acetonitrile solvent might be 
responsible for the differences in reactivity between the flow glycosylations and the batch 
glycosylations in DCM performed previously. Although, this explanation does not account for 
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the anchimeric assistance from the C-2 benzoyl group, which is also likely to stabilise the 
oxocarbenium ion in a similar way to acetonitrile solvent.  
 
Scheme 64. Mechanism proposed by Li and co-workers for the formation of 1,6-anhydro sugars 
164 from the corresponding 6-O-silyl ether protected glycosides.160 
TIPS protected donor 97 was treated with TMSOTf in DCM to learn whether 1,6-
anhydro sugar 163 is formed and determine whether the solvent is the key issue. It turned 
out that using DCM as the solvent, some product 163 is indeed formed as determined by 
qualitative 1H NMR analysis, amongst other products, but not as completely as in acetonitrile. 
It appears that since DCM does not interact with the oxocarbenium ion to the same extent as 
acetonitrile, it may prevent TIPS deprotection and formation of 163, however, this prevention 
is not complete. Presumably during a glycosylation reaction using a TIPS-bearing donor such 
as 97, the formation of 1,6-anhydro product 163 and the formation of the desired glycoside 
are in competition. The solvent can influence which product is favoured, with acetonitrile 
favouring intramolecular reaction to make 163 whilst DCM favours intermolecular 
glycosylation. 
To further investigate the influence of solvent on a glycosylation in flow, a reaction 
using glycosyl acceptor 102, featuring benzyl-linked I-Tag2, with donor 97 was performed. 
Acceptor 102, unlike the more polar acceptor 155, is soluble in DCM and so a flow reaction 
using DCM as solvent could be performed. It was thought that under these conditions, high 
yields of glycosylation product might be obtained using donor 97, as was the case in batch 
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reactions. Unfortunately, this was not the case, as shown in Scheme 65. Pathway A shows the 
result of a previously performed reaction in batch. Under these conditions, disaccharide 165 
is formed in high yield, with no loss of the TIPS group.146 Conversely, pathway B shows the 
result of a flow glycosylation I performed under very similar conditions, using DCM as the 
reaction solvent. A mixture of disaccharides 165 and TIPS-deprotected 166 were observed, 
with a combined conversion from acceptor 102 of approximately 50 %. Furthermore, I 
performed a flow experiment using disaccharide 166 as glycosyl acceptor with donor 97 to 
make a trisaccharide. The trisaccharide was observed once again as a mixture of product still 
bearing the TIPS group and its desilylated counterpart, but in just 42 % combined conversion 
compared to 94 % isolated yield of the TIPS-bearing trisaccharide using the same reagents in 
batch. 
Whilst the conversion to product of 40-50 % using DCM as the solvent in the flow 
reactions is significantly better than the 10-20 % seen when MeCN is used, it is substantially 
worse than the very high batch yields of product previously reported. Presumably the low 
conversion in flow results from the donor reacting intramolecularly to form 1,6-anhydro sugar 
163, despite DCM being used as solvent rather than MeCN. Furthermore, partial loss of the 
TIPS group on the glycosyl product appears to be unavoidable in flow, regardless of solvent 
choice, but is not observed whatsoever in batch. These curious results highlight that the 
continuous flow regime seems to open and exploit new regions of chemical reactivity not 
observed under batch conditions. Whilst in this instance the observed reactivity was 
unwelcome, it is noteworthy that the flow regime not only changes the rate of reactions but 
can also alter the fundamental chemistry that occurs compared to batch. 




Scheme 65. Batch and flow reactions in DCM using the same glycosyl donor and acceptor. A. 
Conditions and result of previously performed batch reaction using donor 97 and saccharide derived 
acceptor 102.146 B. Flow reaction I performed using the same donor and acceptor.  
 Consideration of Alternative Protecting Group Strategies 
In order to move forward with the project, new glycosyl donors were required. The 
choice of protecting groups was paramount and had to meet several criteria. Firstly, the O-2 
protecting group had to be able to participate anchimerically during the glycosylation 
reaction, or a mixture of anomers could be formed. Secondly, the O-6 protecting group had 
to be installed selectively on O-6. Thirdly, the O-6 protecting group had to be stable under the 
glycosylation conditions, or the undesired 1,6-anhydro sugar could form again. Fourthly, the 
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O-6 protecting group had to be stable during manipulations of other protecting groups 
around the molecule. Finally, the O-6 protecting group had to be orthogonal or semi-
orthogonal to the protecting groups at O-2,3 and 4 so that it could be selectively removed to 
permit oligosaccharide assembly. 
 Several protecting groups initially appeared to be sensible choices, but upon closer 
inspection do not meet all the criteria listed. para-Methoxy benzyl ethers are easy to install 
and stable to many reaction conditions used in chemical carbohydrate synthesis, whilst 
removal with one electron oxidising agents such as ceric ammonium nitrate (CAN) or DDQ is 
generally selective and high yielding.8 However, literature reports suggest they are not always 
stable with respect to TMSOTf,161 and thus the undesired 1,6-anhydro product could result. 
The tert-butyldiphenylsilyl ether (TBDPS) protecting group can be installed selectively at O-6 
in the presence of secondary hydroxyl groups and is more stable towards acid catalysed 
hydrolysis than the TIPS group. However, the publication by Li and co-workers indicates the 
TBDPS group could also be cleaved under the reaction conditions, likely making it unsuitable.  
 A good choice for the O-6 protecting group might be an allyl ether, since they can be 
selectively removed in the presence of most other protecting groups using a heterogeneous 
palladium catalyst. One potential problem with this group is unwanted reactivity during 
deprotection of anomeric protecting groups. Common anomeric protecting groups such as 
thioethers or para-methoxyphenyl ethers are usually deprotected using N-bromosuccinimide 
(NBS) and CAN respectively. Both reagents are likely to react with the C=C double bond found 
in the allyl ether and so an allyl ether group may be synthetically challenging to install 
orthogonally. Finally, the chloroacetate group was considered as an O-6 protecting group. It 
ought to be stable towards TMSOTf, is reasonably straightforward to install, and can be 
removed selectively in the presence of other ester protecting groups such as benzoyl or 
acetate groups.162 
Acetyl protecting groups are quick and easy to install, for example on O-2,3,4, 
however, if C-6 has an unprotected free alcohol, O-4 acetate groups are known to frequently 
migrate to O-6. Thus benzoyl, or perhaps pivaloyl (tert-butyl) esters are better suited as O-
2,3,4 protecting groups, since they are more stable with respect to migration. 
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When all the above considerations were taken into account, it was decided that donor 
167 should be a suitable donor for construction of β-1,6-glucans in flow, and thus it was 
synthesised as shown in Scheme 66. Donor 167 can be synthesised in five steps from D-
glucose 1. Whilst yields are generally fairly low, this is partially offset by the small number of 
steps required to synthesise the donor from simple starting materials. Anomeric protection 
using the N,O-dimethylhydroxylamine group can be performed on glucose directly in water 
to give 168 in 62 % yield. The chloroacetate group can then be regioselectively introduced to 
the primary C-6 alcohol at low temperature to give 169, with subsequent perbenzoylation 
affording fully protected 170 in 46 % yield over two steps. Removal of the anomeric protecting 
group with NCS followed by formation of the trichloroacetimidate group furnishes donor 167 
in 25 % yield over two steps. The low yield seen here is primarily due to loss of compound 
whilst performing column chromatography of donor 167. It is known that 
trichloroacetimidate donors can degrade when exposed to mildly acidic silica gel. Generally, 
it is possible to circumvent this problem by using a small volume of triethylamine in the 
column chromatography solvents to neutralise the silica. However, in this instance, that 
strategy was ineffective, since the isolated yield was low regardless of silica neutralisation. 
Nevertheless, with donor 167 in hand, it could be tested for its suitability in flow glycosylation 
reactions.  




Scheme 66. Synthetic route to make donor 167 from glucose 1. 
 Influence of Temperature on Glycosylations 
 The reaction of donor 167 with acceptor 155 to give I-Tagged glycoside 172 using the 
optimised flow reaction conditions at RT pleasingly showed 85 % conversion to product, 
present entirely as the β anomer,  as shown in entry 1 of Table 16. The high conversion 
observed may challenge the importance of the armed-disarmed donor concept under these 
specific flow glycosylation conditions, as donor 167 is certainly disarmed, but gives the same 
product conversion as armed model donor 62 under the same reaction conditions. However, 
given the disarmed nature of the donor, the temperature dependence of glycosylation 
reactions using donor 167 was probed in order to increase yield still further.  
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Table 16. Temperature dependence of the glycosylation reaction using donor 167 and acceptor 155. 
 
Entry Temperature / ˚C 
NMR Yield of 
Product 172 (%) 
1 RT 85 
2 0 81 (67)a 
3 50 94 
4 75 90 
                                                              aIsolated yield. 
 Different temperatures were achieved by submerging the flow reactor in either an ice-
water bath or an oil bath set at an elevated temperature. Entry 2 of Table 16 reveals that 
performing the reaction at 0 ˚C is mildly detrimental to the reaction, giving 81 % conversion 
to product 172 compared to 85 % at RT. Conversely, elevating the temperature to 50 or 75 ˚C 
is beneficial to reaction progress (entries 3 and 4), with 94 % conversion at 50 ̊ C being optimal 
for this reaction. 
 At this point, the model reaction between donor 62 and acceptor 155 was revisited to 
investigate temperature dependence in this system. The results are summarised in Table 17. 
In this case, both lowering and raising the temperature of the reaction (entries 2,3 and 4) 
appears to be marginally beneficial for the reaction, although the best result was obtained by 
lowering the temperature to 0 ˚C. By contrasting the experimental results of temperature 
dependence, the reactivity difference between the disarmed donor 167 and armed donor 62 
is highlighted. It appears that in the case of 167, raising reaction temperature helps to 
overcome the inherent lack of reactivity for this donor up to 50 ˚C. Raising the temperature 
still further to 75 ˚C may result in undesired side reactions that begin to cause a dip in 
conversion to the desired product. In the case of donor 62, raising the temperature does seem 
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to boost reaction progress a little, but lowering the temperature may help to temper the high 
reactivity of the donor, resulting in the highest product conversion observed. 
Table 17. Temperature dependence of the glycosylation reaction using armed model donor 62 and 
acceptor 155. 
 
Entry Temperature / ˚C 
NMR Yield of 
Product 156 (%) 
1 RT 85 
2 0 94 
3 50 90 
4 75 90 
 
 With the optimal temperature for the reaction using donor 167 found, experiments 
could progress in order to try and build an oligosaccharide using this key structural motif. 
 Reactions Using a Chloroacetate Protected Donor 
4.6.6.1.  Deprotection Conditions 
 With I-Tagged product 172 in hand, the next step was to determine deprotection 
conditions for the chloroacetate group at C-6. Vliegenthart and co-workers reported the 
tertiary amine DABCO as a selective dechloroacetylation reagent (Scheme 67).162 DABCO 
selectively cleaves the chloroacetate group on the substrate in the presence of benzoyl esters 
in just 45 min. Furthermore, no benzoyl neighbouring group migration is observed. This 
approach therefore seemed like an ideal deprotection strategy for the I-Tagged glycoside 172. 




Scheme 67. Orthogonal dechloroacetylation reaction reported by Vliegenthart and co-workers.162 
 Unfortunately, the dechloroacetylation reaction of 172 did not proceed as smoothly 
as expected (Scheme 68). By MS quantitative conversion of starting material to a single peak 
at m/z 615.0 was seen which suggested complete reaction. However, TLC showed two spots 
in the expected polarity region rather than one, whilst 1H NMR spectroscopy revealed that 
neighbouring group migration had occurred. Under the basic reaction conditions, benzoyl 
migration from C-4 to C-6 took place rapidly, forming an inseparable mixture of the desired 
C-6 alcohol 100 and undesired C-4 alcohol 173. Further experiments were performed 
adjusting stoichiometry of DABCO and solvent used, but neighbouring group migration was 
found to occur in all cases. 
 
Scheme 68. Dechloroacetylation using DABCO leading to an inseparable mixture of desired product 
100 and neighbouring group migration product 173. 
 To overcome this problem, a deprotection strategy that did not use basic conditions 
was needed. Earlier in the project it was discovered that a methanolic solution of HCl partially 
cleaved the acetate group of I-Tagged glycoside 161 over 16 h (Scheme 62). It was reasoned 
that since the carbonyl group in a chloroacetate group is more electrophilic than the carbonyl 
group in an acetate group owing to the inductive electron withdrawal of the chlorine atom, 
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the chloroacetate group should be at least equally, if not more, susceptible to acid catalysed 
transesterification than the acetate group. To test this hypothesis, 172 was treated with 20 
eq of a 0.8 M HCl solution in methanol. Pleasingly, after 3 h reaction, NMR spectroscopy 
revealed desired deprotected product 100 as the sole product (Scheme 69).  
 
Scheme 69. Acid catalysed transesterification of the chloroacetate group in 172 occurs selectively to 
give product 100 quantitatively. 
4.6.6.2.  Flow-to-pot Glycosylation-Deprotection Strategy 
 From this point onward, I-Tag2 was preferentially used over I-Tag1, since the final step 
of the I-Tag supported oligosaccharide preparation would be I-Tag cleavage. This is much 
simpler with benzyl linked I-Tag2 than with propyl linked I-Tag1. It was envisaged that a rapid 
and straightforward two step glycosylation-deprotection strategy may be performed using 
donor 167. As had been previously done with the TIPS protected donors, the glycosylation 
solution leaving the flow reactor was fed directly into a methanolic HCl solution to facilitate 
immediate dechloroacetylation. Subsequent purification through solvent washing affords the 
pure I-Tagged saccharide product with a free C-6 hydroxyl group. Using this strategy, 
glycoside 102 was prepared in 92 % yield over two steps, as shown in Scheme 70. This was an 
excellent starting point from which to begin building an oligosaccharide chain. 




Scheme 70. Rapid glycosylation-deprotection-trituration strategy affords glycoside 102 in excellent 
yield over two steps. 
4.6.6.3.  Irreproducibility of Reactions Using a Chloroacetate Protected Donor 
 Excellent glycosylation results using donor 167 had been obtained. Frustratingly, these 
results were subsequently found to be irreproducible. Glycosylation experiments using either 
acceptor 155 or 157 were performed many times in an attempt to replicate the earlier results 
obtained (Scheme 71). A huge range of conversions to product were recorded by NMR 
spectroscopy, ranging from just 25 % at the lower end up to 78 % at the higher, though this is 
still substantially lower than the conversions of >90 % seen previously. The conversion to 
product percentage figure appeared to be almost random when performing consecutive 
experiments, with no clear pattern.  
 
Scheme 71. Highly inconsistent results were found when donor 167 was used for subsequent 
glycosylations. 
 Initially, reaction conditions in the experiments described in Scheme 71 were 
maintained precisely the same as the experiments that had been previously performed. When 
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these conditions failed to give the same high yields as they had previously, variables were 
altered to determine the cause of the problem. Purification of glycosyl acceptors 155 and 157 
by reverse-phase HPLC and freeze-drying had no effect on glycosylations, suggesting that 
moisture or an impurity in the acceptor was not the issue. Distillation of TMSOTf and ensuring 
the use of very dry solvent similarly did not improve the reaction. The donor 167 was also 
dried thoroughly under high vacuum to remove any volatile impurities or solvents, including 
water, that may be preventing reaction from taking place. This measure also had no effect. 
Glycoside 102 was used as an acceptor with donor 167 to determine whether a different 
acceptor may help, however the result, shown in Scheme 72, was disappointing. 1H NMR 
analysis of the crude material showed 21 % conversion of acceptor 102 to product 
disaccharide 166. Disaccharide 166 was obtained in just 15 % isolated yield following HPLC 
purification. 
 
Scheme 72. Reaction of glycosyl acceptor 102 with donor 167 and subsequent dechloroacetylation 
gave disaccharide 166 in poor yield. 
 Finally, all variables were maintained other than the donor in a control experiment. 
Using model perbenzylated donor 62 with acceptor 155 once again gave product 156 in 93 % 
conversion, as would be expected from previous results. This experiment confirmed that 
whatever issue was preventing glycosylation from occurring came from the donor 167. Donor 
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167 had at this point been synthesised a total of three times, each by different synthetic 
routes. The first two quantities synthesised (the synthetic pathway for one of which is shown 
in Scheme 66) had worked well in the glycosylation. However, the third quantity prepared 
had never worked well. It was therefore assumed that whatever was preventing glycosylation 
from happening must be some impurity in the third quantity of donor 167. However, by 1H 
and 13C NMR analysis, this quantity of donor was at least as pure as the first two, if not more 
so, as shown in Figure 26. The third quantity was subjected to column chromatography 
purification once again to try and remove any impurity that may be interfering with the 
glycosylation. Subsequent use of this purified quantity of donor 167 in a flow reaction proved 
the column chromatography to be ineffective, as conversion to product 174 was just 32 %. 
Next, the donor was dissolved in DCM and aqueous washes with water and brine were 
performed to remove any inorganic salt impurities in the donor sample that would not be 
visible through 1H and 13C NMR spectroscopy. Subsequent solvent removal and another 
glycosylation test proved that the aqueous wash had made no difference to the glycosylation 
outcome. 
 To overcome whatever problem there was with the third quantity of donor 167, a 
fourth quantity was prepared following the synthetic route shown in Scheme 66, with the 1H 
NMR spectrum shown in Figure 26. As the donor obtained through this route had worked well 
previously, it was hoped that another quantity of donor prepared this way would also perform 
well in glycosylations. However, when a glycosylation reaction was performed using the 
fourth quantity of donor 167 and acceptor 157, a poor conversion to product 174 of 
approximately 47 % was seen, demonstrating that the synthesis route was not the cause of 
the problem.  
 Often, when purifying trichloroacetimidate donors by column chromatography, a 
small amount of triethylamine added to the elution solvents may help to prevent acid 
catalysed hydrolysis of the donor. This had been the purification strategy for most of the 
trichloroacetimidate donors synthesised by my hand, for example model donor 62, and no 
issues had been encountered. But it was reasoned that if residual triethylamine, or salts 
thereof, were present in donor 167, even in very small quantities, they may quench the 
TMSOTf and retard glycosylation. Thus, the fourth quantity of donor 167 was subjected to 
column chromatography once again, but this time with no triethylamine added. Testing the 
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freshly purified sample with acceptor 155 showed just 25 % conversion to product 172. 
Analysis of the crude reaction mixture by MS and NMR spectroscopy revealed mostly 
hydrolysed donor 171. 
 
Figure 26. Comparison of the 1H NMR spectra of the four quantities of donor 167 synthesised. Using 
the 1st and 2nd quantities of donor 167 gave high yields of glycoside product, whilst using the 3rd and 
4th quantities failed to replicate the previous high product yields. 
 At this point, the list of possible reasons I (and my helpful lab colleagues) could 
imagine for reaction failure was exhausted. Hence, it was conceded that in this system, donor 
167 was too inconsistent for use. However, there was one further experiment conducted 
using donor 167 that gave a further clue about the purity of the donor. Having a stock of 
donor 167 to hand, this donor was chosen as the starting material to prepare target molecule 
177. The synthesis is shown in Scheme 73. 4-(Chloromethyl)benzyl alcohol was glycosylated 
with donor 167 under the standard flow glycosylation conditions. 1H NMR spectroscopic 
analysis at this point proved there was no acceptor remaining in the crude product, suggesting 
it had all been consumed in the reaction. Deprotection of the chloroacetate group was then 
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performed using methanolic HCl as previously described. Next, treatment with 1-
methylimidazole and potassium triflate generates I-Tag2 through nucleophilic substitution of 
the chlorine atom, but also causes partial neighbouring group migration of the C-4 benzoyl 
group to C-6, owing to the basicity of 1-methylimidazole. This gives a mixture of I-Tagged 
products 102 and 176. The mixture is then treated with a sodium methoxide solution to 
remove all benzoyl groups over 3 h. Thus, desired compound 177 is furnished in 49 % yield 
over four steps. 
 
Scheme 73. Synthetic route from donor 167 to I-Tagged glucose 177. 
 All evidence acquired thus far indicated that some impurity present in the later 
quantities of donor 167 was responsible for the poor yields acquired. However, the smooth 
glycosylation of donor 167 with neutral acceptor 4-(chloromethyl)benzyl alcohol indicates 
that this is unlikely. Two possible explanations for the observed irreproducibility were 
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hypothesised. Firstly, there may have been some impurity present in the first two quantities 
of donor synthesised that actually helped the glycosylation with I-Tagged acceptors to 
proceed in high yields. Hence, the lack of this beneficial impurity in later quantities prevented 
such complete glycosylation from occurring. Secondly, since I-Tagged glycosyl acceptors have 
very highly polarised ionic charges in close proximity to the reacting alcohol group, one might 
expect the nucleophilicity of that alcohol group to decrease through a variety of factors, 
perhaps including inductive electronic components and the influence of the solvation shell. 
Therefore, since the I-Tagged glycosyl acceptors suffer from poor nucleophilicity, inconsistent 
glycosylation results might be expected. Conversely, neutral glycosyl acceptors such as 4-
(chloromethyl)benzyl alcohol are more nucleophilic and hence higher glycosylation yields are 
seen when these acceptors are used. 
 Synthesis of β-1,2-Glucans Using a Super-Armed Donor 
 As a result of the inconsistent results acquired using donors with an orthogonal C-6 
protecting group, the construction of β-1,2-glucans using donor 159 that had given positive 
results in glycosylation experiments thus far was pursued. It was reasoned that synthesising 
β-1,2-glucans could showcase the utility of the I-Tag supported flow glycosylation method just 
as well as synthesising β-1,6-glucans. The C-2 acetate group present on donor 159 allows 
complete β selectivity in glycosidic bond formation and subsequent deprotection using 
sodium methoxide would liberate a free C-2 alcohol group that may then be used as a glycosyl 
acceptor. Thus, the reaction between donor 159 and acceptor 157 gave glycoside 178 in 
quantitative conversion by 1H NMR spectroscopy. Purification by trituration gave 178 in 84 % 
isolated yield (Scheme 74). Subsequent acetate removal gives free alcohol 179 in good yield. 
  




Scheme 74. Glycosylation of donor 159 with acceptor 157 gives I-Tagged sugar 178 in excellent 
yield. Subsequent acetate deprotection liberates glycosyl acceptor 179. 
 Monosaccharide 179 was then used in a glycosylation reaction using the standard 
optimised flow conditions. It was hoped that the reaction would proceed in high yield, 
however, acceptor 179 bears a secondary alcohol. Secondary alcohols are more sterically 
hindered than primary alcohols, and thus it is common to see reduced reactivity of secondary 
alcohols in glycosylations. Often longer reaction times or elevated temperatures are used to 
force secondary alcohols to undergo complete reaction. Realising these concerns, 
disaccharide 180 was synthesised in 56 % conversion from acceptor 179 as shown in Scheme 
75. This partial conversion from acceptor to product causes difficulty during purification. 
Highly polar I-Tagged acceptors 155 and 157 are water soluble, and thus any unreacted 
acceptor may be separated from the I-Tagged glycoside product through an aqueous wash. 
In this case, both acceptor 179 and product 180 are saccharide-derived I-Tagged molecules 
and thus their separation by simple solvent washes is impossible. However, they can be 
separated by HPLC or size-exclusion chromatography. Thus, it was decided to take advantage 
of this partial glycosylation to prepare different oligosaccharide fragments in one pot and do 
a single chromatographic purification at the end of the synthesis to separate the mixture of 
oligosaccharides in a manner similar to that described in the prior publication concerning 
combinatorial ICROS.146 
 




Scheme 75. Reaction of donor 159 and acceptor 179 gives disaccharide 180 in 56 % conversion. 
 The next step was thus to take the 44:56 ratio mixture of 179:180 and treat with 
sodium methoxide to remove the acetate group from 180 to furnish disaccharide acceptor 
181. Reaction progress was monitored by MS, showing complete acetate removal over 24 h 
using 0.8 eq of sodium methoxide. However, after workup and trituration, a very low mass of 
products was recorded, much lower than what would be expected from the mass of 
reactants. Furthermore, the ratio of monosaccharide to disaccharide had changed 
substantially from that observed immediately after glycosylation. The reason for this was the 
neutralisation method. After complete acetate removal, the pH of the solution was brought 
to 7. In this case, neutralisation was achieved using Amberlite acidic resin, which bears surface 
sulfonic acid groups. It became evident that these resin-bound sulfonic acid groups, after 
proton donation, would become sulfonate anionic residues that require a cation to balance 
the charges. Since the I-Tagged products are themselves cationic, they could bind to the solid 
resin, resulting in the observed low product mass after solution is separated from the resin 
beads. Hence, the oligosaccharide synthesis was repeated, with sodium methoxide 
neutralisation achieved with aqueous hydrochloric acid solution. 
 The second synthesis of monosaccharide acceptor 179 was achieved in the same 
manner as previously, however, fully protected glycoside 178 was not purified prior to basic 
acetate deprotection. Instead, solvent was removed from the crude glycosylation mixture, 
then the residue was dissolved in sodium methoxide solution directly. Subsequent 
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purification gave product 179 in 72 % yield over two steps, slightly higher than the 63 % yield 
over two steps reported in Scheme 74. In the same manner, acceptor 179 was transformed 
into product 181 as shown in Scheme 76. In close agreement with the result found previously 
in Scheme 75, 55 % conversion from 179 to 181 was seen by 1H NMR spectroscopic analysis. 
Given this 45:55 ratio of 179:181, an expected combined mass could be calculated based upon 
the number of moles of acceptor 179 used for the reaction. The “yield” of the product mixture 
was determined to be 76 % over two steps. Presumably the reason for loss of products is due 
to minor amounts of I-Tagged material being dissolved in the trituration solvent washes and 
mechanical losses during workup steps such as drying the organic solution with magnesium 
sulfate desiccant and subsequent filtration. 
 
Scheme 76. Glycosylation using acceptor 179 and immediate deprotection gives disaccharide 181. 
 The next step was to subject the mixture of mono- and disaccharide acceptors 179 
and 181 to the flow glycosylation conditions using donor 159 once again to synthesise a 
trisaccharide, whilst increasing the proportion of disaccharide present in the product mixture. 
At this point, since the 1H NMR spectra contained too many overlapping multiplets to be of 
use for characterising the product mixture, mass spectra were relied upon exclusively, using 
the inherently strong signal intensity for I-Tagged compounds to monitor the reaction. Note 
that reliable quantitative information cannot be extracted from these mass spectra, however, 
they are nonetheless useful for determining which species are present with some 
approximation as to quantity based on peak height, since molar amount and peak height are 
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positively correlated. Immediately following the glycosylation reaction, the ESI mass 
spectrum appeared as shown in Figure 27. Peaks at m/z 635 and 1067 correspond to 
unreacted acceptors 179 and 181. The peak at m/z 1109 corresponds to disaccharide 180, 
formed by reaction of acceptor 179 with a molecule of donor. Likewise, trisaccharide 182, 
formed by reaction of disaccharide acceptor 181 with a molecule of donor, is responsible for 
the peak at m/z 1541. Note that the negative ion mass spectrum simply shows a very large 
peak at m/z 148.8, corresponding to the triflate counterion common to all the I-tagged 
cations. 
 
Figure 27. ESI mass spectrum of the crude reaction mixture acquired following the glycosylation 
reaction using the 179/181 glycosyl acceptor mixture. m/z values for the signals are labelled, with 
the causative chemical species shown by an arrow from the corresponding m/z value. 
 As deacetylation began, it was noted that acetate deprotection of trisaccharide 182 
was significantly slower than disaccharide 180. To speed up the reaction, a total of 2.75 eq of 
NaOMe were added over 48 h to achieve complete reaction. Mass spectrometry showed the 
coalescence of the two disaccharide peaks into a single peak at 1067 as 180 transforms to 
181, whilst the trisaccharide peak had a value of 1499 corresponding to product 183 following 
complete deprotection. Moving forward, the mono-/di-/trisaccharide mixture was 
glycosylated once again with donor 159 to make a tetrasaccharide, and the product mixture 
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was treated with sodium methoxide. The deprotection of disaccharide 180 and trisaccharide 
182 was complete within 19 h using 2.5 eq NaOMe, however, the tetrasaccharide was very 
resistant to acetate deprotection, even when a large (>20 eq) amount of sodium methoxide 
was added complete deprotection could not be achieved. As a result, it was reasoned that 
the tetrasaccharide would be a sensible maximal oligosaccharide length for this synthesis, 
since smaller oligosaccharides could be easily deprotected in the presence of protected 
tetrasaccharide. Thus, further glycosylations might incrementally enrich the proportion of 
longer oligosaccharides up to tetrasaccharide by partially consuming the mono-, di- and 
trisaccharides acceptors in each glycosylation reaction. Unfortunately, due to time 
constraints, no further glycosylations were carried out on this product mixture and the 
constituent oligosaccharides were not separated. Thus, a drawing of the final mass spectrum 
acquired is shown in Figure 28. 
 
Figure 28. ESI mass spectrum of the final β-1,2-glucan saccharide mixture synthesised. 
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 Fmoc Protected Donors for β-1,6-Glucan Preparation 
 Since the β-1,2-glucan synthesis gave only moderate conversions once secondary 
acceptors were used, the construction of β-1,6-glucans that used primary alcohol acceptors 
exclusively was revisited once again. Earlier work had proven that several C-6 orthogonal 
protecting groups including silyl ethers and chloroacetate groups were unsuitable, however, 
one protecting group that had not yet been considered was the 9-fluorenylmethoxycarbonyl 
(Fmoc) group. The Fmoc group is commonly used in peptide synthesis to protect amines as a 
carbamate,163 but upon reaction with an alcohol rather than an amine 9-
fluorenylmethoxycarbonyl chloride forms a carbonate group that acts as a base labile 
protecting group.  
 Previous work by Boons and co-workers164 showed that the Fmoc protecting group 
could be installed on a carbohydrate alcohol group and tolerates other protecting group 
manipulations around the molecule. One potential stumbling block is the introduction of the 
acetimidate group for the formation of a trichloroacetimidate donor, since this reaction 
generally requires catalysis by an organic base such as DBU that is also likely to cleave the 
Fmoc group. However, the authors found that using sodium hydride as the base allowed 
installation of the trichloroacetimidate group whilst leaving the Fmoc protecting group intact. 
Moreover, the Boons group used Fmoc-protected trichloroacetimidate donors in high yielding 
glycosylations with TMSOTf as the promoter. Finally, Fmoc deprotection using triethylamine 
in DCM was demonstrated to proceed in high yield. This combination of factors made the 
Fmoc group appear to be a suitable C-6 protecting group choice for my system. One concern 
was that the basic deprotection conditions may result in undesired neighbouring group 
migration in the manner caused by DABCO as shown in Scheme 68. Nonetheless, donor 186 
was synthesised as shown in Scheme 77. Previously synthesised intermediate 187 was chosen 
as the starting material. Treatment with FmocCl furnishes fully protected 188 in 83 % yield. 
Subsequent deprotection of the anomeric para-methoxyphenyl group using CAN gives 
hemiacetal 189 in 78 % yield. Finally, sodium hydride mediated introduction of the 
trichloroacetimidate group gives donor 186 as a mixture of anomers, however, only the α 
anomer could be completely separated by column chromatography. 




Scheme 77. Synthesis of orthogonally protected donor 186 bearing an Fmoc group from 
intermediate 187. 
 Using donor 186 in a flow glycosylation with acceptor 157 gave I-Tagged glycoside 190 
in 80 % isolated yield using the optimised glycosylation conditions, as shown in Scheme 78.  
 
Scheme 78. Glycosylation of acceptor 157 with donor 186 furnishes product 190 in good yield. 
Subsequent basic Fmoc deprotection results in C-4 benzoyl group migration to C-6. 
 However, the ensuing basic Fmoc deprotection caused the C-4 benzoyl group to 
partially migrate to C-6, resulting in an inseparable mixture of desired compound 102 and 
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migration product 176. This lamentable result cemented the intolerance of benzoyl protected 
glycoside 102 to basic conditions. Nevertheless, the synthesis of donor 186 and its subsequent 
high yielding glycosylation proved that the Fmoc protecting group was well-suited to the 
glycosylation protocol. It was reasoned that since there is no evidence of migration of the 
benzoyl groups at C-2 or C-3, changing the C-4 protecting group to one that is incapable of 
migration, whilst maintaining the other protecting groups, ought to result in a viable 
protecting group pattern. Thus, 4-O-benzyl protected donor 191 was synthesised as shown in 
Scheme 79.  
 
Scheme 79. Synthetic route from starting material 192 to donor 191. 
 The synthesis begins with anomerically protected starting material 192. Copper(II) 
triflate catalysed benzylidenation gives 193, with perbenzoylation of this compound giving 
fully protected 194 in 70 % yield over two steps. Next, regioselective benzylidene reduction 
using borane-THF and copper(II) triflate installs a benzyl group at C-4 selectively to give 195 
in 78 % yield. Introduction of the Fmoc group at C-6 proceeded in good yield, although caused 
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unexpected anomerisation. para-Methoxyphenyl removal with CAN gives hemiacetal 197 in 
excellent yield. Finally, sodium hydride mediated installation of the trichloroacetimidate 
group initially produced an anomeric mixture, as judged by TLC and TLC-MS. However, 
allowing the reaction to equilibrate over 19 h results in anomerisation to the α anomer 
exclusively. Thus, donor 191 was prepared in 74 % yield as a single anomer.  
 When donor 191 was glycosylated with acceptor 157 at room temperature (entry 1, 
Table 18), an excellent conversion to product 198 of 87 % was seen by 1H NMR spectroscopy. 
In order to optimise temperature for glycosylation of this donor, other glycosylation 
experiments were performed at 0 ˚C, 50 ˚C and 75 ˚C (entries 2-4). Intriguingly, altering 
temperature makes virtually no difference to product conversion, so room temperature was 
the best option for pragmatic reaction setup reasons. 
Table 18. Temperature dependence of the glycosylation reaction using donor 191 and acceptor 157. 
 
Entry Temperature / ˚C 
NMR Yield of 
Product 198 (%) 
1 RT 87 
2 0 90 
3 50 87 
4 75 88 
 
 Crucially, basic deprotection of 198 with triethylamine occurs quantitatively as judged 
by MS, whilst NMR spectroscopy and TLC show only desired product 199 with no migration 
side products. Applying the glycosylation and basic deprotection together in a flow-to-pot 
strategy as shown in Scheme 80 furnishes product 199 in 74 % yield over two steps after 
purification. A workup procedure was developed for this system in order to allow complete 
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purification whilst minimising product losses to the aqueous phase. The DCM/NEt3 mixture is 
diluted with 1 M HCl (aq.) and more DCM in order to protonate the triethylamine and extract 
it into the aqueous phase, whilst the product remains in the DCM phase. Washing the DCM 
phase with a portion of water removes lingering highly polar impurities. The aqueous 
washings are combined and washed with a further portion of DCM, which is then combined 
with the original DCM phase. This is done because the I-Tagged product 199 is polar enough 
that it may dissolve partially in the aqueous phase and thus an organic wash helps to extract 
any product in the aqueous phase back to the organic. This acidic aqueous phase in then 
discarded. Next, the DCM phase is washed with NaHCO3 (sat. aq.) to deprotonate any final traces 
of triethylammonium cation, and a further water wash is performed. Once again, washing the 
combined aqueous portions with DCM and combining DCM washes maintains the maximal 
amount of product in the organic phase. Finally, the DCM phase is dried with magnesium 
sulfate, filtered and the solvent is removed under reduced pressure. This aqueous workup 
approach was required because 1H NMR spectra revealed triethylammonium salt impurities 
in the product mixture when only an acidic wash was performed, whereas performing an 
acidic wash followed by a basic wash avoids this problem. Subsequent washes with 
hexane/Et2O and drying under vacuum gives pure product 199. 
 
Scheme 80. Flow-to-pot glycosylation-deprotection using donor 193 and acceptor 159 furnishes 
product 199 in very good yield. 
 At this stage of the project, a very fast flow-to-pot glycosylation-deprotection strategy 
has been developed using donor 191. This furnishes 199, a glycosyl acceptor that ought to 
serve as an excellent I-Tag supported scaffold for chain elongation and hence β-1,6-glucan 
synthesis. 
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5.  Conclusions and Outlook 
 The studies performed during this PhD project represent a contribution to overcoming 
the impediments to efficient oligosaccharide construction laid out in the project aims through 
several avenues. Firstly, throughout each of the projects a series of glycosyl acceptors and 
donors were synthesised on a multi-gram scale. These include primary and secondary alcohol 
acceptors, including some that bear an I-Tag support. Donors prepared include glucals and 
galactals and several glucose-type trichloroacetimidate donors. Most of these donors and 
acceptors were prepared via multiple step syntheses in which rationally selected protecting 
groups were manipulated to control the steric and electronic properties of the donor. For 
certain novel compounds, for instance trichloroacetimidate donors 160, 167, 186 and 191 
(Figure 29) bespoke routes to the target molecules were developed and optimised. 
 
Figure 29. Bespoke synthetic pathways to novel trichloroacetimidate donors 160, 167, 186 and 191 
were developed and optimised. 
 Next, organocatalytic glycosylation reactions were screened. Triazolium salt 128 was 
tested for its ability to catalyse 2-deoxyglycoside synthesis from a galactal donor, either alone 
or synergistically with thiourea 86. Poor product conversion was observed, though this may 
be rationalised by a consideration of the pKa values of the different species. Further work by 
colleagues identified thiourea 86 and BINOL-derived phosphoric acid 129 as dual 
organocatalysts for the efficient, high yielding synthesis of α 2-deoxyglycosides. To better 
understand the reaction mechanism, an experiment using methanol-d4 was performed.  A 
mixture of two isotopically labelled products 130 and 131 was obtained from the reaction and 
thus valuable mechanistic information about the glycosylation reaction was accrued. 
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 Glycal activation via transition metal catalysis was concurrently explored as a strategy 
for 2-deoxyglycoside preparation. To that end, palladium catalysis was investigated. Following 
a screen of palladium catalysts and phosphine ligands conducted by colleagues, optimisation 
of the reaction conditions was carried out for model substrates using PdII catalyst 113 and 
phosphine ligand 114. Conditions were met that gave 99 % conversion (and subsequent 86 % 
isolated yield) of acceptor alcohol 41 to product 2-deoxy-disaccharide 44, with total α 
selectivity. Using the optimised reaction conditions, a series of primary and secondary 
alcohols were screened for compatibility with the glycosylation protocol. In general, excellent 
yields and α selectivity were obtained for primary alcohol acceptors in reasonable and 
convenient overnight reaction times of 17-23 h. Secondary alcohol acceptors proved more 
problematic; however, good yields were obtained for saccharide-derived glycosyl acceptors. 
Secondary general aliphatic and aromatic alcohols should, in general, be avoided as 
substrates in this methodology, owing to poor product formation and α/β selectivity. 
Furthermore, a probable reaction mechanism is discussed in light of mechanistic 
experimental data. 
 Ultimately, two novel catalytic strategies for 2-deoxyglycoside preparation were 
developed. The broad substrate scope and versatility of these reactions was explored and 
mechanistic information was collected, culminating in the publication of the findings. 
However, there is significant scope for further work in this area. Palladium is a rather 
expensive and scarce transition metal. An attractive alternative would be a metal catalyst that 
is cheaper and more abundant than palladium, but one that is also able to catalyse 
stereoselective 2-deoxyglycoside synthesis. Moreover, in the optimised conditions for the 
glycosylation protocol developed, 0.3 eq of palladium complex 113 is required for each 
reaction. This is a high catalyst loading that may limit the green credentials of this 
glycosylation strategy, since a significant amount of metal waste is produced in each reaction. 
It would be preferable to identify a metal catalyst or organocatalyst that permits rapid 2-
deoxyglycoside synthesis at low catalyst loading, thus maximising the environmental and 
economic benefits of catalysis. 
 Another key issue that could be overcome in the future is the stereochemical outcome 
of the glycosylation reaction. Both catalytic 2-deoxyglycoside preparations discussed in this 
thesis favour α selectivity in the product. Ideally, a catalyst would be discovered that produces 
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the β anomer preferentially, overcoming the inherent bias for formation of the α anomer. 
Access to either the α or β 2-deoxyglycoside anomer selectively from a common glycosyl 
donor through complementary catalytic glycosylation approaches would represent an 
exceptionally useful tool in the glycoscientist’s synthetic toolbox. 
 Moving forward, the gold catalysed synthesis of 2-deoxyglycosides in flow was 
explored, but little success was achieved. Several of the promising early results using benzoyl 
protected glycosyl acceptor 74 proved to be unique to that compound, since other acceptors 
performed poorly. What is clear is that the catalytic system is sensitive to impurities, even 
when repeating batch reactions. The identity of these impurities is not clear, due to 
inconsistent results that were very difficult to interpret. Overall, it was discovered that this 
reaction protocol is not well-suited to continuous flow methodology, despite similar gold 
catalysed glycosylations being performed in flow in the literature. Nonetheless, this was 
useful information to gather and the limits of the approach were found. 
 Finally, my attention was turned towards the glycosylation of I-Tagged sugars in flow, 
with some excellent results being obtained in this area. Optimisation of the model reaction 
between perbenzylated donor 62 and I-Tagged alcohol 155 was conducted, during which the 
residence time, concentration, stoichiometry of TMSOTf and donor and reaction temperature 
were all altered and optimised. In the best conditions, product 156 was formed in 94 % 
conversion in just 15 seconds. Thus, previously performed lengthy overnight glycosylations in 
batch were successfully shortened to a matter of seconds in flow under exceptionally mild 
and practical conditions. Furthermore, the rapid and simple trituration purification method 
minimises the volume of volatile organic solvents required which is environmentally 
beneficial as well as being cheaper. One can envisage the entire glycosylation-deprotection-
trituration sequence being performed over the course of just a few hours, enabling extremely 
quick and facile oligosaccharide assembly. 
 Substrate scope was then explored, in particular with respect to silyl ether protected 
donor 97. Batch reactions using this donor could not be replicated in flow due to unexpected 
reactivity of the silyl ether group, including partial deprotection during the course of the 
glycosylation and intramolecular cyclisation of the donor to form 1,6-anhydro sugar 163. 
Changing solvent, temperature or any other variable did not prevent this reaction pathway 
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and thus it seems that the observed reactivity is a feature of the flow regime. The use of an 
ethereal HCl solution for silyl ether deprotection is noteworthy, as it is much faster than a 
methanolic HCl solution and does not cause unwanted acetate group deprotection. 
 Chloroacetate protected donor 167 was synthesised as an alternative to a silyl ether 
protected donor. Initial results showed excellent conversion to products using the optimised 
conditions, whilst acid catalysed transesterification was found to be a good deprotection 
strategy that avoided benzoyl group migration. Subsequent experiments showed that the 
initial results were irreproducible, despite efforts to recover previously observed reactivity. 
The reasons for the irreproducibility are speculated upon in light of the successful reaction of 
donor 167 with 4-(chloromethyl)benzyl alcohol. Avoiding this donor for future experiments 
would be prudent to avoid inconsistent results. 
 The synthesis of β-1,2-glucans using super-armed donor 159 was also explored. 
Secondary alcohol acceptor 179 was synthesised in 72 % yield over two steps. Using acceptor 
179, moderate conversion to product disaccharide 180 of 56 % was found. Repeated 
glycosylations produced a mixture of mono-, di-, tri- and tetrasaccharides through an iterative 
glycosylation-deprotection-trituration sequence, with reaction progress monitored by mass 
spectrometry. In the immediate future, this mixture could be separated by chromatography 
to give a small library of different oligosaccharides. 
There may be more simple and efficient ways to prepare β-1,2-glucans using this I-Tag 
supported flow glycosylation strategy that could be incorporated into future work. Firstly, the 
reaction of secondary glycosyl acceptors in the flow glycosylation system was not optimised, 
since acceptor 155 used for reaction optimisation was a primary alcohol. It may be the case 
that re-optimising the flow glycosylation reaction for secondary acceptors by altering 
variables such as stoichiometry of donor and TMSOTf, temperature and residence time will 
allow more complete conversion than the 55 % seen in Scheme 75 and Scheme 76. Secondly, 
if complete conversion in the glycosylation is not observed, further glycosylations on the 
product mixture with no deprotection step may be useful, as shown in Scheme 81. 




Scheme 81. Suggested strategy of re-subjecting reaction mixture to glycosylation conditions in order 
to encourage complete conversion of acceptor 179 to product 180. 
 The first flow glycosylation gives 55 % conversion of 179 to 180 as previously. 
However, at this point, the mixture of fully protected disaccharide product and unreacted 
acceptor can be dried, combined with another 2 eq of donor 159 and re-subjected to the flow 
reaction conditions, causing further conversion of 179 to 180. In this manner, minimal 
purification is needed, whilst conversion to product 180 can be maximised. If needed several 
glycosylation runs could be performed to achieve complete conversion of the glycosyl 
acceptor to product. Under normal circumstances, such an approach might be very time 
consuming, however, owing to the extremely short reaction times required for these flow 
glycosylations and rapid reaction analysis due to the I-Tag moiety, such a strategy becomes 
an expedient option for oligosaccharide synthesis. 
 Towards the end of the PhD project, Fmoc protected donors were explored as a route 
to make β-1,6-glucans. Whilst donor 186 bearing benzoyl protecting groups at C-2,3 and 4 
undergoes smooth glycosylation, basic deprotection results in neighbouring group migration 
to produce an inseparable mixture of compounds. However, donor 191 featuring a C-4 benzyl 
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ether protecting group may be used to synthesise glycosyl acceptor 199 in 74 % yield over 
two steps using a flow-to-pot deprotection strategy; achieved by flowing glycosylation 
reaction solution into a “deprotection” solution to begin deprotection immediately following 
glycosylation. This approach circumvents the need for intermediary purification steps and 
increases reaction yield. Hence, the use of donor 191 appears to be an excellent basis for the 
preparation of β-1,6-glucans in future work, using acceptor 199 as the foundation for 
preparing a library of β-1,6-glucan oligosaccharides. 
 The I-Tag supported flow glycosylation strategy requires further refinement to 
become more pragmatic and widely applicable. However, the successful development of the 
method thus far suggests it may constitute a useful contribution to glycoscience in the future. 
There are several areas where further work would propel the utility of the method and our 
understanding of it.  
 Firstly, silyl ether protected donors were discovered to undergo unexpected 
deprotection during flow glycosylations. Further exploration of the subtle reactivity 
differences between different flow and batch reactors would make for an interesting study 
to shed light on this phenomenon. One could explore reactions using various glycosyl donors 
bearing silyl ether protecting groups with different Lewis acid glycosylation promoters. 
Reactions could be performed in batch and flow reactors of different sizes; altering stirring 
rates, residence times, solvent and concentration to determine how they affect the 
propensity for silyl ether deprotection and formation of 1,6-anhydro sugars. This would help 
to build up a practical picture of how reactivity fluctuates dependent on these parameters. 
 The methodology should also be explored using a diverse range of glycosyl donors, 
with carbohydrate structures that feature in biologically relevant oligosaccharides. For 
instance, galactose and mannose derived donors could be tested, as well as 2-amino-2-deoxy 
sugars. Glycosyl donor 200, which should theoretically be easily accessible from previously 
synthesised compounds, could be used to construct β-1,4-glucans. A suggested synthesis of 
200 is shown in Scheme 82. Beginning from previously prepared benzylidene 194, 
regioselective reductive ring opening would furnish secondary alcohol 201. Subsequent 
treatment with chloroacetyl chloride and 2,4,6-collidine would install the chloroacetyl group 
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at C-4 to give 202. Anomeric para-methoxyphenyl group removal and introduction of the 
trichloroacetimidate group would furnish donor 200. 
 
Scheme 82. Potential synthetic pathway to donor 200 that might be used for construction of β-1,4-
glucans. 
 Whilst the chloroacetyl protecting group installed at the C-6 position on donor 167 
caused neighbouring group migration issues during deprotection, that ought not to occur in 
the case of donor 200. In the publication by Vliegenthart and co-workers162 describing amine 
DABCO as a selective dechloroacetylation reagent, the researchers used substrates that were 
structurally similar to 200 (Scheme 67). This suggests that the C-4 chloroacetyl protecting 
group on a glucose derived monosaccharide can be quickly and easily removed without the 
C-3 benzoyl group migrating to C-4. Thus, donor 200 should work well as the basis for I-Tag 
supported construction of β-1,4-glucans in flow with rapid chloroacetate deprotection under 
basic conditions.  
 Another area where future work might improve the usefulness of this glycosylation 
strategy is in the synthesis of 1,2-cis glycosides. Thus far, only 1,2-trans glycosides (or 
anomeric mixtures) have been synthesised owing to the difficulties in controlling the 
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stereochemistry of the glycosidic bond. However, one of the approaches discussed in section 
2.2. for 1,2-cis glycoside preparation could be incorporated into this I-Tag supported flow 
strategy, allowing a wider array of carbohydrate architectures to be accessed. 
 Investigation of some of the suggested future research directions and the resultant 
preparation of diverse oligosaccharides would demonstrate the utility and versatility of I-Tag 
supported glycosylation in flow. This should form a convincing argument for adoption of this 
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6.  Experimental 
 General Experimental Details 
 Chemicals were purchased and used without further purification, except for 
benzaldehyde dimethyl acetal and trimethylsilyl trifluoromethanesulfonate, which were 
distilled prior to use. Dry solvents were obtained by distillation using standard procedures or 
by passage through a column of anhydrous alumina using equipment from Anhydrous 
Engineering (University of Bristol) based on the Grubbs’ design.165 Reactions requiring 
anhydrous conditions were performed under nitrogen; glassware was either flame dried 
immediately prior to use or placed in an oven (155 °C) for at least 3 hours and allowed to cool 
under reduced pressure; liquid reagents, solutions or solvents were added via syringe through 
rubber septa; solid reagents were added via Schlenk type adapters. Reactions were 
monitored by TLC on Kieselgel 60 F254 (Merck). Detection was by examination under UV light 
(254 nm) and by charring with 10 % sulfuric acid in ethanol or potassium permanganate 
solution. Flash column chromatography was performed using silica gel [Merck, 230−400 mesh 
(40−63 μm)]. The crude material was applied to the column as a solution or by pre-adsorption 
on silica, as appropriate. Extracts were concentrated in vacuo using both a Büchi rotary 
evaporator (bath temperatures up to 60 °C) at a pressure of either 15 mmHg (diaphragm 
pump) or 0.1 mmHg (oil pump), as appropriate, and a high vacuum line at room temperature. 
Water soluble compounds were freeze dried on a Lyotrap Plus (LTE Scientific LTD).  
 1H, 13C and 19F NMR spectra were measured at 25 ˚C in the solvent stated with Varian, 
Bruker or Jeol spectrometers operating at the field strengths listed. Chemical shifts are 
quoted in parts per million to two decimal places with spectra referenced to the residual 
solvent peak (CDCl3: 1H = 7.26 ppm and 13C = 77.16 ppm; CD3CN: 1H = 1.94 ppm and 13C = 1.32 
and 118.26 ppm; CD3OD: 1H = 3.31 ppm and 13C = 49.00 ppm; D2O: 1H = 4.79 ppm), 19F NMR 
chemical shifts are also quoted in ppm but are unreferenced, coupling constants (J) given in 
Hertz (Hz) as observed. Multiplicities are abbreviated as: app (apparent), b (broad), s (singlet), 
d (doublet), t (triplet), q (quartet), p (pentet), m (multiplet) or combinations thereof. The 
abbreviation ax denotes an axial proton, whilst eq denotes an equatorial proton. Assignments 
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of 1H and 13C NMR signals were made where possible, using COSY, TOCSY, HSQC and HMBC 
experiments. Assignments for carbohydrate derivatives are shown in Figure 30: 
 
Figure 30. Format for NMR assignments of carbohydrate chemicals synthesised. 
 High- and low-resolution mass spectra were obtained from the University of Bristol 
Mass Spectrometry Service by ESI or MALDI modes.  Reactions followed by MALDI were 
analysed using a Bruker Daltonics UltrafleXtreme time-of-flight/time-of-flight mass 
spectrometer. 2,5-Dihydroxybenzoic acid in MeCN was used as matrix. LC-MS spectra were 
recorded on a LC Packings Famos system with a Bruker esquire 6000 mass spectrometer. 
Infrared spectra were recorded in the range 4000 – 400 cm-1 on a Perkin Elmer Spectrum Two 
Spectrometer. Optical rotations were measured on a Bellingham + Stanley ADP220 
polarimeter. The units of the specific rotation, (deg⋅mL)/(g⋅dm), are implicit and are not 
included with the reported value. Concentration c is given in g/100 mL. Preparative HPLC was 
performed on a Grace Discovery Sciences Reveleris Prep System. For purification, the 
instrument was set to monitor the ELSD signal in addition to UV detection at 220 nm, 254 nm 
and 280 nm. For reverse phase purifications a Phenomenex Luna 5 μm C18(2) 100 Å AXIA 
packed (250 x 21.2 mm) column was used. For normal phase purifications, FlashPure EcoFlex 
cartridges loaded with either 4 g, 12 g, 40 g or 120 g of silica were used.  
 Named, but unnumbered compounds in the experimental section are listed first, 
followed by numbered compounds in numerical order. The final compounds contained in this 
experimental are: 1,2,3,4,6-penta-O-acetyl-D-galactopyranoside, 1,2,3,4,6-penta-O-acetyl-D-
glucopyranoside, 41, 44, 53, 54, 62, 74, 92, 97, 100, 102, 120, 121, 122, 123, 125, 126, 130, 
131, 139, 140, 147, 151 (two alternate routes to this compound), 152, 155, 156, 157, 159, 
160, 161, 163, 166, 167, 168, 170, 172, 174, 177, 178, 179, 181/183/184/185, 186, 187, 190, 
191, 192, 194, 199, 204, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214, 215, 216, 217, 218, 
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219, 220, 221, 222 and 223. Compounds that are not explicitly numbered in the main text of 
this thesis are instead numbered for the first time in the experimental. Compounds 204-208 
pertain to section 4.1.1. Glycosyl Acceptor Syntheses, being either precursor compounds or 
glycosyl acceptors. Compounds 209-217 apply to section 4.3.2. Acceptor Scope, being 
glycosylation products from the palladium catalysed glycosylation method described in that 
section. Compounds 218-220 are relevant to section 4.6.3. Reactions Using Triisopropylsilyl 
Ether Protected Donors, being precursor compounds to the trichloroacetimidate donors 
reported in that section. Finally, compounds 221-223 pertain to section 4.6.2. Exploration of 
Substrate Scope, being glycosylation products from the I-Tag supported flow glycosylation 
reactions described in Table 13. 
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 Synthetic Procedures 
General Procedure for Palladium Catalysed Glycosylation Reactions 
 Glycal glycosyl donor, glycosyl acceptor, metal catalyst and ligand were weighed into 
an oven-dried microwave vial and the vial was sealed with a cap with septum. The reagents 
were dried under vacuum for at least 30 min, after which time anhydrous DCM was added 
under a nitrogen atmosphere. The vial cap was wrapped with Parafilm and the reaction 
mixture left to stir (500 rpm) at 50 ℃ under a nitrogen atmosphere. Upon complete reaction 
as judged by TLC and/or 1H NMR spectroscopy, the reaction was quenched by passing the 
mixture through a pad of Celite, with additional washing with DCM. Solvent was then 
removed under reduced pressure and the crude product was purified by chromatography. 
General Procedure for I-Tag Glycosylations in Flow 
 Glycosyl acceptor and glycosyl donor were placed in a dry vial and dried under vacuum 
for 30 min. Another dry vial was also placed under vacuum for 30 min. After this drying period, 
anhydrous solvent was added to the donor/acceptor vial under nitrogen. To the other vial, 
anhydrous solvent was added under nitrogen, followed by trimethylsilyl 
trifluoromethanesulfonate. The flow microreactor and attached tubing were flushed with 
nitrogen. The donor/acceptor solution and TMSOTf solution were each taken up in a syringe 
and installed onto a syringe pump. The solutions were then injected into the microreactor 
(total internal volume of reactor chip and outlet tubing = 32.8 μL) at the desired flow rate 
corresponding to the residence time (15 seconds, 65.60 μL/min in each syringe for a 
combined flow rate of 131.20 μL/min in reactor zone) via the inlet tubing. The mixture that 
flowed from the microreactor was dropped in a flask containing reagent grade solvent in air 
to quench the reaction. Reaction solution was collected for a specific time, after which time 
the reaction mixture solvent was removed under reduced pressure, unless otherwise stated. 
The crude product was dissolved in DCM and washed with water, then the water was 
extracted with further portions of DCM. The DCM phases were collected, dried with 
magnesium sulfate, filtered and the solvent was removed under reduced pressure. The dried 
residue was washed with appropriate solvents with sonication then dried under reduced 
pressure to yield the title compound. 








 α-D-galactopyranose (3.00 g, 16.65 mmol) was dissolved in pyridine (48 mL) and acetic 
anhydride (24 mL) was added to the resulting solution. The mixture was stirred at RT for 60 h. 
The mixture was then diluted with DCM (30 mL) and washed with 1 M HCl (aq.) (3 x 30 mL), 5 
M HCl (aq.) (30 mL) and brine (30 mL). The organic phase was dried using magnesium sulfate 
and filtered. Solvent was removed under reduced pressure to yield the crude product as a 
light brown oil that slowly crystallised to an off-white solid. The crude product was then 
recrystallised from ethanol, the solid product formed was vacuum filtered using Hirsch 
apparatus and dried under vacuum for 3 h to yield a mixture of anomers (α:β = 11:1) of the 
title compound as an off-white solid (2.53 g, 39 %), with spectroscopic details in accordance 
with the literature;166 1H NMR δ H  (400 MHz, Chloroform-d) 6.37 (1 H, d, J 1.8, H-1α), 5.69 (1 
H, d, J 8.3, H-1β), 5.51 – 5.47 (1 H, m, H-4α), 5.37 – 5.28 (2 H, m, H-2α, H-3α), 5.07 (1 H, dd, J 
10.4, 3.2, H-3β), 4.33 (1 H, td, J 6.7, 1.4, H-5α), 4.16 – 4.01 (2 H, m, H-6aα, H-6bα), 2.17 – 2.06 
(6 H, m, C(O)CH3α), 2.03 (3 H, s, C(O)CH3α), 2.01 (3 H, s, C(O)CH3α), 1.99 (3 H, s, C(O)CH3α); 
13C NMR δ C  (101 MHz, Chloroform-d) δ C 170.49, 170.26, 170.00, 169.05 (5 C=O), 89.83 (C-
1α), 68.88 (C-5α), 67.54, 67.48 (C-3α and C-4α), 66.56 (C-2α), 61.37 (C-6α), 21.01, 20.78, 







α-D-glucopyranose (7.50 g, 41.63 mmol) was dissolved in pyridine (120 mL) and acetic 
anhydride (60 mL) was added to the resulting solution. The mixture was stirred at RT for 21 h. 
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The mixture was then diluted with DCM (75 mL) and washed with 1 M HCl (aq.) (3 x 75 mL), 
5 M HCl (aq.) (75 mL) and brine (75 mL). The organic phase was dried using magnesium sulfate 
and filtered. Solvent was removed under reduced pressure to yield a white solid that was 
dried under vacuum for 20 h to yield a mixture of anomers (α:β = 10:1) of the title compound 
as a white solid (13.85 g, 85 %), with spectroscopic details in accordance with the literature;167 
1H NMR δ H (400 MHz, Chloroform-d) 6.32 (1 H, d, J 3.6, H-1α), 5.70 (1 H, d, J 8.3, H-1β), 5.46 
(1 H, t, J 9.9, H-3α), 5.23 (1 H, d, J 9.4, H-4β), 5.18 – 5.04 (2 H, m, H-2α, H-4α), 4.26 (1 H, dd, J 
12.7, 4.2, H-6aα), 4.15 – 4.04 (2 H, m, H-5α, H-6bα), 2.17 (3 H, s, C(O)CH3α), 2.08 (3 H, s, 
C(O)CH3α), 2.03 (3 H, s, C(O)CH3α), 2.01 (3 H, s, C(O)CH3α), 2.00 (3 H, s, C(O)CH3α); 13C NMR 
δ C (101 MHz, Chloroform-d) 170.75, 170.34, 169.77, 169.51, 168.87 (5 C=O), 89.18 (C-1α), 
69.94 (C-3α, C-5α), 69.30 (C-2α), 68.00 (C-4α), 61.57 (C-6α), 21.00, 20.82, 20.78, 20.68, 20.57 
(5 C(O)CH3); m/z (ESI-MS+) C16H22O11Na+ ([M + Na]+) calculated: 413.11; found 413.10. 








 Methyl α-D-glucopyranoside 115 (10.00 g, 51.50 mmol) was dried under vacuum for 
1 h in a flame-dried flask before being dissolved in anhydrous DMF (200 mL) under a nitrogen 
atmosphere. Imidazole (8.77 g, 128.75 mmol) was added and the solution cooled to 0 ℃. 
TIPSCl (11.25 mL, 52.53 mmol) was added dropwise and the resulting mixture was stirred at 
RT overnight. The solvent was then removed under reduced pressure and the residue was 
dissolved in DCM (300 mL). The resulting solution was washed with water (300 mL) and brine 
(300 mL), dried using magnesium sulfate and filtered. Removal of solvent under reduced 
pressure afforded silylated intermediate 116. This intermediate was dissolved in anhydrous 
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DMF (200 mL) in a flame-dried flask under a nitrogen atmosphere and cooled to 0 ℃. Sodium 
hydride (60 % in mineral oil, 12.36 g, 309.00 mmol) was added and the mixture was stirred 
for 60 min at RT, after which time the mixture was again cooled to 0 ℃. Benzyl bromide 
(36.70 mL, 309.00 mmol) was added dropwise and the reaction mixture was stirred for 18 h 
at RT, after which time methanol (50 mL) was added. Solvent was removed under reduced 
pressure and the residue was dissolved in DCM (300 mL). The resulting solution was washed 
with water (2 x 200 mL), dried using magnesium sulfate, filtered and the solvent was removed 
under reduced pressure to afford a benzylated intermediate. This intermediate was partially 
purified by column chromatography (Hexane:EtOAc 19:1 → 16:1) then dissolved in a 1 M 
solution of TBAF in THF (61.80 mL, 61.80 mmol). The resulting solution was stirred for 2 h 
15 min at RT. After this time the solvent was removed under reduced pressure and the residue 
was dissolved in DCM (300 mL), washed with water (2 x 200 mL), dried using magnesium 
sulfate, filtered and the solvent was removed under reduced pressure to afford a crude 
product. The crude product was purified by column chromatography (Hexane:EtOAc 9:1 → 
8:2 → 7:3 → 6:4) to afford the title compound 41 (14.80 g, 62 %) as a white solid, with 
spectroscopic details in accordance with the literature;108 1H NMR δ H (400 MHz, Chloroform-
d) 7.41 – 7.27 (15 H, m, Harom), 4.99 (1 H, d, J 10.9, PhCHH), 4.93 – 4.76 (3 H, m, PhCH2), 4.67 
(1 H, d, J 9.1, PhCHH), 4.64 (1 H, d, J 8.1, PhCHH), 4.58 (1 H, d, J 3.6, H-1), 4.01 (1 H, t, J 9.3, H-
3), 3.82 – 3.62 (3 H, m, H-5, H-6a, H-6b), 3.57 – 3.47 (2 H, m, H-2, H-4), 3.37 (3 H, s, OCH3), 
1.64 (1 H, br s, OH); 13C NMR δ C (101 MHz, Chloroform-d) 138.87, 138.27, 138.25 (3 4˚ Carom), 
128.61, 128.54, 128.26, 128.17, 128.10, 128.08, 128.01, 127.75 (15 Carom), 98.32 (C-1), 82.09 
(C-3), 80.12 (C-2), 77.54 (C-4), 75.88, 75.16, 73.57 (3 PhCH2), 70.79 (C-5), 62.01 (C-6), 55.32 
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 Following the general procedure for palladium catalysed glycosylation reactions, 
glycosyl donor tri-O-benzyl-D-galactal 126 (0.050 g, 0.120 mmol), glycosyl acceptor methyl 
2,3,4-tri-O-benzyl-α-D-glucopyranoside 41 (0.042 g, 0.090 mmol), metal catalyst 
bis(acetonitrile)dichloropalladium (II) 113 (0.009 g, 0.036 mmol) and ligand 2-(di-tert-
butylphosphanyl)-1-phenyl-1H-pyrrole 114 (0.010 g, 0.036 mmol) were dissolved in 2 mL of 
anhydrous DCM. The reaction mixture was stirred for 21 h before being quenched. Following 
purification by column chromatography (Hexane:EtOAc 8:1 → 5:1 → 4:1) the title compound 
44 was obtained as a yellow oil (0.068 g, 86 %, α:β >30:1), with spectroscopic details in 
accordance with the literature;108 1H NMR δ H (301 MHz, Chloroform-d) 7.42 – 7.17 (30 H, m, 
Harom), 5.02 (1 H, app d, J 3.1, H-1’), 4.98 (1 H, d, J 10.8, PhCHH), 4.91 (1 H, d, J 11.6, PhCHH), 
4.84 (1 H, d, J 10.9, PhCHH), 4.80 (1 H, d, J 11.0, PhCHH), 4.78 (1 H, d, J 12.2, PhCHH), 4.67 (1 
H, d, J 12.2, PhCHH), 4.60 (1 H, d, J 3.7, H-1), 4.59 (1 H, d, J 11.6, PhCHH), 4.57 (2 H, s, PhCH2), 
4.52 (1 H, d, J 10.9, PhCHH), 4.40 (1 H, d, J 11.8, PhCHH), 4.33 (1 H, d, J 11.9, PhCHH), 3.98 (1 
H, t, J 9.2, H-3), 3.90 – 3.83 (3 H, m, H-3’, H-4’, H-5’), 3.81 (1 H, dd, J 11.2, 4.6, H-6a), 3.71 (1 
H, ddd, J 10.0, 4.6, 1.8, H-5), 3.61 (1 H, dd, J 11.4, 1.9, H-6b), 3.57 – 3.49 (2 H, m, H-6a’, H-6b’), 
3.51 (1 H, dd, J 9.7, 3.5, H-2) 3.46 (1 H, dd, J 9.9, 9.2, H-4), 3.31 (3 H, s, OCH3), 2.20 (1 H, td, J 
12.5, 3.7, H-2ax’), 2.01 (1 H, app dd, J 12.8, 4.5, H-2eq’); 13C NMR δ C (76 MHz, Chloroform-d) 
139.02, 138.88, 138.52, 138.39, 138.30, 138.28 (6 4˚ Carom), 128.61, 128.55, 128.45, 128.34, 
128.33, 128.19, 128.17, 128.05, 127.83, 127.82, 127.79, 127.72, 127.62, 127.54 (30 Carom), 
98.42 (C-1’), 98.00 (C-1), 82.26 (C-3), 80.15 (C-2), 78.05 (C-4), 75.95 (PhCH2), 75.10 (PhCH2), 
74.42, 74.35 (C-3’, PhCH2), 73.47 (PhCH2), 73.42 (PhCH2), 73.05 (C-4’), 70.37 (PhCH2), 70.21 
(C-5’), 69.96 (C-5), 69.53 (C-6’), 66.16 (C-6), 55.16 (OCH3) 31.16 (C-2’); m/z (ESI-MS+) 
C55H60O10Na+ ([M + Na]+) calculated 903.41; found 903.41. 




Methyl 2,3-di-O-benzyl-4,6-O-benzylidene-α-D-glucopyranoside 205 (8.50 g, 
18.38 mmol) was dried under vacuum for 1 h in a flame-dried flask before being dissolved in 
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anhydrous DMF (180 mL) under a nitrogen atmosphere. The solution was cooled to 0 ℃ and 
triethylsilane (28.6 mL, 179.06 mmol) was added. Trifluoroacetic acid (14.1 mL, 184.26 mmol) 
was then added dropwise and the reaction mixture was left to stir at 0 ℃ for 30 min. When 
the reaction was judged to be complete by 1H NMR spectroscopy, the reaction mixture was 
quenched by addition of triethylamine (26.4 mL) and methanol (22 mL). DCM (260 mL) was 
added to the reaction mixture and the organic phase washed with water (2 x 220 mL) and 
brine (220 mL), dried using magnesium sulfate, filtered and the solvent was removed under 
reduced pressure to give a crude product as a yellow oil. Following purification by column 
chromatography (DCM:Et2O 95:5) the title compound 53 was obtained as a pale yellow oil 
(3.16 g, 37 %) with spectroscopic details in accordance with the literature;108 1H NMR δ H (400 
MHz, Chloroform-d) 7.42 – 7.27 (15 H, m, Harom), 5.01 (1 H, d, J 11.4, PhCH2), 4.77 (1 H, d, J 
12.2, PhCH2), 4.74 (1 H, d, J 11.5, PhCH2), 4.66 (1 H, d, J 12.0, PhCH2), 4.64 (1 H, d, J 3.5, H-1), 
4.60 (1 H, d, J 12.2, PhCH2), 4.54 (1 H, d, J 12.1, PhCH2), 3.79 (1 H, t, J 9.2, H-3), 3.75 – 3.65 (3 
H, m, H-5, H-6a, H-6b), 3.61 (1 H, t, J 9.1, H-4), 3.54 (1 H, dd, J 9.5, 3.5, H-2), 3.39 (3 H, s, OCH3), 
2.33 (1 H, s, OH); 13C NMR δ C (101 MHz, Chloroform-d) 138.93, 138.18, 138.13 (3 4˚ Carom), 
128.72, 128.60, 128.49, 128.26, 128.13, 128.08, 127.98, 127.77, 127.75 (15 Carom), 98.33 (C-
1), 81.59 (C-3), 79.72 (C-2), 75.57 (PhCH2), 73.72 (PhCH2), 73.30 (PhCH2), 70.86 (C-4), 70.01 








 Following the general procedure for palladium catalysed glycosylation reactions, 
glycosyl donor tri-O-benzyl-D-galactal 126 (0.100 g, 0.240 mmol), glycosyl acceptor methyl 
2,3,6-tri-O-benzyl-α-D-glucopyranoside 53 (0.084 g, 0.180 mmol), metal catalyst 
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bis(acetonitrile)dichloropalladium (II) 113 (0.019 g, 0.072 mmol) and ligand 2-(di-tert-
butylphosphanyl)-1-phenyl-1H-pyrrole 114 (0.021 g, 0.072 mmol) were dissolved in 2 mL of 
anhydrous DCM. The reaction mixture was stirred for 45 h before being quenched. Following 
purification by column chromatography (Hexane:EtOAc 9:2) the title compound 54 was 
obtained as a yellow oil (0.114 g, 72 %, α:β = 4:1), with spectroscopic details in accordance 
with the literature.108 Note that only characteristic, non-overlapping, distinguishable NMR 
spectroscopy signals are given for the minor β anomer; 1H NMR δ H (500 MHz, Chloroform-d) 
α anomer: 7.38 – 7.17 (30 H, m, Harom), 5.47 (1 H, app d, J 3.7, H-1’), 4.99 (1 H, d, J 10.8, 
PhCHH), 4.88 (1 H, d, J 11.7, PhCHH), 4.73 (1 H, d, J 12.1, PhCHH), 4.65 (1 H, d, J 11.0, PhCHH), 
4.64 – 4.55 (3 H, m, H-1, PhCH2), 4.57 – 4.48 (3 H, m, PhCH2), 4.38 (1 H, d, J 12.0, PhCHH), 4.36 
(1 H, d, J 11.7, PhCHH), 4.30 (1 H, d, J 11.7, PhCHH), 3.87 (1 H, t, J 9.1, H-3), 3.85 (1 H, bs, H-
4’), 3.82 (1 H, t, J 6.6, H-5’), 3.78 (1 H, ddd, J 12.2, 4.5, 2.3, H-3’), 3.74 – 3.68 (1 H, m, H-5), 
3.68 – 3.59 (3 H, m, H-4, H-6a, H-6b), 3.51 (1 H, dd, J 9.8, 3.4, H-2), 3.51 – 3.43 (2 H, m, H-6a’, 
H-6b’), 3.39 (3 H, s, OCH3), 2.13 (1 H, td, J 12.4, 4.0, H-2ax’,), 1.87 (1 H, dd, J 12.5, 4.5, H-2eq’); 
β anomer: 5.24 (1H, app d, J = 3.5 Hz, H-1’), 2.24 (1H, td, J = 12,4, 3.7 Hz, H-2ax’); 13C NMR δ 
C (126 MHz, Chloroform-d) α anomer: 138.91, 138.60, 138.58, 138.53, 138.20, 138.16 (6 4˚ 
Carom), 128.58, 128.53, 128.46, 128.44, 128.33, 128.30, 128.26, 128.05, 127.95, 127.78, 
127.76, 127.73, 127.68, 127.67, 127.63, 127.44, 127.43 (30 Carom), 99.82 (C-1’), 97.92 (C-1), 
82.20 (C-3), 80.17 (C-2), 76.04 (C-4), 75.66 (PhCH2), 74.62 (C-3’), 74.38 (PhCH2), 73.59 (PhCH2), 
73.41 (PhCH2), 73.19 (PhCH2), 72.89 (C-4’), 70.85 (C-5’), 70.53 (PhCH2), 70.04 (C-5), 69.73, 
69.69 (C-6, C-6’), 55.34 (OCH3), 31.76 (C-2’); β anomer: 93.5 (C-1’); m/z (ESI-MS+) 
C55H60O10Na+ ([M + Na]+) calculated 903.4; found 903.4. 




 2,3,4,6-Tetra-O-benzyl-D-glucopyranose (4.00 g, 7.40 mmol) was dried under vacuum 
for 1 h before being dissolved in anhydrous DCM (45 mL). Trichloroacetonitrile (11.13 mL, 
111.00 mmol) and DBU (0.55 mL, 3.70 mmol) were added and the resulting solution was 
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stirred at RT for 55 min under a nitrogen atmosphere, after which time TLC (Hexane:EtOAc 
8:2) showed the reaction to be complete. Solvent was then removed under reduced pressure 
and the crude product was purified by column chromatography (Hexane:EtOAc 9:1) using 
neutralised silica (1 % NEt3) to give the title compound 62 as a colourless syrup (4.88 g, 96 %) 
with spectroscopic details in accordance with the literature;168 1H NMR δ H (400 MHz, 
Chloroform-d) 8.59 (1 H, s NH), 7.37 – 7.27 (18 H, m, Harom), 7.19 – 7.12 (2 H, m, Harom), 6.54 
(1 H, d, J 3.4, H-1), 4.97 (1 H, dd, J 11.1, 1.7, PhCHH), 4.90 – 4.81 (2 H, m, PhCH2), 4.76 (1 H, d, 
J 11.7, PhCHH), 4.72 – 4.66 (1 H, m, PhCHH), 4.62 (1 H, d, J 12.1, PhCHH), 4.54 (1 H, d, J 10.7, 
PhCHH), 4.48 (1 H, d, J 12.0, PhCHH), 4.06 (1 H, td, J 9.4, 1.7, H-3), 4.00 (1 H, dd, J 10.2, 2.5, H-
5), 3.83 – 3.76 (3 H, m, H-2, H-4, H-6a), 3.68 (1 H, dd, J 11.0, 1.9, H-6b); 13C NMR δ C (101 MHz, 
Chloroform-d) 161.45 (CNH), 138.73, 138.17, 138.08, 137.96 (4 4˚ Carom), 128.54, 128.52, 
128.49, 128.48, 128.20, 128.13, 128.08, 127.95, 127.86, 127.84, 127.76, 127.74 (Carom), 94.51 
(C-1), 91.41 (CCl3), 81.51 (C-3), 79.49 (C-2), 76.94 (C-4), 75.77 (PhCH2), 75.46 (PhCH2), 73.61 
(PhCH2), 73.25 (C-5), 73.01 (PhCH2), 68.17 (C-6); m/z (ESI-MS+) C36H36Cl3NO6Na+ ([M + Na]+) 
calculated 706.15; found 706.15. 







 Methyl α-D-glucopyranoside 115 (7.00 g, 36.05 mmol) was dried under vacuum for 1 h 
in a flame-dried flask before being dissolved in anhydrous pyridine (210 mL) under a nitrogen 
atmosphere. Imidazole (5.39 g, 79.17 mmol) was added and the solution was cooled to 0 ℃. 
TIPSCl (8.4 mL, 39.26 mmol) was then added dropwise and the resulting mixture was stirred 
at RT for 16 h under nitrogen, after which time benzoyl chloride (33.6 mL, 289.22 mmol) was 
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added and the reaction mixture was stirred for a further 24 h under nitrogen at RT. Methanol 
(14 mL) was then added and the reaction mixture was diluted with DCM (200 mL). The 
resulting solution was washed with 1 M HCl (aq.) (2 x 200 mL), NaHCO3 (sat. aq.) (200 mL) and 
water (200 mL). The organic phase was dried using magnesium sulfate, filtered and the 
solvent was removed under reduced pressure to afford fully protected intermediate 117. 
Intermediate 117 was dissolved in a solution of THF (112 mL), water (42 mL) and TFA (30 mL) 
and then stirred for 48 h at RT, after which time the solvent was removed under reduced 
pressure by forming an azeotrope with toluene. The crude product was purified by column 
chromatography (Hexane:EtOAc 12:1 → 6:1 → 4:1 → 3:1) to afford the title compound 74 
(12.32 g, 67 %) as a white solid, with spectroscopic details in accordance with the literature;108 
1H NMR δ H (400 MHz, Chloroform-d) 8.01 – 7.94 (4 H, m, Harom), 7.91 – 7.85 (2 H, m, Harom), 
7.58 – 7.47 (2 H, m, Harom), 7.46 – 7.34 (5 H, m, Harom), 7.33 – 7.23 (2 H, m, Harom), 6.24 (1 H, t, 
J 9.7, H-3), 5.49 (1 H, t, J 9.9, H-4), 5.33 – 5.23 (2 H, m, H-2, H-1), 4.05 (1 H, dt, J 10.2, 2.9, H-
5), 3.86 (1 H, dd, J 13.0, 2.2, H-6a), 3.75 (1 H, dd, J 13.0, 3.7, H-6b), 3.59 (1 H, br s, OH), 3.47 
(3 H, s, OCH3); 13C NMR δ C (101 MHz, Chloroform-d) 166.71, 166.00, 165.98 (3 C=O), 133.92, 
133.54, 133.33 (3 4˚ Carom), 130.15, 130.06, 129.79, 129.27, 129.13, 128.68, 128.57, 128.56, 
128.45 (15 Carom), 97.29 (C-1), 72.16 (C-2), 70.21 (C-3), 69.80 (C-5), 69.72 (C-4), 61.20 (C-6), 
55.83 (OCH3); m/z (ESI-MS+) C28H26O9Na+ ([M + Na]+) calculated: 529.15; found 529.14; 
C27H23O8+ ([M – OCH3]+) calculated: 475.14; found 475.14. 




 Methyl 4,6-O-benzylidene-α-D-glucopyranoside 204 (6.50 g, 23.03 mmol) was 
dissolved in a mixture of DCM (200 mL), NaOH aq. (0.68 M, 50.8 mL), benzyl bromide (3.3 mL, 
27.63 mmol) and tetrabutylammonium hydrogensulfate (1.56 g, 4.61 mmol). The mixture was 
stirred vigorously for 24 h at RT. The organic phase was then separated, washed with water 
(150 mL) and brine (150 mL), dried using magnesium sulfate, filtered and the solvent was 
removed under reduced pressure. Following purification by column chromatography 
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(Hexane:EtOAc, 8:2 → 3:1) the title compound 92 was obtained as a white solid (3.02 g, 35 %) 
with spectroscopic details in accordance with the literature;108 1H NMR δ H (500 MHz, 
Chloroform-d) 7.50 (2 H, dd, J 7.0, 2.4, Harom), 7.46 – 7.28 (8 H, m, Harom), 5.52 (1 H, s, 
PhC(H)OO), 4.79 (1 H, d, J 12.1, PhCHH), 4.70 (1 H, d, J 12.2, PhCHH), 4.62 (1 H, d, J 3.7, H-1), 
4.26 (1 H, dd, J 10.1, 4.8, H-6a), 4.16 (1 H, td, J 9.3, 2.2, H-3), 3.82 (1 H, td, J 9.9, 4.8, H-5), 3.70 
(1 H, t, J 10.3, H-6b), 3.54 – 3.42 (2 H, m, H-2, H-4), 3.38 (3 H, s, OCH3), 2.72 (1 H, d, J 2.3, OH); 
13C NMR δ C (126 MHz, Chloroform-d) 138.01, 137.18 (2 4˚ Carom), 129.26, 128.65, 128.37, 
128.23, 128.18, 126.42 (Carom), 102.03 (PhC(H)OO), 98.72 (C-1), 81.35 (C-4), 79.66 (C-2), 73.43 
(PhCH2), 70.34 (C-3), 69.06 (C-6), 62.11 (C-5), 55.46 (OCH3); m/z (ESI-MS+) C21H24O6Na+ ([M + 
Na]+) calculated 395.1; found 395.1. 




 Phenyl 2,3,4-tri-O-benzoyl-6-O-triisopropylsilyl-β-D-thioglucopyranoside 219 (4.87 g, 
6.57 mmol) was dissolved in a 10:1 acetone:water mixture (165 mL) and cooled to 0 ℃. NBS 
(2.34 g, 13.14 mmol) that had been freshly recrystallised from water was added and the 
resulting solution was stirred for 100 min at RT after which time TLC (Hexane:EtOAc 8:2) 
showed the reaction to be complete. Most acetone solvent was removed under reduced 
pressure and DCM (200 mL) was added to the residue. The resulting organic solution was 
washed with NaHCO3 (sat. aq.) (35 mL), dried using magnesium sulfate, filtered and the solvent 
was removed under reduced pressure. The crude product was purified by column 
chromatography (Hexane:EtOAc 95:5 → 92:8 → 87:13) to give the free hemiacetal 
intermediate as an anomeric mixture (2.74 g, 4.22 mmol). This intermediate was dried under 
vacuum for 1 h before being dissolved in anhydrous DCM (100 mL). Trichloroacetonitrile 
(6.35 mL, 63.30 mmol) and DBU (0.31 mL, 2.11 mmol) were added and the resulting solution 
was stirred at RT for 1 h under a nitrogen atmosphere, after which time TLC (Hexane:EtOAc 
8:2) showed the reaction to be complete. Solvent was then removed under reduced pressure 
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and the crude product was purified by column chromatography (Hexane:EtOAc 94:6) using 
neutralised silica (1 % NEt3) to give the title compound 97 as a white solid (2.79 g, 53 % over 
2 steps) with spectroscopic details in accordance with the literature;144 1H NMR δ H (400 MHz, 
Chloroform-d) 8.57 (1 H, s, NH), 7.95 (4 H, m, Harom), 7.91 – 7.84 (2 H, m, Harom), 7.55 – 7.26 (9 
H, m, Harom), 6.83 (1 H, d, J 3.6, H-1), 6.23 (1 H, t, J 10.0, H-3), 5.74 (1 H, t, J 10.0, H-4), 5.54 (1 
H, dd, J 10.2, 3.6, H-2), 4.37 (1 H, dt, J 10.3, 3.6, H-5), 3.98 – 3.88 (2 H, m, H-6a, H-6b), 1.09 – 
0.94 (21 H, m, TIPS); 13C NMR δ C (101 MHz, Chloroform-d) 165.91, 165.61, 165.21 (3 C=O), 
160.72 (CNH), 133.58, 133.41, 133.28, 130.06, 129.95, 129.89, 129.31, 129.24, 128.88, 
128.53, 128.48, 128.44 (Carom), 93.50 (C-1), 91.07 (CCl3), 73.94 (C-5), 71.16 (C-2), 70.69 (C-3), 
68.80 (C-4), 62.63 (C-6), 18.01, 12.06 (TIPS); m/z (ESI-MS+) C38H44Cl3NO9SiNa+ ([M + Na]+) 









glucopyranoside trifluoromethanesulfonate 172 (0.0517 g, 0.061 mmol) was dissolved in a 
mixture of DCM (1 mL) and a solution of HCl, 0.8 M in MeOH (1.54 mL, 1.229 mmol). The 
resulting solution was stirred at RT for 16 h in air, after which time TLC showed the reaction 
to be complete. The reaction mixture was diluted with DCM (5 mL) and water (5 mL). Product 
was extracted into the DCM phase, then the aqueous phase was washed with further DCM 
portions (2 x 5 mL) and all DCM portions were combined, dried using magnesium sulfate, 
filtered and the solvent was removed under reduced pressure. The crude residue was washed 
with Et2O (3 x 5 mL) then dried under reduced pressure to yield the title compound 100 as an 
off-white solid (0.0351 g, 75 %) with spectroscopic details in accordance with the literature;144 
1H NMR δ H (400 MHz, Acetonitrile-d3) 8.45 (1 H, s, NCHN), 7.95 – 7.89 (4 H, m, Harom), 7.79 – 
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7.74 (2 H, m, Harom), 7.62 – 7.57 (2 H, m, Harom), 7.52 (1 H, ddt, J 8.8, 7.2, 1.3, Harom), 7.48 – 
7.41 (4 H, m, Harom), 7.38 – 7.33 (2 H, m, Harom), 7.29 (2 H, app d, J 1.6, NCHCHN, NCHCHN), 
5.87 (1 H, t, J 9.6, H-3), 5.53 (1 H, t, J 9.7, H-4), 5.37 (1 H, dd, J 9.8, 8.0, H-2), 4.96 (1 H, d, J 8.0, 
H-1), 4.24 – 4.10 (2 H, m, NCH2), 3.96 (1 H, ddd, J 10.0, 5.0, 2.4, H-5), 3.91 – 3.84 (1 H, m, (C-
1)OCHH), 3.83 (3 H, s, NCH3), 3.77 (1 H, dd, J 12.5, 2.3, H-6a), 3.75 – 3.65 (2 H, m, H-6b, (C-
1)OCHH), 2.12 – 1.98 (2 H, m, OCH2CH2CH2N); 13C NMR δ C (101 MHz, Acetonitrile-d3) 166.42, 
166.32, 166.07 (3 C=O), 137.28 (NCHN), 134.65, 134.53, 130.39, 130.17, 130.15, 130.11, 
129.97, 129.68, 129.61, 129.53 (Carom), 124.56 (NCHCHN), 123.39 (NCHCHN), 101.21 (C-1), 
75.37 (C-5), 74.57 (C-3), 73.10 (C-2), 70.26 (C-4), 66.56 ((C-1)OCH2), 61.47 (C-6), 47.58 (NCH2), 
36.79 (NCH3), 30.50 (OCH2CH2CH2N); 19F NMR δ F (377 MHz, Acetonitrile-d3) -79.30 (-OTf); m/z 
(TLC-MS+ (ESI)) C34H35N2O9+ ([M - OTf]+) calculated 615.2; found 615.0; (TLC-MS- (ESI)) CF3O3S- 





















 Following the general procedure for I-Tag glycosylations in flow using glycosyl 
acceptor 1-(4-(hydroxymethyl)benzyl)-3-methyl-1H-imidazol-3-ium 
trifluoromethanesulfonate 157 (0.1762 g, 0.500 mmol, 1 eq) and glycosyl donor 2,3,4-tri-O-
benzoyl-6-O-chloroacetyl-α-D-glucopyranosyl trichloroacetimidate 167 (0.7133 g, 
1.000 mmol, 2 eq). 2.50 mL of anhydrous MeCN was added to the donor/acceptor vial, 
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resulting in a solution of volume 3.20 mL and therefore approximately 0.156 M in acceptor 
and 0.312 M in donor. To the other vial, 4.00 mL of anhydrous acetonitrile was added, 
followed by trimethylsilyl trifluoromethanesulfonate (43.4 μL, 0.240 mmol) to make a 0.06 M 
solution. The flow reaction was performed at 50 ℃. Reaction solution was collected from the 
flow reactor directly into a solution of HCl, 1.25 M in MeOH (8.00 mL, 8.000 mmol), for a total 
of 47 min. The resulting acidic solution was stirred at RT for 16 h in air. After this time TLC-MS 
showed complete conversion to the desired product. The solution was diluted with DCM 
(15 mL) and water (15 mL). Product was extracted into the DCM phase, then the aqueous 
phase was washed with further DCM portions (2 x 15 mL) and all DCM portions were 
combined, dried using magnesium sulfate, filtered and the solvent was removed under 
reduced pressure. The crude residue was washed with Et2O:DCM 9:1 (6 x 5 mL) and Et2O:DCM 
86:14 (10 mL) then dried under reduced pressure to yield the title compound 102 as an off-
white solid (0.3674 g, 92 %) with spectroscopic details in accordance with the literature;144 1H 
NMR δ H (400 MHz, Chloroform-d) 9.10 (1 H, s, NCHN), 7.97 – 7.88 (4 H, m, Harom), 7.85 – 7.78 
(2 H, m, Harom), 7.56 – 7.48 (2 H, m, Harom), 7.47 – 7.32 (5 H, m, Harom) 7.30 – 7.18 (8 H, m, Harom, 
NCHCHN, NCHCHN), 5.91 (1 H, t, J 9.7, H-3), 5.55 – 5.46 (2 H, m, H-2, H-4), 5.27 (2 H, s, NCH2), 
4.93 – 4.87 (2 H, m, H-1, (C-1)OCHH), 4.70 (1 H, d, J 12.5, (C-1)OCHH), 3.90 – 3.79 (5 H, m, H-
5, H-6a, NCH3), 3.71 (1 H, dd, J 12.3, 4.2, H-6b); 13C NMR δ C (101 MHz, Chloroform-d) 166.18, 
165.91, 165.40 (3 C=O), 138.68 (4˚ CaromCH2O(C-1)), 136.94 (NCHN), 133.84, 133.64, 133.43 
(Carom), 132.44 (4˚ CaromCH2N), 130.04, 129.87, 129.81, 129.23, 129.09, 128.95, 128.80, 128.67, 
128.65, 128.63, 128.46 (Carom), 123.75 (NCHCHN), 122.15 (NCHCHN), 100.49 (C-1), 74.83 (C-
5), 72.93 (C-3), 72.10 (C-2), 70.83 ((C-1)OCH2), 69.60 (C-4), 61.23 (C-6), 53.17 (NCH2), 36.52 
(NCH3); m/z (TLC-MS+ (ESI)) C39H37N2O9+ ([M - OTf]+) calculated 677.2; found 677.1; (TLC-MS- 
(ESI)) CF3O3S- ([OTf]-) calculated 149; found 149. 
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Methyl-β-D-galactopyranoside 118 (4.85 g, 24.98 mmol) was dried under vacuum for 
1 h in a flame-dried flask before being dissolved in anhydrous acetonitrile (100 mL) under a 
nitrogen atmosphere. CopperII triflate (0.54 g, 1.49 mmol) and benzaldehyde dimethyl acetal 
(4.5 mL, 29.86 mmol) were added and the solution was sonicated under a nitrogen 
atmosphere for 70 min, after which time the reaction was quenched by addition of 
triethylamine (5 mL) and the solvent was removed under reduced pressure. Following 
purification by column chromatography (DCM:MeOH 19:1) methyl-4,6-O-benzylidene-β-D-
galactopyranoside 119 was obtained as a white solid. The methyl-4,6-O-benzylidene-β-D-
galactopyranoside 119 was dried under vacuum for 1 h in a flame-dried flask before being 
dissolved in anhydrous DMF (150 mL) under a nitrogen atmosphere. The solution was cooled 
to 0 ℃ and sodium hydride (60 % in mineral oil, 3.10 g, 77.50 mmol) was added. The reaction 
mixture was stirred for 15 min at 0 ℃ then 30 min at RT. The solution was cooled to 0 ℃ again 
and benzyl bromide (9.2 mL, 77.50 mmol) was added dropwise. After being left to stir under 
nitrogen for 18 h at RT, methanol (10 mL) was added to the reaction mixture, then the solvent 
was removed under reduced pressure. The residue was dissolved in DCM (250 mL), washed 
with water (2 x 120 mL) and brine (120 mL), dried using magnesium sulfate, filtered and the 
solvent was removed under reduced pressure to give a crude product. Following purification 
by column chromatography (Hexane:EtOAc 9:1 → 7:3 → 1:1) the title compound 120 was 
obtained as a white solid (9.00 g, 78 %) with spectroscopic details in accordance with the 
literature;108 1H NMR δ H (400 MHz, Chloroform-d) 7.61 – 7.52 (2 H, m, Harom), 7.44 – 7.27 (13 
H, m, Harom), 5.50 (1 H, s, PhC(H)OO), 4.91 (1 H, d, J 10.9, PhCH2), 4.82 – 4.72 (3 H, m, PhCH2), 
4.36 – 4.29 (2 H, m, H-6a, H-1), 4.12 (1 H, dd, J 3.7, 1.1, H-4), 4.03 (1 H, dd, J 12.3, 1.8, H-6b), 
3.85 (1 H, dd, J 9.7, 7.6, H-2), 3.59 (3 H, s, OCH3), 3.60 – 3.53 (1 H, m, H-3), 3.33 (1 H, q, J 1.5, 
H-5); 13C NMR δ C (101 MHz, Chloroform-d) 139.04, 138.55, 137.96 (3 4˚ Carom), 129.05, 128.46, 
128.39, 128.24, 128.15, 127.88, 127.79, 127.64, 126.66 (15 Carom), 104.85 (C-1), 101.49 
(PhC(H)OO), 79.30 (C-3), 78.58 (C-2), 75.36 (PhCH2), 74.08 (C-4), 72.13 (PhCH2), 69.36 (C-6), 
66.53 (C-5), 57.19 (OCH3); m/z (ESI-MS+) C28H30O6Na+ ([M + Na]+) calculated 485.19; found 
485.19. 
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 Methyl 2,3-di-O-benzyl-4,6-O-benzylidene-β-D-galactopyranoside 120 (10.68 g, 
23.09 mmol) was dried under vacuum for 1 h in a flame-dried flask before being dissolved in 
anhydrous DCM (200 mL) under a nitrogen atmosphere. The solution was cooled to 0 ℃ and 
triethylsilane (18.5 mL, 115.45 mmol) was added. Trifluoroacetic acid (8.9mL, 115.45 mmol) 
was then added dropwise and the reaction mixture was left to stir at 0 ℃ for 30 min. When 
the reaction was judged to be complete by 1H NMR spectroscopy, the reaction mixture was 
quenched by addition of triethylamine (37 mL) and methanol (31 mL). The organic phase was 
washed with water (130 mL) and brine (130 mL), dried using magnesium sulfate, filtered and 
the solvent was removed under reduced pressure to give a crude product. Following 
purification by column chromatography (Hexane:EtOAc 9:1 → 7:3) the title compound 121 
was obtained as a colourless oil (8.88 g, 83 %) with spectroscopic details in accordance with 
the literature;108 1H NMR δ H (400 MHz, Chloroform-d) 7.43 – 7.24 (15 H, m, Harom), 4.91 (1 H, 
d, J 11.1, PhCHH), 4.74 (1 H, d, J 11.3, PhCHH), 4.73 (2 H, s, PhCH2), 4.61 (2 H, s, PhCH2), 4.29 
(1 H, d, J 7.7, H-1), 4.04 (1 H, d, J 3.3, H-4), 3.83 (1 H, dd, J 9.9, 6.0, H-6a), 3.76 (1 H, dd, J 9.9, 
5.9, H-6b), 3.65 (1 H, dd, J 9.4, 7.7, H-2), 3.60 – 3.56 (1 H, m, H-5), 3.58 (3 H, s, OCH3), 3.51 (1 
H, dd, J 9.4, 3.4, H-3), 2.53 (1 H, s, OH); 13C NMR δ C (101 MHz, Chloroform-d) 138.78, 138.12, 
138.00 (3 4˚ Carom), 128.56, 128.55, 128.41, 128.16, 127.99, 127.94, 127.89, 127.87, 127.70 
(15 Carom), 104.83 (C-1), 80.68 (C-3), 79.12 (C-2), 75.24 (PhCH2), 73.84 (PhCH2), 73.26 (C-5), 
72.50 (PhCH2), 69.33 (C-6), 66.96 (C-4), 57.05 (OCH3); m/z (ESI-MS+) C28H32O6Na+ ([M + Na]+) 
calculated 487.2; found 487.2. 
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 Methyl 2,3-di-O-benzyl-4,6-O-benzylidene-β-D-galactopyranoside 120 (9.00 g, 
19.46 mmol), methanol (100 mL) and p-toluenesulfonic acid monohydrate (1.85 g, 
9.73 mmol) were added to a flask and sonicated for 90 min, after which time triethylamine 
(8 mL) was added and the solvent was removed under reduced pressure. Following 
purification by column chromatography (Hexane:EtOAc 3:1 → 1:1 → EtOAc) the title 
compound 122 was obtained as an oil (6.20 g, 85 %, β:α ≈ 12:1), with spectroscopic details in 
accordance with the literature;169 1H NMR δ H (500 MHz, Chloroform-d) 7.40 – 7.27 (10 H, m, 
Harom), 4.90 (1 H, d, J 11.0, PhCHH), 4.75 – 4.71 (3 H, m, PhCH2), 4.30 (1 H, d, J 7.7, H-1), 4.00 
(1 H, dd, J 3.4, 1.2, H-4), 3.98 (1 H, dd, J 11.7, 6.5, H-6a), 3.86 – 3.81 (1 H, m, H-6b), 3.64 (1 H, 
dd, J 9.4, 7.7, H-2), 3.58 (3 H, s, OCH3), 3.51 (1 H, dd, J 9.3, 3.5, H-3), 3.47 (1 H, ddd, J 6.3, 4.7, 
1.2, H-5), 2.66 (1 H, bs, C-4(OH)), 2.24 (1 H, bs, C-6(OH)); 13C NMR δ C (126 MHz, Chloroform-
d) 138.73, 137.88 (2 4˚ Carom), 128.64, 128.45, 128.18, 128.11, 127.98, 127.76 (10 Carom), 
104.97 (C-1), 80.49 (C-3), 79.05 (C-2), 75.27 (PhCH2), 74.02 (C-5), 72.71 (PhCH2), 67.62 (C-4), 
62.73 (C-6), 57.22 (OCH3); m/z (ESI-MS+) C21H26O6Na+ ([M + Na]+) calculated 397.16; found 
397.16. 




 Methyl 2,3-di-O-benzyl-β-D-galactopyranoside 122 (6.20 g, 16.56 mmol) was dried 
under vacuum for 1 h in a flame-dried flask before being dissolved in anhydrous DMF (100 mL) 
under a nitrogen atmosphere. Imidazole (2.25 g, 33.12 mmol) was added and the resulting 
solution was cooled to 0 ℃. To this solution TIPSCl (5.3 mL, 24.84 mmol) was added dropwise 
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and the resulting mixture was stirred at RT for 18 h under nitrogen, after which time the 
solvent was removed under reduced pressure. The residue was dissolved in DCM (150 mL) 
and washed with water (75 mL) and brine (75 mL), dried using magnesium sulfate, filtered 
and the solvent was removed under reduced pressure. Following purification by column 
chromatography (Hexane:EtOAc 99:1 → 9:1) the title compound 123 was obtained as a white 
solid (8.36 g, 95 %); 1H NMR δ H (500 MHz, Chloroform-d) 7.40 – 7.27 (10 H, m, Harom), 4.90 (1 
H, d, J 11.1, PhCHH), 4.76 – 4.72 (3 H, m, PhCH2), 4.27 (1 H, d, J 7.8, H-1), 4.07 – 4.05 (1 H, m, 
H-4), 4.01 (1 H, dd, J 10.0, 6.5, H-6a), 3.91 (1 H, dd, J 10.0, 5.3, H-6b), 3.66 (1 H, dd, J 9.4, 7.7, 
H-2), 3.55 (3 H, s, OCH3), 3.49 (1 H, dd, J 9.4, 3.3, H-3), 3.40 (1 H, t, J 6.0, H-5), 2.59 (1 H, d, J 
1.9, OH), 1.14 – 1.00 (21 H, m, Si(iPr)3); 13C NMR δ C (126 MHz, Chloroform-d) 138.94, 138.23 
(2 4˚ Carom), 128.58, 128.42, 128.16, 127.96, 127.94, 127.67 (10 Carom), 104.93 (C-1), 80.90 (C-
3), 79.32 (C-2), 75.25 (PhCH2), 74.56 (C-5), 72.52 (PhCH2), 66.70 (C-4), 62.67 (C-6), 56.96 
(OCH3), 18.09, 18.06, 12.04 (9 C(iPr)); m/z (ESI-HRMS) C30H46O6SiNa+ ([M + Na]+) calculated 
553.2956; found 553.2934; C29H43O5Si+ ([M – OMe]+) calculated 499.2874; found 499.2851; 
IR νmax/cm-1 3490br, 2941, 2865, 1454, 1383, 1202, 1100, 1074, 882, 806, 735, 670; [𝜶]𝑫
𝟐𝟐 + 





 D-Galactal 124 (0.50 g, 3.42 mmol) was dried under vacuum for 1 h in a flame-dried 
flask before being dissolved in anhydrous DMF (5 mL) under a nitrogen atmosphere. Imidazole 
(2.10 g, 30.85 mmol) was added, followed by tert-butyldimethylsilyl 
trifluoromethanesulfonate (4.7 mL, 20.52 mmol) dropwise and the reaction was left to stir 
under a nitrogen atmosphere for 25 h at 50 ℃. The reaction mixture was then poured over 
hexane (20 mL) and crushed ice. The aqueous phase was washed with hexane (2 x 10 mL) and 
hexane fractions were combined. The hexane phase was washed with water (2 x 10 mL) and 
brine (2 x 10 mL), dried using magnesium sulfate, filtered and the solvent was removed under 
reduced pressure. Following purification by column chromatography (Hexane:DCM 9:1 + 
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1 % NEt3), the title compound 125 was obtained as a colourless syrup (1.45 g, 87 %) with 
spectroscopic details in accordance with the literature;108 1H NMR δ H (500 MHz, Chloroform-
d) 6.21 (1 H, dd, J 6.2, 0.8, H-1), 4.65 (1 H, app s, H-2), 4.20 – 3.97 (4 H, m, H-3, H-4, H-5, H-
6a), 3.86 (1 H, d, J 8.3, H-6b), 0.91 (9 H, s, C(CH3)3), 0.90 (9 H, s, C(CH3)3), 0.90 (9 H, s, C(CH3)3), 
0.10 (3 H, s, SiCH3), 0.10 (3 H, s, SiCH3), 0.07 (3 H, s, SiCH3), 0.07 (3 H, s, SiCH3), 0.05 (6 H, s, 
SiCH3); 13C NMR δ C (126 MHz, Chloroform-d) 142.82 (C-1), 102.80 (C-2), 79.73, 69.33, 65.28 
(C-3, C-4, C-5), 61.07 (C-6), 26.19, 26.13, 26.05 (9 C(CH3)3), 18.61, 18.42, 18.35 (3 C(CH3)3), -
4.05, -4.23, -4.60, -4.77, -4.98, -5.09 (6 SiCH3); m/z (ESI-MS+) C24H52O4Si3Na+ ([M + Na]+) 






 D-Galactal 124 (4.00 g, 27.37 mmol) was dried under vacuum for 30 min in a flame-
dried flask before being dissolved in anhydrous DMF (200 mL) and cooled to 0 ˚C under a 
nitrogen atmosphere. Sodium hydride (60 % in mineral oil, 6.57 g, 164.23 mmol) was added 
and the mixture stirred for 30 min at RT, after which time the mixture was again cooled to 
0 ℃. Benzyl bromide (19.5 mL, 164.23 mmol) was added dropwise and the reaction mixture 
was stirred for 16.5 h at RT, after which time methanol (20 mL) was added. Solvent was 
removed under reduced pressure and the residue was dissolved in DCM (100 mL). The 
resulting solution was washed with water (100 mL), then the aqueous phase was washed with 
DCM (2 x 50 mL) and the organic washings were combined. The combined DCM phase was 
washed with brine (100 mL), dried using magnesium sulfate, filtered and the solvent was 
removed under reduced pressure. The crude residue was purified by column chromatography 
(Hexane:EtOAc 20:1 → 15:1 → 10:1). To remove amine impurity 127 that co-eluted with the 
title compound during column chromatography, the residue was dissolved in hexane (100 mL) 
and washed with 1 M HCl (aq.) (2 x 100 mL), NaHCO3 (sat. aq.) (100 mL) and water (100 mL). The 
hexane phase was dried using magnesium sulfate, filtered and the solvent was removed 
 6.  Experimental  
174 
 
under reduced pressure to yield the title compound 126 as a colourless syrup (7.63 g, 67 %) 
with spectroscopic details in accordance with the literature;170 1H NMR δ H (400 MHz, 
Chloroform-d) 7.38 – 7.27 (15 H, m, Harom), 6.38 (1 H, dd, J 6.2, 1.5, H-1), 4.92 – 4.84 (2 H, m, 
H-2, PhCHH), 4.70 – 4.59 (3 H, m, PhCH2), 4.52 (1 H, d, J 11.9, PhCHH), 4.44 (1 H, d, J 11.9, 
PhCHH), 4.23 – 4.16 (2 H, m, H-3, H-5), 3.99 – 3.93 (1 H, m, H-4), 3.79 (1 H, dd, J 10.2, 7.2, H-
6a), 3.66 (1 H, dd, J 10.1, 5.1, H-6b); 13C NMR δ C (101 MHz, Chloroform-d) 144.33 (C-1), 
138.65, 138.51, 138.14 (3 4˚ Carom), 128.52, 128.46, 128.28, 128.03, 127.83, 127.69, 127.58 
(Carom), 100.10 (C-2), 75.83 (C-5), 73.55 (PhCH2), 73.45(PhCH2), 71.42 (C-4), 71.02 (PhCH2), 
70.88 (C-3), 68.57 (C-6); m/z (ESI-MS+) C27H28O4Na+ ([M + Na]+) calculated 439.2; found 439.2. 










 In a flame-dried microwave vial donor tri-O-benzyl-D-galactal 126 (0.1000 g, 
0.240 mmol) was dried under vacuum for 16 h. In a separate flame-dried microwave vial, 
N,N′−bis(3,5−bis(trifluoromethyl)phenyl)-thiourea 86 (0.0120 g, 0.0240 mmol) and (R)-3,3′-
bis(3,5-bis(trifluoromethyl)phenyl)-1,1′-binaphthyl-2,2′-diyl hydrogenphosphate 129 
(0.0185 g, 0.024 mmol) were also dried under vacuum for 16 h. Anhydrous DCM (2 mL) was 
added to the thiourea-acid vial and the resulting solution was stirred at RT under a nitrogen 
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atmosphere for 30 min. After this time, methanol-d4 (8.1 μL, 0.199 mmol) which had been 
dried using activated 3Å molecular sieves, was added to the thiourea-acid solution. The 
resulting solution was then added to the vial containing the glycosyl donor. The reaction was 
stirred at RT under a nitrogen atmosphere for 3 h 15 min, after which time TLC (Hexane:EtOAc 
7:3) showed the reaction to be complete. Solvent was then removed under reduced pressure. 
Following column chromatography (Hexane:EtOAc 10:1) the title compounds 130 and 131 
were obtained as an inseparable isotopic mixture (0.0712 g, 79 % combined yield) in a ratio 
of 130:131 = 54:46 as determined by 1H NMR spectroscopy by comparison of the H-2 peaks. 
Spectroscopic details were in accordance with the literature for previously reported 
compound 130 and the isotopologue of 131, methyl 2-deoxy-3,4,6-tri-O-benzyl-α-D-lyxo-
hexapyranoside;150 1H NMR δ H (400 MHz, Chloroform-d) 7.42 – 7.24 (15 H, m, Harom), 4.96 (1 
H, d, J 11.6, PhCHH), 4.90 (1 H, app d, J 3.8, H-1), 4.66 (1 H, d, J 11.6, PhCHH), 4.62 (2 H, s, 
PhCH2), 4.55 (1 H, d, J 11.8, PhCHH), 4.46 (1 H, d, J 11.7, PhCHH), 4.00 – 3.87 (3 H, m, H-3, H-
4, H-5), 3.65 – 3.61 (2 H, m, H-6a, H-6b), 2.32 – 2.18 (1 H, m, H-2ax 130 and 131), 2.03 (1 H, 
ddt, J 12.7, 4.5, 1.3, H-2eq 131); 13C NMR δ C (101 MHz, Chloroform-d) 138.92, 138.65, 138.18 
(3 4˚ Carom), 128.51, 128.50, 128.37, 128.33, 127.90, 127.80, 127.65, 127.40 (Carom), 98.98 (C-
1), 74.77 (app d, C-3), 74.43 (PhCH2), 73.60 (PhCH2), 73.17 (app d, C-4), 70.54 (PhCH2), 69.89 
(C-5), 69.76 (C-6), 31.26 (C-2 131), 30.81 (app d, C-2 130); m/z (ESI-HRMS) 130 C28H29D4O5+ 
([M + H]+) calculated: 453.2574; found 453.2577; C28H28D4O5Na+ ([M + Na]+) calculated: 
475.2393; found 475.2386; 131 C28H30D3O5+ ([M + H]+) calculated: 452.2511; found 452.2521; 
C28H29D3O5Na+ ([M + Na]+) calculated: 474.2330; found 474.2334. 





 Following the general procedure for palladium catalysed glycosylation reactions, 
glycosyl donor tri-O-benzyl-D-galactal 126 (0.100 g, 0.240 mmol), glycosyl acceptor phenethyl 
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alcohol 134 (0.022 g, 0.180 mmol), metal catalyst bis(acetonitrile)dichloropalladium (II) 113 
(0.019 g, 0.072 mmol) and ligand 2-(di-tert-butylphosphanyl)-1-phenyl-1H-pyrrole 114 
(0.021 g, 0.072 mmol) were dissolved in 2 mL of anhydrous DCM. The reaction mixture was 
stirred for 18 h before being quenched. Following purification by column chromatography 
(Hexane:EtOAc 6:1), in which α and β anomers were separated, the title compound 139 was 
obtained as a pale yellow oil (0.067 g, 69 %); 1H NMR δ H (500 MHz, Chloroform-d) 7.40 – 7.14 
(20 H, m, Harom), 4.98 (1 H, app d, J 3.5, H-1), 4.92 (1 H, d, J 11.6, PhCHHO), 4.61 (1 H, d, J 11.2, 
PhCHHO), 4.60 (2 H, s, PhCH2O), 4.47 (1 H, d, J 11.8, PhCHHO), 4.39 (1 H, d, J 11.8, PhCHHO), 
3.89 (1 H, ddd, J 12.0, 4.6, 2.5, H-3), 3.86 (1 H, app s, H-4), 3.85 – 3.79 (1 H, m, PhCH2CHHO), 
3.70 (1 H, t, J 6.5, H-5), 3.61 (1 H, dt, J 9.8, 6.7, PhCH2CHHO), 3.56 (1 H, dd, J 9.4, 6.7, H-6a), 
3.51 (1 H, dd, J 9.3cc, 6.1, H-6b), 2.86 (2 H, t, J 7.0, PhCH2CH2O), 2.21 (1 H, td, J 12.2, 3.7, H-
2ax), 1.98 (1 H, app dd, J 12.5, 4.4, H-2eq); 13C NMR δ C (126 MHz, Chloroform-d) 139.21 (4˚ 
CaromCH2CH2O), 139.07, 138.71, 138.31 (3 4˚ CaromCH2O), 129.08, 128.54, 128.48, 128.40, 
128.33, 128.32, 127.85, 127.74, 127.66, 127.59, 127.49, 126.31 (16 Carom), 97.80 (C-1), 74.78 
(C-3), 74.38 (PhCH2O), 73.51 (PhCH2O), 73.17 (C-4), 70.49 (PhCH2O), 69.95 (C-5), 69.71 (C-6), 
68.12 (PhCH2CH2O), 36.33 (PhCH2CH2O), 31.33 (C-2); m/z (ESI-HRMS) C35H38O5Na+ ([M + Na]+) 
calculated 561.2611; found 561.2596; IR νmax/cm-1 3063, 3029, 2919, 2866, 1497, 1454, 1359, 
1207, 1095, 1062, 1028, 959, 735, 697; [𝜶]𝑫
𝟐𝟑 + 63 [c 0.65, DCM]. 




Methyl 2,3-di-O-benzyl-α-D-glucopyranoside 206 (0.80 g, 2.14 mmol) was dried under 
vacuum for 1 h in a flame-dried flask before being dissolved in anhydrous DMF (12 mL) under 
a nitrogen atmosphere. Imidazole (0.29 g, 4.28 mmol) and TIPSCl (0.67 mL, 3.21 mmol) were 
added and the resulting mixture stirred at RT for 20 h under nitrogen, after which time the 
solvent was removed under reduced pressure. The residue was dissolved in DCM (9 mL) and 
washed with water (5 mL) and brine (5 mL), dried using magnesium sulfate, filtered and the 
solvent was removed under reduced pressure. Following purification by column 
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chromatography (Petroleum ether (40-60):EtOAc 9:1) and drying under vacuum for 3 h the 
title compound 140 was obtained as a colourless oil (0.58 g, 51 %) with spectroscopic details 
in accordance with the literature;108 1H NMR δ H (301 MHz, Chloroform-d) 7.43 – 7.27 (10 H, 
m, Harom), 4.98 (1 H, d, J 11.3, PhCHH), 4.81 (1 H, d, J 11.4, PhCHH), 4.78 (1 H, d, J 12.0, PhCHH), 
4.66 (1 H, d, J 12.1, PhCHH), 4.61 (1 H, d, J 3.5, H-1), 3.88 (2 H, d, J 4.8, H-6a, H-6b), 3.83 (1 H, 
dd, J 9.6, 8.4, H-3), 3.69 – 3.52 (2 H, m, H-4, H-5), 3.49 (1 H, dd, J 9.4, 3.7, H-2), 3.39 (3 H, s, 
OCH3), 2.78 (1 H, s, OH), 1.18 – 1.00 (21 H, m, TIPS); 13C NMR δ C (76 MHz, Chloroform-d) 
139.08, 138.33 (2 4˚ Carom), 128.63, 128.57, 128.20, 128.14, 128.00, 127.84 (10 Carom), 98.14 
(C-1), 81.65 (C-3), 79.65 (C-2), 75.64 (PhCH2), 73.32 (PhCH2), 72.72 (C-4), 70.78 (C-5), 64.84 (C-
6), 55.18 (OCH3), 18.06 (SiCH(CH3)2), 11.99 (SiCH(CH3)2); m/z (ESI-MS+) C30H46O6SiNa+ ([M + 
Na]+) calculated 553.30; found 553.29. 





 Following the general procedure for palladium catalysed glycosylation reactions, 
glycosyl donor tri-O-benzyl-D-galactal 126 (0.100 g, 0.240 mmol), glycosyl acceptor benzyl 
alcohol 137 (0.020 g, 0.180 mmol), metal catalyst bis(acetonitrile)dichloropalladium (II) 113 
(0.019 g, 0.072 mmol) and ligand 2-(di-tert-butylphosphanyl)-1-phenyl-1H-pyrrole 114 
(0.021 g, 0.072 mmol) were dissolved in 2 mL of anhydrous DCM. The reaction mixture was 
stirred for 17 h before being quenched. Following purification by column chromatography 
(Hexane:EtOAc 9:1) the title compound 147 was obtained as a colourless oil (0.091 g, 96 %) 
with spectroscopic details in accordance with the literature;171 1H NMR δ H (500 MHz, 
Chloroform-d) 7.37 – 7.22 (20 H, m, Harom), 5.08 (1 H, app d, J 3.5, H-1), 4.93 (1 H, d, J 11.6, 
PhCHH), 4.67 (1 H, d, J 11.9, PhCHH), 4.62 (1 H, d, J 11.7, PhCHH), 4.59 (2 H, d, J 1.3, PhCH2), 
4.50 (1 H, d, J 11.8, PhCHH), 4.47 (2 H, d, J 11.9, PhCHH), 4.43 (1 H, d, J 11.8, PhCHH), 3.99 (1 
H, ddd, J 12.0, 4.6, 2.5, H-3), 3.96 (1 H, t, J 6.7, H-5), 3.94 (1 H, bs, H-4), 3.61 (1 H, dd, J 9.4, 
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6.8, H-6a), 3.56 (1 H, dd, J 9.4, 6.0, H-6b), 2.25 (1 H, td, J 12.4, 3.8, H-2ax), 2.07 – 2.01 (1 H, m, 
H-2eq); 13C NMR δ C (126 MHz, Chloroform-d) 139.05, 138.68, 138.29, 138.02 (4 4˚ Carom), 
128.54, 128.52, 128.51, 128.37, 128.35, 128.09, 127.91, 127.81, 127.77, 127.65, 127.63, 
127.48 (20 Carom), 97.26 (H-1), 75.02 (C-3), 74.44 (PhCH2), 73.63 (PhCH2), 73.17 (C-4), 70.65 
(PhCH2), 70.25 (C-5), 69.74 (C-6), 69.06 (PhCH2), 31.30 (C-2); m/z (ESI-MS+) C34H36O5Na+ ([M 







 Following the general procedure for palladium catalysed glycosylation reactions, 
glycosyl donor tri-O-benzyl-D-galactal 126 (0.100 g, 0.240 mmol), glycosyl acceptor methyl 
2,3,4-tri-O-benzoyl-α-D-glucopyranoside 74 (0.091 g, 0.180 mmol), metal catalyst 
bis(acetonitrile)dichloropalladium (II) 113 (0.019 g, 0.072 mmol) and ligand 2-(di-tert-
butylphosphanyl)-1-phenyl-1H-pyrrole 114 (0.021 g, 0.072 mmol) were dissolved in 2 mL of 
anhydrous DCM. The reaction mixture was stirred for 18 h before being quenched. Following 
purification by column chromatography (Hexane:EtOAc 6:1 → 4:1) the title compound 151 
was obtained as a pale yellow oil (0.136 g, 82 %, α:β >30:1), with spectroscopic details in 
accordance with the literature;108 1H NMR δ H (500 MHz, Chloroform-d) 8.03 – 7.98 (2 H, m, 
Harom), 7.97 – 7.92 (2 H, m, Harom), 7.91 – 7.86 (2 H, m, Harom), 7.56 – 7.48 (1 H, m, Harom), 7.49 
– 7.44 (1 H, m, Harom), 7.44 – 7.34 (7 H, m, Harom), 7.34 – 7.23 (13 H, m, Harom), 7.23 – 7.18 (2 
H, m, Harom), 6.14 (1 H, t, J 9.9, H-3), 5.66 (1 H, t, J 9.9, H-4), 5.30 (1 H, dd, J 10.2, 3.7, H-2), 
5.22 (1 H, d, J 3.6, H-1), 5.02 (1 H, app d, J 3.3, H-1’), 4.91 (1 H, d, J 11.6, PhCHH), 4.59 (1 H, d, 
J 11.6, PhCHH), 4.57 (2 H, s, PhCH2), 4.34 (1 H, d, J 12.0, PhCHH), 4.26 (1 H, d, J 12.0, PhCHH), 
4.21 (1 H, ddd, J 10.2, 4.4, 3.1, H-5), 3.97 (1 H, ddd, J 12.0, 4.6, 2.4, H-3’), 3.89 (1 H, s, H-4’), 
3.88 (1 H, dd, J 11.3, 4.4, H-6a), 3.89 – 3.83 (1 H, m, H-5’), 3.60 (1 H, dd, J 11.1, 3.1, H-6b), 3.42 
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(2 H, t, J 6.2, H-6a’, H-6b’), 3.41 (3 H, s, OCH3), 2.20 (1 H, td, J 12.4, 3.7, H-2ax’), 2.00 (1 H, app 
dd, J 12.7, 4.7, H-2eq’); 13C NMR δ C (126 MHz, Chloroform-d) 165.97, 165.94, 165.39 (3 C=O), 
139.03, 138.73, 138.34 (3 4˚ Carom(Bn)), 133.46, 133.37, 133.15 (3 Carom (Bz)), 130.06, 129.89, 
129.78 (6 Carom (Bz)), 129.44, 129.32, 129.23 (3 4˚ Carom(Bz)), 128.52, 128.50, 128.47, 128.38, 
128.30, 128.27, 127.63, 127.59, 127.58, 127.55, 127.54 (18 Carom), 98.23 (C-1’), 97.11 (C-1), 
74.57 (C-3’), 74.38 (PhCH2), 73.28 (PhCH2), 73.15 (C-4’), 72.19 (C-2), 70.85 (C-3), 70.53 
(PhCH2), 70.01 (C-5’), 69.63 (C-4), 69.51 (C-6’), 68.30 (C-5), 65.87 (C-6), 55.59 (OCH3), 31.04 












 Glycosyl acceptor methyl 2,3,4-tri-O-benzoyl-α-D-glucopyranoside 74 (0.0406 g, 
0.0800 mmol, 1 eq) and glycosyl donor tri-O-benzyl-D-galactal 126 (0.0500 g, 0.1200 mmol, 
1.5 eq) were placed in a dry vial and dried under vacuum for 30 min. Gold catalyst 
chloro[tris(para-trifluoromethylphenyl)phosphine]gold (I) 70 (0.0016 g, 0.0023 mmol, 
0.03 eq) and silver triflate (0.0012 g, 0.0047 mmol, 0.06 eq) were placed in another dry vial 
and dried under vacuum for 30 min. After this drying period, 0.4 mL of anhydrous toluene 
was added to each vial, to make a donor/acceptor solution that is approximately 0.200 M in 
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acceptor 74 and 0.300 M in donor 126, and a catalyst solution that is approximately 0.006 M 
in gold catalyst 70 and 0.012 M in silver triflate. The catalyst solution was sonicated for 
1 minute under nitrogen to aid dissolution. The flow reactor, consisting of two inlet tubes 
(each with internal volume = 0.2027 mL), joining at a T-junction leading to a 5 m reactor tube 
(internal volume = 2.451 mL) was flushed with anhydrous toluene. Equal volumes (0.20 mL) 
of the two reactant solutions were taken and injected into the two inlet tubing pieces of the 
reactor via a double syringe pump. Anhydrous toluene syringes were then connected to the 
reactor and the solvent was used to push the reacting solutions through the reactor tubing, 
setting the desired flow rate corresponding to the residence time (15 minutes, 0.0817 mL/min 
in each syringe for a combined flow rate of 0.1634 mL/min in reactor tubing). The mixture 
that flowed from the microreactor was dropped in a flask containing triethylamine to quench 
the reaction. Solution from the flow reactor was collected for a total of 45 min to ensure that 
all product was collected. The reaction mixture solvent was removed under reduced pressure 
and the crude product was purified by column chromatography (Hexane:EtOAc 9:1 → 4:1). 
The title compound 151 was obtained as a pale-yellow oil (0.0328 g, 89 %), with spectroscopic 







 Following the general procedure for palladium catalysed glycosylation reactions, 
glycosyl donor tri-O-benzyl-D-galactal 126 (0.100 g, 0.240 mmol), glycosyl acceptor 1,2:3,4-di-
O-isopropylidene-α-D-galactopyranose 63 (0.047 g, 0.180 mmol), metal catalyst 
bis(acetonitrile)dichloropalladium (II) 113 (0.019 g, 0.072 mmol) and ligand 2-(di-tert-
butylphosphanyl)-1-phenyl-1H-pyrrole 114 (0.021 g, 0.072 mmol) were dissolved in 2 mL of 
anhydrous DCM. The reaction mixture was stirred for 42 h before being quenched. Following 
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purification by column chromatography (Hexane:EtOAc 8:1 → 5:1) during which α and β 
anomers were separated, the title compound 152 was obtained as a colourless oil (0.044 g, 
36 %) with spectroscopic details in accordance with the literature;108 1H NMR δ H (500 MHz, 
Chloroform-d) 7.39 – 7.27 (15 H, m, Harom), 5.54 (1 H, d, J 5.0, H-1), 5.06 (1 H, app d, J 3.0, H-
1’), 4.94 (1 H, d, J 11.6, PhCHH), 4.64 (1 H, d, J 11.6, PhCHH), 4.64 – 4.59 (3 H, m, H-3, PhCH2), 
4.51 (1 H, d, J 11.8, PhCHH), 4.45 (1 H, d, J 11.8, PhCHH), 4.33 (1 H, dd, J 5.0, 2.4, H-2), 4.24 (1 
H, dd, J 7.9, 1.9, H-4), 4.01 – 3.95 (4 H, m, H-3’, H-4’, H-5’, H-5), 3.77 (1 H, dd, J 10.7, 6.8, H-
6a’), 3.69 (1 H, dd, J 10.7, 6.4, H-6b’), 3.64 (1 H, dd, J 9.2, 7.4, H-6a), 3.57 (1 H, dd, J 9.2, 5.6, 
H-6b), 2.28 – 2.21 (1 H, m, H-2ax’), 2.08 – 2.02 (1 H, m, H-2eq’), 1.54 (3 H, s, C(CH3)), 1.45 (3 
H, s, (C(CH3)), 1.35 (6 H, s C(CH3)); 13C NMR δ C (126 MHz, Chloroform-d) 139.07, 138.74, 
138.27 (3 4˚ Carom), 128.50, 128.36, 128.31, 127.95, 127.76, 127.59, 127.44 (15 Carom), 109.44, 
108.66 (2 C(CH3)2), 97.66 (C-1’), 96.49 (C-1), 74.84 (CH), 74.45 (PhCH2), 73.52 (PhCH2), 73.02 
(CH), 71.22 (C-4), 70.81, 70.76 (C-2, C-3), 70.55 (PhCH2), 69.96 (CH), 69.33 (C-6), 65.98 (CH), 
65.67 (C-6’), 31.27 (C-2’), 26.27, 26.12, 25.09, 24.69 (4 C(CH3)); m/z (ESI-MS+) C39H48O10Na+ 
([M + Na]+) calculated 699.3; found 699.3. 




 3-Bromopropanol (5.00 mL, 55.40 mmol), 1-methylimidazole (13.25 mL, 
166.20 mmol), potassium trifluoromethanesulfonate (20.85 g, 110.80 mmol) and anhydrous 
acetonitrile (100 mL) were added to an oven-dried flask. The resulting mixture was heated 
under reflux at 80 ℃ under a N2 atmosphere for 21 h. 1H NMR analysis of the crude material 
revealed that the alcohol starting material had been converted to the product quantitatively. 
The reaction mixture was filtered and the solvent was removed under reduced pressure. The 
crude product was heated to 80 ℃ under vacuum (0.6 mbar) overnight and subsequently 
triturated five times (Et2O:DCM 13:7). To remove final traces of 1-methylimidazole, a 0.50 g 
portion of the product was purified by reverse phase HPLC (Water:MeCN) and freeze-dried, 
to afford the title compound 155 (0.40 g, 80 %) as a colourless oil, with spectroscopic details 
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in accordance with the literature;172 1H NMR δ H (400 MHz, Chloroform-d) 8.48 (1 H, s, NCHN), 
7.41 (1 H, t, J 1.8, NCHCHN), 7.35 (1 H, t, J 1.8, NCHCHN), 4.26 (2 H, t, J 7.0, CH2), 3.84 (3 H, s, 
CH3), 3.54 (2 H, t, J 5.9, CH2), 2.41 (1 H, bs, OH), 2.05 – 1.98 (2 H, m, CH2); 13C NMR δ C (101 
MHz, Chloroform-d) 137.20 (NCHN), 124.59, 123.51 (2 NCHCHN), 58.48 (CH2), 47.74 (CH2), 
36.85 (CH3), 33.09 (CH2); 19F NMR δ F (377 MHz, Chloroform-d) -74.04 (-OTf); m/z (ESI-MS+) 







 Following the general procedure for I-Tag glycosylations in flow using glycosyl 
acceptor 1-(3-hydroxypropyl)-3-methyl-1H-imidazol-3-ium trifluoromethanesulfonate 155 
(0.0581 g, 0.200 mmol, 1 eq) and glycosyl donor 2,3,4,6-tetra-O-benzyl-α-D-glucopyranosyl 
trichloroacetimidate 62 (0.2740 g, 0.400 mmol, 2.0 eq). 1.0 mL of anhydrous acetonitrile was 
added to the donor/acceptor vial, resulting in a solution of volume 1.20 mL and therefore 
approximately 0.167 M in acceptor and 0.333 M in donor. To the other vial, 1.5 mL of 
anhydrous acetonitrile was added, followed by trimethylsilyl trifluoromethanesulfonate 
(16.3 μL, 0.090 mmol) to make a 0.06 M solution. Reaction solution was collected for a total 
of 12 min 45 sec into reagent grade DCM. The crude product was washed with water (3 mL), 
then the water was extracted with DCM (2 x 15 mL). The dried residue was washed with 
Hexane:Et2O 1:1 (3 x 5 mL) then dried under reduced pressure to yield the title compound 
156 as an oil (0.0954 g, 84 %, α:β = 1:1.4); 1H NMR δ H (500 MHz, Acetonitrile-d3) 8.45 (1 H, s, 
NCHN α), 8.40 (1 H, s, NCHN β), 7.41 – 7.18 (m, Harom), 4.93 – 4.87 (m, H-1 α), 4.87 – 4.65 (m, 
PhCH2), 4.59 – 4.47 (m, PhCH2), 4.42 (1 H, d, J 7.8, H-1 β), 4.31 – 4.16 (m, CH2), 3.84 – 3.60 
(m), 3.71 (3 H, s, NCH3 β), 3.63 (3 H, s, NCH3 α), 3.55 – 3.48 (m), 3.43 (1 H, dt, J 10.3, 6.1, (C-
1)OCHH α), 3.29 (1 H, t, J 8.5, H-2 β), 2.11 (4 H, dt, J 9.7, 6.0, CH2CH2CH2); 13C NMR δ C (126 
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MHz, Acetonitrile-d3) 140.07, 139.87, 139.85, 139.54, 139.50, 139.48, 139.43, 139.35 (8 4˚ 
Carom), 137.29 (NCHN β), 137.23 (NCHN α), 129.44, 129.37, 129.33, 129.27, 129.23, 129.03, 
128.96, 128.90, 128.86, 128.81, 128.78, 128.66, 128.62, 128.58, 128.54, 128.47, 124.42, 
124.31, 123.59, 123.48 (44 Carom), 103.98 (C-1 β), 97.64 (C-1 α), 85.25, 83.01 (C-2 β), 82.58, 
81.08, 78.91, 78.86, 76.03, 75.92, 75.66, 75.47, 75.21, 75.19, 73.83, 73.80, 73.61, 71.53, 
69.98, 69.96, 66.57, 65.35 ((C-1)OCH2), 48.14 (CH2), 47.77 (CH2), 36.70 (NCH3), 36.65 (NCH3), 
30.72 (CH2CH2CH2), 30.21 (CH2CH2CH2); m/z (ESI-HRMS) C41H47N2O6+ ([M – OTf]+) calculated: 
663.3429; found 663.3407; IR νmax/cm-1 3155w, 3032w, 2871w, 1726, 1603w, 1574w, 1497, 
1454, 1361, 1258s, 1225, 1160, 1069s, 1030s, 915w, 827, 740, 699, 638, 623. 




 4-(Chloromethyl)benzyl alcohol (2.00 g mL, 12.77 mmol), 1-methylimidazole (4.07 mL, 
51.08 mmol), potassium trifluoromethanesulfonate (4.69 g, 24.90 mmol) and anhydrous 
acetonitrile (50 mL) were added to an oven-dried flask. The resulting mixture was heated 
under reflux at 90 ℃ under a N2 atmosphere for 21 h. 1H NMR analysis of the crude material 
revealed that the alcohol starting material had been converted to the product quantitatively. 
The reaction mixture was filtered and the solvent was removed under reduced pressure. The 
crude product was triturated three times with hexane and three times using Et2O:DCM 13:7. 
To remove final traces of 1-methylimidazole, a 0.930 g portion of the crude product was 
dissolved in a mixture of water:MeCN (95:5, 4.5 mL) to give a cloudy mixture, which was 
passed through a syringe-tip filter to remove the solids. The resulting solution was purified by 
reverse phase HPLC (Water:MeCN) and freeze-dried, to afford the title compound 157 (0.511 
g, 55 %) as a colourless oil, with spectroscopic details in accordance with the literature;173 1H 
NMR δ H (400 MHz, Acetonitrile-d3) 8.56 (1 H, s, NCHN), 7.45 – 7.31 (6 H, m, Harom), 5.30 (2 H, 
s, NCH2), 4.59 (2 H, s, HOCH2), 3.81 (3 H, s, CH3); 13C NMR δ C (101 MHz, Acetonitrile-d3) 144.36 
(4˚ CaromCH2OH), 137.10 (NCHN), 133.32 (4˚ CaromCH2N), 129.49, 128.24 (4 Carom), 124.92, 
123.15 (2 NCHCHN), 64.03 (HOCH2), 53.48 (NCH2), 36.87 (CH3); 19F NMR δ F (377 MHz, 
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Acetonitrile-d3) -79.31 (CF3); m/z (ESI-MS+) C12H15N2O+ ([M – OTf]+) calculated: 203.1179; 
found 203.1188. 







 Tri-O-benzyl-D-glucal 36 (2.00 g, 4.80 mmol) was dissolved in a 4:1 acetone:water 
mixture (40 mL) and stirred at RT. A solid mixture of Oxone® (18.44 g, 60.00 mmol) and 
sodium bicarbonate (10.08 g, 120.00 mmol) was added in small portions over 60 min with 
stirring to give a milky mixture. 40 min after all the Oxone®/sodium bicarbonate mixture had 
been added TLC (Hexane:EtOAc 6:4) showed the reaction to be complete. Most of the acetone 
solvent was removed under reduced pressure and EtOAc (100 mL) and water (100 mL) were 
added to the residue. Product was extracted into the organic phase, and the aqueous phase 
was washed with further EtOAc (2 x 100 mL), then all EtOAc washings were combined. The 
resulting organic solution was washed with water (100 mL) and brine (100 mL), dried using 
magnesium sulfate, filtered and the solvent was removed under reduced pressure. The crude 
product was purified by column chromatography (Hexane:EtOAc 7:3 → 6:4 → 1:1) to give the 
diol intermediate as an anomeric mixture. This intermediate was dissolved in anhydrous 
pyridine (32 mL) and acetic anhydride (16 mL) and stirred at RT for 16 h under a nitrogen 
atmosphere, after which time TLC (Hexane:EtOAc 6:4) showed the reaction to be complete. 
The reaction mixture was diluted with DCM (100 mL) and washed with 2 M HCl (aq.) (3 x 40 mL), 
5 M HCl (aq.) (40 mL), NaHCO3 (sat. aq.) (2 x 40 mL) and brine (40 mL), dried using magnesium 
sulfate, filtered and the solvent was removed under reduced pressure. The resulting 
acetylated intermediate was dried under vacuum for 1 h before being dissolved in anhydrous 
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THF (20 mL) under a nitrogen atmosphere. DMAPA (3.03 mL, 24.00 mmol) was added and the 
resulting solution was stirred at RT for 90 min, after which time TLC (Hexane:EtOAc 6:4) 
showed the reaction to be complete. The reaction mixture was diluted with DCM (100 mL), 
washed with 1 M HCl (aq.) (70 mL) and brine (70 mL), dried using magnesium sulfate, filtered 
and the solvent was removed under reduced pressure to give the free hemiacetal 
intermediate as an anomeric mixture. This intermediate was dried under vacuum for 1 h 
before being dissolved in anhydrous DCM (30 mL). Trichloroacetonitrile (7.22 mL, 
72.00 mmol) and DBU (0.36mL, 2.40 mmol) were added and the resulting solution was stirred 
at RT for 70 min under a nitrogen atmosphere, after which time TLC (Hexane:EtOAc 6:4) 
showed the reaction to be complete. Solvent was then removed under reduced pressure and 
the crude product was purified by column chromatography (Hexane:EtOAc 95:5 → 9:1) using 
neutralised silica (1 % NEt3) to give the title compound 159 as an oil (0.78 g, 26 % over 4 steps) 
with spectroscopic details in accordance with the literature;174-176 1H NMR δ H (500 MHz, 
Chloroform-d) 8.57 (1 H, s, NH), 7.36 – 7.27 (13 H, m, Harom), 7.21 – 7.16 (2 H, m, Harom), 6.53 
(1 H, d, J 3.6, H-1), 5.08 (1 H, dd, J 10.0, 3.6, H-2), 4.86 (2 H, app t, J 11.0, PhCH2), 4.78 (1 H, d, 
J 11.4, PhCHH), 4.64 (1 H, d, J 12.0, PhCHH), 4.59 (1 H, d, J 10.6, PhCHH), 4.51 (1 H, d, J 12.0, 
PhCHH), 4.10 (1 H, t, J 9.6, H-3), 4.02 (1 H, ddd, J 10.1, 3.4, 1.9, H-5), 3.89 (1 H, dd, J 10.1, 9.2, 
H-4), 3.82 (1 H, dd, J 11.1, 3.4, H-6a), 3.71 (1 H, dd, J 11.1, 1.9, H-6b), 1.94 (3 H, s, CH3); 13C 
NMR δ C (126 MHz, Chloroform-d) 170.17 (C=O), 161.15 (CNH), 138.41, 137.98, 137.95 (3 4˚ 
Carom), 128.60, 128.54, 128.53, 128.28, 128.08, 128.03, 127.93, 127.87 (Carom), 94.18 (C-1), 
91.19 (CCl3), 79.63 (C-3), 77.16 (C-4), 75.56 (PhCH2), 75.53 (PhCH2), 73.65, 73.58 (PhCH2, C-5), 
72.52 (C-2), 68.02 (C-6), 20.73 (CH3); m/z (ESI-MS+) C31H32Cl3NO7Na+ ([M + Na]+) calculated 

















 3,4-Di-O-benzyl-6-O-(triisopropylsilyl)-D-glucal 220 (20.47 g, 42.40 mmol) was 
dissolved in a 4:1 acetone:water mixture (355 mL) and stirred at RT. A solid mixture of Oxone® 
(32.59 g, 106.01 mmol) and sodium bicarbonate (17.81 g, 212.02 mmol) was added in small 
portions over 90 min with stirring to give a milky mixture.  1 h after all the Oxone®/sodium 
bicarbonate mixture had been added, TLC (Hexane:EtOAc 7:3) showed the reaction to be 
complete. Most acetone solvent was removed under reduced pressure and EtOAc (100 mL) 
and water (100 mL) were added to the residue. Product was extracted into the organic phase, 
and the aqueous phase was washed with further EtOAc (2 x 100 mL), then all EtOAc washings 
were combined. The resulting organic solution was washed with water (100 mL) and brine 
(100 mL), dried using magnesium sulfate, filtered and the solvent was removed under 
reduced pressure. The crude product was purified by normal phase HPLC (Hexane:EtOAc) to 
give the diol intermediate as an anomeric mixture (11.80 g, 22.84 mmol). This intermediate 
was dissolved in anhydrous pyridine (184 mL) and acetic anhydride (46 mL) and stirred at RT 
for 20 h under a nitrogen atmosphere, after which time TLC (Hexane:EtOAc 8:2) showed the 
reaction to be complete. Most of the solvent was removed under reduced pressure, then the 
residue was diluted with DCM (200 mL) and washed with 1 M HCl (aq.) (2 x 100 mL), 
NaHCO3 (sat. aq.) (100 mL) and brine (100 mL), dried using magnesium sulfate, filtered and the 
solvent was removed under reduced pressure. The resulting acetylated intermediate was 
dried under vacuum for 1 h before being dissolved in anhydrous THF (120 mL) under a 
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nitrogen atmosphere. DMAPA (14.41 mL, 114.20 mmol) was added and the resulting solution 
stirred at RT for 2.5 h, after which time TLC (Hexane:EtOAc 8:2) showed the reaction to be 
complete. Solvent was removed under reduced pressure and the residue was dissolved in 
DCM (200 mL) and washed with 1 M HCl (aq.) (200 mL) and brine (200 mL). As a result of very 
poor phase separation during workup, NaHCO3 (sat. aq.) was added to aid phase separation. The 
DCM phase was dried using magnesium sulfate, filtered and the solvent was removed under 
reduced pressure. Following purification by normal phase HPLC (Petroleum Ether b.p. 
40-60 ˚C:EtOAc) the free hemiacetal intermediate was obtained as an anomeric mixture 
(5.63 g, 10.08 mmol). This intermediate was dried under vacuum for 1 h before being 
dissolved in anhydrous DCM (216 mL) and cooled to 5 ˚C. Trichloroacetonitrile (10.10 mL, 
100.75 mmol) and DBU (0.60 mL, 4.03 mmol) were added and the resulting solution was 
stirred at RT for 40 min under a nitrogen atmosphere, after which time TLC 
(Hexane:EtOAc 9:1) showed the reaction to be complete. Solvent was then removed under 
reduced pressure and the crude product was purified by column chromatography 
(Hexane:EtOAc 93:7) to give the title compound 160 as an oil (4.95 g, 17 % over 4 steps); 1H 
NMR δ H (500 MHz, Chloroform-d) 8.52 (1 H, s, NH), 7.38 – 7.26 (10 H, m, Harom), 6.51 (1 H, d, 
J 3.6, H-1), 5.01 (1 H, dd, J 10.0, 3.6, H-2), 4.89 (2 H, app t, J 10.9, PhCH2), 4.77 (2 H, app dd, J 
11.0, 2.7, PhCH2), 4.11 (1 H, ddd, J 9.7, 7.3, 1.7, H-3), 4.03 (1 H, dd, J 11.4, 2.6, H-6a), 3.95 (1 
H, d, J 11.1, H-6b), 3.91 – 3.86 (2 H, m, H-4, H-5), 1.93 (3 H, s, C(O)CH3), 1.12 – 1.03 (21 H, m, 
TIPS); 13C NMR δ C (126 MHz, Chloroform-d) 170.22 (C=O), 161.17 (CNH), 138.47, 138.23 (2 4˚ 
Carom), 128.65, 128.54, 128.25, 128.06, 128.04, 127.89 (Carom), 94.29 (C-1), 91.33 (CCl3), 79.67 
(C-3), 77.02 (C-4), 75.63 (PhCH2), 75.55 (PhCH2), 74.90 (C-5), 72.71 (C-2), 62.03 (C-6), 20.76 
(C(O)CH3), 18.16, 18.12, 12.12 (TIPS); m/z (ESI-HRMS) C33H46Cl3NO7SiNa+ ([M + Na]+) 
calculated 724.2001; found 724.1983; C31H45O6Si+ ([M – OC(NH)CCl3]+) calculated 541.2980; 
found 541.2968; IR νmax/cm-1 3345w, 3031w, 2942, 2893, 2866, 1749 (C=O), 1673 (C=N), 1497, 
1455, 1365, 1294, 1228, 1157, 1136, 1060s, 1049s, 1028, 1014, 969, 914, 883, 831, 794, 736, 
697, 682, 645; [𝜶]𝑫
𝟐𝟑 + 53 [c 1.22, DCM]. 









 Following the general procedure for I-Tag glycosylations in flow using glycosyl 
acceptor 1-(3-hydroxypropyl)-3-methyl-1H-imidazol-3-ium trifluoromethanesulfonate 155 
(0.0232 g, 0.080 mmol, 1 eq) and glycosyl donor 2-O-acetyl-3,4-di-O-benzyl-6-O-
triisopropylsilyl-α-D-glucopyranosyl trichloroacetimidate 160 (0.1125 g, 0.160 mmol, 2 eq). 
0.40 mL of anhydrous acetonitrile was added to the donor/acceptor vial, resulting in a 
solution of volume 0.50 mL and therefore approximately 0.160 M in acceptor and 0.320 M in 
donor. To the other vial, 0.80 mL of anhydrous acetonitrile was added, followed by 
trimethylsilyl trifluoromethanesulfonate (8.7 μL, 0.048 mmol) to make a 0.06 M solution. The 
flow reaction was performed at RT. Reaction solution was collected into a mixture of DCM 
and sodium acetate for a total of 6 min. Following completion of the flow reaction, the 
product mixture was filtered and the solvent was removed under reduced pressure. The 
crude glycosylation product was washed with hexane (2 x 3 mL) and hexane:Et2O 3:1 
(2 x 3 mL). The residue was dissolved in DCM (2 mL) and HCl, 0.8 M in MeOH (3 mL) and the 
resulting solution was stirred at RT for 1 h in air to fully remove the silyl ether group from the 
product. Solvent was then removed under reduced pressure and the residue was washed with 
water (2 x 3 mL). The combined aqueous washes were washed with DCM (4 x 6 mL) and the 
combined DCM washes were added back to the flask containing product residue. The 
resulting solution was dried using magnesium sulfate, filtered and the solvent was removed 
under reduced pressure. The residue was washed with hexane:Et2O 1:1 (3 x 3 mL) then dried 
under reduced pressure to yield the title compound 161 (0.0060 g, 14 % over 2 steps); 1H 
NMR δ H (500 MHz, Chloroform-d) 9.10 (1 H, s, NCHN), 7.36 – 7.20 (12 H, m, Harom), 4.80 (2 H, 
app dd, J 11.1, 5.3, PhCH2), 4.70 – 4.62 (3 H, m, PhCH2, H-2), 4.35 – 4.25 (3 H, m, H-1, NCH2), 
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3.98 – 3.95 (1 H, m, H-6a), 3.94 (3 H, s, NCH3), 3.91 – 3.83 (1 H, m, (C-1)OCHH), 3.74 (1 H, dd, 
J 12.1, 4.6, H-6b), 3.68 – 3.62 (2 H, m, H-3, (C-1)OCHH), 3.60 (1 H, t, J 9.1, H-4), 3.38 (1 H, ddd, 
J 9.2, 4.6, 2.3, H-5), 2.12 – 2.05 (2 H, m, NCH2CH2), 1.92 (3 H, s, (C=O)CH3); 13C NMR δ C (126 
MHz, Chloroform-d) 169.93 (C=O), 138.20, 137.93 (2 4˚ Carom), 137.61 (NCHN), 128.66, 128.59, 
128.23, 128.12, 127.98, 127.96 (Carom), 123.30 (NCHCHN), 122.65 (NCHCHN), 100.59 (C-1), 
82.64 (C-3), 77.85 (C-4), 75.80 (C-5), 75.37, 75.14 (2 PhCH2), 73.19 (C-2), 66.15 ((C-1)OCH2), 
61.03 (C-6), 47.82 (NCH2), 36.45 (NCH3), 30.03 (NCH2CH2), 21.04 ((C=O)CH3); m/z (ESI-HRMS) 
C29H37N2O7+ ([M – OTf]+) calculated: 525.2595; found 525.2591; (TLC-MS- (ESI)) CF3O3S- ([OTf]-
) calculated 148.9; found 149.1; IR νmax/cm-1 3475br (OH), 3153w, 3115w, 2959, 2924, 2856, 
1743 (C=O), 1574, 1497w, 1455, 1430w, 1374, 1255s, 1226, 1160, 1076, 1046, 1030s, 912w, 
804w, 755, 701, 639s, 624, 573, 518, 472, 418w; [𝜶]𝑫
𝟐𝟒 0 [c 0.41, DCM]. Note that due to 
sparing solubility of the product in DCM, the solution used to determine optical rotation was 





 2,3,4-Tri-O-benzoyl-6-O-triisopropylsilyl-α-D-glucopyranosyl trichloroacetimidate 97 
(0.1269 g, 0.160 mmol, 1.0 eq) was dried under vacuum. 0.4 mL of anhydrous acetonitrile was 
added, followed by trimethylsilyl trifluoromethanesulfonate (8.7 μL, 0.048 mmol). The 
resulting solution was swirled under nitrogen for 3 minutes, then reagent grade acetonitrile 
was added with air. The solvent was removed under reduced pressure and the resultant solid 
was washed with acetonitrile (3 x 0.7 mL). The residue was dried under vacuum to give the 
title compound 163 as a white solid with spectroscopic details in accordance with the 
literature;160 1H NMR δ H (400 MHz, Chloroform-d) 8.19 – 8.11 (4 H, m, Harom), 8.11 – 8.06 (2 
H, m, Harom), 7.66 – 7.56 (3 H, m, Harom), 7.53 – 7.39 (6 H, m, Harom), 5.75 (1 H, bs, H-1), 5.45 (1 
H, app p, J 1.7, H-2,3 or 4), 5.12 – 5.09 (1 H, m, H-2,3 or 4), 5.09 – 5.06 (1 H, m, H-2,3 or 4), 
4.90 (1 H, dq, J 4.2, 1.4, H-5), 4.39 (1 H, dd, J 7.8, 1.0, H-6a), 3.98 (1 H, dd, J 7.7, 5.7, H-6b); 13C 
NMR δ C (101 MHz, Chloroform-d) 165.48, 165.23, 164.82 (3 C=O), 133.82, 133.71, 133.67, 
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130.18, 130.15, 130.05 (Carom), 129.46, 129.44, 129.19 (3 4˚ Carom), 128.77, 128.58 (Carom), 
99.60 (C-1), 73.96 (C-5), 70.31, 69.92, 69.22 (C-2,3,4), 65.66 (C-6); m/z (ESI-MS+) C27H22O8Na+ 
([M + Na]+) calculated 497.1; found 497.1; C27H23O8+ ([M + H]+) calculated 475.1; found 475.1. 
4-(1-Methyl-3-methyleneimidazolium)-benzyl 2,3,4-tri-O-benzoyl-6-O-(2,3,4-tri-O-benzoyl-









Following the general procedure for I-Tag glycosylations in flow using glycosyl 
acceptor 4-(1-methyl-3-methyleneimidazolium)benzyl 2,3,4-tri-O-benzoyl-β-D-
glucopyranoside trifluoromethanesulfonate 102 (0.3510 g, 0.425 mmol, 1 eq) and glycosyl 
donor 2,3,4-tri-O-benzoyl-6-O-chloroacetyl-α-D-glucopyranosyl trichloroacetimidate 167 
(0.6057 g, 0.849 mmol, 2.0 eq). 2.12 mL of anhydrous acetonitrile was added to the 
donor/acceptor vial, resulting in a solution of volume 2.6 mL and therefore approximately 
0.163 M in acceptor and 0.327 M in donor. To the other vial, 3.5 mL of anhydrous acetonitrile 
was added, followed by trimethylsilyl trifluoromethanesulfonate (38.0 μL, 0.210 mmol) to 
make a 0.06 M solution. The flow reactor was submerged in an oil bath at 50 ˚C to allow the 
flow reaction to occur at 50 ˚C. Reaction solution was collected for a total of 39 min. The 
product solution from the flow reactor was collected directly into a mixed solution of DCM 
(6.8 mL) and HCl, 1.25 M in MeOH (6.8 mL, 8.49 mmol) to begin immediate chloroacetate 
deprotection. The reaction solution was stirred at RT in air for 16 h, after which time TLC-MS 
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showed reaction to be complete. The reaction mixture was diluted with DCM and then 
washed with water. The aqueous phase was washed with a further portion DCM, then the 
DCM phases were combined, dried with magnesium sulfate, filtered and the solvent was 
removed under reduced pressure. The dried residue was washed with Et2O three times, 
DCM:Et2O 1:9 twice and DCM:Et2O 86:14 once then dried under reduced pressure. Desired 
product 166 and unreacted glycosyl acceptor 102 were separated by normal-phase HPLC 
(DCM:MeOH) to yield the title compound 166 as a single anomer (0.0822 g, 15 %) with 
spectroscopic details in accordance with the literature;146 1H NMR δ H (500 MHz, Chloroform-
d) 9.14 (1 H, s, NCHN), 7.94 – 7.85 (8 H, m, Harom), 7.80 – 7.77 (2 H, m, Harom), 7.77 – 7.73 (2 H, 
m, Harom), 7.55 – 7.22 (19 H, m, Harom, NCHCHN), 7.22 – 7.19 (2 H, m, Harom), 7.18 (1 H, t, J 1.9, 
NCHCHN), 7.16 – 7.13 (2 H, m, Harom), 5.88 (1 H, t, J 9.7, H-3’), 5.79 (1 H, t, J 9.6, H-3), 5.45 – 
5.40 (3 H, m, H-2’, H-2, H-4), 5.38 (1 H, t, J 9.7, H-4’), 5.29 (2 H, d, J 1.8, NCH2), 4.91 (1 H, d, J 
7.9, H-1’), 4.72 (1 H, d, J 7.9, H-1), 4.62 (1 H, d, J 12.6, (C-1)OCHH), 4.42 (1 H, d, J 12.6, (C-
1)OCHH), 4.16 (1 H, dd, J 10.9, 2.7, H-6a), 4.00 (1 H, ddd, J 9.4, 6.2, 2.7, H-5), 3.91 (3 H, s, 
NCH3), 3.85 (1 H, dd, J 11.0, 6.3, H-6b), 3.81 – 3.73 (2 H, m, H-5’, H-6a’), 3.65 – 3.60 (1 H, m, 
H-6b’); 13C NMR δ C (126 MHz, Chloroform-d) 166.12, 165.90, 165.80, 165.71, 165.36, 165.27 
(6 C=O), 138.44 (4˚ Carom), 137.06 (NCHN), 133.84, 133.74, 133.59, 133.49, 133.43, 133.36 
(Carom), 132.31 (4˚ Carom), 130.01, 130.00, 129.90, 129.84, 129.82, 129.78, 129.28, 129.20, 
129.16, 129.04, 128.93, 128.89, 128.82, 128.73, 128.65, 128.57, 128.45, 128.39 (Carom), 
123.73 (NCHCHN), 122.07 (NCHCHN), 101.08 (C-1’), 99.78 (C-1), 74.79 (C-5’), 73.49 (C-5), 
72.91 (C-3’, C-3), 71.94, 71.90 (C-2’, C-2), 70.09 (C-4), 69.41 (C-4’), 68.37 (C-6), 61.10 (C-6’), 
53.27 (NCH2), 36.60 (NCH3); m/z (TLC-MS+ (ESI)) C66H59N2O17+ ([M - OTf]+) calculated 1151.4; 
found 1151.4. 









glucopyranosyl)hydroxylamine 170 (8.78 g, 14.35 mmol) was dissolved in THF:Water 9:1 
(528 mL) and N-chlorosuccinimide (3.83 g, 28.69 mmol) was added. The resulting solution was 
warmed to 60 ˚C and stirred for 2 h 40, after which time TLC (Hexane:EtOAc 6:4) showed the 
reaction to be complete. The solution was cooled to RT, then the solvent was removed under 
reduced pressure. The crude residue was purified by column chromatography (Hexane:EtOAc 
3:1 → 7:3)  to give the free hemiacetal intermediate 171 as an anomeric mixture (7.11 g), 
which was used directly in the next step. Hemiacetal intermediate 171 was dried under 
vacuum for 1 h before being dissolved in anhydrous DCM (250 mL). The resulting solution was 
cooled to 5 ˚C and trichloroacetonitrile (12.53 mL, 124.97 mmol) and DBU (0.75 mL, 
5.00 mmol) were added. The resulting solution was stirred for 1 h under a nitrogen 
atmosphere, after which time TLC (Hexane:EtOAc 7:3) showed the reaction to be complete. 
Water was added and the two phases were washed together. The DCM phase was then 
separated, dried using magnesium sulfate, filtered and the solvent was removed under 
reduced pressure. Diethyl ether was added to the residue, and the resulting solution was 
decanted off, leaving a dark coloured impurity behind. The solvent was then removed under 
reduced pressure and the crude product was purified by column chromatography 
(Hexane:EtOAc 85:15 → 8:2) using neutralised silica (1 % NEt3) to give the title compound 167 
as a solid (2.55 g, 25 % over 2 steps); 1H NMR δ H (400 MHz, Chloroform-d) 8.67 (1 H, s, NH), 
7.98 – 7.92 (4 H, m, Harom), 7.88 – 7.83 (2 H, m, Harom), 7.56 – 7.48 (2 H, m, Harom), 7.47 – 7.33 
(5 H, m, Harom), 7.33 – 7.27 (2 H, m, Harom), 6.81 (1 H, d, J 3.7, H-1), 6.25 (1 H, t, J 10.0, H-3), 
5.71 (1 H, t, J 10.0, H-4), 5.59 (1 H, dd, J 10.2, 3.7, H-2), 4.52 (1 H, ddd, J 10.3, 4.3, 2.7, H-5), 
4.46 – 4.36 (2 H, m, H-6a, H-6b), 4.12 (2 H, d, J 3.2, CH2Cl); 13C NMR δ C (101 MHz, Chloroform-
d) 167.12 (OC(O)CH2Cl), 165.73, 165.52, 165.44 (3 C=O (Bz)), 160.66 (CNH), 133.88, 133.75, 
133.50, 130.07, 130.06, 129.84, 128.92, 128.67, 128.63, 128.60, 128.56, 128.51 (Carom), 93.19 
(C-1), 90.80 (CCl3), 70.72 (C-2), 70.47 (C-5), 70.07 (C-3), 68.43 (C-4), 63.53 (C-6), 40.78 (CH2Cl); 
m/z (ESI-HRMS) C31H25Cl4O10NNa+ ([M + Na]+) calculated 734.0125; found 734.0113; IR 
νmax/cm-1 1766, 1731s (C=O), 1677, 1601, 1584, 1451, 1314, 1264s, 1177, 1143, 1106, 1094, 
1069, 1024, 970, 918, 836, 795, 708s, 686, 645; [𝜶]𝑫
𝟐𝟓 + 49 [c 1.68, DCM]. 
 







 D-Glucose 1 (10.00 g, 55.51 mmol) was dissolved in water (75 mL) and cooled to 0 ℃. 
N,O-Dimethylhydroxylamine hydrochloride (5.96 g, 61.06 mmol) and sodium acetate (5.01 g, 
61.06 mmol) were dissolved in a minimal volume of water and the resulting solution was 
added to the glucose solution dropwise. The resulting reactant solution was stirred at RT in 
air for 21 h, after which time TLC (DCM:MeOH 7:3) showed formation of product, but still 
significant amounts of starting material remaining. A further portion of N,O-
dimethylhydroxylamine hydrochloride (2.71 g, 27.75 mmol) and sodium acetate (2.28 g, 
27.75 mmol) were dissolved in a minimal volume of water and the resulting solution was 
added to the glucose solution to encourage more complete reaction. The resulting reactant 
solution was stirred at RT in air for a further 20 h, then solvent was evaporated. To the crude 
product, methanol (50 mL) was added and the mixture was sonicated. The mixture was then 
filtered with additional methanol washing and the filtrate was collected, then the solvent was 
removed under reduced pressure. Following column chromatography (DCM:MeOH 85:15), 
the title compound 168 was obtained as a white solid (7.64 g, 62 %) with spectroscopic details 
in accordance with the literature;177 1H NMR δ H (400 MHz, Deuterium Oxide) 4.17 – 4.08 (1 
H, m, H-1), 3.94 (1 H, dd, J 12.4, 2.0, H-6a), 3.79 – 3.72 (1 H, m, H-6b), 3.60 (3 H, s, OCH3), 3.58 
– 3.49 (2 H, m, H-2, H-4), 3.47 – 3.34 (2 H, m, H-3, H-5), 2.77 (3 H, s, NCH3); 13C NMR δ C (101 
MHz, Deuterium Oxide) 95.20 (C-1), 79.72 (C-5), 79.43 (C-2), 72.12 (C-4), 71.84 (C-3), 63.24 
(C-6), 62.28 (OCH3), 40.35 (NCH3); m/z (ESI-MS+) C8H17NO6Na+ ([M + Na]+) calculated 













 Following a modification of the procedure reported by Glaudemans and co-
workers,178 N,O-dimethyl-N-(β-D-glucopyranosyl)hydroxylamine 168 (7.42 g, 33.24 mmol) 
was dried under vacuum for 1 h. Anhydrous DMF (167 mL) was added under a nitrogen 
atmosphere and the resulting solution was cooled to -60 ˚C using a chloroform/dry ice bath. 
2,4,6-Collidine (5.84 mL, 44.21 mmol) was then added. In a separate dry flask, chloroacetyl 
chloride (3.44 mL, 43.21 mmol) was dissolved in anhydrous toluene (11 mL) and the resulting 
solution was added to the sugar solution dropwise.  The reacting solution was stirred for 
30 min at -60 ˚C under nitrogen, after which time TLC (DCM:MeOH 9:1) showed the reaction 
to be complete. The solution was warmed to RT, toluene (166 mL) was added and the mixture 
was filtered to remove solids. Solvent was then removed under reduced pressure. To the 
residue, acetone (55 mL) was added and the resulting mixture was sonicated for 5 min. The 
mixture was then filtered, solids were discarded, and solvent was removed from the filtrate 
under reduced pressure. The crude residue was purified by normal phase HPLC (DCM:MeOH) 
to give N,O-dimethyl-N-(6-O-chloroacetyl-β-D-glucopyranosyl)hydroxylamine 169 (7.42 g), a 
portion of which (4.36 g) was used directly in the next step. N,O-Dimethyl-N-(6-O-
chloroacetyl-β-D-glucopyranosyl)hydroxylamine 169 (4.36 g) was dried under vacuum for 1 h. 
Anhydrous acetonitrile (29 mL) was added under a nitrogen atmosphere and the resulting 
mixture was heated to 45 ˚C. In a separate dry flask, benzoyl chloride (9.13 mL, 78.56 mmol) 
and anhydrous pyridine (5.88 mL, 72.74 mmol) were dissolved in anhydrous acetonitrile 
(29 mL) and the resulting solution was quickly added to the sugar suspension.  The reacting 
solution was stirred for 1 h 15 min at 45 ˚C under nitrogen, after which time TLC 
(Hexane:EtOAc 8:2) showed the reaction to be complete. The reaction solution was cooled to 
RT, then EtOAc (100 mL) and water (100 mL) were added. The EtOAc phase was washed with 
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1 M HCl (aq.) (2 x 75 mL), NaHCO3 (sat. aq.) (75 mL) and water (75 mL), dried using magnesium 
sulfate, filtered and the solvent was removed under reduced pressure. The crude material 
was purified by normal phase HPLC (Hexane:EtOAc) to give the title compound 170 as a white 
solid (5.45 g, 46 % over 2 steps); 1H NMR δ H (400 MHz, Chloroform-d) 7.97 – 7.88 (4 H, m, 
Harom), 7.84 – 7.79 (2 H, m, Harom), 7.51 (2 H, ddt, J 7.9, 7.0, 1.3, Harom), 7.45 – 7.34 (5 H, m, 
Harom), 7.32 – 7.23 (2 H, m, Harom), 5.91 (1 H, t, J 9.6, H-3), 5.65 (1 H, t, J 9.5, H-2), 5.55 (1 H, t, 
J 9.8, H-4), 4.58 (1 H, d, J 9.3, H-1), 4.47 (1 H, dd, J 12.2, 5.1, H-6a), 4.41 (1 H, dd, J 12.1, 3.1, 
H-6b), 4.06 (2 H, s, CH2Cl), 4.02 (1 H, ddd, J 9.9, 5.0, 3.1, H-5), 3.43 (3 H, s, OCH3), 2.79 (3 H, s, 
NCH3); 13C NMR δ C (101 MHz, Chloroform-d) 167.18 (OC(O)CH2Cl), 165.90, 165.43, 165.36 (3 
C=O (Bz)), 133.70, 133.36, 129.95, 129.88, 129.86, 129.55, 128.97, 128.82, 128.62, 128.50, 
128.41 (Carom), 92.68 (C-1), 74.06 (C-3), 73.62 (C-5), 69.55 (C-4), 69.10 (C-2), 64.34 (C-6), 60.48 
(OCH3), 40.83 (CH2Cl), 37.59 (NCH3); m/z (ESI-HRMS) C31H31ClNO10+ ([M + H]+) calculated 
612.1631; found 612.1630; IR νmax/cm-1 2941w, 1764, 1728s (C=O), 1601, 1451, 1411w, 
1369w, 1314, 1280, 1260s, 1178, 1138, 1093, 1069, 1026, 1013, 975, 940w, 802w, 709, 687; 
[𝜶]𝑫
𝟐𝟓 + 19 [c 2.16, DCM]. 
3-(3-Methylimidazolium)-1-propyl 2,3,4-tri-O-benzoyl-6-O-chloroacetyl-β-D-




 Following the general procedure for I-Tag glycosylations in flow using glycosyl 
acceptor 1-(3-hydroxypropyl)-3-methyl-1H-imidazol-3-ium trifluoromethanesulfonate 155 
(0.1161 g, 0.400 mmol, 1 eq) and glycosyl donor 2,3,4-tri-O-benzoyl-6-O-chloroacetyl-α-D-
glucopyranosyl trichloroacetimidate 167 (0.5707 g, 0.800 mmol, 2.0 eq). 2.00 mL of 
anhydrous acetonitrile was added to the donor/acceptor vial, resulting in a solution of volume 
2.4 mL and therefore approximately 0.167 M in acceptor and 0.333 M in donor. To the other 
vial, 3.00 mL of anhydrous acetonitrile was added, followed by trimethylsilyl 
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trifluoromethanesulfonate (32.6 μL, 0.180 mmol) to make a 0.06 M solution. The flow reactor 
was submerged in an ice-water bath to allow the flow reaction to occur at 0 ˚C. Reaction 
solution was collected for a total of 33 min. The crude product was dissolved in DCM (20 mL) 
and washed with water (4 mL), then the water was extracted with a further portion of DCM 
(20 mL). The dried residue was washed with Et2O twice, DCM:Et2O 5:95 three times and  
DCM:Et2O 1:9 five times then dried under reduced pressure to yield the title compound 172 
as a single anomer (0.2026 g, 67 %); 1H NMR δ H (400 MHz, Acetonitrile-d3) 8.31 (1 H, s, NCHN), 
7.96 – 7.88 (4 H, m, Harom), 7.78 – 7.74 (2 H, m, Harom), 7.60 (2 H, m, Harom), 7.52 (1 H, ddt, J 
7.6, 6.7, 1.3, Harom), 7.45 (4 H, td, J 7.7, 3.4, Harom), 7.39 – 7.33 (2 H, m, Harom), 7.28 (1 H, t, J 
1.7, NCHCHN), 7.26 (1 H, t, J 1.7, (NCHCHN), 5.89 (1 H, t, J 9.6, H-3), 5.57 (1 H, t, J 9.7, H-4), 
5.39 (1 H, dd, J 9.7, 8.0, H-2), 4.97 (1 H, d, J 8.0, H-1), 4.46 (1 H, dd, J 12.3, 4.9, H-6a), 4.40 (1 
H, dd, J 12.4, 2.6, H-6b), 4.21 (2 H, s, CH2Cl), 4.23 – 4.18 (1 H, m, H-5), 4.12 (2 H, td, J 6.8, 3.5, 
OCH2CH2CH2N), 3.87 (1 H, ddd, J 11.0, 7.1, 4.8, OCHHCH2CH2N), 3.81 (3 H, s, NCH3), 3.68 (1 H, 
ddd, J 10.7, 6.2, 5.0, OCHHCH2CH2N), 2.11 – 1.99 (2 H, m, OCH2CH2CH2N); 13C NMR δ C (101 
MHz, Acetonitrile-d3) 168.08, 166.26, 166.05, 165.99 (4 C=O), 136.96 (NCHN), 134.63, 134.51, 
130.32, 130.07, 129.97, 129.82, 129.75, 129.55 (Carom), 124.44 (NCHCHN), 123.33 (NCHCHN), 
101.22 (C-1), 74.17 (C-3), 72.82 (C-2), 72.47 (C-5), 69.98 (C-4), 66.92 (OCH2CH2CH2N), 64.25 
(C-6), 47.50 (OCH2CH2CH2N), 41.93 (CH2Cl), 36.76 (NCH3), 30.38 (OCH2CH2CH2N); m/z (ESI-
HRMS) C36H36ClN2O10+ ([M - OTf]+) calculated 691.2053; found 691.2077; (TLC-MS- (ESI)) 
CF3O3S- ([OTf]-) calculated 148.9; found 149.0; IR νmax/cm-1 3155w, 3116w, 2961w, 1731s 
(C=O), 1601w, 1452, 1318, 1261s, 1226, 1163, 1109, 1096, 1070, 1030, 712, 639; [𝜶]𝑫



















 Following the general procedure for I-Tag glycosylations in flow using glycosyl 
acceptor 1-(4-(hydroxymethyl)benzyl)-3-methyl-1H-imidazol-3-ium 
trifluoromethanesulfonate 157 (0.0564 g, 0.160 mmol, 1 eq) and glycosyl donor 2,3,4-tri-O-
benzoyl-6-O-chloroacetyl-α-D-glucopyranosyl trichloroacetimidate 167 (0.2283 g, 
0.320 mmol, 2.0 eq). 0.80 mL of anhydrous acetonitrile was added to the donor/acceptor vial, 
resulting in a solution of volume 0.93 mL and therefore approximately 0.172 M in acceptor 
and 0.344 M in donor. A stock solution of TMSOTf (0.06 M in MeCN) was made by dissolving 
TMSOTf (0.109 mL, 0.600 mmol) in 10 mL anhydrous MeCN. 1.0 mL of this stock solution was 
taken into a syringe and used for this reaction.  The flow reaction was performed at RT. 
Reaction solution was collected for a total of 12 min 30 sec. The crude product was dissolved 
in DCM (5 mL) and washed with water (5 mL), then the water was extracted with further 
portions of DCM (2 x 5 mL). The dried residue was washed with Et2O (2 x 6 mL), DCM:Et2O 
5:95 (3 x 6 mL) and  DCM:Et2O 1:9 (4 x 6 mL) then dried under reduced pressure to yield the 
title compound 174 as a single anomer (0.0950 g,  75 %); 1H NMR δ H (500 MHz, Chloroform-
d) 9.16 (1 H, s, NCHN), 7.93 – 7.87 (4 H, m, Harom), 7.81 – 7.78 (2 H, m, Harom), 7.56 – 7.48 (2 H, 
m, Harom), 7.44 – 7.33 (5 H, m, Harom), 7.29 – 7.21 (7 H, m, Harom, NCHCHN), 7.17 (1 H, t, J 1.8, 
NCHCHN), 5.86 (1 H, t, J 9.7, H-3), 5.58 (1 H, t, J 9.7, H-4), 5.55 (1 H, dd, J 9.8, 7.9, H-2), 5.28 
(2 H, s, NCH2), 4.92 – 4.88 (2 H, m, H-1, (C-1)OCHH), 4.69 (1 H, d, J 12.6, (C-1)OCHH), 4.43 – 
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4.40 (2 H, m, H-6a, H-6b), 4.10 (2 H, s, CH2Cl), 4.09 – 4.03 (1 H, m, H-5), 3.90 (3 H, s, NCH3); 13C 
NMR δ C (126 MHz, Chloroform-d) 167.21 (C=O (ClAc)), 165.83, 165.40, 165.28 (3 C=O (Bz)), 
138.56 (4˚ CaromCH2O(C-1)), 137.11 (NCHN), 133.80, 133.67, 133.47 (Carom), 132.32 (4˚ 
CaromCH2N), 129.94, 129.88, 129.84, 129.17, 129.15, 128.81, 128.78, 128.67, 128.65, 128.63, 
128.46 (Carom), 123.68 (NCHCHN), 122.04 (NCHCHN), 100.18 (C-1), 72.77 (C-3), 72.13 (C-5), 
71.89 (C-2), 70.52 ((C-1)OCH2), 69.30 (C-4), 63.93 (C-6), 53.26 (NCH2), 40.87 (CH2Cl), 36.58 
(NCH3); m/z (ESI-HRMS) C41H38ClN2O10+ ([M - OTf]+) calculated 753.2209; found 7533.2208; 
(TLC-MS- (ESI)) CF3O3S- ([OTf]-) calculated 148.9; found 149.0; IR νmax/cm-1 3151w, 3072w, 
2960w, 1729 (C=O), 1601, 1583w, 1492w, 1452, 1412w, 1365w, 1315, 1259s, 1225, 1159, 
1106, 1095, 1070, 1030, 978, 939w, 853w, 803w, 756w, 711, 688w, 638, 623, 573, 518; [𝜶]𝑫
𝟐𝟐 
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 Following the general procedure for I-Tag glycosylations in flow using glycosyl 
acceptor 4-(chloromethyl)benzyl alcohol (0.0689 g, 0.440 mmol, 1 eq) and glycosyl donor 
2,3,4-tri-O-benzoyl-6-O-chloroacetyl-α-D-glucopyranosyl trichloroacetimidate 167 (0.6277 g, 
0.880 mmol, 2.0 eq). 2.20 mL of anhydrous DCM was added to the donor/acceptor vial, 
resulting in a solution of volume 2.75 mL and therefore approximately 0.160 M in acceptor 
and 0.320 M in donor. A stock solution of TMSOTf (0.06 M in DCM) was made by dissolving 
TMSOTf (0.217 mL, 1.200 mmol) in 20 mL anhydrous DCM. 3.0 mL of this stock solution was 
taken into a syringe and used for this reaction. The flow reaction was performed at RT. 
Reaction solution was collected for a total of 41 min 30 sec. The crude product was collected 
in DCM (20 mL) and washed with water (8 mL), then the water was extracted with a further 
portion of DCM (20 mL). The dried residue was dissolved in a minimal volume of DCM, then 
HCl, 1.25 M in MeOH (7.04 mL, 8.800 mmol) was added. The resulting solution was stirred for 
16 h at RT in air, then diluted with DCM (15 mL) and water (10 mL) and product was extracted 
into the DCM phase. The aqueous phase was washed with a further DCM portion (15 mL) then 
DCM washings were combined, dried using magnesium sulfate, filtered and the solvent was 
removed under reduced pressure. The dried residue was washed with hexane three times to 
give impure intermediate 175. Intermediate 175 was dried under reduced pressure for 1 h, 
before being dissolved in anhydrous MeCN (5 mL) under a nitrogen atmosphere. 1-Methyl 
imidazole (0.14 mL, 1.76 mmol) and potassium trifluoromethanesulfonate (0.3312 g, 
1.76 mmol) were added and the resulting mixture was heated under reflux at 90 ˚C and stirred 
for 18 h, after which time TLC (DCM:MeOH 94:6) showed the reaction to be complete and 
suggested neighbouring group migration having occurred. Solvent was removed under 
reduced pressure, then DCM and 1 M HCl (aq.) were added to the residue and product was 
extracted into the DCM phase. The aqueous phase was washed with DCM twice more, then 
DCM portions were combined, dried using magnesium sulfate, filtered and the solvent was 
removed under reduced pressure. The crude residue was washed with Et2O once and 
DCM:Et2O 5:95 twice to give a mixture of I-Tagged products 102 and 176. This mixture was 
dissolved in methanol (2.2 mL) and sodium methoxide (50.0 μL, 0.22 mmol, 25 % wt in MeOH) 
was added. The solution was stirred at RT for 3 h after which time TLC-MS showed the 
reaction to be complete. The solution was then brought to pH 7, as monitored by universal 
indicator paper, using 1 M HCl (aq.). Solvent was removed under reduced pressure, then the 
residue was diluted with DCM and water and product was extracted into the aqueous phase. 
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Water was removed under reduced pressure. The crude product was purified by reverse-
phase HPLC (Water:MeCN) to yield the title compound 177 (0.1110 g, 49 % over 4 steps) as a 
solid; 1H NMR δ H (500 MHz, Methanol-d4) 8.95 (1 H, s, NCHN), 7.58 (1 H, d, J 2.0, NCHCHN), 
7.56 (1 H, d, J 2.0, NCHCHN), 7.53 – 7.48 (2 H, m, Harom), 7.43 – 7.38 (2 H, m, Harom), 5.39 (2 H, 
s, NCH2), 4.94 (1 H, d, J 12.3, (C-1)OCHH), 4.70 (1 H, d, J 12.3, (C-1)OCHH), 4.35 (1 H, dd, J 7.7, 
0.9, H-1), 3.92 (3 H, s, NCH3), 3.89 (1 H, dd, J 12.0, 2.1, H-6a), 3.68 (1 H, dd, J 11.8, 5.5, H-6b), 
3.37 – 3.23 (4 H, m, H-2, H-3, H-4, H-5); 13C NMR δ C (126 MHz, Methanol-d4) 140.64 (4˚ 
CaromCH2O(C-1)) , 134.44 (4˚ CaromCH2N), 129.91, 129.65 (Carom), 125.21 (NCHCHN), 123.60 
(NCHCHN), 103.41 (C-1), 78.10, 78.04, 75.11, 71.66 (C-2, C-3, C-4, C-5), 71.07 ((C-1)OCH2), 
62.77 (C-6), 53.83 (NCH2), 36.52 (NCH3); m/z (ESI-HRMS) C18H25N2O6+ ([M – OTf]+) calculated: 
365.1707; found 365.1712; (TLC-MS- (ESI)) CF3O3S- ([OTf]-) calculated 149.0; found 148.8; IR 
νmax/cm-1 3419br (OH), 3156w, 3113w, 2968w, 2929w, 1577, 1452, 1416, 1253s, 1225, 1160, 
1076, 1028s, 758, 638, 574, 517; [𝜶]𝑫
𝟐𝟓 - 24 [c 1.08, MeOH]. 
4-(1-Methyl-3-methyleneimidazolium)benzyl 2-O-acetyl-3,4,6-tri-O-benzyl-β-D-








 Following the general procedure for I-Tag glycosylations in flow using glycosyl 
acceptor 1-(4-(hydroxymethyl)benzyl)-3-methyl-1H-imidazol-3-ium 
trifluoromethanesulfonate 157 (0.1409 g, 0.400 mmol, 1 eq) and glycosyl donor 2-O-acetyl-
3,4,6-tri-O-benzyl-α-D-glucopyranosyl trichloroacetimidate 159 (0.5060 g, 0.800 mmol, 
2.0 eq). 2.00 mL of anhydrous MeCN was added to the donor/acceptor vial, resulting in a 
solution of volume 2.48 mL and therefore approximately 0.161 M in acceptor and 0.322 M in 
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donor. A stock solution of TMSOTf (0.06 M in MeCN) was made by dissolving TMSOTf (0.217 
mL, 1.200 mmol) in 20 mL anhydrous MeCN. 2.6 mL of this stock solution was taken into a 
syringe and used for this reaction. Reaction solution was collected for a total of 33 min 15 sec. 
The crude product was dissolved in DCM (20 mL) and washed with water (8 mL), then the 
water was extracted with DCM (20 mL) and DCM portions were combined. The dried residue 
was washed with Et2O (7 x 8 mL), then dried under reduced pressure to yield the title 
compound 178 as a single anomer (0.2604 g, 84 %); 1H NMR δ H (500 MHz, Chloroform-d) 9.03 
(1 H, s, NCHN), 7.36 – 7.22 (19 H, m, Harom), 7.21 – 7.17 (2 H, m, Harom), 5.26 (2 H, s, NCH2), 
5.01 (1 H, t, J 8.5, H-2), 4.85 (1 H, d, J 12.3, (C-1)OCHH), 4.80 (2 H, app dd, J 11.1, 3.0, PhCH2), 
4.67 (1 H, d, J 11.4, PhCHH), 4.61 – 4.54 (3 H, m, PhCH2), 4.52 (1 H, d, J 12.1, PhCHH), 4.47 (1 
H, d, J 7.9, H-1), 3.81 (3 H, s, NCH3), 3.80 – 3.73 (2 H, m, H-6a, H-6b), 3.72 (1 H, d, J 9.2, H-4), 
3.68 (1 H, t, J 9.0, H-3), 3.51 (1 H, ddd, J 9.4, 4.2, 2.2, H-5), 1.96 (3 H, s, (C=O)CH3); 13C NMR δ 
C (126 MHz, Chloroform-d) 169.82 (C=O), 138.89 (4˚ CaromCH2O(C-1)), 138.12, 138.01, 137.88 
(3 4˚ Carom (Bn)), 136.58 (NCHN), 132.44 (4˚ CaromCH2N), 128.96, 128.51, 128.47, 128.30, 
127.99, 127.95, 127.89, 127.87, 127.83, 127.80 (Carom), 123.82 (NCHCHN), 122.18 (NCHCHN), 
100.34 (C-1), 82.85 (C-3), 77.93 (C-4), 75.23, 75.12, 75.06 (C-5, 2 PhCH2), 73.52 (PhCH2), 73.23 
(C-2), 70.11 ((C-1)OCH2), 68.64 (C-6), 52.98 (NCH2), 36.32 (NCH3), 20.96 ((C=O)CH3); m/z (ESI-
HRMS) C41H45N2O7+ ([M – OTf]+) calculated: 677.3221; found 677.3211; (TLC-MS- (ESI)) CF3O3S- 
([OTf]-) calculated 149.0; found 148.8; IR νmax/cm-1 3153w, 3031w, 2918w, 2873, 1744, 1454, 
1365, 1259s, 1227, 1154, 1061, 1031s, 736, 700, 638; [𝜶]𝑫












glucopyranoside trifluoromethanesulfonate 178 (0.2562 g, 0.310 mmol) was dissolved in 
methanol (1.55 mL) and sodium methoxide (14.2 μL, 0.062 mmol, 25 % wt in MeOH) was 
added. The solution was stirred at RT for 19 h after which time TLC-MS showed the reaction 
to be complete. The solution was then brought to pH 7, as monitored by universal indicator 
paper, using 1 M HCl (aq.). Most methanol solvent was removed under reduced pressure, then 
the residue was diluted with DCM and washed with water. The aqueous phase was washed 
with two further portions of DCM and the DCM portions were combined, dried using 
magnesium sulfate, filtered and the solvent was removed under reduced pressure. The dried 
residue was washed with Et2O (2 x 8 mL), then acetonitrile was added and the mixture was 
filtered. Solvent was removed under reduced pressure to yield the title compound 179 
(0.1817 g, 75 %); 1H NMR δ H (500 MHz, Acetonitrile-d3) 8.75 (1 H, s, NCHN), 7.46 (2 H, app d, 
J 7.9, Harom), 7.40 – 7.25 (20 H, m, Harom), 7.23 – 7.20 (2 H, m, Harom), 5.31 (2 H, s, NCH2), 4.92 
(1 H, d, J 11.3, PhCHH), 4.85 (1 H, d, J 12.4, (C-1)OCHH), 4.78 (2 H, app dd, J 11.1, 8.5, PhCH2), 
4.65 (1 H, d, J 12.4, (C-1)OCHH), 4.58 – 4.50 (3 H, m, PhCH2), 4.40 (1 H, d, J 7.7, H-1), 3.79 (3 
H, s, NCH3), 3.74 (1 H, dd, J 10.9, 1.8, H-6a), 3.69 (1 H, dd, J 10.9, 4.1, H-6b), 3.57 – 3.46 (3 H, 
m, H-3, H-4, H-5), 3.43 (1 H, t, J 8.2, H-2); 13C NMR δ C (126 MHz, Acetonitrile-d3) 140.12, 
140.08, 139.53, 139.47 (4 4˚ Carom) , 137.22 (NCHN), 134.13 (4˚ Carom), 129.50, 129.43, 129.25, 
129.17, 129.12, 128.82, 128.72, 128.71, 128.49, 128.47, 128.30 (Carom), 124.86 (NCHCHN), 
123.10 (NCHCHN), 103.11 (C-1), 85.73 (C-3), 78.54 (C-4), 75.51, 75.48, 75.33 (C-2, C-5, 2 
PhCH2), 73.75 (PhCH2), 70.81 ((C-1)OCH2), 69.93 (C-6), 53.30 (NCH2), 36.83 (NCH3); m/z (ESI-
HRMS) C39H43N2O6+ ([M – OTf]+) calculated: 635.3116; found 635.3098; (TLC-MS- (ESI)) CF3O3S- 
([OTf]-) calculated 149.0; found 148.8; IR νmax/cm-1 3440br, 3031w, 2869, 1573, 1497, 1454, 
1360, 1256, 1224, 1156, 1112, 1055s, 1028s, 910, 826, 732s, 698, 637s, 623, 573, 517, 463; 
[𝜶]𝑫
𝟐𝟑 - 3 [c 1.55, DCM]. 
4-(1-Methyl-3-methyleneimidazolium)benzyl 3,4,6-tri-O-benzyl-2-O-(3,4,6-tri-O-benzyl-β-
D-glucopyranosyl)-β-D-glucopyranoside trifluoromethanesulfonate 181, 4-(1-methyl-3-
methyleneimidazolium)benzyl 3,4,6-tri-O-benzyl-2-O-(3,4,6-tri-O-benzyl-2-O-(3,4,6-tri-O-
benzyl-β-D-glucopyranosyl)-β-D-glucopyranosyl)-β-D-glucopyranoside 
trifluoromethanesulfonate 183, 4-(1-methyl-3-methyleneimidazolium)benzyl 3,4,6-tri-O-
benzyl-2-O-(3,4,6-tri-O-benzyl-2-O-(3,4,6-tri-O-benzyl-2-O-(2-O-acetyl-3,4,6-tri-O-benzyl-β-
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Following the general procedure for I-Tag glycosylations in flow using glycosyl 
acceptor 4-(1-methyl-3-methyleneimidazolium)benzyl 3,4,6-tri-O-benzyl-β-D-
glucopyranoside trifluoromethanesulfonate 179 (0.2113 g, 0.269 mmol, 1 eq) and glycosyl 
donor 2-O-acetyl-3,4,6-tri-O-benzyl-α-D-glucopyranosyl trichloroacetimidate 159 (0.3427 g, 
0.538 mmol, 2.0 eq). 1.35 mL of anhydrous MeCN was added to the donor/acceptor vial, 
resulting in a solution of volume 1.70 mL and therefore approximately 0.158 M in acceptor 
and 0.316 M in donor. A stock solution of TMSOTf (0.06 M in MeCN) was made by dissolving 
TMSOTf (0.217 mL, 1.200 mmol) in 20 mL anhydrous MeCN. 2.0 mL of this stock solution was 
taken into a syringe and used for this reaction. The flow reaction was performed at RT. 
Reaction solution was collected for a total of 25 min into reagent grade DCM, then solvent 
was removed under reduced pressure. The crude residue was washed with hexane:Et2O 1:1 
(4 x 4 mL), then the product mixture was analysed by 1H NMR spectroscopy, revealing a 
mixture of 179:180 in a 45:55 ratio. The product mixture was dissolved in a minimal volume 
of methanol and sodium methoxide (46.2 μL, 0.202 mmol, 25 % wt in MeOH) was added. The 
solution was stirred at RT for 24 h after which time TLC-MS showed the reaction to be 
complete. The solution was then brought to pH 7, as monitored by universal indicator paper, 
using 1 M HCl (aq.). The reaction solution was diluted with DCM and washed with water. The 
aqueous phase was washed with two further portions of DCM and the DCM portions were 
combined, dried using magnesium sulfate, filtered and the solvent was removed under 
reduced pressure. The dried residue was washed with hexane:Et2O 1:3 (8 mL) and 
hexane:Et2O 1:1 (4 x 8 mL), then dried under reduced pressure to give 0.2003 g of a 45:55 
mixture of 179:181 which were used as the glycosyl acceptors in the next flow reaction. 
Following the general procedure for I-Tag glycosylations in flow using glycosyl acceptors 179 
and 181 (0.2003 g) and glycosyl donor 2-O-acetyl-3,4,6-tri-O-benzyl-α-D-glucopyranosyl 
trichloroacetimidate 159 (0.2510 g, 0.394 mmol). 0.96 mL of anhydrous MeCN was added to 
the donor/acceptor vial, resulting in a solution of volume 1.25 mL. 1.50 mL of the TMSOTf 
(0.06 M in MeCN) stock solution was taken into a syringe and used for this reaction. The flow 
reaction was performed at RT. Reaction solution was collected for a total of 17 min 15 sec 
into reagent grade DCM, then solvent was removed under reduced pressure. The crude 
residue was analysed by TLC-MS, revealing a mixture of monosaccharide 179, disaccharides 
180 and 181 and trisaccharide 182. The product mixture was dissolved in a minimal volume 
of methanol and sodium methoxide (33.8 μL, 0.148 mmol, 25 % wt in MeOH) was added. The 
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solution was stirred at RT for 18 h, but TLC-MS showed the reaction was not yet complete. A 
further portion of sodium methoxide (67.6 μL, 0.296 mmol, 25 % wt in MeOH) was added and 
the reaction mixture was stirred at RT for a further 24 h, then another portion of sodium 
methoxide (22.3 μL, 0.098 mmol, 25 % wt in MeOH) was added and the reaction mixture was 
stirred at RT for a further 6 h, to allow complete deacetylation. The solution was then brought 
to pH 7, as monitored by universal indicator paper, using 1 M HCl (aq.). The reaction solution 
was diluted with DCM and washed with water. The aqueous phase was washed with two 
further portions of DCM and the DCM portions were combined, dried using magnesium 
sulfate, filtered and the solvent was removed under reduced pressure. The dried residue was 
washed with hexane:Et2O 1:1 (3 x 8 mL), then dried under reduced pressure to give 0.2341 g 
of a mixture of 179:181:183, which were used as the glycosyl acceptors in the next flow 
reaction. Following the general procedure for I-Tag glycosylations in flow using glycosyl 
acceptors 179, 181 and 183 (0.2341 g) and glycosyl donor 2-O-acetyl-3,4,6-tri-O-benzyl-α-D-
glucopyranosyl trichloroacetimidate 159 (0.2038 g, 0.320 mmol). 0.80 mL of anhydrous MeCN 
was added to the donor/acceptor vial, resulting in a solution of volume 1.18 mL. 1.50 mL of 
the TMSOTf (0.06 M in MeCN) stock solution was taken into a syringe and used for this 
reaction. The flow reaction was performed at RT. Reaction solution was collected for a total 
of 16 min 20 sec into reagent grade DCM, then solvent was removed under reduced pressure. 
The crude residue was analysed by  TLC-MS, revealing a mixture of monosaccharide 179, 
disaccharides 180 and 181, trisaccharides 182 and 183 and tetrasaccharide 184. The crude 
residue was washed with hexane:Et2O 2:1 (2 x 10 mL), then dissolved in a minimal volume of 
methanol before sodium methoxide (91.4 μL, 0.400 mmol, 25 % wt in MeOH) was added. The 
solution was stirred at RT for 19 h, at which point TLC-MS showed that deacetylation was 
complete for the di- and trisaccharides, but not for the tetrasaccharide. A further portion of 
sodium methoxide (500.0 μL, 2.188 mmol, 25 % wt in MeOH) was added and the reaction 
mixture was stirred at RT for a further 53 h, however, complete deprotection of 
tetrasaccharide 184 was not possible. The solution was then brought to pH 7, as monitored 
by universal indicator paper, using 1 M HCl (aq.). The reaction solution was diluted with DCM 
and washed with water. The aqueous phase was washed with two further portions of DCM 
and the DCM portions were combined, dried using magnesium sulfate, filtered and the 
solvent was removed under reduced pressure. The dried residue was washed with 
hexane:Et2O 1:1 (6 x 8 mL) and hexane:Et2O 1:2 (2 x 8 mL), then dried under reduced pressure 
 6.  Experimental  
206 
 
to give 0.1370 g of a mixture of 179:181:183:184:185. This mixture was only analysed by MS 








 4-Methoxyphenyl 2,3,4-tri-O-benzoyl-β-D-glucopyranoside 187 (0.250 g, 0.418 mmol) 
was dried for 1 h under vacuum before being dissolved in anhydrous DCM (3.7 mL) under a 
nitrogen atmosphere. The resulting solution was cooled to 0 ℃ then anhydrous pyridine 
(92.9 μL, 1.15 mmol) was added. Fluorenylmethyloxycarbonyl chloride (0.216 g, 0.835 mmol) 
was added in small portions over 30 min with stirring. Following complete 
fluorenylmethyloxycarbonyl chloride addition, the resulting solution was stirred for 2 h at RT, 
after which time TLC (Hexane:EtOAc 7:3) showed the reaction to be complete. Methanol 
(0.05 mL) was added to quench excess fluorenylmethyloxycarbonyl chloride, then solvent was 
removed under reduced pressure, with co-evaporation with toluene (3 x 1 mL). The residue 
was dissolved in DCM (5 mL) and washed with water (2 x 3 mL), NaHCO3 (sat. aq.) (3 mL) and 
brine (3 mL), dried using magnesium sulfate, filtered and the solvent was removed under 
reduced pressure. Following column chromatography (Hexane:EtOAc 8:2), 4-methoxyphenyl 
2,3,4-tri-O-benzoyl-6-O-(9-fluorenylmethoxycarbonyl)-β-D-glucopyranoside 188 (0.284 g, 
0.345 mmol, 83 %) was obtained. This product was dissolved in a mixture of DCM:MeCN 
(10 mL, 1:9) at RT. To this solution water (1 mL) was added such that, with vigorous stirring, 
the resulting solution consists of a single phase. Ceric ammonium nitrate (0.379 g, 
0.691 mmol) was added and the solution stirred for 5.5 h at RT, after which time TLC 
(Hexane:EtOAc 6:4) and TLC-MS (C42H34O11Na+ ([M + Na]+) calculated 737.2; found 737.5) 
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showed the reaction to be complete. Most of the solvent was removed under reduced 
pressure, and the residue was diluted with EtOAc (30 mL). The resulting solution was washed 
with water (2 x 20 mL), dried using magnesium sulfate, filtered and the solvent was removed 
under reduced pressure. Following column chromatography (Hexane:EtOAc 7:3) the free 
hemiacetal intermediate 189 (0.194 g, 0.271 mmol, 78 %) was obtained. This intermediate 
was dried for 1 h under vacuum before being dissolved in a mixture of anhydrous 
DCM:trichloroacetonitrile  (10 mL, 1:1) under a nitrogen atmosphere. To this solution, sodium 
hydride (60 % in mineral oil, 0.0033 g, 0.0813 mmol) was added and the resulting solution 
was stirred overnight at RT under a nitrogen atmosphere, after which time TLC (Hexane:EtOAc 
8:2) showed the reaction to be complete, with the product present as two anomers. Silica 
was added, then the solvent was removed under reduced pressure to dry load the product. 
Following column chromatography (Hexane:EtOAc 8:2), the title compound 186 (0.230 g, 
99 %, α:β = 1:0.85) was obtained as two anomers that could be partially separated by column 
chromatography. Only the α anomer could be obtained in sufficiently high purity for complete 
characterisation. Note that only characteristic, non-overlapping, distinguishable NMR 
spectroscopy signals are given for the β anomer; 1H NMR α anomer: δ H (500 MHz, 
Chloroform-d) 8.65 (1 H, s, NH), 7.97 (4 H, td, J 8.0, 1.4, Harom), 7.88 (2 H, dd, J 8.3, 1.4, Harom), 
7.77 (2 H, d, J 7.5, Harom), 7.62 (2 H, dd, J 15.2, 7.5, Harom), 7.54 – 7.49 (2 H, m, Harom), 7.47 – 
7.28 (11 H, m, Harom), 6.86 (1 H, d, J 3.7, H-1), 6.28 (1 H, t, J 9.9, H-3), 5.77 (1 H, t, J 10.0, H-4), 
5.64 (1 H, dd, J 10.2, 3.7, H-2), 4.58 (1 H, dt, J 10.3, 3.8, H-5), 4.45 – 4.43 (2 H, m, H-6a, H-6b), 
4.41 (1 H, dd, J 10.3, 7.5, COCHHCH), 4.32 (1 H, dd, J 10.3, 7.7, COCHHCH), 4.26 (1 H, t, J 7.5, 
COCH2CH); β anomer: δ H (400 MHz, Chloroform-d) 6.26 (1 H, d, J 7.6, H-1); 13C NMR α 
anomer: δ C (126 MHz, Chloroform-d) 165.79, 165.52, 165.39 (3 C=O (Bz)), 160.63 (CNH), 
154.92 (C=O (Fmoc)), 143.57, 143.37, 141.40, 141.37 (4˚ Carom), 133.76, 133.71, 133.47, 
130.07, 130.05, 129.86, 128.98, 128.73, 128.67, 128.63, 128.58, 128.50, 128.02, 127.36, 
125.51, 125.40, 120.15, 120.14 (Carom), 93.23 (C-1), 90.82 (CCl3), 70.76, 70.63, 70.49 (C-2, C-5, 
COCH2CH), 70.21 (C-3), 68.64 (C-4), 65.62 (C-6), 46.77 (COCH2CH); β anomer: δ C (126 MHz, 
Chloroform-d) 95.91 (C-1); m/z α anomer: C44H34Cl3NO11Na+ ([M + Na]+) calculated 880.1090; 
found 880.1070; C42H33O10+ ([M – OC(NH)CCl3]+) calculated 697.2068; found 697.2060; IR α 
anomer: νmax/cm-1 3468w, 3350w, 3069w, 2957w, 2923w, 1727s (C=O), 1678, 1601, 1451, 
1316, 1259s, 1178, 1160, 1105, 1093, 1069, 1026, 970, 825, 795, 760, 742, 708s, 686; α 
anomer: [𝜶]𝑫
𝟐𝟔 + 10 [c 1.06, DCM]. 
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4-Methoxyphenyl β-D-glucopyranoside 192 (7.33 g, 25.62 mmol) was dried for 1 h 
under vacuum before being dissolved in anhydrous pyridine (125 mL) under a nitrogen 
atmosphere. To this solution, imidazole (3.49 g, 51.24 mmol) was added and the solution was 
cooled to 0 ℃. Triisopropylsilyl chloride (6.59 mL, 30.74 mmol) was added dropwise and the 
reaction was stirred at RT for 18 h. After this time, TLC (DCM:MeOH 95:5) showed the 
silylation reaction to be complete. The solvent was removed under reduced pressure and the 
residue was dissolved in DCM (150 mL). The DCM phase was washed with water (2 x 100 mL) 
and the resulting aqueous phase was furthered washed with DCM (100 mL), then DCM 
washings were combined. The combined organic phase was dried using magnesium sulfate, 
filtered and the solvent was removed under reduced pressure. The crude product was 
purified by column chromatography (DCM:MeOH 99:1 → 96:4 → 95:5) to give 4-
methoxyphenyl 6-O-triisopropylsilyl-β-D-glucopyranoside (10.04 g, 89 %), with identity and 
purity confirmed by 1H NMR spectroscopy. 4-Methoxyphenyl 6-O-triisopropylsilyl-β-D-
glucopyranoside (5.85 g, 13.22 mmol) was dried for 1 h under vacuum before being dissolved 
in anhydrous pyridine (80 mL) under a nitrogen atmosphere. Benzoyl chloride (12.29 mL, 
105.79 mmol) was added, and the solution was stirred at RT for 17 h under a nitrogen 
atmosphere. After this time, TLC (Hexane:EtOAc 8:2) showed the benzoylation reaction to be 
complete. Methanol (15 mL) was cautiously added to quench excess benzoyl chloride, then 
solvent was removed under reduced pressure. The residue was dissolved in DCM (100 mL) 
and the resulting organic solution was washed with 1 M HCl (aq.) (2 x 75 mL), NaHCO3 (sat. aq.) 
(75 mL) and water (75 mL), dried using magnesium sulfate, filtered and the solvent was 
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removed under reduced pressure.  The resulting benzoylated intermediate was dissolved in 
MeCN (100 mL) in air at RT. HCl in diethyl ether (100 mL, 200 mmol, 2.0 M) was added and 
the resulting solution was stirred at RT for 2 h, after which time TLC (Hexane:EtOAc 6:4) 
showed the reaction to be complete. The solution was then cautiously brought to pH 7, as 
monitored by universal indicator paper, using 1 M NaOH (aq.). The ethereal phase was 
separated from the aqueous phase, dried using magnesium sulfate, filtered and the solvent 
was removed under reduced pressure. The crude product was purified by column 
chromatography (Hexane:EtOAc 8:2 → 7:3 → 6:4) to give the title compound 187 (6.75 g, 
85 % over 2 steps) with spectroscopic details in accordance with the literature;179 1H NMR δ 
H (500 MHz, Chloroform-d) 7.99 – 7.94 (4 H, m, Harom), 7.89 – 7.84 (2 H, m, Harom), 7.57 – 7.35 
(7 H, m, Harom), 7.32 – 7.27 (2 H, m, Harom), 6.99 – 6.93 (2 H, m, Harom), 6.82 – 6.76 (2 H, m, 
Harom), 6.00 (1 H, t, J 9.7, H-3), 5.75 (1 H, dd, J 9.8, 7.9, H-2), 5.58 (1 H, t, J 9.7, H-4), 5.30 (1 H, 
d, J 7.9, H-1), 3.93 – 3.86 (2 H, m, H-5, H-6a), 3.82 – 3.76 (1 H, m, H-6b), 3.75 (3 H, s, CH3); 13C 
NMR δ C (126 MHz, Chloroform-d) 166.11, 165.96, 165.22 (3 C=O), 155.93, 151.12 (2 4˚ Carom), 
133.86, 133.45, 130.09, 129.94, 129.92, 129.31, 128.93, 128.67, 128.63, 128.60, 128.55, 
128.48 (Carom (Bz)), 118.98, 114.75 (Carom (PMP)), 100.96 (C-1), 75.06 (C-5), 72.86 (C-3), 71.93 
(C-2), 69.54 (C-4), 61.56 (C-6), 55.76 (CH3); m/z (TLC-MS+ (ESI)) C34H30O10Na+ ([M + Na]+) 
calculated 621.2; found 621.2; C36H33NO10Na+ ([M + MeCN + Na]+) calculated 662.2; found 
662.2; C68H60O20Na+ ([2M + Na]+) calculated 1219.4; found 1219.1. 
4-(1-Methyl-3-methyleneimidazolium)benzyl 2,3,4-tri-O-benzoyl-6-O-(9-
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Following the general procedure for I-Tag glycosylations in flow using glycosyl 
acceptor 1-(4-(hydroxymethyl)benzyl)-3-methyl-1H-imidazol-3-ium 
trifluoromethanesulfonate 157 (0.0289 g, 0.082 mmol, 1 eq) and glycosyl donor 2,3,4-tri-O-
benzoyl-6-O-(9-fluorenylmethoxycarbonyl)-D-glucopyranosyl trichloroacetimidate 186 
(0.1404 g, 0.163 mmol, 2.0 eq). 0.41 mL of anhydrous acetonitrile was added to the 
donor/acceptor vial, resulting in a solution of volume 0.49 mL and therefore approximately 
0.167 M in acceptor and 0.334 M in donor. A stock solution of TMSOTf (0.06 M in MeCN) was 
made by dissolving TMSOTf (0.109 mL, 0.600 mmol) in 10 mL anhydrous MeCN. 0.75 mL of 
this stock solution was taken into a syringe and used for this reaction.  The flow reaction was 
performed at RT. Reaction solution was collected for a total of 6 min in reagent grade DCM. 
The crude product was dissolved in DCM (5 mL) and washed with water (5 mL), then the water 
was extracted with further portions of DCM (2 x 5 mL). The dried residue was washed with 
hexane (5 mL), hexane:Et2O 1:1 (2 x 5 mL), hexane:Et2O 1:3 (2 x 5 mL), and Et2O (3 x 5 mL), 
then dried under reduced pressure to yield the title compound 190 as a single anomer 
(0.0553 g,  80 %); 1H NMR δ H (500 MHz, Chloroform-d) 9.19 (1 H, s, NH), 7.95 – 7.90 (4 H, m, 
Harom), 7.82 (2 H, app dd, J 8.4, 1.4, Harom), 7.75 (2 H, app d, J 7.5, Harom), 7.64 – 7.46 (4 H, m, 
Harom), 7.47 – 7.16 (15 H, m, Harom), 7.16 (1 H, s, NCHCHN), 7.07 (1 H, s, NCHCHN), 5.88 (1 H, t, 
J 9.6, H-3), 5.62 – 5.53 (2 H, m, H-2, H-4), 5.25 (2 H, s, NCH2), 4.94 – 4.86 (2 H, m, H-1, (C-
1)OCHH), 4.67 (1 H, d, J 12.5, (C-1)OCHH), 4.47 – 4.33 (4 H, m, H-6a, H-6b, OCH2CH(Fmoc)), 
4.22 (1 H, t, J 7.3, OCH2CH(Fmoc)), 4.08 (1 H, dt, J 9.5, 4.0, H-5), 3.89 (3 H, s, NCH3); 13C NMR 
(126 MHz, Chloroform-d) δ 165.89, 165.41, 165.28 (3 C=O (Bz)), 154.94 (C=O (Fmoc)), 143.45, 
143.34, 141.41, 141.39 4 (4˚ Carom(Fmoc)), 138.64 (4˚ CaromCH2O(C-1)), 137.33 (NCHN), 132.12 
(4˚ CaromCH2N), 129.99, 129.90, 129.88, 129.23, 129.16, 128.86, 128.81, 128.78, 128.64, 
128.63, 128.47, 128.09, 127.37, 125.34, 125.30 (Carom), 123.55 (NCHCHN), 121.91 (NCHCHN), 
120.22 (Carom), 100.15 (C-1), 72.87 (C-3), 72.40 (C-5), 71.91 (C-2 or C-4), 70.41 ((C-1)OCH2), 
70.28 (OCH2CH(Fmoc)), 69.55 (C-2 or C-4), 66.29 (C-6), 53.39 (NCH2), 46.79 (OCH2CH(Fmoc)), 
36.69 (NCH3); m/z (ESI-HRMS) C54H47N2O11+ ([M - OTf]+) calculated 899.3174; found 899.3183; 
(TLC-MS- (ESI)) CF3O3S- ([OTf]-) calculated 148.9; found 148.9; IR νmax/cm-1 3068w, 2960w, 
1732 (C=O), 1602, 1581w, 1450, 1316, 1258s, 1158, 1106, 1094, 1069, 1030, 975, 853w, 761, 
743, 710, 638, 621; [𝜶]𝑫
𝟐𝟐 - 5 [c 0.63, DCM]. 











 4-Methoxyphenyl 2,3-di-O-benzoyl-4,6-O-benzylidene-β-D-glucopyranoside 194 (1.74 
g, 2.99 mmol) was dried under vacuum for 1 h before borane-THF (20.00 mL, 20.00 mmol, 
1.0 M solution in THF) was added under a nitrogen atmosphere. The mixture was stirred at 
RT for 10 min, then copperII triflate (0.162 g, 0.448 mmol) was added, turning the cloudy off-
white mixture to black over approximately 5 min. The mixture was sonicated for 1 h under a 
nitrogen atmosphere. The mixture stayed cloudy, indicating incomplete dissolution of starting 
material. To aid dissolution, approximately 5 mL of anhydrous DCM was added to the reaction 
mixture, then the mixture was sonicated for a further 4.5 h. After this time TLC (Hexane:EtOAc 
7:3) and TLC-MS (C34H32O9Na+ ([M + Na]+) calculated 607.2; found 607.1) showed the reaction 
to be complete. The reaction mixture was cooled to 0 ℃, then NEt3 (0.42 mL, 2.99 mmol) and 
methanol (5.4 mL) were added to quench the reaction. Solvent was then removed under 
reduced pressure, with co-evaporation with methanol. The crude material was purified by 
normal phase HPLC (Hexane:EtOAc) to give 4-methoxyphenyl 2,3-di-O-benzoyl-4-O-benzyl-β-
D-glucopyranoside 195 (1.37 g), which was used directly in the next step. 4-Methoxyphenyl 
2,3-di-O-benzoyl-4-O-benzyl-β-D-glucopyranoside 195 (1.37 g, 2.34 mmol) was dried under 
vacuum for 1 h before being dissolved in anhydrous DCM (21 mL) under a nitrogen 
atmosphere. The resulting solution was cooled to 0 ℃, then anhydrous pyridine (0.52 mL, 
6.44 mmol) was added. Fluorenylmethyloxycarbonyl chloride (1.21 g, 4.69 mmol) was added 
in small portions over 30 min with stirring. Following complete fluorenylmethyloxycarbonyl 
chloride addition, the resulting solution was stirred for 2 h at RT, after which time TLC 
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(Hexane:EtOAc 7:3) showed the reaction to be complete. Methanol (0.28 mL) was added to 
quench excess fluorenylmethyloxycarbonyl chloride, then solvent was removed under 
reduced pressure, with co-evaporation with toluene (3 x 4 mL). The residue was dissolved in 
DCM (20 mL) and washed with water (2 x 15 mL), NaHCO3 (sat. aq.) (15 mL) and brine (15 mL), 
dried using magnesium sulfate, filtered and the solvent was removed under reduced 
pressure. The crude material was purified by normal phase HPLC (Hexane:EtOAc) to give 4-
methoxyphenyl 2,3-di-O-benzoyl-4-O-benzyl-6-O-(9-fluorenylmethoxycarbonyl)-D-
glucopyranoside 196 (1.59 g, α:β = 1:1) as an anomeric mixture which was used directly in the 
next step. Fully protected glycoside 196 was dissolved in a mixture of MeCN:water (20 mL, 
4:1) and cooled to 0 ℃. Ceric ammonium nitrate (2.16 g, 3.94 mmol) was added and the 
solution stirred for 45 min at 0 ℃, after which time TLC (Hexane:EtOAc 6:4) showed the 
reaction to be complete. Most of the solvent was removed under reduced pressure, and the 
residue was diluted with DCM (75 mL). The resulting solution was washed with water 
(2 x 70 mL), dried using magnesium sulfate, filtered and the solvent was removed under 
reduced pressure. Following purification by normal phase HPLC (Hexane:EtOAc) the free 
hemiacetal intermediate 197 (1.24 g, α:β = 4:1) was obtained as an anomeric mixture which 
was used directly in the next step. Hemiacetal 197 was dried for 1 h under vacuum before 
being dissolved in anhydrous DCM (18 mL) under a nitrogen atmosphere. To this solution 
trichloroacetonitrile (2.66 mL, 26.54 mmol) and sodium hydride (60 % in mineral oil, 0.0127 g, 
0.531 mmol) were added and the resulting solution was stirred for 15 min at RT under a 
nitrogen atmosphere. After this time, TLC (Hexane:EtOAc 7:3) showed partial reaction of 
starting material to form two anomeric products. A further portion of NaH (0.0127 g, 
0.531 mmol) was added and the solution was stirred for a further 30 min. After this time, TLC 
revealed a change in anomeric ratio as judged by spot intensity, with a greater proportion of 
α anomer than at 15 min. To continue anomerising product to bias the α anomer, the reaction 
mixture was heated to 40 ℃ for 2 h, then returned to RT and stirred for 16 h. After this time, 
TLC showed complete reaction of starting material with almost entirely α anomer present. 
Silica was added, then the solvent was removed under reduced pressure to dry load the 
product. Following column chromatography (Hexane:EtOAc 85:15), the title compound 191 
was obtained as a white solid (1.11 g, 44 % over 4 steps); 1H NMR δ H (400 MHz, Chloroform-
d) 8.58 (1 H, s, NH), 8.02 – 7.96 (2 H, m, Harom), 7.96 – 7.92 (2 H, m, Harom), 7.79 (2 H, dd, J 7.5, 
3.0, Harom), 7.66 (2 H, m, Harom), 7.57 – 7.46 (2 H, m, Harom), 7.46 – 7.31 (8 H, m, Harom), 7.17 (5 
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H, app q, J 3.5, 3.1, Harom), 6.73 (1 H, d, J 3.6, H-1), 6.16 (1 H, td, J 9.7, 2.2, H-3), 5.49 (1 H, dd, 
J 10.2, 3.6, H-2), 4.67 – 4.58 (2 H, m, PhCH2), 4.56 (1 H, dd, J 12.0, 2.1, H-6a), 4.52 – 4.40 (3 H, 
m, H-6b, OCH2CH), 4.34 – 4.27 (2 H, m, H-5, OCH2CH), 4.08 (1 H, t, J 9.7, H-4); 13C NMR δ C 
(101 MHz, Chloroform-d) 165.72, 165.64 (2 C=O (Bz)), 160.80 (CNH), 154.97 (C=O (Fmoc)), 
143.49, 143.34, 141.45, 136.76 (4˚ Carom), 133.64, 133.52, 130.02, 129.85, 129.43, 128.72, 
128.63, 128.60, 128.56, 128.54, 128.37, 128.35, 128.08, 127.38, 127.35, 125.34, 125.28, 
120.23 (Carom), 93.41 (C-1), 90.83 (CCl3), 75.28 (PhCH2), 75.10 (C-4), 72.35 (C-3), 71.66 (C-5), 
70.87 (C-2), 70.31 (OCH2CH), 65.63 (C-6), 46.87 (OCH2CH); m/z (ESI-HRMS) C44H36Cl3O10NNa+ 
([M + Na]+) calculated 866.1297; found 866.1289; IR νmax/cm-1 3344, 1726 (C=O), 1676, 1601, 
1451, 1315, 1261, 1178, 1158, 1107, 1095, 1069, 1033, 1022, 1002, 971, 921, 826, 795, 759, 
742, 709, 646; [𝜶]𝑫
𝟐𝟖 + 53 [c 1.21, DCM]. 




1,2,3,4,6-Penta-O-acetyl-β-D-glucopyranoside (20.00 g, 51.24 mmol) and 4-
methoxyphenol (7.00 g, 56.36 mmol) were dried under vacuum for 1 h before being dissolved 
in anhydrous DCM (250 mL) and cooled to 0 ℃ under a nitrogen atmosphere. To this solution, 
boron trifluoride diethyl etherate (19.0 mL, 153.71 mmol) was added dropwise. The resulting 
solution was stirred at RT for 18 h. The mixture was then cautiously quenched using NaHCO3 
(sat. aq.) (400 mL). The product was extracted from the reaction mixture using DCM (100 mL) 
and the combined DCM phase was washed with water (200 mL), dried using magnesium 
sulfate, filtered and the solvent was removed under reduced pressure. The crude residue was 
dissolved in methanol (200 mL) at RT in air. Sodium methoxide (0.94 mL, 4.10 mmol, 25 % wt 
in MeOH) was added dropwise and the resulting solution was stirred for 2 h after which time 
TLC (DCM:MeOH 9:1) showed the reaction to be complete. The solution was then brought to 
pH 7, as monitored by universal indicator paper, using Amberlite acidic resin. The resulting 
neutralised solution was filtered, then silica was added. The solvent was removed under 
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reduced pressure to dry load the crude material on to silica. Following column 
chromatography (DCM:MeOH 9:1 → 8:2) the title compound 192  was obtained as a white 
solid (10.59 g, 72 % over 2 steps, α:β = 1:5.3) with spectroscopic details in accordance with 
the literature.180 Note that only characteristic, non-overlapping, distinguishable NMR 
spectroscopy signals are given for the minor α anomer; 1H NMR α anomer: δ H (400 MHz, 
Methanol-d4) 5.33 (1 H, d, J 3.7, H-1), 3.54 (1 H, dd, J 9.8, 3.8, H-2); β anomer: δ H (400 MHz, 
Methanol-d4) 7.08 – 7.02 (2 H, m, Harom), 6.86 – 6.80 (2 H, m, Harom), 4.79 – 4.76 (1 H, m, H-1), 
3.91 – 3.86 (1 H, m, H-6a), 3.74 (3 H, s, CH3), 3.73 – 3.67 (1 H, m, H-6b), 3.47 – 3.37 (4 H, m, 
H-2, H-3, H-4, H-5); 13C NMR α anomer: δ C (101 MHz, Methanol-d4) 100.35 (H-1); β anomer: 
δ C (101 MHz, Methanol-d4) 156.61, 153.19 (2 4˚ Carom), 119.20, 115.47 (Carom), 103.41 (C-1), 
78.04, 77.95, 74.94, 71.39 (C-2, C-3, C-4, C-5), 62.53 (C-6), 56.04 (CH3); m/z (TLC-MS+ (ESI)) 
C15H21NO7Na+ ([M + MeCN + Na]+) calculated 350; found 350; C26H36O14Na+ ([2M + Na]+) 
calculated 595; found 595. 







 4-Methoxyphenyl β-D-glucopyranoside 192 (10.59 g, 36.99 mmol) and copperII triflate 
(0.669 g, 1.85 mmol) were dried under vacuum for 1 h. Anhydrous acetonitrile (370 mL) was 
added under a nitrogen atmosphere. Benzaldehyde dimethyl acetal (11.15 mL, 73.98 mmol) 
was added and the solution was sonicated under a nitrogen atmosphere for 90 min, after 
which time TLC (DCM:MeOH 9:1) and TLC-MS (C22H25NO7Na+ ([M + MeCN + Na]+) calculated 
438.2; found 438.2; C40H44O14Na+ ([2M + Na]+) calculated 771.3; found 771.4) showed the 
reaction to be complete.  The cloudy reaction mixture was quenched by addition of 
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triethylamine (5 mL). The solvent was removed under reduced pressure to give crude 
benzylidenated intermediate 193. The crude intermediate 193 was dried under vacuum for 
1 h, then dissolved in anhydrous pyridine (300 mL) under a nitrogen atmosphere. Benzoyl 
chloride (21.49 mL, 184.95 mmol) was added, and the solution was stirred at RT for 16 h under 
a nitrogen atmosphere. After this time, TLC (Hexane:EtOAc 8:2) showed the benzoylation 
reaction to be complete. Methanol (30 mL) was cautiously added to quench excess benzoyl 
chloride, then solvent was removed under reduced pressure. The residue was dissolved in 
DCM (200 mL) and the resulting organic solution was washed with 1 M HCl (aq.) (2 x 150 mL), 
NaHCO3 (sat. aq.) (150 mL) and water (150 mL), dried using magnesium sulfate, filtered and the 
solvent was removed under reduced pressure. Following purification by column 
chromatography (Hexane:EtOAc 1:0 → 85:15 → 8:2 → 7:3 → EtOAc) the title compound 194 
was obtained as an off-white solid (15.01 g, 70 % over 2 steps); 1H NMR δ H (500 MHz, 
Chloroform-d) 7.99 (4 H, ddd, J 8.5, 4.9, 1.4, Harom), 7.55 – 7.48 (2 H, m, Harom), 7.45 – 7.30 (9 
H, m, Harom), 6.96 – 6.91 (2 H, m, Harom (PMP)), 6.81 – 6.76 (2 H, m, Harom (PMP)), 5.85 (1 H, t, 
J 9.5, H-3), 5.72 (1 H, dd, J 9.4, 7.7, H-2), 5.58 (1 H, s, PhCHOO), 5.26 (1 H, d, J 7.7, H-1), 4.47 
(1 H, dd, J 10.6, 5.0, H-6a), 4.04 (1 H, t, J 9.5, H-4), 3.94 (1 H, t, J 10.3, H-6b), 3.80 (1 H, td, J 
9.7, 4.9, H-5), 3.75 (3 H, s, CH3); 13C NMR δ C (126 MHz, Chloroform-d) 165.74, 165.35 (2 C=O), 
156.00, 151.12 (2 4˚ Carom), 136.84, 133.44, 133.29, 129.99, 129.96, 129.50, 129.31, 129.21, 
128.55, 128.47, 128.35, 126.27 (Carom), 119.15, 114.71 (Carom (PMP)), 101.70 (PhCHOO), 
101.59 (C-1), 78.76 (C-4), 72.55 (C-2), 72.19 (C-3), 68.78 (C-6), 66.91 (C-5), 55.75 (CH3); m/z 
(ESI-HRMS) C34H34NO9+ ([M + NH4]+) calculated 600.2228; found 600.2220; C27H23O7+ ([M - 
OPMP]+) calculated 459.1438; found 459.1432; IR νmax/cm-1 1725 (C=O), 1601, 1506, 1451, 
1374, 1314, 1270, 1216, 1179, 1092s, 1070s, 1027, 1008, 912, 851, 829, 756, 708s, 650; [𝜶]𝑫
𝟐𝟒 
+ 41 [c 0.90, DCM]. 












Following the general procedure for I-Tag glycosylations in flow using glycosyl 
acceptor 1-(4-(hydroxymethyl)benzyl)-3-methyl-1H-imidazol-3-ium 
trifluoromethanesulfonate 157 (0.0282 g, 0.080 mmol, 1 eq) and glycosyl donor 2,3-di-O-
benzoyl-4-O-benzyl-6-O-(9-fluorenylmethoxycarbonyl)-α-D-glucopyranosyl 
trichloroacetimidate 191 (0.1352 g, 0.160 mmol, 2 eq). 0.40 mL of anhydrous MeCN was 
added to the donor/acceptor vial, resulting in a solution of volume 0.49 mL and therefore 
approximately 0.163 M in acceptor and 0.327 M in donor. To the other vial, 0.80 mL of 
anhydrous acetonitrile was added, followed by trimethylsilyl trifluoromethanesulfonate 
(8.7 μL, 0.048 mmol) to make a 0.06 M solution. The flow reaction was performed at RT. 
Reaction solution was collected into a mixture of DCM:NEt3 3:1 (4 mL) for a total of 6 min 
10 sec and the resulting solution was stirred at RT for 20 min in air to remove the Fmoc group. 
After this time TLC-MS showed complete conversion to the desired product. The solution was 
diluted with DCM (5 mL) and washed with 1 M HCl (aq.) (8 mL) and water (8 mL). The combined 
aqueous phases were washed with a portion of DCM (5 mL), then DCM washes were 
combined and the aqueous washes discarded. The DCM phase was then washed with NaHCO3 
(sat. aq.) (8 mL) and water (8 mL). The combined aqueous phases were washed with a portion 
of DCM (5 mL), then DCM washes were combined and the aqueous washes discarded. The 
DCM phase was dried using magnesium sulfate, filtered and the solvent was removed under 
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reduced pressure.  The crude residue was washed with hexane:Et2O 1:1 (2 x 6 mL), 
hexane:Et2O 2:3 (2 x 6 mL) and hexane:Et2O 1:2 (6 mL) then dried under reduced pressure to 
yield the title compound 199 as a solid (0.0394 g, 74 %); 1H NMR δ H (500 MHz, Chloroform-
d) 9.02 (1 H, s, NCHN), 7.88 (4 H, app t, J 8.8, Harom), 7.47 (2 H, app t, J 7.4, Harom), 7.37 – 7.29 
(4 H, m, Harom), 7.23 (1 H, s, NCHCHN), 7.18 – 7.09 (10 H, m, Harom, NCHCHN), 5.69 (1 H, t, J 
9.6, H-3), 5.35 (1 H, dd, J 9.9, 8.0, H-2), 5.19 (2 H, s, NCH2), 4.85 – 4.74 (2 H, m, H-1, (C-1)OCHH), 
4.63 – 4.53 (3 H, m, (C-4)OCH2Ph, (C-1)OCHH), 4.00 – 3.91 (2 H, m, H-4, H-6a), 3.85 – 3.80 (1 
H, m, H-6b), 3.79 (3 H, s, NCH3), 3.58 (1 H, dt, J 9.5, 3.2, H-5); 13C NMR δ C (126 MHz, 
Chloroform-d) 165.79, 165.54 (2 C=O), 138.58, 137.32 (4˚ Carom), 136.64 (NCHN), 133.47, 
133.34, 132.50, 129.75, 129.39, 129.27, 128.90, 128.53, 128.49, 128.41, 128.25, 128.00 
(Carom), 123.81 (NCHCHN), 122.11 (NCHCHN), 100.39 (C-1), 75.83 (C-5), 75.70 (C-4), 75.04 (C-
3), 74.87 ((C-4)OCH2Ph), 72.29 (C-2), 70.63 ((C-1)OCH2), 61.25 (C-6), 52.91 (NCH2), 36.33 
(NCH3); m/z (ESI-HRMS) C39H39N2O8+ ([M - OTf]+) calculated 663.2701; found 663.2695; (TLC-
MS- (ESI)) CF3O3S- ([OTf]-) calculated 148.9; found 149.1; IR νmax/cm-1 3470br (OH), 3152w, 
3066w, 2926w, 1723 (C=O), 1601, 1583, 1574, 1563, 1452, 1411w, 1362w, 1315, 1255s, 1225, 
1157, 1095, 1070s, 1047, 1028s, 1001, 911, 853, 826, 804, 755, 736, 711, 638, 623, 574, 518; 
[𝜶]𝑫
𝟐𝟒 + 11 [c 0.70, DCM]. Note that due to sparing solubility of the product in DCM, the 
solution used to determine optical rotation was passed through a syringe tip filter prior to the 
measurement being taken. 




 Methyl α-D-glucopyranoside 115 (10.00 g, 51.50 mmol) was dried under vacuum for 
1 h in a flame-dried flask before being dissolved in anhydrous acetonitrile (200 mL) under a 
nitrogen atmosphere. CopperII triflate (0.93 g, 2.57 mmol) and benzaldehyde dimethyl acetal 
(9.3 mL, 61.80 mmol) were added and the solution was sonicated under a nitrogen 
atmosphere for 3 h, after which time the reaction was quenched by addition of triethylamine 
(2 mL) and the solvent was removed under reduced pressure. Following purification by 
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column chromatography (DCM → DCM:MeOH 96:4) the title compound 204 was obtained as 
a white solid (13.13 g, 90 %), with spectroscopic details in accordance with the literature;181 
1H NMR δ H (400 MHz, Chloroform-d) 7.53 – 7.45 (2 H, m, Harom), 7.42 – 7.33 (3 H, m, Harom), 
5.52 (1 H, s, PhC(H)OO), 4.76 (1 H, d, J 3.7, H-1), 4.28 (1 H, dd, J 9.6, 4.2, H-6a), 3.91 (1 H, t, J 
9.2, H-3), 3.84 – 3.68 (2 H, m, H-5, H-6b), 3.60 (1 H, t, J 6.0, H-2), 3.48 (1 H, at, J 9.2, H-4), 3.44 
(3 H, s, OCH3); 13C NMR δ C (101 MHz, Chloroform-d) 137.17 (4˚ Carom), 129.37, 128.45, 126.45 
(Carom), 102.06 (PhC(H)OO), 99.93 (C-1), 81.06 (C-4), 72.96 (C-2), 71.77 (C-3), 69.05 (C-6), 62.49 
(C-5), 55.67 (OCH3); m/z (ESI-MS+) C14H18O6Na+ ([M + Na]+) calculated: 305.1; found 305.1; 
C14H19O6+ ([M + H]+) calculated 283.1; found 283.1. 




 Methyl 4,6-O-benzylidene-α-D-glucopyranoside 204 (1.10 g, 3.90 mmol) was dried 
under vacuum for 1 h in a flame-dried flask before being dissolved in anhydrous DMF (28 mL) 
under a nitrogen atmosphere. The solution was cooled to 0 ℃ and sodium hydride (60 % in 
mineral oil, 0.39 g, 9.75 mmol) was added before the reaction mixture was stirred for 15 min 
at 0 ℃ then 30 min at RT. The solution was cooled to 0 ℃ again and benzyl bromide (1.39 mL, 
11.70 mmol) was added dropwise. After being left to stir under nitrogen overnight, methanol 
(1 mL) was added to the reaction mixture then solvent was removed under reduced pressure. 
The residue was dissolved in DCM (35 mL), washed with water (2 x 12 mL) and brine (12 mL), 
dried using magnesium sulfate, filtered and the solvent was removed under reduced pressure 
to give a crude product. Following purification by column chromatography (Hexane:EtOAc 
4:1) the title compound 205 was obtained as a white solid (1.16 g, 64 %) with spectroscopic 
details in accordance with the literature;108 1H NMR δ H (400 MHz, Chloroform-d) 7.50 (2 H, 
dd, J 7.4, 2.2, Harom), 7.42 – 7.27 (13 H, m, Harom), 5.56 (1 H, s, PhC(H)OO), 4.92 (1 H, d, J 11.3, 
PhCHH), 4.86 (1 H, d, J 12.1, PhCHH), 4.84 (1 H, d, J 11.3, PhCHH), 4.71 (1 H, d, J 12.1, PhCHH), 
4.60 (1 H, d, J 3.7, H-1), 4.27 (1 H, dd, J 10.1, 4.7, H-6a), 4.05 (1 H, t, J 9.3, H-3), 3.84 (1 H, td, J 
9.9, 4.7, H-5), 3.71 (1 H, t, J 10.2, H-6b), 3.61 (1 H, t, J 9.3, H-4), 3.57 (1 H, dd, J 9.3, 3.8, H-2), 
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3.41 (3 H, s, OCH3); 13C NMR δ C (101 MHz, Chloroform-d) 138.85, 138.29, 137.54 (3 4˚ Carom), 
129.04, 128.58, 128.44, 128.35, 128.26, 128.16, 128.05, 127.72, 126.16 (15 Carom), 101.39 
(PhC(H)OO), 99.38 (C-1), 82.27 (C-4), 79.30 (C-2), 78.74 (C-3), 75.49 (PhCH2), 73.93 (PhCH2), 
69.20 (C-6), 62.46 (C-5), 55.49 (OCH3); m/z (ESI-MS+) C28H30O6Na+ ([M + Na]+) calculated 
485.19; found 485.19. 




 Methyl 2,3-di-O-benzyl-4,6-O-benzylidene-α-D-glucopyranoside 205 (1.05 g, 
2.27 mmol), methanol (11 mL) and p-toluenesulfonic acid monohydrate (0.043 g, 0.23 mmol) 
were added to a flask and sonicated for 1 h at RT, after which time triethylamine (0.42 mL) 
was added and the solvent was removed under reduced pressure. Following purification by 
column chromatography (Hexane:EtOAc 3:1 → 1:1 → EtOAc) the title compound 206 was 
obtained as a yellow oil (0.79 g, 93 %) with spectroscopic details in accordance with the 
literature;108 1H NMR δ H (400 MHz, Chloroform-d) 7.42 – 7.28 (10 H, m, Harom), 5.01 (1 H, d, J 
11.4, PhCHH), 4.76 (2 H, dd, J 11.8, 1.9, PhCH2), 4.66 (1 H, d, J 12.0, PhCHH), 4.62 (1 H, d, J 3.6, 
H-1), 3.82 (1 H, at, J 8.9, H-3),  3.76 (2 H, app bs, H-6a, H-6b), 3.64 – 3.54 (2 H, m, H-4, H-5), 
3.50 (1 H, dd, J 9.5, 3.5, H-2), 3.38 (3 H, s, OCH3); 13C NMR δ C (101 MHz, Chloroform-d) 138.76, 
138.03 (2 4˚ Carom), 128.54, 128.47, 128.2 , 128.09, 127.96, 127.81, 126.69 (10 Carom), 98.18 
(C-1), 81.41 (C-3), 79.78 (C-2), 75.42 (PhCH2), 73.14 (PhCH2), 70.88 (C-5), 70.25 (C-4), 62.10 (C-
6), 55.23 (OCH3); m/z (ESI-MS+) C21H26O6Na+ ([M + Na]+) calculated 397.16; found 397.16. 
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 Methyl 4,6-O-benzylidene-α-D-glucopyranoside 204 (6.00 g, 21.25 mmol) was dried 
under vacuum in a flame-dried flask for 1 h, before being dissolved in anhydrous DCM 
(200 mL) under a nitrogen atmosphere. Imidazole (5.79 g, 85.00 mmol) and TMSCl (8.1 mL, 
63.75 mmol) were added and the resulting solution was stirred for 24 h at RT. After this time, 
the solution was washed with water (2 x 150 mL) and brine (100 mL), dried using magnesium 
sulfate, filtered and the solvent was removed under reduced pressure. Following purification 
by column chromatography (Hexane:EtOAc, 99:1 → 96:4) the title compound 207 was 
obtained as a white solid (7.33 g, 81 %) with spectroscopic details in accordance with the 
literature;108 1H NMR δ H (500 MHz, Chloroform-d) 7.49 (2 H, dd, J 7.6, 2.0, Harom), 7.39 – 7.31 
(3 H, m, Harom), 5.50 (1 H, s, PhC(H)OO), 4.62 (1 H, d, J 3.7, H-1), 4.27 (1 H, dd, J 10.0, 4.8, H-
6a), 3.96 (1 H, t, J 8.9, H-3), 3.81 (1 H, td, J 9.9, 4.8, H-5), 3.71 (1 H, t, J 10.2, H-6b), 3.62 (1 H, 
dd, J 8.8, 3.8, H-2), 3.42 (3 H, s, OCH3), 3.41 (1 H, t, J 9.3, H-4), 0.17 (9 H, s, Si(CH3)3), 0.10 (9 
H, s, Si(CH3)3); 13C NMR δ C (126 MHz, Chloroform-d) 137.56 (4˚ Carom), 129.01, 128.25, 126.32 
(5 Carom), 101.84 (PhC(H)OO), 101.16 (C-1), 82.26 (C-4), 74.30 (C-2), 71.92 (C-3), 69.26 (C-6), 
62.48 (C-5), 55.52 (OCH3), 0.82 (Si(CH3)3), 0.47 (Si(CH3)3); m/z (ESI-MS+) C20H34O6Si2Na+ ([M + 
Na]+) calculated 449.18; found 449.18. 




 Methyl 2,3-di-O-trimethylsilyl-4,6-O-benzylidene-α-D-glucopyranoside 207 (7.30 g, 
17.11 mmol), was added to a flask containing activated molecular sieves, before being 
dissolved in anhydrous DCM (150 mL) under a nitrogen atmosphere. Benzaldehyde (2.08 mL, 
20.53 mmol) and triethylsilane (3.28 mL, 20.53 mmol) were added and the solution was 
stirred for 30 min at RT. The solution was then cooled to -78 ℃ and trimethylsilyl 
trifluoromethanesulfonate (0.31 mL, 1.71 mmol) was added dropwise. The reaction was 
monitored by TLC. After 1 h, TBAF (1.0 M in THF, 34.2 mL, 34.22 mmol) was added and the 
solution was gradually warmed to RT. After 90 min, the reaction mixture was passed through 
a Celite pad and the solvent was removed under reduced pressure. Following purification by 
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column chromatography (Hexane:EtOAc, 7:3 → 6:4) the title compound 208 was obtained as 
a white solid (3.08 g, 48 %) with spectroscopic details in accordance with the literature;108 1H 
NMR δ H (500 MHz, Chloroform-d) 7.54 – 7.47 (2 H, m, Harom), 7.39 (5 H, m, Harom), 7.36 – 7.27 
(3 H, m, Harom), 5.58 (1 H, s, PhC(H)OO), 4.97 (1 H, d, J 11.6, PhCHH), 4.81 (1 H, d, J 3.5, H-1), 
4.80 (1 H, d, J 12.0, PhCHH), 4.31 (1 H, dd, J 10.0, 4.6, H-6a), 3.88 – 3.81 (2 H, m, H-3, H-5), 
3.78 (1 H, d, J 10.2, H-6b), 3.76 – 3.71 (1 H, m, H-2), 3.65 (1 H, t, J 9.2, H-4), 3.45 (3 H, s, OCH3), 
2.38 (1 H, d, J 7.4, OH); 13C NMR δ C (126 MHz, Chloroform-d) 138.57, 137.46 (2 4˚ Carom), 
129.07, 128.50, 128.35, 128.10, 127.82, 126.14 (Carom), 101.40 (PhC(H)OO), 99.99 (C-1), 82.06 
(C-4), 78.96 (C-3), 74.91 (PhCH2), 72.52 (C-2), 69.13 (C-6), 62.70 (C-5), 55.51 (OCH3); m/z (ESI-







 Following the general procedure for palladium catalysed glycosylation reactions, 
glycosyl donor tri-O-benzyl-D-galactal 126 (0.050 g, 0.120 mmol), glycosyl acceptor phenyl 
2,3,4-tri-O-benzoyl-β-D-thioglucopyranoside 133 (0.053 g, 0.090 mmol), metal catalyst 
bis(acetonitrile)dichloropalladium (II) 113 (0.009 g, 0.036 mmol) and ligand 2-(di-tert-
butylphosphanyl)-1-phenyl-1H-pyrrole 114 (0.010 g, 0.036 mmol) were dissolved in 1 mL of 
anhydrous DCM. The reaction mixture was stirred for 21 h before being quenched. Following 
purification by column chromatography (Hexane:EtOAc 9:1 → 8:2), during which α and β 
anomers were separated, the title compound 209 was obtained as a solid (0.051 g, 56 %) with 
spectroscopic details in accordance with the literature;108 1H NMR δ H (500 MHz, Chloroform-
d) 8.00 – 7.93 (2 H, m, Harom), 7.93 – 7.87 (2 H, m, Harom), 7.83 – 7.77 (2 H, m, Harom), 7.56 – 
7.19 (29 H, m, Harom), 5.86 (1 H, t, J 9.6, H-3), 5.56 (1 H, t, J 9.8, H-4), 5.46 (1 H, t, J 9.7, H-2), 
5.00 (1 H, d, J 10.0, H-1), 4.99 (2 H, app d, J 3.0, H-1’), 4.88 (1 H, d, J 11.6, PhCHH), 4.57 (1 H, 
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d, J 11.6, PhCHH), 4.49 (2 H, s, PhCH2), 4.38 (1 H, d, J 11.9, PhCHH), 4.31 (1 H, d, J 12.0, PhCHH), 
4.01 (1 H, ddd, J 9.9, 4.9, 3.2, H-5), 3.92 – 3.81 (3 H, m, H-3’, H-4’, H-6a), 3.81 (1 H, s, H-4’), 
3.67 (1 H, dd, J 11.2, 3.3, H-6b), 3.46 (2 H, dd, J 6.5, 2.2, H-6a’, H-6b’), 2.16 (1 H, td, J 12.4, 3.7, 
H-2ax’), 1.97 – 1.89 (1 H, ddt, J 12.7, 4.6, 1.3, H-2eq’); 13C NMR δ C (126 MHz, Chloroform-d) 
165.96, 165.23, 165.21 (3 C=O) , 139.03, 138.76, 138.37 (3 4˚ Carom(Bn)), 133.48, 133.43, 
133.30 (3 4˚ Carom(Bz)), 133.02 (Carom), 132.19 (4˚ Carom(SPh)), 130.01, 129.90, 129.87, 129.41, 
129.20, 129.05, 129.03, 128.55, 128.52, 128.44, 128.40, 128.35, 128.32, 128.30, 127.70, 
127.62, 127.58, 127.47 (Carom), 98.42 (C-1’), 86.16 (C-1), 77.15 (C-5), 74.91 (C-3’), 74.57 (C-3), 
74.40 (PhCH2), 73.32 (PhCH2), 73.19 (C-4’), 70.67, 70.64 (PhCH2, C-2), 69.98 (C-5’), 69.79 (C-
4), 69.62 (C-6’), 66.55 (C-6), 31.04 (C-2’); m/z (ESI-MS+) C60H56O12SNa+ ([M + Na]+) calculated 
1023.3; found 1023.3. 
2-Deoxy-3,4,6-tri-O-benzyl-α-D-lyxo-hexopyranosyl-(1→O)-N-tert-butoxycarbonyl-L-serine 





 Following the general procedure for palladium catalysed glycosylation reactions, 
glycosyl donor tri-O-benzyl-D-galactal 126 (0.100 g, 0.240 mmol), glycosyl acceptor Boc-L-
serine methyl ester (0.039 g, 0.180 mmol), metal catalyst bis(acetonitrile)dichloropalladium 
(II) 113 (0.019 g, 0.072 mmol) and ligand 2-(di-tert-butylphosphanyl)-1-phenyl-1H-pyrrole 114 
(0.021 g, 0.072 mmol) were dissolved in 2 mL of anhydrous DCM. The reaction mixture was 
stirred for 18 h before being quenched. Following purification by column chromatography 
(Hexane:EtOAc 7:3) the title compound 210 was obtained as a colourless oil (0.101 g, 88 %), 
with spectroscopic details in accordance with the literature;182 1H NMR δ H (500 MHz, 
Chloroform-d) 7.40 – 7.20 (15 H, m, Harom), 5.45 (1 H, d, J 8.9, NH), 4.93 (1 H, bs, H-1), 4.92 (1 
H, d, J 11.5, PhCHH), 4.64 – 4.55 (3 H, m, PhCH2), 4.52 (1 H, d, J 11.8, PhCHH), 4.49 – 4.45 (1 
H, m, NHCH), 4.43 (1 H, d, J 11.8, PhCHH), 3.93 (1 H, bs, H-4), 3.92 – 3.80 (4 H, m, H-3, H-5, 
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NHCHCH2O), 3.73 (3 H, s, OCH3), 3.63 – 3.54 (2 H, m, H-6a, H-6b), 2.21 (1 H, td, J 12.4, 3.8, H-
2ax), 1.94 (1 H, dd, J 12.8, 4.3, H-2eq), 1.45 (9 H, s, OC(CH3)3); 13C NMR δ C (126 MHz, 
Chloroform-d) 171.24 (C(O)OCH3), 155.62 (NHC(O)), 138.90, 138.49, 138.15 (3 4˚ Carom), 
128.54, 128.51, 128.34, 128.33, 127.93, 127.81, 127.71, 127.66, 127.53 (15 Carom), 99.01 (C-
1), 80.17 (OC(CH3)3), 74.48, 74.44 (C-3, PhCH2), 73.60 (PhCH2), 72.84 (C-4), 70.56 (PhCH2), 
70.38 (C-5), 69.33 (C-6), 68.70 (NHCHCH2O), 54.13 (NHCH), 52.55 (OCH3), 31.13 (C-2), 28.46 
(3 OC(CH3)3); m/z (ESI-MS+) C36H45NO9Na+ ([M + Na]+) calculated 658.3; found 658.3. 




 Following the general procedure for palladium catalysed glycosylation reactions, 
glycosyl donor tri-O-benzyl-D-galactal 126 (0.100 g, 0.240 mmol), 1-heptanol 136 (0.021 g, 
0.180 mmol), metal catalyst bis(acetonitrile)dichloropalladium (II) 113 (0.019 g, 0.072 mmol) 
and ligand 2-(di-tert-butylphosphanyl)-1-phenyl-1H-pyrrole 114 (0.021 g, 0.072 mmol) were 
dissolved in 2 mL of anhydrous DCM. The reaction mixture was stirred for 18.5 h before being 
quenched. Following purification by column chromatography (Hexane:EtOAc 9:1) the title 
compound 211 was obtained as a yellow oil (0.060 g, 63 %, α:β = 9:1); 1H NMR δ H (500 MHz, 
Chloroform-d) 7.38 – 7.27 (15 H, m, Harom), 4.99 (1 H, app d, J 3.5, H-1), 4.95 (1 H, d, J 11.7, 
PhCHH), 4.64 (1 H, d, J 11.5, PhCHH), 4.62 (2 H, s, PhCH2), 4.53 (1 H, d, J 11.8, PhCHH), 4.45 (1 
H, d, J 11.9, PhCHH), 3.96 (1 H, ddd, J 11.6, 4.6, 2.5, H-3), 3.94 (1 H, d, J 3.2, H-4), 3.92 (1 H, t, 
J 6.5, H-5), 3.66 – 3.56 (3 H, m, H-6a, H-6b, OCHH(CH2)5CH3), 3.38 (1 H, dt, J 9.7, 6.6, 
OCHH(CH2)5CH3), 2.24 (1 H, td, J 12.3, 11.7, 4.0, H-2ax), 2.03 – 1.98 (1 H, m, H-2eq), 1.57 (2 H, 
p, J 6.7, OCH2CH2(CH2)4CH3), 1.35 – 1.23 (8 H, m, O(CH2)2(CH2)4CH3), 0.93 – 0.88 (3 H, m, 
O(CH2)6CH3); 13C NMR δ C (126 MHz, Chloroform-d) 139.09, 138.75, 138.31 (3 4˚ Carom), 128.51, 
128.50, 128.36, 128.33, 127.88, 127.77, 127.61, 127.60, 127.46 (15 Carom), 97.86 (C-1), 75.09 
(C-3), 74.41 (PhCH2), 73.60 (PhCH2), 73.22 (C-4), 70.60 (PhCH2), 69.93 (C-5), 69.77 (C-6), 67.65 
(OCH2(CH2)5CH3), 31.97 (O(CH2)2(CH2)4CH3), 31.46 (C-2), 29.71 (OCH2CH2(CH2)4CH3), 29.27, 
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26.35, 22.77 ( 3 O(CH2)2(CH2)4CH3), 14.25 (O(CH2)6CH3); m/z (ESI-HRMS) C34H44O5Na+ ([M + 
Na]+) calculated 555.3081; found 555.3076; IR νmax/cm-1 3030, 2924, 2856, 1725, 1496, 1454, 
1357, 1273, 1204, 1165, 1094, 1057, 1027, 903, 734, 697. 





 Following the general procedure for palladium catalysed glycosylation reactions, 
glycosyl donor tri-O-benzyl-D-galactal 126 (0.100 g, 0.240 mmol), cinnamyl alcohol 138 
(0.024 g, 0.180 mmol), metal catalyst bis(acetonitrile)dichloropalladium (II) 113 (0.019 g, 
0.072 mmol) and ligand 2-(di-tert-butylphosphanyl)-1-phenyl-1H-pyrrole 114 (0.021 g, 
0.072 mmol) were dissolved in 2 mL of anhydrous DCM. The reaction mixture was stirred for 
23 h before being quenched. Following purification by column chromatography 
(Hexane:EtOAc 11:1) the title compound 212 was obtained as a solid (0.065 g, 66 %), with 
spectroscopic details in accordance with the literature;183 1H NMR δ H (500 MHz, Chloroform-
d) 7.40 – 7.20 (20 H, m, Harom), 6.57 (1 H, d, J 15.9, OCH2CH=CHPh), 6.29 (1 H, dt, J 15.9, 6.2, 
OCH2CH=CHPh), 5.10 (1 H, app d, J 3.5, H-1), 4.94 (1 H, d, J 11.6, PhCHHO), 4.63 (3 H, d, J 11.9, 
PhCHHO, PhCH2O), 4.52 (1 H, d, J 11.8, PhCHHO), 4.43 (1 H, d, J 11.8, PhCHHO), 4.29 (1 H, ddd, 
J 12.9, 5.7, 1.5, OCHHCH=CHPh), 4.13 (1 H, ddd, J 12.9, 6.7, 1.3, OCHHCH=CHPh), 4.01 – 3.95 
(2 H, m, H-3, H-5), 3.94 (1 H, bs, H-4), 3.61 (2 H, dd, J 6.4, 3.4, H-6a, H-6b), 2.27 (1 H, td, J 12.4, 
3.8, H-2ax), 2.05 (1 H, dd, J 12.7, 4.7, H-2eq); 13C NMR δ C (126 MHz, Chloroform-d) 139.04, 
138.70, 138.28 (3 4˚ Carom(Bn)), 136.82 (4˚ CaromCH=CH), 132.83 (OCH2CH=CHPh), 128.68, 
128.55, 128.52, 128.36, 128.35, 127.90, 127.83, 127.81, 127.66, 127.63, 127.45, 126.64 (16 
Carom), 125.73 (OCH2CH=CHPh), 97.30 (C-1), 74.98 (C-3), 74.44 (PhCH2), 73.64 (PhCH2), 73.21 
(C-4), 70.63 (PhCH2), 70.19 (C-5), 69.84 (C-6), 67.82 (OCH2CH=CHPh), 31.34 (C-2); m/z (ESI-
MS+) C36H38O5Na+ ([M + Na]+) calculated 573.3; found 573.3. 
 









 Following the general procedure for palladium catalysed glycosylation reactions, 
glycosyl donor tri-O-benzyl-D-galactal 126 (0.100 g, 0.240 mmol), glycosyl acceptor methyl 
2,3-di-O-benzyl-6-O-triisopropylsilyl-α-D-glucopyranoside 140 (0.096 g, 0.180 mmol), metal 
catalyst bis(acetonitrile)dichloropalladium (II) 113 (0.019 g, 0.072 mmol) and ligand 2-(di-tert-
butylphosphanyl)-1-phenyl-1H-pyrrole 114 (0.021 g, 0.072 mmol) were dissolved in 2 mL of 
anhydrous DCM. The reaction mixture was stirred for 46 h before being quenched. The crude 
product was partially purified by column chromatography (Hexane:EtOAc 6:1), before being 
dissolved in a mixture of 1 M solution of TBAF in THF (1 mL) and THF (2 mL).  The resulting 
reaction mixture was left to stir for 2 h 15 min at RT, until the reaction was judged to be 
complete by TLC. Solvent was removed under reduced pressure and the product purified by 
column chromatography (Hexane:EtOAc 6:1 → 11:9) to afford the title compound 213 as a 
yellow oil (0.091 g, 64 %), with spectroscopic details in accordance with the literature;108 1H 
NMR δ H (500 MHz, Chloroform-d) 7.41 – 7.26 (25 H, m, Harom), 5.57 (1 H, app d, J 3.9, H-1’), 
5.05 (1 H, d, J 11.0, PhCHH), 4.89 (1 H, d, J 11.9, PhCHH), 4.78 (1 H, d, J 12.0, PhCHH), 4.71 (1 
H, d, J 11.0, PhCHH), 4.65 (1 H, d, J 12.1, PhCHH), 4.61 (1 H, d, J 3.5, H-1), 4.58 (1 H, d, J 11.9, 
PhCHH), 4.58 (2 H, s, PhCH2), 4.54 (1 H, d, J 12.2, PhCHH), 4.44 (1 H, d, J 12.2, PhCHH), 3.95 (1 
H, t, J 9.2, H-3), 3.89 (1 H, t, J 9.4, H-4), 3.89 – 3.82 (3 H, m, H-3’, H-5’, H-6a), 3.78 (1 H, bs, H-
4’), 3.68 (1 H, ddd, J 12.5, 6.4, 2.1, H-6b), 3.63 – 3.56 (2 H, m, H-2, H-6a’), 3.55 (1 H, dt, J 9.7, 
2.4, H-5), 3.39 (3 H, s, OCH3), 3.33 (1 H, t, J 6.6, OH), 3.26 (1 H, dd, J 9.8, 3.7, H-6b’), 2.15 (1 H, 
td, J 12.5, 4.2, H-2ax’), 1.88 (1 H, ddt, J 12.8, 4.6, 1.4, H-2eq’); 13C NMR δ C (126 MHz, 
Chloroform-d) 138.59, 138.49, 138.42, 138.08, 137.33 (5 4˚ Carom), 128.50, 128.41, 128.31, 
128.26, 128.24, 128.00, 127.95, 127.75, 127.72, 127.68, 127.65, 127.33 (25 Carom), 99.76 (C-
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1’), 98.20 (C-1), 82.29 (C-3), 80.07 (C-2), 75.62 (PhCH2), 74.70 (C-3’), 74.46 (C-5’), 73.95 
(PhCH2), 73.65 (PhCH2), 73.37 (PhCH2), 72.96 (C-4’), 71.59 (C-4), 70.71, 70.66, 70.60 (PhCH2, 
C-5, C-6’), 60.53 (C-6), 55.23 (OCH3), 31.32 (C-2’); m/z (ESI-MS+) C48H54O10Na+ ([M + Na]+) 







 Following the general procedure for palladium catalysed glycosylation reactions, 
glycosyl donor tri-O-benzyl-D-galactal 126 (0.100 g, 0.240 mmol), glycosyl acceptor methyl 
2,3,6-tri-O-benzyl-β-D-galactopyranoside 121 (0.084 g, 0.180 mmol), metal catalyst 
bis(acetonitrile)dichloropalladium (II) 113 (0.019 g, 0.072 mmol) and ligand 2-(di-tert-
butylphosphanyl)-1-phenyl-1H-pyrrole 114 (0.021 g, 0.072 mmol) were dissolved in 2 mL of 
anhydrous DCM. The reaction mixture was stirred for 45 h before being quenched. Following 
purification by column chromatography (Hexane:EtOAc 8:2) the title compound 214 was 
obtained as a yellow oil (0.112 g, 70 %, α:β = 3.5:1), with spectroscopic details in accordance 
with the literature.108 Note that only characteristic, non-overlapping, distinguishable NMR 
spectroscopy signals are given for the minor β anomer; 1H NMR δ H (500 MHz, Chloroform-d) 
α anomer: 7.42 – 7.16 (30 H, m, Harom), 5.06 (1 H, app d, J 3.4, H-1’), 4.93 (1 H, d, J 11.5, 
PhCHH), 4.89 (1 H, d, J 11.5, PhCHH), 4.87 (1 H, d, J 11.5, PhCHH), 4.80 (1 H, d, J 11.0, PhCHH), 
4.65 (1 H, d, J 11.4, PhCHH), 4.61 (1 H, d, J 11.2, PhCHH), 4.57 (1 H, d, J 11.4, PhCHH), 4.55 (1 
H, d, J 12.9, PhCHH), 4.51 (2 H, s, PhCH2), 4.41 (1 H, ddd, J 9.1, 4.8, 1.3, H-5’), 4.24 (1 H, d, J 
7.7, H-1), 4.15 (2 H, s, PhCH2), 4.13 (1 H, d, J 3.1, H-4), 4.03 (1 H, bs, H-4’), 4.00 (1 H, ddd, J 
12.0, 4.5, 2.4, H-3’), 3.66 – 3.58 (4 H, m, H-6a’, H-2, H-6a, H-6b), 3.57 (3 H, s, OCH3), 3.57 – 
3.52 (1 H, m, H-5), 3.39 (1 H, dd, J 10.0, 3.1, H-3), 3.28 (1 H, dd, J 8.4, 4.8, H-6b’), 2.21 (1 H, td, 
J 12.2, 3.7, H-2ax’), 2.03 (1 H, ddt, J 12.4, 4.5, 1.4, H-2eq’); β anomer: 5.27 (1 H, app d, J 3.4, 
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H-1’), 2.26 (1 H, td, J 12.4, 3.7, H-2ax’), 1.87 (1 H, dd, J 12.6, 4.5, H-2eq’); 13C NMR δ C (126 
MHz, Chloroform-d) α anomer: 139.31, 138.88, 138.81, 138.66, 138.26, 137.44 (6 4˚ Carom), 
128.67, 128.50, 128.37, 128.36, 128.34, 128.24, 128.21, 128.17, 128.15, 127.97, 127.71, 
127.59 (24 Carom), 105.28 (C-1), 99.80 (C-1’), 80.24 (C-3), 78.90 (C-2), 75.14 (PhCH2), 74.63, 
74.55 (PhCH2, C-3’), 73.87 (PhCH2), 73.29 (PhCH2), 73.17, 73.15 (C-4, C-5), 72.89 (C-4’), 72.11 
(PhCH2), 70.59 (PhCH2), 69.75 (C-5’), 68.52 (C-6’), 68.02 (C-6), 57.57 (OCH3), 31.65 (C-2’); β 
anomer: 93.52 (C-1’); m/z (ESI-MS+) C55H60O10Na+ ([M + Na]+) calculated 903.41; found 
903.41; C47H50O8Na+ ([M + Na - BnO - MeO]+) calculated 765.34; found 765.35. 





 Following the general procedure for palladium catalysed glycosylation reactions, 
glycosyl donor tri-O-benzyl-D-galactal 126 (0.100 g, 0.240 mmol), glycosyl acceptor (p-
methoxy) phenol 141 (0.022 g, 0.180 mmol), metal catalyst bis(acetonitrile)dichloropalladium 
(II) 113 (0.019 g, 0.072 mmol) and ligand 2-(di-tert-butylphosphanyl)-1-phenyl-1H-pyrrole 114 
(0.021 g, 0.072 mmol) were dissolved in 2 mL of anhydrous DCM. The reaction mixture was 
stirred for 24 h before being quenched. Following purification by column chromatography 
(Hexane:EtOAc 9:1) the title compound 215 was obtained as a yellow oil (0.062 g, 64 %, 
α:β = 2:1) with spectroscopic details in accordance with the literature.184 Note that only 
characteristic, non-overlapping, distinguishable NMR spectroscopy signals are given for the 
minor β anomer; 1H NMR α anomer: δ H (500 MHz, Chloroform-d) 7.42 – 7.20 (15 H, m, Harom), 
6.99 (2 H, m, C6H4OCH3), 6.79 (2 H, m, C6H4OCH3), 5.59 (1 H, app d, J 3.3, H-1), 4.97 (1 H, d, J 
11.5, PhCHH), 4.68 (2 H, s, PhCH2), 4.65 (1 H, d, J 11.6, PhCHH), 4.43 (1 H, d, J 11.6, PhCHH), 
4.37 (1 H, d, J 11.6, PhCHH), 4.13 (1 H, ddd, J 12.1, 4.6, 2.5, H-3), 4.09 (1 H, t, J 6.5, H-5), 4.01 
(1 H, d, J 2.3, H-4), 3.76 (3 H, s, OCH3), 3.69 – 3.53 (2 H, m, H-6a, H-6b), 2.38 (1 H, td, J 12.4, 
3.7, H-2ax), 2.21 (1 H, ddt, J 12.8, 4.7, 1.4, H-2eq); β anomer: δ H (500 MHz, Chloroform-d) 
 6.  Experimental  
228 
 
5.09 (1 H, d, J 3.5, H-1), 2.25 (1 H, td, J 12.4, 3.8, H-2a), 2.05 (1 H, dd, J 12.6, 4.8, H-2b); 13C 
NMR α anomer: δ C (126 MHz, Chloroform-d) 154.86 (4˚ CaromOCH3), 151.06 (4˚ CaromO(C-1)), 
138.96, 138.61, 138.21 (3 4˚ Carom(Bn)), 128.58, 128.45 - 127.48 (15 Carom), 118.16 (2 
C6H4OCH3), 114.63 (2 C6H4OCH3), 97.57 (C-1), 74.75 (C-3), 74.54 (PhCH2), 73.48 (PhCH2), 73.09 
(C-4), 70.71, 70.70 (PhCH2, C-5), 69.51 (C-6), 55.76 (OCH3), 31.47 (C-2); β anomer: δ C (126 
MHz, Chloroform-d) 97.25 (C-1); m/z (ESI-MS+) C34H36O6Na+ ([M + Na]+) calculated 563.2; 
found 563.2. 











 Following the general procedure for palladium catalysed glycosylation reactions, 
glycosyl donor tri-O-benzyl-D-galactal 126 (0.100 g, 0.240 mmol), glycosyl acceptor 
cholesterol 142 (0.035 g, 0.180 mmol), metal catalyst bis(acetonitrile)dichloropalladium (II) 
113 (0.019 g, 0.072 mmol) and ligand 2-(di-tert-butylphosphanyl)-1-phenyl-1H-pyrrole 114 
(0.021 g, 0.072 mmol) were dissolved in 2 mL of anhydrous DCM. The reaction mixture was 
stirred for 44 h before being quenched. Following purification by column chromatography 
(Hexane:EtOAc 10:1) the title compound 216 was obtained as a yellow oil (0.060 g, 42 %, 
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α:β = 6:1), with spectroscopic details in accordance with the literature;185 1H NMR δ H (500 
MHz, Chloroform-d) 7.38 – 7.23 (15 H, m, Harom), 5.27 (1 H, app d, J 4.8, C=CH (cholesteryl)), 
5.15 (1 H, app d, J 3.6, H-1), 4.94 (1 H, d, J 11.6, PhCHH), 4.65 – 4.60 (3 H, m, PhCH2), 4.51 (1 
H, d, J 11.7, PhCHH), 4.44 (1 H, d, J 11.8, PhCHH), 4.01 (1 H, t, J 6.5, H-5), 3.97 (1 H, ddd, J 11.9, 
4.5, 2.5, H-3), 3.95 (1 H, app bs, H-4), 3.60 (2 H, qd, J 9.5, 6.4, H-6a, H-6b), 3.50 – 3.42 (1 H, m, 
OCH (cholesteryl)), 2.29 (2 H, d, J 7.6, OCHCH2C=C (cholesteryl)), 2.24 (1 H, td, J 12.2, 3.8, H-
2ax), 2.01 (1 H, dt, J 12.6, 3.6, cholesteryl), 1.99 – 1.91 (2 H, m, H-2eq, CH (cholesteryl)), 1.91 
– 1.78 (3 H, m, cholesteryl), 1.64 – 1.30 (10 H, m, cholesteryl), 1.30 – 1.24 (2 H, m, cholesteryl), 
1.21 – 0.95 (12 H, m, cholesteryl), 0.92 (3 H, d, J 6.5, CH3 (cholesteryl)), 0.88 (6 H, dd, J 6.6, 
2.2, CH(CH3)2 (cholesteryl)), 0.68 (3 H, s, CH3 (cholesteryl)); 13C NMR δ C (126 MHz, 
Chloroform-d) 141.05 (OCHCH2C=C (cholesteryl)), 139.13, 138.79, 138.31 (3 4˚ Carom), 128.51, 
128.49, 128.32, 127.88, 127.74, 127.60, 127.58, 127.44 (15 Carom), 121.76 (OCHCH2C=C 
(cholesteryl)), 95.84 (C-1), 76.27 (OCH (cholesteryl), 75.22 (C-3), 74.41 (PhCH2), 73.57 (PhCH2), 
73.31 (C-4), 70.63 (PhCH2), 69.99 (C-5), 69.80 (C-6), 56.93, 56.30, 50.26, 42.48, 40.18, 39.93, 
39.68, 37.26, 36.86, 36.35, 35.94, 32.09, 32.05 (13 C (cholesteryl)), 31.84 (C-2), 28.39, 28.17, 
27.97, 24.46, 23.98 (5 C (cholesteryl)), 22.98, 22.72 (2 CH(CH3)2 (cholesteryl)), 21.20, 19.53 (2 
C (cholesteryl)), 18.87, 12.01 (2 CH3 (cholesteryl)); m/z (ESI-MS+) C54H74O5Na+ ([M + Na]+) 
calculated 825.5; found 825.6. 






 Following the general procedure for palladium catalysed glycosylation reactions, 
glycosyl donor tri-O-benzyl-D-galactal 126 (0.100 g, 0.240 mmol), glycosyl acceptor (-)-
menthol 143 (0.028 g, 0.180 mmol), metal catalyst bis(acetonitrile)dichloropalladium (II) 113 
(0.019 g, 0.072 mmol) and ligand 2-(di-tert-butylphosphanyl)-1-phenyl-1H-pyrrole 114 
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(0.021 g, 0.072 mmol) were dissolved in 2 mL of anhydrous DCM. The reaction mixture was 
stirred for 42 h before being quenched. Following purification by column chromatography 
(Hexane:EtOAc 13:1) the title compound 217 was obtained as a colourless solid (0.031 g, 30 %, 
α:β = 6:1). Note that only characteristic, non-overlapping, distinguishable NMR spectroscopy 
signals are given for the minor β anomer; 1H NMR α anomer: δ H (500 MHz, Chloroform-d) 
7.40 – 7.21 (15 H, m, Harom), 5.03 (1 H, app d, J 3.5, H-1), 4.94 (1 H, d, J 11.7, PhCHH), 4.65 – 
4.61 (3 H, m, PhCH2), 4.51 (1 H, d, J 11.9, PhCHH), 4.44 (1 H, d, J 12.1, PhCHH), 4.07 (1 H, t, J 
6.5, H-5), 3.96 – 3.91 (2 H, m, H-3, H-4), 3.58 (2 H, dd, J 6.5, 3.0, H-6a, H-6b), 3.30 (1 H, td, J 
10.6, 4.4, OCH (menthyl)), 2.24 – 2.16 (1 H, m, H-2ax), 2.13 – 2.07 (1 H, m, OCHCHH (menthyl)), 
2.04 (1 H, td, J 7.1, 2.5, OCHCHCH(CH3)2 (menthyl)), 2.00 (1 H, ddt, J 12.5, 4.6, 1.5, H-2eq), 1.66 
– 1.57 (2 H, m, OCHCH2CH(CH3)CHH (menthyl), OCHCH(iPr)CHH (menthyl)), 1.42 – 1.29 (1 H, 
m, OCHCH2CH(CH3) (menthyl)), 1.18 (1 H, ddt, J 13.3, 10.3, 3.0, OCHCH(iPr) (menthyl)), 0.98 – 
0.86 (5 H, m, OCHCHH (menthyl), OCHCH2CH(CH3)CHH (menthyl), CH(CH3)(CH3) (menthyl)), 
0.82 (3 H, d, J 6.6, OCHCH2CH(CH3) (menthyl)), 0.81 – 0.78 (1 H, m, OCHCH(iPr)CHH (menthyl)), 
0.76 (3 H, d, J 7.0, CH(CH3)(CH3) (menthyl)); β anomer: δ H (500 MHz, Chloroform-d) 4.49 – 
4.47 (1 H, m, H-1); 13C NMR α anomer: δ C (126 MHz, Chloroform-d) 139.17, 138.81, 138.40 
(3 4˚ Carom), 128.51, 128.48, 128.32, 128.30, 127.75, 127.72, 127.61, 127.57, 127.45 (15 Carom), 
99.95 (C-1), 80.16 (OCH (menthyl)), 75.13 (C-3), 74.38 (PhCH2), 73.55 (PhCH2), 73.40 (C-4), 
70.54 (PhCH2), 70.06 (C-5), 69.89 (C-6), 49.06 (OCHCH(iPr) (menthyl)), 43.07 (OCHCH2 
(menthyl)), 34.54 (OCHCH(iPr)CH2 (menthyl)), 31.86, 31.83 (C-2, OCHCH2CH(CH3) (menthyl)), 
25.90 (OCHCHCH(CH3)2 (menthyl)), 23.45 (OCHCH2CH(CH3)CH2 (menthyl)), 22.42 
(OCHCH2CH(CH3) (menthyl)), 21.33 (CH(CH3)(CH3) (menthyl)), 16.50 (CH(CH3)(CH3) (menthyl)); 
β anomer: δ C (126 MHz, Chloroform-d) 97.59 (C-1); m/z (ESI-HRMS) C37H48O5Na+ ([M + Na]+) 
calculated 595.3394; found 595.3386; IR νmax/cm-1 3028, 2945, 2919, 2867, 1496, 1454, 1357, 
1203, 1166, 1093, 1061, 1027, 734, 697. 
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 1,2,3,4,6-Penta-O-acetyl-β-D-glucopyranoside (10.00 g, 25.62 mmol) was dried under 
vacuum for 1 h before being dissolved in anhydrous dichloromethane (50 mL) and cooled to 
0 ℃ under a nitrogen atmosphere. To this solution, thiophenol (5.3 mL, 51.24 mmol) was 
added, followed by boron trifluoride diethyl etherate (9.5 mL, 76.86 mmol) dropwise. The 
resulting solution was stirred at RT for 18 h. The mixture was then cautiously quenched using 
NaHCO3 (sat. aq.). The product was extracted from the reaction mixture using further portions 
of DCM (2 x 50 mL) and the combined DCM phase was washed with brine (3 x 50 mL), dried 
using magnesium sulfate, filtered and the solvent was removed under reduced pressure. The 
crude residue was purified by recrystallisation from diethyl ether to provide the title 
compound 218 (8.39 g, 74 %) as a white solid with spectroscopic details in accordance with 
the literature;108 1H NMR δ H (400 MHz, Chloroform-d) 7.52 – 7.46 (2 H, m, Harom), 7.34 – 7.28 
(3 H, m, Harom), 5.22 (1 H, t, J 9.4, H-3), 5.04 (1 H, t, J 9.8, H-4), 4.97 (1 H, dd, J 10.1, 9.2, H-2), 
4.70 (1 H, d, J 10.1, H-1), 4.21 (1 H, d, J 5.0, H-6a), 4.17 (1 H, dd, J 12.3, 2.7, H-6b), 3.72 (1 H, 
ddd, J 10.1, 5.0, 2.7, H-5), 2.08 (3 H, s, CH3), 2.08 (3 H, s, CH3), 2.01 (3 H, s, CH3), 1.99 (3 H, s, 
CH3); 13C NMR δ C (101 MHz, Chloroform-d) 170.72, 170.32, 169.53, 169.39 (4 C=O), 133.25 
(4˚ Carom), 131.76, 129.07, 128.55 (Carom), 85.86 (C-1), 75.92 (C-5), 74.09 (C-3), 70.06 (C-2), 
68.33 (C-4), 62.27 (C-6), 20.88, 20.86, 20.72, 20.71 (4 CH3); m/z (ESI-MS+) C20H24O9Na+ ([M + 
Na]+) calculated 463.10; found 463.10. 






 Phenyl 2,3,4,6-tetra-O-acetyl-β-D-thioglucopyranoside 218 (6.48 g, 14.71 mmol) was 
dried under vacuum for 1 h before being dissolved in methanol (50 mL) and cooled to 0 ℃. 
Sodium methoxide (0.34 mL, 1.47 mmol, 25 % wt in MeOH) was added dropwise and the 
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resulting solution was stirred at 0 ℃ for 40 min after which time TLC (DCM:MeOH 9:1) showed 
the reaction to be complete. The solution was then brought to pH 7, as monitored by universal 
indicator paper, using 1 M HCl (aq.). Solvent was removed from the resulting neutralised 
solution under reduced pressure to give a crude mass of 4.29 g of impure phenyl-β-D-
thioglucopyranoside containing NaCl salts. A 2.14 g portion of this impure phenyl-β-D-
thioglucopyranoside (approx. 7.86 mmol) was dried for 1 h under vacuum before being 
dissolved in anhydrous pyridine (50 mL) under a nitrogen atmosphere. To this solution, 
imidazole (1.07 g, 15.72 mmol) was added and the solution was cooled to 0 ℃. 
Triisopropylsilyl chloride (2.02 mL, 9.43 mmol) was added dropwise and the reaction was 
stirred at RT for 18 h. After this time, TLC (DCM:MeOH 95:5) showed the silylation reaction to 
be complete. Benzoyl chloride (7.30 mL, 62.88 mmol) and DMAP (0.097 g, 0.79 mmol) were 
then added, and the solution was stirred at RT for 26 h under a nitrogen atmosphere. After 
this time, TLC (Hexane:EtOAc 9:1) showed the benzoylation reaction to be complete. 
Methanol (15 mL) was cautiously added to quench excess benzoyl chloride, then the reaction 
mixture was diluted with DCM (150 mL). The resulting organic solution was washed with 
1 M HCl (aq.) (2 x 100 mL), NaHCO3 (sat. aq.) (100 mL) and water (100 mL), dried using magnesium 
sulfate, filtered and the solvent was removed under reduced pressure. The crude product was 
purified by column chromatography (Hexane:EtOAc 93:7 → 85:15) to give the title compound 
219 (4.87 g, 90 % over 3 steps), with spectroscopic details in accordance with the literature;108 
1H NMR δ H (400 MHz, Chloroform-d) 7.96 – 7.91 (2 H, m, Harom), 7.91 – 7.86 (2 H, m, Harom), 
7.80 – 7.75 (2 H, m, Harom), 7.54 – 7.41 (4 H, m, Harom), 7.38 – 7.17 (10 H, m, Harom), 5.87 (1 H, 
t, J 9.5, H-3), 5.54 (1 H, t, J 9.2, H-4), 5.46 (1 H, t, J 9.7, H-2), 5.04 (1 H, d, J 10.0, H-1), 3.97 – 
3.87 (3 H, m, H-5, H-6a, H-6b), 1.10 – 0.95 (21 H, m, TIPS); 13C NMR δ C (101 MHz, Chloroform-
d) 165.95, 165.17, 165.16 (3 C=O), 133.33, 133.19, 132.70, 132.61 (4 4˚ Carom), 129.93, 129.83, 
129.79, 129.40, 129.24, 129.01, 128.98, 128.44, 128.42, 128.31, 128.09 (Carom), 86.46 (C-1), 
79.99 (C-5), 74.72 (C-3), 70.78 (C-2), 69.34 (C-4), 63.07 (C-6), 18.01 (CH(CH3)2), 11.97 
(CH(CH3)2); m/z (ESI-MS+) C42H48O8SSiNa+ ([M + Na]+) calculated 763.3; found 763.3; 
C22H35O4Si+ ([M - SPh - 2 OBz + 2 H]+) calculated 391.2; found 391.3. 
 
 







 D-Glucal (10.00 g, 68.43 mmol) was dried under vacuum for 1 h in a flame-dried flask 
before being dissolved in anhydrous DMF (160 mL) under a nitrogen atmosphere. Imidazole 
(9.32 g, 136.85 mmol) was added and the resulting solution was cooled to 0 ˚C. TIPSCl 
(19.06 mL, 88.95 mmol) was added dropwise and the reaction was left to stir under a nitrogen 
atmosphere for 18 h at RT. The solvent was removed under reduced pressure and the residue 
was dissolved in DCM (250 mL), then washed with water (250 mL). The aqueous phase was 
washed with DCM (2 x 100 mL) and DCM fractions were combined. The DCM phase was 
washed with brine (200 mL), dried using magnesium sulfate, filtered and the solvent was 
removed under reduced pressure. The crude residue was partially purified by column 
chromatography (Hexane:EtOAc 85:15 → 6:4), to give impure intermediate 6-O-
(triisopropylsilyl)-D-glucal. This intermediate was dried under vacuum for 1 h in a flame-dried 
flask before being dissolved in anhydrous DMF (160 mL) under a nitrogen atmosphere and 
cooled to 0 ˚C. Sodium hydride (60 % in mineral oil, 13.68 g, 342.15 mmol) was added and the 
mixture stirred for 60 min at RT, after which time the mixture was again cooled to 0 ℃. Benzyl 
bromide (24.4 mL, 205.3 mmol) was added dropwise and the reaction mixture stirred for 18 h 
at RT, after which time methanol (15 mL) was added cautiously. The solvent was removed 
under reduced pressure and the residue was dissolved in DCM (250 mL), then washed with 
water (2 x 150 mL). The combined aqueous phase was washed with DCM (100 mL) and the 
DCM fractions were combined. The DCM phase was washed with brine (200 mL), dried using 
magnesium sulfate, filtered and the solvent was removed under reduced pressure. Following 
purification by normal phase HPLC (Hexane:EtOAc), the title compound 220 was obtained as 
an oil (20.47 g, 61 % over 2 steps) with spectroscopic details in accordance with the 
literature;186 1H NMR δ H (500 MHz, Chloroform-d) 7.43 – 7.34 (10 H, m, Harom), 6.43 (1 H, dd, 
J 6.2, 1.4, H-1), 4.91 (1 H, d, J 11.3, PhCHH), 4.88 (1 H, dd, J 6.1, 2.7, H-2), 4.81 (1 H, d, J 11.3, 
PhCHH), 4.68 (1 H, d, J 11.7, PhCHH), 4.62 (1 H, d, J 11.9, PhCHH), 4.25 (1 H, ddt, J 5.5, 2.7, 
1.4, H-3), 4.09 (1 H, dd, J 11.2, 3.6, H-6a), 4.04 (1 H, dd, J 11.2, 2.5, H-6b), 4.01 – 3.94 (2 H, m, 
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H-4, H-5), 1.15 – 1.08 (21 H, m, TIPS); 13C NMR δ C (126 MHz, Chloroform-d) 144.89 (C-1), 
138.60, 138.57 (2 4˚ Carom), 128.51, 128.50, 128.49, 128.02, 127.89, 127.88, 127.79, 127.74, 
127.71 (Carom), 99.71 (C-2), 78.25 (C-4 or C-5), 75.81 (C-3), 74.17 (C-4 or C-5), 73.93 (PhCH2), 
70.74 (PhCH2), 62.08 (C-6), 18.12, 18.08, 12.12 (TIPS); m/z (ESI-MS+) C29H42O4SiNa+ ([M + Na]+) 










 Following the general procedure for I-Tag glycosylations in flow using glycosyl 
acceptor 1-(4-(hydroxymethyl)benzyl)-3-methyl-1H-imidazol-3-ium 
trifluoromethanesulfonate 157 (0.0705 g, 0.200 mmol, 1 eq) and glycosyl donor 2,3,4,6-tetra-
O-benzyl-α-D-glucopyranosyl trichloroacetimidate 62 (0.4110 g, 0.600 mmol, 3.0 eq). 1.0 mL 
of anhydrous acetonitrile was added to the donor/acceptor vial, resulting in a solution of 
volume 1.3 mL and therefore approximately 0.154 M in acceptor and 0.462 M in donor. To 
the other vial, 1.5 mL of anhydrous acetonitrile was added, followed by trimethylsilyl 
trifluoromethanesulfonate (32.5 μL, 0.180 mmol) to make a 0.12 M solution. Reaction 
solution was collected for a total of 17 min. The crude product was washed with water 
(2 x 2.5 mL), then the water was extracted with DCM (3 x 5 mL). The dried residue was washed 
with hexane (3 x 5 mL) and hexane:Et2O 1:1 (6 x 5 mL) then dried under reduced pressure to 
yield the title compound 221 as an oil (0.1350 g, 90 %, α:β = 1:2); 1H NMR δ H (500 MHz, 
Acetonitrile-d3) 8.56 (2 H, bs, NCHN α and β), 7.48 – 7.20 (m, Harom), 5.03 (1 H, d, J 3.5, H-1 α), 
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4.92 – 4.46 (m), 3.81 (3 H, s, NCH3 β), 3.80 (3 H, s, NCH3 α), 3.86 – 3.46 (m), 3.40 (1 H, dd, J 
8.5, 7.9, H-2 β); 13C NMR δ C (126 MHz, Acetonitrile-d3) 140.04, 139.99, 139.87, 139.71, 
139.58, 139.53, 139.49, 139.45 (4˚ Carom), 137.08 (NCHN α and β), 134.23, 134.19 (4˚ Carom), 
129.69, 129.60, 129.54, 129.50, 129.27, 129.26, 129.21, 129.19, 129.16, 128.90, 128.84, 
128.83, 128.79, 128.78, 128.75, 128.74, 128.72, 128.59, 128.54, 128.50, 128.50, 128.46, 
128.39, 128.36, 128.25 (Carom), 124.96 (NCHCHN), 124.93 (NCHCHN), 123.14 (NCHCHN), 
103.35 (C-1 β), 96.96 (C-1 α), 85.27, 83.08 (C-2 β), 82.56, 81.09, 78.83, 78.77, 75.95, 75.87, 
75.52, 75.44, 75.40, 75.16, 73.79, 73.78, 73.15, 71.53, 71.03, 69.88, 69.82, 69.45, 36.89 
(NCH3), 36.88 (NCH3); 19F NMR δ F (470 MHz, Acetonitrile-d3) -79.18 (-OTf); m/z (ESI-HRMS) 
C46H49N2O6+ ([M – OTf]+) calculated: 725.3585; found 725.3583; IR νmax/cm-1 3148w, 3064w, 
3031w, 2867w, 1574w, 1497, 1454, 1361, 1259s, 1225, 1160, 1070, 1030s, 913w, 826w, 741, 
699, 638, 623. 
3-(3-Methylimidazolium)-propyl 2,3,4-tri-O-benzoyl-6-O-(2,3,4,6-tetra-O-benzyl-D-









 Following the general procedure for I-Tag glycosylations in flow using glycosyl 
acceptor 3-(3-methylimidazolium)-1-propyl 2,3,4-tri-O-benzoyl-β-D-glucopyranoside 
trifluoromethanesulfonate 100 (0.1529 g, 0.200 mmol, 1 eq) and glycosyl donor 2,3,4,6-tetra-
O-benzyl-α-D-glucopyranosyl trichloroacetimidate 62 (0.2740 g, 0.400 mmol, 2.0 eq). 1.0 mL 
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of anhydrous acetonitrile was added to the donor/acceptor vial, resulting in a solution of 
volume 1.20 mL and therefore approximately 0.167 M in acceptor and 0.333 M in donor. To 
the other vial, 1.5 mL of anhydrous acetonitrile was added, followed by trimethylsilyl 
trifluoromethanesulfonate (16.3 μL, 0.090 mmol) to make a 0.06 M solution. Reaction 
solution was collected for a total of 15 min. The crude product was washed with water (3 mL), 
then the water was extracted with DCM (2 x 15 mL). The dried residue was washed with 
Hexane:Et2O 1:1 (3 x 5 mL) then dried under reduced pressure, before being passed through 
a silica plug with DCM:MeOH 93:7, yielding the title compound 222 as a solid (0.1825 g, 86 %, 
α:β = 1:2.5); 1H NMR δ H (500 MHz, Acetonitrile-d3) 8.27 (1 H, s, NCHN β), 8.13 (1 H, s, NCHN 
α), 7.93 – 7.86 (m, Harom), 7.75 (m, Harom), 7.62 – 7.49 (m, Harom), 7.47 – 7.19 (m, Harom), 7.19 – 
7.17 (1 H, m, NCHCHN β), 7.10 (1 H, t, J 1.8, NCHCHN α), 5.86 (m), 5.62 – 5.52 (m), 5.33 (1 H, 
dd, J 9.8, 8.0, H-2 β), 5.23 (1 H, dd, J 9.7, 8.0, H-2 α), 4.99 – 4.94 (m, H-1’ α), 4.92 – 4.87 (m, 
H-1 β, H-1 α), 4.86 – 4.73 (m), 4.72 – 4.65 (m), 4.54 (1 H, d, J 10.9), 4.51 (1 H, d, J 7.8, H-1’ β), 
4.50 – 4.44 (m), 4.39 (1 H, d, J 11.9), 4.34 (1 H, d, J 11.9), 4.22 – 4.15 (m), 4.09 (1 H, dd, J 11.5, 
2.5), 4.06 – 3.95 (m), 3.95 – 3.81 (m), 3.79 – 3.74 (m), 3.76 (3 H, s, NCH3 β), 3.75 (3 H, s, NCH3 
α), 3.72 – 3.43 (m), 3.39 (1 H, dd, J 10.9, 2.0), 3.32 (1 H, dd, J 9.0, 7.8, H-2’ β), 1.92 – 1.86 (m, 
CH2CH2CH2); 13C NMR δ C (126 MHz, Acetonitrile-d3) 166.36, 166.35, 166.11, 166.01, 166.00 
(C=O), 139.85, 139.59, 139.54, 139.46, 139.40, 139.32 (Carom), 136.95 (NCHN β), 136.92 (NCHN 
α), 134.67, 134.66, 134.56, 130.49, 130.44, 130.34, 130.15, 130.14, 130.08, 129.98, 129.95, 
129.87, 129.86, 129.68, 129.59, 129.57, 129.53, 129.30, 129.27, 129.24, 129.22, 129.18, 
129.00, 128.87, 128.77, 128.75, 128.68, 128.57, 128.52, 128.51, 128.49, 128.43 (Carom), 
124.44 (NCHCHN β), 124.32 (NCHCHN α), 123.42 (NCHCHN β), 123.31 (NCHCHN α), 104.54 (C-
1’ β), 101.18 (C-1 β, C-1 α), 97.42 (C-1’ α), 85.15, 82.98, 82.43, 81.13, 78.97, 78.72, 75.99, 
75.87, 75.61, 75.44, 75.37, 75.12, 74.51, 74.49, 74.01, 73.73, 73.66, 73.49, 73.30, 73.04, 
72.97, 71.21, 70.64, 70.30, 69.79, 69.71, 68.81, 67.27, 66.87, 47.99, 47.67, 36.83 (NCH3), 30.36 
(CH2CH2CH2); m/z (ESI-HRMS) C68H69N2O14+ ([M – OTf]+) calculated: 1137.4743; found 
1137.4731; IR νmax/cm-1 3067w, 2940w, 2862, 1730s (C=O), 1601, 1584w, 1496w, 1452, 1362, 
1315, 1257s, 1224, 1153, 1092s, 1068s, 1029s, 853w, 740, 710s, 700, 638s, 622. 
 
 








 Following the general procedure for I-Tag glycosylations in flow using glycosyl 
acceptor 1-(3-hydroxypropyl)-3-methyl-1H-imidazol-3-ium trifluoromethanesulfonate 155 
(0.0348 g, 0.120 mmol, 1 eq) and glycosyl donor 2-O-acetyl-3,4,6-tri-O-benzyl-α-D-
glucopyranosyl trichloroacetimidate 159 (0.1529 g, 0.240 mmol, 2.0 eq). 0.60 mL of 
anhydrous acetonitrile was added to the donor/acceptor vial, resulting in a solution of volume 
0.75 mL and therefore approximately 0.160 M in acceptor and 0.320 M in donor. To the other 
vial, 1.00 mL of anhydrous acetonitrile was added, followed by trimethylsilyl 
trifluoromethanesulfonate (10.9 μL, 0.060 mmol) to make a 0.06 M solution. Reaction 
solution was collected for a total of 10 min. The crude product was washed with water (3 mL), 
then the water was extracted with DCM (2 x 10 mL). The dried residue was washed with 
hexane:Et2O 1:1 three times and hexane:Et2O 1:3 three times then dried under reduced 
pressure to yield the title compound 223 as a single anomer (0.0590 g, 73 %); 1H NMR δ H 
(500 MHz, Chloroform-d) 9.04 (1 H, s, NCHN), 7.38 – 7.22 (14 H, m, Harom), 7.20 (2 H, dd, J 7.4, 
1.9, Harom), 6.89 (1 H, s, NCHCHN), 4.84 – 4.73 (3 H, m, 2 PhCH2, H-2), 4.66 (1 H, d, J 11.3, 
PhCHH), 4.57 (2 H, d, J 10.9, PhCH2), 4.50 (1 H, d, J 11.6, PhCHH), 4.33 (1 H, d, J 8.1, H-1), 4.31 
– 4.26 (2 H, m, OCH2CH2CH2N), 3.80 (3 H, s, NCH3), 3.78 – 3.59 (6 H, m, H-3, H-4, H-6a, H-6b, 
OCH2CH2CH2N), 3.53 – 3.45 (1 H, m, H-5), 2.13 (2 H, d, J 7.4, OCH2CH2CH2N), 1.95 (3 H, s, 
COCH3); 13C NMR δ C (126 MHz, Chloroform-d) 169.98 (C=O), 138.09, 137.94, 137.84 (3 4˚ 
Carom), 137.47 (NCHN), 128.68, 128.64, 128.56, 128.11, 128.09, 128.03, 127.99 (15 Carom), 
123.30 (NCHCHN), 122.79 (NCHCHN), 100.93 (C-1), 82.78, 77.89 (C-3, C-4), 75.47 (PhCH2), 
75.22 (PhCH2), 74.77 (C-5), 73.61 (PhCH2), 73.20 (C-2), 68.84 (C-6), 66.14 (OCH2CH2CH2N), 
47.68 (OCH2CH2CH2N), 36.52 (NCH3), 30.14 (OCH2CH2CH2N), 21.11 (COCH3); m/z (ESI-HRMS) 
C36H43N2O7+ ([M – OTf]+) calculated: 615.3065; found 615.3055; IR νmax/cm-1 2925w, 2868w, 
 6.  Experimental  
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1740 (C=O), 1573w, 1497w, 1454, 1369, 1259s, 1225, 1154, 1088, 1057, 1030s, 915, 834w, 
798w, 747, 700, 638s, 623; [𝜶]𝑫
𝟐𝟓 - 9 [c 0.67, DCM]. 
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